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11 There is at bottom only one genuinely scientific treatment 
for all diseases, and that is to stimulate the phagocytes. 
Stimulate the phagocytes. Drugs are a delusion. 11 
G. B. Shaw (1906) 
The Doctor I s Dilemma, Act I. 
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ABSTRACT 
·A rapid, objective indicator of pyogemc infection would 
be of great value in the practice of clinical medicine. On the 
basis of earlier studies it was claimed that the nitroblue tetrazolium 
( NBT) test might fulfill such a role. In view of the potential 
value of this test, it was reassessed m order to determine its 
diagnostic accuracy and clinical value. The results obtained in 
this study did not conform with those previously published. Elevated 
NBT scores were not diagnostic of pyogenic infection, there was 
a wide overlap of the results of tests performed on patients with 
pyogenic disease, patients with other diseases and normal subjects. 
In addition, there was a significant observer error in the interpretation 
of the slide preparations. The extent of this error was reduced 
with experience, but was still considerable in the hands of 
experienced observers. 
In the NBT test, the dye enters neutrophils by 
phagocytosis of NBT in particulate form, complexed to heparin 
and/or '· fibrinogen. The proportion of neutrophils which phagocytose 
these complexes seems to be related to the severity of illness of 
the patient. As serum from these patients is capable of enhancing 
phagocytosis of complexed dye by normal cells, a humeral factor 
could be responsible for the increased phagocytosis of complexed 
NBT indicated by a positive test. , Of the compounds tested, m 
an m vitro model system designed to simulate the NBT test, 
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a,l_acid glycoprotein, immunoglobulins and endotoxin, in 
concentrations that occur in vivo, enhanced NBT reduction. 
Any one of these compounds, singly or in combination, could 
be responsible for positive NBT tests. 
There was a poor correlation between the results 
of NBT test performed by the method of Park et al ( 1968) on 
blood taken into heparin as anticoagulant, and by the method of 
Gordon et al (1973) with EDTA as anticoagulant. This suggests 
that phagocytosis of the dye in the two tests might be modified by 
different factors. In the test on blood with EDT A as anticoagulant 
there was good evidence for the enhancement of NBT reduction 
by a humeral factor and the NBT score correlated very well with 
the serum concentration of a:1-acid glycoprotein which could possibl-y: 
contribute to the positive results of NBT tests performed by this 
method. When heparin was used as anticoagulant, the 
evidence suggesting the enhancement of NBT reduction by a 
humeral factor was less clear, and the correlation between the 
NBT score and serum concentration'· of al-acid glycoprotein 
was less significant. This discrepancy couid resu lt from the fact 
that heparin itself enhances NBT reduction, or that he parin, 
which is highly acidic, might m a sk any opsonising effe ct of 
ci-acid glycoprotein which is de pendent upon its a ci dic nature. 
The physiological roles of hepa rin a nd al-acid 
glycoprotein in man, and fetuin in some a nimals, are unknown. 
They might act as non-specific opsonms. Heparin might be 
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released as a result of a focal insult to act as a local opsonm, 
whereas the acid glycoproteins are produced predominantly at 
times of stress and could function as a non- specific circulating 
opsomsmg system, for the phagocytosis of inert particles or 
autologous debris, or of invading microorganisms m the early 
stages of infection, while a specific immunological counter 
attack is in preparation. 
The dose response of phagocytosis by neutrophils 
from the blood of normal subjects to endotoxin stimulation can be. 
used as a standard for comparison with the dose response of 
other neutrophils. In this system it was demonstrated that 
neutrophils from patients with Crohn 's disease, diabetes mellitus, 
geriatric patients, patients receiving therapy with sodium auro-
thiomalate and prednisone, and the majority of patients with 
hypogammaglobulinaemia, phagocytose complexed NBT and reduce 
the dye normally. It would also appear extremely unlikely that 
reports that immunoglobulins or complement are obligatory for 
dye reduction, are correct. Howe ver, it was demonstrated 
that immature bone marrow neutrophils, and neutrophils previously 
exposed to immune complexes, do not demonstrate the normal 
increment of NBT reduction after e ndotoxin stimulation. It was 
demonstrated in the quantitative NBT test that immature neutrophils 
have a normal capacity to reduce the dye, so the abnormally low 
reduction in a stimu!ated NBT test is almost certainly a result 
of diminished phagocytosis. False-negative NBT tests in severely 
ill patients probably result from the replacement of normal 
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circulating neutrophils by a pool of less mature neutrophils, or 
much less commonly, as a result of circulating immune complexes. 
The NB T test does not seem to have much wide 
application as a diagnostic test for infection, however, it may 
prove to be very useful in assessing the maturity of circulating 
neutrophils and as a screening test for the diagnosis of, and for 
monitoring the response to therapy of, patients with immune 
complex disease. 
The quantitative NBT test is different to the NBT 
test. It is performed on leukocytes suspended in a protein free 
solution rather than in whole blood. It is useful in the diagnosis 
of chronic granulomatous disease of childhood ( C GDC) and in 
assessing whether the failure of NBT reduction by neutrophils 
in the NBT test results from the failure of the phagocytosis of · 
complexed NBT or whether the cell has an abnormally low 
capacity to reduce the dye. Reduction of the dye in this test 
system is closely related to the release of LOH, a cytoplasmic 
marker enzyme, from the cells. This suggests that the dye is 
reduced by compoundsr released from the cells as a result of 
the toxicity of NBT, which is enhanced by endotoxin and latex, 
on the outer membrane of the cell. The actual enzymes a nd 
mechanisms responsible for the bactericidal activity of neutrophils, 
and for reduction of dye, are still unclear. The combined 
failure of both these processes in neutrophils of patients with 
CGDC or neutrophiis of normal subjects after exposure to very 
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high concentrations of hydrocortisone, suggests that they might 
• 
share a common mechanism. Asco~bic acid could play an 
important role in the transport of electrons from the HMP shunt 
to superoxides, or other free radicals, which could be rAsponsible 
for both the final step of dye reduction and microbial death. 
C GDC 1s characterised by chronic infection 
resultant upon defective leukocyte microbicidal activity. Liposomes 
might be useful vehicles for the transport of compounds into 
neutrophils arid macrophages. They could be used, initially on 
an experimental basis in vitro, to establish whether or not 
entrapped antibiotics, ascorbic acid, various HzOz generating 
systems, or enzyme systems enhance ceHular bactericidal 
capacity. The tissue distribution of these p a rticle s after intra-
venous injection was traced by using entrappe d NBT as a 
marker, which indicated not only the distr ibution of these particles, 
but which also gave some idea of the rate of liposomal : 
degradation. The distribution of these lipid spherule s to 
phagocytic cells' of the; RES suggests that the y might be useful 
in the in vivo treatment of C GDC with microbic idal s yste ms 
demonstrated to be effective in vitro. They may a lso be of use 
in the treatment of chronic infective, m e tabol ic and neoplas tic 
conditions involving phagocytic cells. 
In vitro, the selective binding of r e d uced NB T to 
lipoproteins was discovered by investigating the obser vation that 




m plasma. This property allows the use of reduced NBT as 
a pre stain m the electrophoretic separation of lipoproteins. It 
is specific, has a vivid blue colour, does not require an organic 
solvent and does not seem to r:hange the immune reactivity of 
lipoproteins. The electrophoretic separation of lipoproteins, 
prestained with reduced NBT, on polyacrylamide, was found to 
be simple, accurate and reproducible. The classical lipoprotein 
bands were demonstrated and in addition several slow a bands 
were observed in serum from normal subjects and an inter-/3 
band, possibly the Sf 12-20 fraction of the LDL, .was seen in 
the serum of some normal and hyperlipoproteinaemic subjects. 
If it is shown that NBT uniformly stains lipoproteins, rather 
than being selectively concentrated in any particular lipid, and 
that densitometry of electrophoretic strips accurately reflects the 
lipoprotein concentration, this technique could be a very useful, 
simple, cheap and rapid method for lipoprotein quantitation. 
8 
ACKNuWLEDGEMENTS 
I would like to express my gratitude and appreciation 
to the many people who have made these studies possible: 
To my wife Barbara and our daughters, Terry· and 
Jessica, for their constant encouragement and tolerance. 
To Dr. A. J. Levi for his continued encouragement, 
for providing research facilities and access to the patients at 
Northwick Park Hospital, and for assistance in preparation of 
the manuscript. 
To The Vera Levi Medical Research Memorial Fund 
and the Medical Research Council for financial support. 
To Ors. A. Tavill, P. Lachman, D. Brown, 
A. S. McFarlane, Dr. D .A. Tyrell and the staff of the Common 
Cold Research Centre, Salisbury, and Professor J. Soothill for 
helpful discussion and gifts of valuable blood, serum and protein 
samples. 
To Ors. P. Davis, A.C. Allison, G.L. Asherson, 
T. Andrews, M. Denman, D. Webster and A. Howell for 
encouragement, guidance and assistance in preparation of the 
manuscript. 
To Ors. H. Minchin Clarke: B. Lewis, A. Chait 
and A. Pearson for assistance with studies on lipoprote ins, a nd 
to Dr. G. Gregoriadis for helpful discussion on the studies 
described in Chapter 5. 
9 
To Dr. N. Veall for assistance with the use of 
radioisotopes. 
To Mr. M. Healy for the statistical analysis described 
m Chapter 2. 
To Dr. E . Wills and Mrs. J . Richmond for the 
electron microscopy. 
To Miss D. Putman and Miss J. Rigby for their 
technical assistance with some of the studies described in Chapters 
2 and 4. 
To Dr. I. Chanarin, Mr. T. Hearde, Mr. D. Waters 
and Mr. J. Cairns and other members of the Department of 
Haematology at Northwick Park Hospital, for their continued 
assistance throughout these studies. 
To the Department of Medical lllustrati.ons of Northwick 
Park Hospital for preparation of the figures. 
To Janet Thompson and Christine Boulton for the final 
typing of the manuscript, and to all the other members of 
Northwick Park Hospital and the Clinical Research Centre, for 
making this institution such a happy and exciting place in which to 
work. 
The technical work in this thesis was performed by 







CHAPTER I. The introduction of the NBT test into 
clinical medicine. 







test in the diagnosis of bacterial infection. 
Introduction 
Methods 
2.2.l. Patients and controls 
2.2.2. NBT tests 
2.2.3. Counting 
2.2.4. Other investigations 
2.2.5. Statistical analysis 
Results · 
2.3.l. Counting error 
Summary of results 
G eneral discussion on the value of the NBT test 






















CHAPTER 3. The mechanisms involved m the reduction 
of NBT by neutrophiis 
3. I. I. Section I. The entry of NBT into neutrophils m 
the NBT test. 





a. Preparation of cells 87 
b. Suspending media 88 
c. Neutrophils stimulation 88 
d. Incubation with NBT 89 
e. Precipitation of fibrinogen by NBT 89 
f. Precipitation of heparin by NBT 90 
g. Relationship between the concentration of NBT, 90 
the precipitation of fibrinogen and heparin, and 
the percentage of positive neutrophils. 
h. Effect of centrifugation of the NBT solution on 92 
1 • 
J. 
the reduction of NBT by neutrophils 
Substitution of NBT precipitates of heparin and 
plasma proteins for NBT in solution. 
Effect of ficoll on the phagocytosis of latex 
particles and on the reduction of NBT by 
neutrophils. 
k. Electron microscopy of leukocytes after 











a. Reduction of NB T by stimulated neut~ophils 94 
suspended in varic..us media. 
b. Precipitation of fibrinogen by NBT. 96 
c. Precipitation of heparin by NBT. 96 
d. Demonstration of NBT in the precipitates of 98 
fibrinogen and heparin. 
e. Concentration dependent precipitation of fibrinogen 98 
and heparin, and reduction of NB T by stimulated 
neutrophils. 
f. Effects of centrifugation of the NBT solution. 98 
g. Substitution of NBT precipitates of heparin and 99 
plasma proteins for NBT in solution. 
h. Effect of ficoll on the phagocytosis of latex 99 
particles and the reduction of NBT by neutrophils. 
Electron 
. . 
studies of leukocytes after IOI l • m1croscop1c 
exposure to NBT. 
Discussion 103 
Summary of Section I. • 113 
Section 2. Studies on some of the factors which may 114 
e nhance NBT reduction by neutrophils in the NBT 
test. 
3. 2 . 1. Introduction 114 
13 
Page 
3 . 2. 2 . Methods U6 
a. The effect of endotoxin on NBT reduction by U6 
the neutrophils of normal subjects and patient~ 
with a variety of conditions. 
b. The effect of varymg concentrations of heparin ll7 
on NBT reduction by neutrophils. 
c. The effect of various compounds on NBT ll7 
reduction by neutrophils. 
3. 2. 3. Results 120 
a. The effects of endotoxin on NB T reduction by 122 
neutrophils of normal subjects and patients 
with various diseases. 
b. The effect of varying concentrations of heparin 129 
on NBT reduction by neutrophils. 
c. The effect of some other substances on NB T 131 
r e duction by neutrophils. 
3. 2. 4. Discussion 135 
a. The effect of endotoxin, heparin an<l other 136 
compounds on NBT reduction by neutrophils 
1. Effect of endotoxin 
11. Effect of heparin 






b. In vivo factors which might be responsible for 141 
c. 
enhanced NBT reduction m the NBT test. 
The physiological role of heparin, a 1-acid 
glycoprotein and fetuin 
1. Opsonins 
11. Heparin 
m. An hypothesis as to the role of al-acid 
glycoprotein, fetuin, heparin and other 
compounds as promob::rs of phagocytosis. 
3. 2. 5. Summary of Section 2. 
3.3. Section 3. Possible causes of false negative NBT 
tests and studies on the effect of heterologus serum 
on NBT reduction by normal neutrophils 
3. 3. I. Introduction 










a. Exposure of autologous blood and bone marrow 158 
to various compounds. 
b. The effect of immune complexes on NBT 
reduction by human neutrophils. 
c. Animal experiments 
d. The effect of heterologous serum on the 









a. Exposure of autologous blood and bone marrow 
to various compounds 
b. The effect of immune complexes on NBT 
reduction by neutrophils 
c. Animal experiments 
d. The effect of heterologous sera on NBT 
reduction by neutrophils 
3. 3. 5. Discussion 
3. 3. 6. Summary of Section 3 
3.4. Section 4. Mechanisms involved m the reduction of 
NBT by neutrophils 
3. 4. I. Introduction 










a. The effect of saline, endotoxin, latex and heparin 190 
on lactate 1ehydrogenase release, in the presence 
and absence of NBT, and on the quantitative 
reduction of NBT by neutrophils. 
b. LOH release and NBT reduction by peripheral 194 
blood neutrophils of patients with C GDC and a 
patient with hypogammaglobulinaemia, and by 
bone marrow neutrophils. 
c. The effect of endotoxin and PVP on NBT reduction 195 






of Section 4 
The association of reduced NBT with 
serum Jipoproteins and the use of NBT 
as a lipoprotein stain. 
4. I. Introduction 
4. 2. Methods 











a. lmmunoelectrophoresis of NBT prestained and 225 
unstained serum. 
b. Polyacrylamide disc electrophoresis. 226 
c. Cellulose acetate and agarose electrophoresis. 227 
4. 2. 2. Further studies with polyacrylamide disc 
electrophoresis 
227 
a. Methods of prestaining and sample application. 227 
b. The lipoprotein pattern obtained in the serum of 227 
normal and hyperlipidaemic patients after 
prestaining with NBT. 
c. Characterisation of the lipoprotein bands obtained 228 




4.3. ResuUs 230 
4. 3. I. Identification of the serum proteins that bind formazan 230 
a. lmmunoelectrophoresis 230 
b. Acrylamide disc electrophoresis 233 
c. Cellulose acetate ar:d agarose gel electrophoresis 233 
4. 3. 2. Polyacrylamide disc electrophoresis 235 
a. Identification of the optimal prestaining conditions. 235 
b. The lipoprotein pattern of normal and hyper lipid- 239 














5. 2. I. Preparation of liposomes 
5. 2. 2. Entrapment of the dye within liposomes 
5. 2. 3. Animal experiments 
a. Light microscopy 
b. Electron microscopy 
5. 3. Results 



















CHAPTER 6. Conclusions 
SOURCE OF MATERIALS 
INDEX TO FIGURES 
BIBLIOGRAPHY 
INDEX TO .APPENDICES 
APPENDICES 










11As often happens, unraveling a pathological 
situation leads to better comprehension of the normal. 
The study of chronic granulomatous disease of 
childhood ( C GD) , sometimes called 1fatal granulomatous 
disease' , supports this truism. It has certainly 
spurred work on the whole question of how leukocytes -
polymorphonuc!ear leukocytes in particular - ingest 
and kill bacteria. However, only wishful thinking 
could permit the conclusion that the critical questions 
have indeed been properly answered". 
20 
Manfred L. Karnovsky, 197 3. 
I.I. The introduction of the NBT test into clinical medicine 
Janeway and colleagues (Janeway et al, 1954) first 
observed that certain children had the same susceptibility to infection 
as patients with agammaglobulinaemia, despite having elevated levels 
of circulating immunoglobulins. 11 Fatal granulomatous disease" was 
defined as a distinct clinical entity by Berendes, Bridges and Good 
( Berendes et al, 1957, Bridges et al, 1959) , and this condition was 
later found to be associated with a decrease in intraleukocytic 
microbicidal activity ( Ouie et al, 1967). 
It was known that the phagocytic process of normal 
leukocytes is associated with a burst of metabolic activity (Beck, 
1968, Karnovsky, 1968) in which glucose and oxygen consumption 
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Diagrammatic representation of the 'burst of metabolic activity 1 
associated with phagocytosis by neutrophils. Glucose-6-phosphate 
production I, H. M. P. shunt activity 2, NADPH production 3, 
oxygen consumption 4, H202 production S, and bacterial 
iodination 6, are all increased. 
The microbicidal activity of these cells appears to be related to the 
combination of reducing equivalents with oxygen, which may be 
promoted_ by NADPH-oxidase O or NADH-oxidase * ( in conjuction 
with a NAD+-NADPH transhydrogenase ) enzymes. 
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(Iyer et al, 1961, Paul and Sbarra, 1968) and lactate production 
(Sbarra and Karnovsky, 1959, Cohn and Morse, 1960) are increased. 
A large proportion of glucose catabolism, as measured by 
14co
2 
14 production from glucose-I- C, occurs through the hexose mono-
phosFhate shunt ( HMP shunt) ( Evans and Karnovsky, 1962, 
Zatti et al, 1965). The three key metabolic changes that occur 
as a result of phagocytosis are the increased oxygen consumption, 




production (Fig. I. I) . A discussion 
of other metabolic changes associated with phagocytosi~ is included 
m the review article by Klebanoff (1971) • . 
The phagocytosis induces stimulation of O 
2 
consumption, 




formation was found to be greatly depressed in leukocytes of patients 
with chronic granulomatous disease of childhood ( CGDC) ( Holmes 
et al, 1967, Baehner and Nathan, 1967). The bactericidal defect 





production. Cells of these patients are capable of killing 
organisms such as streptococci, pneumococci ( Mandell and Hook, 





, but they have an impaired ability to kill bacteria 
like Staphylococcus aureus and certain low-grade gram-negative 




. This bactericidal defect 
can be partially reversed by redox dyes such as methylene blue 




11 · (Lehrer, 1969), or by 
the introdvction of a H202 generating system in the form of the 
enzy:ne glucose oxidase, into the cell ( Baehner et al, 1970?, 
Johnson and Baehner, 1970). HzOz formed by one organism 
ma)' be utilised for the destruction of a second non-HzOz . 
generating organism ( Klebanoff and Smith, 1970) . 
The importance of H 2o 2 in the bactericial mechanism 
was obvious, but the mechanism by which it results in cell death 
was uncertain. Klebanoff ( 1968) showed that myeloperoxidase, 
an enzyme present in high concentrations m the primary granules 
of the neutrophil, which is released into the phagocytic vacuole 
during granule lysis, has potent bactericidal activity in the presence 
of Hz Oz and an amomc cofactor, particularly a halide (Klebanoff, 
1971) . Iodination of bacteria occurs both in a cell free system 
containing myelopercxidase, HzOz and iodide, and in the intact 
leukocyte following phagocytosis, and a correlation was found to 
exist between iodination and bacterial death (Klebanoff, 1967). 
Iodination by intact cells is greatly depressed or absent in 
leukocytes devoid of myeloperoxidase er leukocytes of patients 
w ith C GDC, and it has been suggested that iodination of cells, 
c ataly~ed by myeloperoxidase, may be the mechanism by which 
Hz Oz exerts its bactericial effect (Klebanoff, 1971) . However, 
only one of five reported patients with an absolute myeloperoxidase 
deficiency had an increased susceptibility to infection, which suggests 
that myeloperoxidase does not play an essential role in the 
b acte ricidal mechanism. 
23 




is the only clearly 
documented biochemical derangement . that results in decreased 
bactericidal activity. Therefore, by studying the condition of 
CGDC in which the µ-oduction of H 2o 2 is defective, it was hoped 
that the pathway of electrons from the HMP shunt to oxygen would 
be established. 
24 
Two key facts related to this pathway are that; one 
of the early metabolic changes in the phagocytosing granulocyte is the 
oxidation of reduced nicotinamide adenine dinucleotide phosphate ( NADPH) 
( Zatti and Rossi, 1965) and that the phagocytosis-induced respiratory 
burst is insensitive to inhibition by lmM cyanide ( Sbarra and 
Karnovsky, 1959, Rossi and Zatti, 1964). Iyer and Quastel (1963) 
found an enzyme in guinea pig leukocyte homogenates which catalysed 
the oxidation of NADP H, and to a lesser extent reduced nicotinamide 
adenine dinucleotide ( NADH), by 02 with the formation of H202, 
but this enzyme and peroxidases, which can also catalyse the 
oxidation of NADP H (Akazawa and Conn, 1958) are partially 
inhibited by lmM cyanide, and the remaining activity is considered to 
be inadequate to account for the respiratory burst ( Baehner et al, 1970b). 
Karnovsky and co-workers ( Evans and Karnovsky, 
1961, Cagan and Kamovsky, 1964, Baehner et al,I970b,Karnovksy, 
I 97 3) proposed an alternative enzyme, NAO H oxidase as the 
' 
primary oxidase. It is distributed equally between lysosomes and 
the cytoplasm ( Stossel et al, 1971) , is insensitive to lmM cyanide, 
and its · activity, which is increased by phagocytosis, is considered 
25 
adequate to account for the respiratory burst ( Baehr.zr et al, 197Gb). 
Baehner and Karnovsky ( 1968) demonstrated defective activity of 
this enzyme in patients with C CDC, but this obsP-rvation has not 
been supported by other workers ( Holmes - Gray and Good, 1971). 
If NADH oxidase is the primary oxidase responsible 
for transport of electrons to oxygen, NADH must be rapidly 
regenerated as there is no change in the NAD+/NADH ratio with 
phagocytosis ( Zatti and Rossi, 1965, Selvaraj and Sbarra, 1967). 
A NAD+-NADPH transhydrogenase enzyme has been detected m 
human leukocytes (Evans and Kaplan, 1966), but guinea ptg 
leukocytes, which have a greater respiratory burst than human 
leukocytes, had minimal activity ( Baehner et al, 1970b). A NADPH-
linked lactate dehydrogenase has been suggested as the coupling 
enzyme ( Evans and Karnovsky, 1961). Its activity has been 
demonstrated m guinea pig, but not in human leukocytes ( Baehner 
et al, 1970bl A dehydroascorbate-NADPH reductase was also 
detected in leukocyte granules, but its activity under the experiment 
conditions used, was considered insufficient to account for the 
observed increase m HMP shunt activity ( Baehner et al, 1970b). 
It is therefore known that during a burst of metabolic 
activity, associated with phagocytosis, there is increased activity 
of the HMP shunt culminating in the production of HzOz which 
plays an important bactericidal role. This process is deranged 
in the condition of CGDC. The normal pathway of electrons from 
NADP H, produced by the HMP shunt, to oxygen, and the basic 


















Diagrammatic representation of the molecular structure of NBT (above) . 
The site at which reduction occurs is also shown (be low ) . 
NBT was first synthesised in 1956 for use as a 
histochemical indicator of dehydrogenase activity ( Nachlas et al, 
1957). It is a p-nitrophenyl substituted ditetrazole (Fig. I. 2) 
which has a strong affinity for electrons. When reduced it 
changes from a light yellow, water soluble compound to a dark 
blue, water insoluble, diformazan (formazan). 
Baehner and Nathan (1967) observed that NBT 
was reduced by neutrophils of normal subjects suspended in a 
balanced salt solution, that reduction was enhanced by phagocytosis 
and that neutr~phils from patients with C GDC reduced the dye at 
an abnormally slow rate in the presence or absence of a phagocytic 
stimulus. The cells and NBT were then mixed and incubated under 
standard conditions in the presence of lmM pdassium cyanide, and 
NBT reduction measured spectrophotometrically after extraction 
with pyridine. By usmg this 'quantitative NBT test r a clear 
distinction could be made between the amount of NBT reduction 
by neutrophils of normal subjects and those from patients with 
CGDC. Whereas the former exhibited a fourfold increase in 
NBT reduction in the presence of latex particles as a phagocytic 
stimulus, NBT reduction by neutrophils of patients with CGDC was 
27 
not increased under similar circumstances , ( Baehner and Nathan, 1968) • 
The quantitative NBT test is the standard procedure 
for the definitive diagnosis of C GDC. It is, however, time 
consuming and intricate and requires cells from a relatively large 




Light micrograph of neutrophils after adhesion to glass slides and exposure 
to NBT by the method of Gifford and Malawista, showing NBT reduction 
by 'formazan cells' ( F), but not by other neutrophils 
Safronin xl,200 
a simple micromethod of exposing cells to NBT, for use as a 
screening test for CGDC. In this test, a drop of blood is 
incubated on a glass slide, the neutrophils are isolated by 
washing off the adherent blood clot and then covered with a 
solution of NBT. After further incubation the NBT is washed 
off and the cells counter stained. Approximately half the adherent 
neutrophils from normal subjects are blue in colour, amorphous 
and swollen and appear degenerate with apparent disintegration of 
their nuclei (Fig. I. 3). These cells have been called 1formazan 
cells' . These changes are not observed in neuti"ophils of patients 
with CGDC. 
Enhanced NBT reduction by neutrophils of normal 
subjec.ts exposed to a phagocytic stimulus, which is known to be 
associated with a burst of metabolic activity, and failure of 
enhanced reduction by neutrophils of patients with CGDC in which 
this burst of metabolic activity does not occur, led Park et al 
( 1968) to postulate that neutrophils of patients with pyogenic 
infection, exposed to the phagocytic stimulus of the infecting 
organism, would reduce the dye to a greater extent than normal, 
unstimulated, neutrophils. In this test, hence referred to as 
the NBT test , blood, taken into heparin as anticoagulant, 1s 
mixed with an equal volume of a O. 1% solution of NBT in phosphate 
buffered saline. After incubation for 15 minutes at 37 °C and a 
further 15 minutes at room temperature, slide preparations are 
29 
I 
made, counter stained, and a count made of the percentage of neutrophils 
FIGURE 1.4. 
Light micrograph of a typical NBT te st slide p r eparation made by the 
method of Park et al (1968) (heparin as anticoagulant). Neutrophils 
are aggre gated around amorphous mater ial and two of the n e utrophils 
contain dense, blue -black formazan d e posits (arrows) . 
Leishmant"s xZ,000 
containing descrete deposits of formazan ( Fig. I. 4. ) • The 
percentage of neutrophils containing . formazan deposits is referred 
to as the NBT score. By these methods, Park et al ( 1968) 
observed a clear distinction between the high NBT score from 
blood of patients with pyogenic infection, and the low NB T score 
from the blood of normal subjects and patients with non-pyogenic 
disease. 
The value of the test as a diagnostic aid in 
clinical medicine was given strong support by further studies on 
both children and adults ( Matula and Paterson, 1971a, Feigin et al, 
1971. Humbert et al, 1971, Sobel et al, 197 3) and by=teading 
articles in major medical journals (Park, 1971, Feigin, 1971, 
Lancet, 1971) . These encouraging reports, and the simple 
techniques involved_ ( allowing its application by even the most 
modestly equipped laboratory), were probably responsible for the 
intense worldwide interest that subsequently developed in the 
31 
NBT test. Within a single eighteen month period (1972-mid 1973), 
twenty one letters relating to the test appeared in the correspondence 
columns of 1The Lancet' alone. 
An important technical difficulty is the tendency of 
neutrophils to clump after incubation with NBT (Graham, 197 3, 
Neuwirtova and Setkova, 1973). Close contact and superimposition · 
of clumped neutrophils and deposits of formazan complicate the 
identifica tion and evaluation of individual cells, while a reciprocal 
decrease in the number of easily identified, unclumped neutrophils 
32 
makes counting both laborious and time consuming. One method 
of facilitating counting 1s neutrophil concentration by centrifugation, 
and this ·has been employed both before (Will and Grauman, 197 3, 
Gordon et al, 1973) and after (Strukelj and Zemva, 1973) incubation 
with NBT. Clumping can be prevented by the use of ethylenediamine 
tetra-acetate ( EDT A) as anticoagulant instead of heparin, but this 
decreases the proportion of neutrophils reducing the dye, in infected 
patients, or after in vitro endotoxin stimulation (Park and Good, 1970, 
von Anner et· al, 1971, Sobel et al, 1973). Gordon et al (1973) 
showed that the addition of the sucrose polymer 1ficoll I to the 
incubation mixture prevented both this loss of sensitivity and clumping 
of cells, while maintaining cellular morphology. It thus appeared that 
a very powerful tool had been developed for the diagnosis of pyogenic 
infection and that a major technical difficulty in its application had 
been circumvented. 
A test of this kind would have tremendous clinical 
application. The body has a fairly non-specific response to disease 
of diverse aetiology, locally in the form of inflammation, and 
generally, as evidenced by fever, leukocytosis and changes in 
humeral factors. Specific therapeutic manoe uvres depend upon 
accurate diagnosis of the aetiology of the disease. Pyogenic 
bacteria are generally susceptible to therapy with antibiotics, but 
conventional methods for differ01tiating bacterial infection from other 
acute diseases are unsatisfactory. When the pathological lesion, 
or products thereof, are directly accessible, microscopy of 
specimens may reveal the causal organism; however, under other 
circumstances, diagnosis depends upon culturing the organism, or 
the demonstration of a specific antibody response, both of which 
are time consuming. In general, the initial diagnosis of bacterial 
infection depends upon the recognition by the clinician of a clinical 
syndrome, aided by helpful but generally non-specific investigations 
such as radiology and examination of the peripheral blood, which 
produce results early in the course of the disease. In severely 
ill patients, therapy is then usually commenced with antibiotics 
likely to be effective against the probable causal organism. The 
diagnosis arid treatment of bacterial infection in the early stages of 
the disease process is very subjective, and its success depends 
to a large extent upon the acumen of the clinician. 
There is great need for a rapid, simple, accurate, 
objective indicator oi bacterial infection. It would have wide 
application in clinical medicine. If acute pyogemc infection could 
be accurately distinguished from other diseases, antibiotic therapy 
could be instituted in acutely ill patients while at the same time 
protecting patients with non-pyogenic infective disease from side 
effects of this therapy ( Brumfitt, 1970) . It would give direction 
to further investigation, it would simplify the identification of infective 
complications of non-infective diseases, in which the clinical . picture 
is obscured by symptoms and signs attributable to the primary 
pathology, or drug therapy thereof, and would allow pati e nts at 
special ri~k of infection to be more closely monitored. 
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Other tests have been proposed for this purpose. 
Leukocyte alkaline phosphatase activity was found to be elevated in 
patients with bacterial infection (Wachstein, 1946) but this has since 
be.en shown to be a non-specific effect ( Valentine and Beck, 1951, 
Beisel, 1967) . 
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The gelationof lysates of amoeb9cytes of the horseshoe 
crab, limulus polyphemus, has been proposed as a highly sensitive 
and specific bioassay for endotoxin, which is useful in the diagnosis 
of systemic i~fections caused by gram-negative bacilli ( Levin et al, 
1970). However, this test was found to be relatively insensitive 
and non-specific when reassessed by Stumacher et al ( 197 3). 
In view of; the great clinical value of a simple 
diagnostic test of pyogenic infection; the fact that the NBT test is 
the only test of this kind that has been found to be of value ( Park 
et al, 1968, Matula and Paterson, 1971a, Feigin et al, 1971 . , 
Humbert et al, 1971, Sobel et al, 1973, Gordon et al, 1973); 
reports of conditions resulting in false-negative and false-positive 
results (Table::; 2. I and 2. 2) ; the absence of any study in which a 
direct comparison has been made between the results of tests 
performed on blood anticoagulated with heparin ( Park et al, 1968) or 
with EDT A ( Gordon et al, 197 3) , the initial purpose of the studies 
in this thesis was to re-evaluate the clinical application and diagnostic 
accuracy of the NBT test, and to compare the results of tests 
performed on the same blood sample anticoagulated either with 
heparin or with EDT A. Further studies were conducted to 
determine the mechanisms of entry of the dye into neutrophil s and 
to examine factors which might be responsible for positive and 
for false-negative test results. During the course of these studies 
it was observed that reduced NBT is not confined to the cellular 
elements of blood, but also occurs in solution in the plasma. As 
reduced NBT is insoluble in water, and binds to cellular protein 
( Nachlas et al, 1957), ;studies were then undertaken to determine 
whether or not this reduced NBT was maintained in solution by 
binding to plasma proteins. The discovery that reduced NBT was 
I 
selectively bound to lipoproteins led to further studies to determine 
the value of this compound as a lipoprotein stain. Finally, the 
use of liposomes as a vehicle for the transport of therapeutic 
agents into cells was proposed as a possible new approach to 
the treatment of patients with CGDC. The anatomical destination 
of these particles after intravenous administration is unknown and 
was studied by using entrapped NBT as a histochemical marker. 
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CHAPTER 2 
A re evaluation of the value of the NBT test m the diagnosis of 
bacterial infection 
2. I. INTRODUCTION 
The Nitroblue Tetrazolium ( NBT) test was 
developed m 1968 by Park et al (1968) as a non-specific in vitro 
diagnostic test for bacterial infection. In this test, blood anti-
. coagulated with heparin ( 7 5- 100 i. u. /ml) 1s incubated with a 
dilute solution of NBT and a count is made of the percentage of 
neutrophils containing intracytoplasmic deposits of dark blue 
formazan, the reduced product of NBT. In patients with bacterial 
or fungal infections the percentage of neutrophils containing formazan, 
called NBT -positive cells, was greater than 10%; in healthy controls 
and patients w ith non-pyogenic diseases the pe rcentage of NBT -
positive cells was IO% or less. Similar findi ngs were recorded m 
children ( Feigin et al, 1971 , Humbert et al, 1971 ) and adults 
(Matula and Paterson, 1971a, Freeman and King, 1972a). 
Occasional false-neg a tive results were attributed to 
an inability of neutrophils to respond to the st im ulus of infection 
( Park and Good, 1970). An in vitro s t imu lation test using 
Escherichia coli endotoxin, w a s d e v e loped ( Park and Good, 1970) 
to indicate the ability of ne utrophils to respond to stimulation, so 
distinguishing be tween true and fal s e-ne gative results. 
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TABLE 2.1. 
Conditions in which inappropriately normal or 















Phenylbutazone and salicylate 
therapy 
Premature infants (infected) 
Sickle cell disease 
Streptococcal pharyngitis 
Systemic bacterial infection , 
Systemic lupus erythematosus 
AUTHORS 
Ridgway and Johnson 1973 
Rubenstein and Pelet 1973 
Freeman et al 197 3a 
Hawkins 197 3 
Drysdale 1972 
Esposito ar.d De Lalla 1972 
Park et al 1968 
Park 1971 
Miller and Kaplan 1970 
Matula and Paterson 1971 b 







C occhi et al 1969 
P ark 1971 
R andall et al 1973 
Ng et a l 1972 
Hawkins 197 3 
Dom 'CS 1972 
Wenge r and Bole 197 3 
37 
TABLE 2.2. 
Conditions other than bacterial infection 1 n which 
positive NBT tests have been reported: 
CONDITION 
Chediak- Higashi Syndrome 




















Grush and Mauer 1969 
Park et al 1968 
Matula and Paterson 1971a 
Humbert et al 1971 
Elgefors and Olling 1972 
He llum and Solberg 1973a 
C atovsky 1971 
v on Anner et al 1971 
Soonattrakul and Anderson 1973 
Matula and Paterson 1971a 
Anderson 1971 
Chretien and Garagusi 1971 
Freeman and King 1972c 
von Anner et al 1971 
Ng et al 1972 
Lauter et al 197 3 
Park et al 1969 
Cocchi et al 1971a 
Humbert et al 1970 
Douwes 1972 
Ashburn et al 1973 
Hellum and Solberg 1973a 
Norden and Reese 1972 
Hum bert et al 1971 
Douwes 1972 
Chre tien and Garagusi 1971 
A shburn et al 1973 
Drys dale 1972 
Goi hrnan-Yahr e t al 1973 
v·o n A nner et al 1971 
/ 
Gru s h and Ma ue r 1969 
Kitani et al 1972 
Humbe rt et al 1971 
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Neutrophil clumping may complicate the identification 
and counting of individual cells and 1s a major technical difficulty 
of the test of Park et al. (1966). Gordon et al. (197 3) reported 
that cell clumping could be inhibited by the use of EDTA instead 
of he par in as anticoagulant, and that the loss of sensitivity of the 
test that results from ·the use of this agent ( Park and Good, 1970), 
was prevented by the addition of the sucrose polymere, ficoll, to 
the incubation mixture. It thus appeared that the NBT test was 
a simple, rapid and accurate method of distinguishing pyogemc 
infection from other acute diseases, and that a major technical 
difficulty had been eradicated. 
The test was re-evaluated m this study because of 
the important potential clinical application of a test of this kind, and 
because reports of false-negative and false-positive test results · 
{ Tables 2. l and 2. 2) cast doubt upon its specificity and accuracy. 
Although the methods of Park et al and Gordon et al, which use _ 
heparin and EDTA as anticoagulant respectively, were independently 
reported as being of diagnos tic value, and had been assumed to 
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have the same basic mech anis m (.Gordon et al, 197 3) , they had not been 
directly compared. 
A pros pective study was initiated to: re-evaluate the 
role of the NBT test as a usefu l indicator of pyogenic infection 
using modifications of the methods of both Park et al (1968) and 
Gordon et al ( 197 3) ; to c ompare the r esults obtained by the two 
methods; to investiga te the individ ual and interobse rve~ error m 
the quantitation of NBT reduction in blood smears, a:1d to compare 
NBT reduction with the total white blood cell count (WBC), 
neutrophil count, a shift to the left of the myeloid series of white 
blood cells, the presence of to:--:ic granulations in the cytoplasm of 
neutrophils, the blood platelet concentration, the erythrocyte 
sedimentation rate (ES R) , and the serum concentration of 
C-reactive protein ( C RP) and a 1-acid glycoprotein. 
2.2. METHODS 
Solubilisation of NBT 
A 0.2% solution of NBT in 0.15 M NaCl was made 
by the addition of IOO mg of solid NBT to 50 ml of O .15 M NaCl 
in a conical flask which was partially immersed in hot water 
(±so°C), the mixture of NBT was mixed with a magnetic stirrer 
for 30 minutes and then filtered through a Millipore filter ( 0. 22.µ). 
This solution was stored at 4 °C and aliquots were diluted to O. I%, 
with an equal volume of phosphate buffered saline containing 9 mM 
phosphate buffer, pH 7. 2, and O .15 M NaCl. 
NBT is more soluble m H20 in which it was rapidly 
dissolived by m1xmg solid NBT and warm water c±so 0 c) by 
vigorous manual shaking. The mixture was not filtered. These 
methods of dissolving NBT were used throughout the studies that 
follow. 
2. 2. I. Patients and Controls 
Details of the 202 patients and 26 controls are 















































































































































































































































































































standard deviation) , sex and elassific~tion of the subjects 1s shown 
in Table 2. 3 . 
Group (Appendix A) 
25 healthy hospital staff and l normal child. 
Groups 2 and 3 ( Appendices B and C) 
66 patients wi~h pyogenic infections. Patients in 
Group 2 had not recieved any antimicrobial therapy (Table 2.4) 
while those in Group 3 (Table 2. 5) had received antimicrobial 
chemotherapy at the time of the test; 4 patients had received therapy 
for longer than I week; the mean period of treatment for the 
remainder was 2. 2 days. The criteria for inclusion of patients m 
• 
these groups was the clinical diagnosis supported by either bacterio-
logical identification of the organism ( in 38 p a tients) , the detection of 
significant quantities of pus ( in 32 patients with abscesses) , or the 
histological picture of acute suppuration in appendicitis ( 2 patients) . 
All patients in Groups 2 and 3 were assessed 
clinicall/ by the author and subdivided ,on the basis of the severity 
of systemic manifestations, into 3 grades. These were absent or 
minimal in patients classified as grade A, which include d patie nts 
with small localised abscesses or post-operative abdominal wound 
abscesses. Grade C patients were severely ill with infe ctions of 
the order of severity of septicaemia or liver abscess. Grade B 
patients had illnesses of intermediate severity. 
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TABLE 2.4. Details of patients with untreated pyogemc 
infections ( Group 2 ). 
DISEASE 






















Infected burn I 
Infected uterus l 
Otitis media l 
Otitis media rod pneumonia I 
Pharyngitis l 





TABLE 2.5. Details of patients with treated pyogemc 
infections ( Group .l..} 
DISEASE 

















Generalised peritonitis 2 
Septicaemia 2 
Arthritis ( suppurative) l 
Bronchopneumonia l 
Cholecystitis · l 
Oesophagitis I 







Group 4 (Appendix D) 
7 patients with bacteriologically proven active 
tuberculosis. 
Group 5 ( Appendix E) 
21 patients with non bacterial infections; I with 
hepatic schistosomiasis; I with massive Ascaris infestation and 19 
with viral disease of which 16 were confirmed serologically; a 
clinical diagnosis was made in 2 cases of rubella and in 1 case with 
Herpes zoster infection. 
Group 6 (.Appendix F) 
91 hospital patients with a diverse range of non-
infective disease including patients with diabetes, haematological path-
ology, 1 auto immune' disease, neoplasia, inflammatory bowel 
disease and a number of miscellaneous conditions. 
Group 7 (Appendix G) 
17 patients m whom bacterial infection was suspected 
but not proven. 
2 patients were included in group 2 ( numbers 18 
and 23 ) and group 6 (numbers 72 and 47 ) . 
Selection of test subjects 
Patients in groups 2-5 and 6 were for the most 
part patients who had been recently admittE:d to one of the wards of 
Northwick Park Hospital, who could be clearly classified into one 
of the study groups or m whom this seemed likely afte r further 
investigation. Most of the patients in group 6 were outpatients at 
Northwick Park Hospital on whom blood tests were being performed. 
13 of the patients in _group 5 were part of a clinical 
trial at the ~ommon Cold Research Centre, Salisbury. There 
was a slight bias towards selection of patients with haematological 
disease, in view of reports of false positive tests on these patients, 
and patients with inflammatory bowel disease because of the author I s 
clinical commitment to a department of gastroenterology. Patients 
were unselected as far as disease severity was concerned and no 
patients were removed from the study after initial selection. 
2 • 2 • 2 . N . B T Tests 
Blood was taken by venepuncture with a disposable 
plastic syringe and I. 0 ml was transferred to plastic test-tubes 
containing O. 05 ml of a heparin solution containing 1000 i. u. /ml. 
(50 i.u./ml) and 5.0 ml to glass bottles containing 12.0 mg of 
disodium E D T A (2.4 mg/ml). All tests were done immediately 
or within I hour of venepuncture after storage of blood samples at 
4°C. 
For the test with heparinised blood, 0. 2 ml was 
incubated at 37°C for IO minutes in a plastic test tube. 0. 2 ml of 
a O. 1% solution of N B T in phosphate buffered saline was then 
added. The mixture was gently shaken,then incubated at 37°C 
for 15 minutes, then at room temperature (±25°C) for another 15 
minutes. The sample was then applied to a glass slide by running 
a drop of the te st mixture down the slide as described by 
Wollm an et al 0972). This method is here referred to as the 
heparin method. 
The E D T A . blood was teste d as above, except 
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that the N B T solution contained ficoll. ( 200 mg/ml) ; the mixture 
was incubated at 37°C for 30 minutes and then at room temperature 
for IS minutes; and the sample was applied to glass slices by 
smearmg. This method is referred to as the E D T A /ficoll 
method. Smears were air dried and stained. 
2 . 2. 3. Counting 
The smears were counted independently by three 
observers who did not know the patient details; one observer 
( observer I) the author, was very experienced ( having previously 
counted 3000 such preparations) , one ( observer 2) was relatively 
experienced in that she was a trained light microscopist and had 
counted 200 slide preparations before commencing the study, and 
the third had minimal experience of light microscopy and no previous 
experience with these tests ( observer 3) . One hundred n e utrophils 
were counted on each slide to obtain the I N B T score 1 • 
The 45 preparations on which the greate st counting 
difference between the two more experienced obse rvers was obtained 
were recounted by both observers to obtain a:1 artificially corrected 
result for comparison with other data. 20 slides prepared by the 
heparin method and 20 prepared by the E D T A /ficoll m ethod w e re 
randomly selected and recounted to asse ss the obse rver e rror. 
The scores obtained by observer I, modifie d in the 
light of observer 2 's results by corre cting obvi ous counting e r ror s , 
were regarded as the test r e sult for inte rgroup c ompari son a nd for 
relating to the other measure ments. 
2.2.4. Other Investigations 
The white blood cell counts were performed on a 
Coulter Counter model S. 
Neutrophil counts and the assessment of platelet 
concentration, and the presence or absence of a shift to the left 
of the myeloid series and toxic granulations in neutrophils were 
performed by an experienced haematology technician. The platelet 
concentration was roughly graded into 5 grades of concentration 
( ( 1-4+) purely on a subjective assessment of the peripheral blood 
smear. The erythrocyte sedimentation rates were determined by 
the Westergren method (Westergren, 1921) in disposable plastic 
tubes ( 1 Dispette') • 
The serum C-reactive protein concentration was 
measured by the Mancini radial immunodiffusion technique (Mancini, 
et al, 1965), usmg commercially available I Partagen I plates and 
standard C R P preparations on 18 patients from groups 2 and 3 
and 18 patients from group 6. The serum concentration of a 1-acid 
glycoprotein was measured by the same technique on 78 patients 
and normal subjects. 0. 4 ml of specific rabbit anti-human serum, 
titre O. 4 mg/ml, was mixed with 36. 0 ml of I. 0% agarose in a 
solution containing Barbital buffer, pH 8. 6, 1omc strength O. 05, and 
0 
calcium lactate I mM at a temperature of 48 C. The mixture was 
rapidly poured onto a glas s slide (IO. 7 x 10. 7 cm, Chance Glass) 
on a. metal level plate, and a llowed to gel. 26 e venly spaced wells 
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were punched in the gel. Serum samples and standard solutions 
of a' -acid glycoprotein ( 50, 100 and 200 mg per ml) were diluted 
l in II in O. ISM saline and 3 µI of each specimen was r~1easured 
into each well by means of a Hamilton syrmge. Standard samples 
were applied in duplicate to each plate m random order. The 
plates were placed in a damp box ·for 48 hours at room temperature 
after which they were washed in O. ISM saline for 24 hours and then 
m water for 2 hours, covered with filter paper (Whatman Number 
I) and air dried. St~ining was performed with O .1% amide black 
m a mixture of methanol, water and glacial acetic acid in the 
ratios of 5: S: I by volume. The plate was de stained for 30 minutes 
in the methanol, water, glacial acetic acid mixture and finally 
rinsed in methanol. The diameter of the precipitation rings was 
2 measured in two directions, and the value of the product, D , 
calculated. The values obtained from the standard solutions were 
used to plot a calibration curve ( o 2 against concentration) from which 
serum concentrations were calculated. 
2. 2. 5. Statistical Analysis 
To equalise the variance, the N B T scores were 
transformed to angles ( Fisher and Yates, 1963) and the E S R , 
W B C and neutrophil counts to logarithms (to the base 10) before 
analysis. A small number of analyses were performed with 
untransformed values. 
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FIG U RE 2 .l. 
N B T scores obta ined with the E D TA/ficoll ( E ) and he p arin ( H ) 
methods m differ e nt subject groups. 
2. 3 Results 
The EDTA/ficoll and heparin NBT scores obtained 
by Observer I in subject groups 1-6 are shown in Fig. 2. I. The 
controls gave consistently low NBT scores by the EDT A/ficoll 
method. In all other groups there was considerable overlap of 
the NBT scores. Consistently high scores were obtained in 
patients from group 6 with inflammatory bowel disease, erythema 
nodosurn, myelofibrosis and diabetic precoma. (Appendix H). 
The re suits of the agreed EDT A/ficoll and heparin 
NBT scores, the ES R, WBC and neutrophil count ( Mean and 
S. E.) for the different groups are shown in Table 2. 6. 
The NBT scores were compared with the ESR, 
WBC and neutrophil counts in groups I, 2, 3, 5 and 6, and the 
correlation coefficients obtained are shown in Table 2. 7. There 
was a highly significant overall correlation between the neutrophil 
count and the heparin score and the E OT A/ficoll score and the ES R. 
Significant correlations were obtained between the heparin score 
and the neutrophil count in groups I and 2, and between the 
EDTA/Ficoll score and the neutrophil count in group I, the 
WBC in group 2 arid neutrophil count overall. 
The mean number of NBT positive neutrophils in each 
group 1s shown in Table 2. 8. 
Feigin et al (1971) constructed nomograms on whi-cih a re 
plotted the NBT score and total number of NBT positive neutrophils 
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TABLE 2 ,6. The NBT scores, erythrocyte sedimentation rate 
( ES R), white blood count (WBC) and neutrophil count in the 
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different groups. Statistical analysis has been done on a transformed 
scale ( angles and logs) and the stand ard errors apply to the 
transformed means. The absolute ( d e transformed) values are also 
given. 
INVESTIGATION 































IO. 2 23.9 
18. 6 29.3 
2.8 2.3 
26 40 




6.5 IO. 2 
0. 81 . 1. 01 
0.031 0.029 
26 40 





3 4 5 6 7 
19. 2 23.5 3.9 I0.8 IO. 5 
26.0 39.0 11.4 19. 2 18. 9 
2.8 5.3 3 .1 I.5 3.4 
25 7 21 88 17 
14.4 II. I 8.4 14. 0 II. 5 
22.3 19. 5 16. 8 22.0 19. 8 
2.8 5.4 3. l I. 5 3.5 
26 7 21 91 17 
42.9 35.2 8.2 23.8 23.4 
I. 63 I. 55 0. 91 .38 I. 37 
0.102 0.182 0. 108 0. 0 54 0. 134 
19 6 17 67 II 
9.6 6.7 7.8 8.2 8.4 
0.98 0.83 0.89 0.91 0 .12 
0.0370.070 0.0410.019 0.045 
26 7 21 91 17 
6.8 4.6 4.4 4.9 5.2 
0.84 0.66 0.65 0.69 0.72 
0.051 0.096 0.0550.027 0.063 
25 7 21 91 16 
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TABLE · 2. 7; The correlation between the NBT score obtained by 
the EDTA/ficoll (E) and heparin ( H) methods and the erythrocyte 
sedimentation rate ( ES R ), total white blood count ( WBC) and neutrophil 
count. Results are expressed as the correlation coefficient with 
number of comparisons. shown. The significant level ( p value) is 
indicated where significant correlations were obtained. 
GROUP METHOD ESR p WBC p 
I. H 0.17(20) 0.15(26) 
E 0.27(20) 0.27(26) 
2. H -0.06(29) 0.27{26) 
E -0.10 (30) 0.41(40) <0.01 
3. H -0.07(19) 0.12 (26) 
E 0.19 09) -0.09(25) 
s. H -0.21 (17) 0.17 (21) 
E 0.47(17) -0.21 (21) 
6. H 0.05(67) -0.02(91) 
E 0.11 (67) -0.02(88) 
TOTAL H 0.12 (169) 0 .18 ( 228) 







0,. IS ( 25) 
-0. I (24) 
Ool4 ( 21) 
-0.10 ( 21) 
0. II (90) 
0 .10 (87) 
0.28 (224) <0.001 






























































































































































































































































































































































































































































































TABLE 2, 9. Comparison between the NBT score and the 
concentration of C reactive protein ( C RP), a 1-acid glycoprotein 
~md the sum of the two. Results are expressed as the correlation 
coefficient. The number of comparisons made is shown in brackets 
and the significance level ( p value) is shown where statistically 
significant. 
PROTEIN 
E OT ALficoll p HEPARIN p 
a 1-Acid glycoprotein 0.39 (78) < 0. 001 0.25 (77) < 0.05 
CRP 0.52 (26) < o. 01 0.297 (26) 























~ • • 
::, 2,000 z • 
• 
:a ... • ,A 0 
0 20 40 60 80 





















z 2, (Xll 
20 40 60 80 
N. B. T. SCORE 
FIGURES 2.2 and 2.3. 
Results of NBT tests on normal subjects (Fig. 2. 2) and patients 
with untreated pyogenic infection (Fig. 2. 3) plotted on nomograms 
constructed by Feigin et al (1971). 
to magnify the discrimination between the groups. Use of these 
nomagrams did not result in greater accuracy in the interpretation 
of the results of either the EDTA/ficoll or heparin NBT tests 
( Figs. 2. 2 and 2. 3) • 
The NBT scores were compared to the serum concen-
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tration of C R P , a' -acid glycoprotein and the sum of these proteins 
(Table 2. 9.) There was a highly significant correlation ( p ( 0. 001) 
between the EDTA/ficoll score and the serum concentration of 
a' -acid glycoprotein. 
A comparison of the clinical assessment of severity of 
illness of patients m groups 2 and 3 with the NBT scores showed 
an increased NBT score with increasing severity. This was more 
striking for the heparin than the EDT A/ficoll method. ( Table 2. IO .p. 58) .. 
A shift to the left of the myeloid cell series and the presence of 
toxic granulations m the cytoplasm of neutrophils was most marked m 
groups 2 and 4. (Table Zoll) 
TABLE 2. II. The percentage of each group of patients showing 
either a shift to the left of the myeloid series or. the pr-ese nce of toxic 
granulations m their neutrophils. 
GROUP I 2 3 4 5 6 7 
Shift to the left of 0 22 4 29 5 19 6 
the myeloid series. 




































































































































































































































































































































































































TABLE 2.12. Comparison between the EDTA/ficoll (E) and 
heparin ( H) NBT scores of patients in groups 2 and 6 in whom 
a shift to the left of the myeloid series and toxic granulations m 
the neutrophils were either present or absent. 
Results are expressed as the correlation coefficient. 
r . 
The number of comparisons is shown in brackets. The significance 
level (p value) is shown where statistically significant. 
NBT SCORE 
Group 2 Group 6 
Inve stig ati ons E H E H 
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present 23.6±7.2(9) 41. 6±7. 0 ( 9) 14.l ±3. 7(17) 24.0±5.l (16) 
Shift to the left p <0.05 
absent 18. 6±4. l ( 30) 23.7±4.3(31) 15.1±2.l ( 71) 16 . 7±1. 9 ( 7 5 ) 
present 27. 8±10. 3 ( 6) so.o±II.0(6) 16.9±6.l (9) 21.2±7.5(9) 
Toxic 
p < 0. 02 granulations 
absent 18.3±3. 7(33) 23.7±"3.7(34) 21.3±5.2(76) 17. 0±1. 8 ( 82) 
, 
A comparison was made in groups 2 and 6 between the 
NBT scores in those patients in whom these parameters were positive 
and those in whom they were negative ( Table 2 .12) . A statistically 
significa nt difference was only obtained in patients in group 2 between 
the NBT scores obtained by the hepa rin method in the presence and 
absence of a shift to the left and toxic granulations ( p ( 0. 05 and 
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FI GURE 2. 4 
[PLATE LET] 
Relationship between results of NBT tests performed 
by the EDTA/ficoll and heparin methods and platelet 
concentrcJtion quantified by examination of the per-
iphera l blood smear and expressed as increasing 
gradiation s from <I to 4. 
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(0.02 respectively). (Table 2.12). 
There was no obvious relationship between the 
NBT score and platelet concentration (Fig. 2.4). 
2. 3. I. Counting Error 
The discrepancies between duplicate counts tended to 
be smaller when the counts were themselves small, and to counter-
act this the counts were transformed to angles ( Fisher and Yates, 
c -· :c-·.-
1963) before analysis ( 2. 2. 5.) In these units the error variances 
were 20. 5 and IS. I and 17. 6 and 20. 3 for counts performed by 
observers 1 and 2 on slides prepared by the E OT A/ficoll and 
heparin methods respectively. These appear to be consistent with 
no difference between methods or between observers. The average 
variance is 18. 4 giving a standard deviation of ~ 4. 28°; this 
+ + 
corresponds to - 7. 5% at a count of 50%, or - 5% at a count of 10%. 
Counting 100 cells in itself gives rise to a variance of 8. 2. After 
allowing for counfo:1g errors the correlations between duplicate counts 
by observers 1 and 2 were very high ( Figs. 2. 5 and 2. 6) , 
estimated at 1. 00 and O. 99 for preparations made by the EDT A/ficoll 
and heparin methods respectively. With the recounts on E DTA/ficoll 
preparations, observer I gave rather different r·eadings on the two 
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FIGURES 2.5 and 2.6 
The relationship between duplicate counts by exper ienced observers 
on slides prepared by the E OT A/ficoll ( Fig. 2. 5) and heparin 
( Fig . 2. 6) methods. 
0 + 
of which was 4. 9 - 1. 43. De spite theee close correlations there 
was an inter-observer difference in the absolute results obtained, 
observer 1 consistently counting higher than observer 2 on the 
preparations from the heparin tests. There was closer agreement 
of the counts performed on slides made by the EDT A/ficoll method 
(Figs. 2. 5 and 2. 6) . 
Again using angular transformations, comparisons were 
made between observers l and 2, both experienced observers, and 
between l and 3, an inexperienced observer on counts from all the 
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test specimens. The correlations between observers 1 and 2 are high, 
but those between observers l and 3 are considerably lower. Observer 
3 seemed to improve with exper-ience with EDT A/fico!l counts but not 
with heparin counts, the mean of which is consistently lower than that of 
observer l (Table 2 .13) • 
TABLE 2 .13. Comparisons between duplicate counts by observers 
and 2 and l and 3 on preparations made by the EDTA/ficoll ( E) 
and heparin methods ( H). Results are expressed as the correlation 
coe ff . t b te1en s o serve d . 
E. H. 
OBSERVERS 
l and 2 0.88 0.78 
I and 2 corrected f?r counting error 0.97 0.87 
1 and 3 first 100 readings 0.32 0.58 
last 100 readings 0.57 0.53 
The EDT A/ficoll and he p a rin scores obta ine d by 
observer · 1 were compared a nd revealed a very low corre lation 
coefficient of O. 34 which w as only r a ised to O. 37 when al low ance w as 
100 
90 
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FIGURE 2. 7. 
Comparison between the NBT sco~es obtained when the test was 
performed simultaneously on the same blood sample by the 
EDT A/ficoll and heparin methods. 
made for observer error (Fig. 2. 7.) • 
2.4. Summary of Results 
A diagnostic test slmuld clearly distinguish between the 
subject group that it is designed to define, and other subject groups., 
if it is to have broad clinical application. This was not found with 
the N B T test. There was a wide overlap in the results from 
patients with pyogenic infection - whether or not antimicrobial 
treatment had commenced - in non-pyogenic infection and in non-
infective disease. In addition, a wide range of values was obtained 
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in healthy controls when the teRt was performed on heparinised blood. 
There was a poor correlation between test results when 
the test was performed simultaneously on the same patients by the 
methods of Park et al (1968) and Gordon et al 0973), suggesting a 
basic difference in the mechanism underlying the two tests. 
The counting error has not been previously commented 
upon. In this study a significant counting error, amounting to a 
standard deviation of 2:" 7. 5% at an N B T score of 50%, was found 
when the slide preparations were quantitated by experienced observers. 
This is not surprising in view of the subjective nature of the counting 
procedure; an evaluation must be made not only of the amount of 
formazan within a cell that qualifies the cell as N B T positive, but 
also whether or not the cell is a neutrophil - large intracellular 
formazan deposits distort cellular morphology and make destinction 
between neutrophils and macrophages difficulL An N B T score of 
IO% had a standard deviation of 2:" 5% in the h ands of experienced 
observers and thus the statement ( Freeman and King, 1972a) 
that N B T scores above 10% are almost universally positive 
would seem to ignore the e~istence of observer error, and appears 
unfounded. The inexperienced observer recorded very different 
results to the experienced observers, between whom there was 
very little inter-observer error after corrections were made for 
the counting error, indicating the importance of experience in 
accurate interpretafr:m of the test result. 
A significant relationship existed between a very crude 
assessment of the magnitude of systemic manifestations of illness 
in patients with bacterial infection and the N B T scores. High 
results were also obtained by both methods of performing the test 
in severely ill patients with non-infective conditions such as diabetic 
pre coma, acute bronchospasm and paraffin inhalation. Unfortunately, 
severity of the systemic manifestations of other disease processes 
was not noted and could not therefore be correlated with the N B T 
scores. It would seem that the N B T score may be related to 
the severity of the illness rather than its causation and this matter 
will be further examined in Chapter 3 together with the relationship 
between the N B T scores and the neutrophil count, E S R , 
platelet concentration and the serum concentration of C . R . P . and 
a '-acid glycoprotein. 
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A high proportion of patients with tuberculosis, inflammatory 
bowel disease and myelofibrosis gave false positive results by both 
methods of performing the test. This has been described in 
myelofibrosis ( Ng et al, . 1972) but not m inflammatory bowel disease. 
Conflicting reports have been produced on results obtained in 
tuberculosis. Negative results were described in tuberculosis when 
the test was _performed in heparinised blood ( Park et al, 1968, 
Humbert et al, 1971 , Matula and Paterson, 1971a) but Park ( 1971) 
67 
later described positive tests in tuberculous meningitis and miliary 
tuberculosis. Fikrig et al (197 3) have subsequently described negative 
tests on 5 patients with tuberculous meningitis. In the present study 
high heparin test scores were obtained in a patient with ileocaecal 
and another with miliary tuberculosis. Gordon et al ( 197 3) found 
high scores in 3 of the 6 patients with pulmonary tuberculosis and m 
a single child with tuberculous meningitis, · whereas m this study 6 of 
the 7 patients with tuberculosis had high E D T A /ficoll scores. 
2. 5. General discussion on the value of the N B T test as a 
diagnostic aid 
The availability of a rapid indicator of acute pyogemc 
infection has important clinical application. It gives direction to 
further lines of investigation and helps safeguard against indiscriminate 
therapeutic manoeuvres. 
Resultant upon the findings of early studies ( Park et al, 
1968, Matula and Paterson, 1971a, Humbert et al, 1971 · and Feigin et al, 
1971) the N B T test stimulated world wide interest and was 
accepted as just such a test in the editorial columns of leading medical 
journals (Lancet, 1971, Park, 1971, Fcigin, 1971) . The question 
arises as to the reason for the difference betwee n the re sults obtained 
















































































































































































































































































































































































































































































































































































the results reported from previous studies which led to the general 
belief in its value. The major factors which could be responsible 
for such a conflict of results are methodological disparity, and 
differences in subject selection and in the interpretation of results 
obtained. Five major studies have been performed usmg the heparin 
method and one, that of Gordon et al (197 3) by the E D T A /ficoll 
method, and reference will be made to these studies by the reference 
figures listed (Table 2. 14) • 
69 
As far as the tec_hnique of performing the test is concerned, 
there are three · major variables; the anticoagulants used, the duration 
and method of storage of the blood and of incubation of the mixture of 
blood and N B . T , and the criteria by which neutrophils are classified 
as either N B T positive or negative. Despite assumptions to the 
contrary ( Gordon et al, 197 3) the E D T A /ficoll and heparin methods 
of performing the test are not directly comparable as indicated by the 
poor correlation obtained by duplicate tests performed in this study on 
the same patients by both methods. In subsequent analysis of the 
studies, that of Gordon et al will be dealt with separately. 
The concentration of heparin has a profound effect on the 
N B . T score obtained on a blood sample. An increase in the 
heparin concentration causes a parallel rise in the N B T score until 
significantly toxic levels are i"e~ched. This effect has been reported by 
other investigators ( von Anner et al, 1971, Hicks and Bennett 1971, 
Bjorksten and Solheim, 1973 and Helium and Solberg 197 3a) and will be 
discussed more fully in Chapter 3. The concentrations of heparin 
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advocated by Park et al ( 1968) induce NB T reduction in a maJor 
proportion of normal neutrophils. With_ regard to the low NBT scores 
obtained in contr_o! subjects in studies A, B, C, D and E it is possible 
that Park et al ( 1968) did not adhere to the heparin concentration 
described and that investigafor.s in studies B, C, D and E, in which 
the methods of Park et al ( 1968) were followed, did not rigidly adhere 
to the method with regard to the concentration of heparin used. 
It is possible that the effect of heparin on NBT reduction 
varies with the . preparation used although the widespread reports of 
the effect of heparin on NB T reduction referred to above would argue 
against this. One possibility is that the heparin concentration . was 
regarded as insignificant and that blood was taken into commercially 
available heparinised containers cf the type used by Wollman et al 
( 1972) which contain economically small quantities of heparin. Similar 
containers in England contain 15 i. u. heparin/ml ( Greyward 
Laboratories, Bedford) . 
The concentration of heparin used in the present study was 
standardised at 50 i. u. per ml . because at the time that the study was 
initiated the relevance of the concentration of heparin was not realised. 
In retrospect it was too high and could account for the high NBT 
scores obtained in some of the control subjects. This does not 
invalidate the study as the heparin concentration was standard and one 
of the most significant findings was the high proportion of patients with 
pyogenic infection in whom the test gave a false-negative result. 
The time lapse between venese ction and commencement of 
the test 1s only stated in studies C and E, in which it was less 
than 30 minutes. In the present study a period of one hour was 
allowed because there was no significant decrease of N . B . T . 
reduction over this time period when blood was stored at 4°C. 
Blood samples were preincubated at 37°C for IO minutes to ensure 
that the temperature was constant when the N B T was added. 
Test tubes incubated in a water bath result m more consistent 
incubation conditions than the concave microslides used in the method 
of Park et al { Helium and Solberg 1973b}. 
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Incubation of the mixture of blood and the N . B T solution 
for IS minutes at 37°C followed by IS minutes at l"oom temperature 1s 
optimal and the protracted incubation at 37°C employed in studies B 
and E would be expected to increase the overlap of the N B T 
scores between normal and abnormal subject groups { Hellum and 
Solberg, 1973b}. The reason for the period of incubation at room 
temperature is unknown and has not been stated { Park et al, 1968), 
but was probably found to be technically convenient durip.g the develop-
ment of the m e thod. For the sake of conformity, the incubation times 
employed by Park et al {1968) and Gord'on et al {1973) for heparin 
and E D T A blood specimens respectively were blindly followed in 
thi s study. 
The criteria for the classification of a cell as N B T 
pos itive varie d from study to study. In studies B and E any formazan 
depo s it, in C, loc a li sed depo3its la r•ger tha n neutrophil granules 
. ' 
and in A a nd D, a 'l a r ge 1 forrna zan deposit, were all t ake n as the 
d is tinction between a negative and positive c e ll. In the present study 
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a positive cell was standardised as one in which the formazan 
deposits were at least the size of a lobe of the nucleus. The criteria 
adopted should not greatly effect the intergroup results of individual 
studies if standardised within each study and the more rigi'd criteria 
adopted in this study should tend to result in comparatively low NBT 
scores. 
The E D T A /ficoll method employed here is identical 
to that employed by Gordon et al 097 3) with the exception that 
centrifugation prior to incubation with NBT was dispensed with. 
This should not greatly effect the results, and the increase in time 
taken in evaluating the slides made from whole blood must be weighed 
against that employed in preparative centrifugation if the relative merits 
of the two methods are to be compared. The discrepancy in the 
results of the present study and those reported from other studies 1s 
unlikely to be due to methodological differences, although high concen-
trations of heparin could account for the high NBT scores obtained 
on some of the uninfected subjects in this study, and thus other possible 
factors must be investigated. 
Subject selection varied enormously from study to study. 
Park et al 0968) and Humbert et al {1971) compared a group of 
normal adults and children with a group of di s eased children, Matula 
and Paterson 0971a) , normal adults with a gro up of . diseased adults, 
and Gordon et al ( 197 3) , normal adults with a n unspe cified group of 
diseased subjects. No de tails of the criteria used for the selection 
of subjects were include d in these studies. Sobel et a l (1973) compared 
afebrile diseased and normal adults · and children with febrile adults 
and children and Feigin et al ( 1971 ) , preoperative afebrile children 
with febrile children. Diseased children have not been directly 
compared with normal children which probably reflects the technical 
or ethical difficulty of obtaining blood from otherwise healthy children. 
In the groups of subjects comprising both adults and children, the 
relative proportion of each have not been detailed. 
The NBT test discriminates clearly between patients 
with pyogenic infection and other subjects according to the results 
obtained in the two earliest studies ( Park et al, 1968 and Matula 
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and Paterson, l97Ia) • The results of subsequent studies refute the 
role of this test as being of any practical value as a reliable indication 
of pyogenic infection in a broad clinical context. The misconception 
as to its value is due both to the incorrect evaluation of the results 
obtained in some of the studies and due to widespread acceptance of 
the test despite this. 'Revised' results of the major studies are listed 
in Table 2 .14. · They are expressed as the percentage of true and 
false positive and negative results obtained in patients with and without 
pyogenic infection obtained by comparing the test result with the upper 
limit of normality of each individual study. All test subjects are 
included in this table, Humbert et al ( 1971) · having excluded 25% of 
their subjects with non- infective disease from their final analysis after 
finding false positive test results 'in a large proportion of patients with 
hae mophilia, and in a large proportion of p at ie nts with osteogenesis 
impe rfecta and their imme diate relatives. The percentage of fal s e 
+ negative results varies from O to 39. 3 with a mean of - 20'$ and 
that of f~lse positive results ( where stated) from O. 8 to 11. 9 with 
+ 
a mean of - 7%. 
The results of the studies of Park et al ( 1968) and 
Matula and Paterson (197Ia)differ significantly from those obtained m 
other studies with regard to the low incidence of fallacious results 
. 
obtained by these authors. This difference 1s most likely to result 
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from different methods of patient selection. Matula and Paterson ( 1971a) 
compared untreated patients with pyogenic bacterial infection with other 
diseases in the majority of which definitive bacteriological cultures 
were obtained but in whom the offending organism was adjudged non 
pathogenic. Park et al (1968) do not indicate whether or not their 
patients with acute bacterial or fungal infection had received treatment 
and compared these patients to 65 patients with other diseases of 
whom only 14% did not have viral diseases or tuberculosis and 6% 
had systemic lupus erythematosu-s., a disease in which false negative 
results are common (Douwes,1972, Wenger and Bole, 1973). Most 
acute pyogenic infections are emminently treatable with antibiotics. 
It is very unlikely that treatment was withheld from these patients, and 
the NBT tests at least in the study of Matula and Paterson (1971a) 
would have been performed in a very acute stage of the disease. The 
weakness of these two studies lies in the poor documentation of not 
only the disease processes included in the groups of patients with 
non-pyogenic disease, but also the se·verity of such disease and time 
during the course of the disease at which the test was performed. 
It is not helpful to compare acutely ill patients with pyogentc infection 
with relatively asymptomatic patients with viral disease, or with 
patients in an inactive or conv9.lescent phase of the disease, and to 
detect a difference between the groups. This in no way m1m1cs 
the clinical dilemma so often posed by an acutely ill patient in whom 
pyogenic infection or non-pyogenic disease could be equally respons-
ible, and underlines the weakness of any trial other than a true 
prospective one in assessing a test of this kind. 
Hints that 'all was not well with the NBT test' came 
from reports from Park and Good, ( 1970) of false negative tests, 
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which provoked the development of the II NBT test stimulated. 11 This 
measures the capacity of neutrophils to reduce NBT after an endo-
toxin stimulus, and when compared to the true NBT score, cari indicate 
a true negative test result, where a high NBT score is obtained 
after stimulation but not by the NBT test proper. False negative 
tests in patients with bacterial infection cannot be excluded if the 
NBT test result is low before and after endotoxin stimulation. Matula 
and Paterson, (197Ib) described · a severely ill patient with gross 
abdominal sepsis in whom the spontaneous NBT test was normal but 
who had a normal response of the NB T test to endotoxin. This di spa-· 
rity was attributed to the massive doses of prednisone administered to 
the patient, despite the observation by the same authors that patients 
rece1vmg large doses of steroids may have spontaneously high test 
scores. 
True pl"ospective trials w e :re performed by Feigin et al 
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( 1971) and Sobel et al ( 197 3) where febrile patients were compared, 
thus ensuring some uniformity of the severity of disease and more 
accurately reflecting the problem that the NBT test was designed to 
solve. In a high percentage of these patients the NBT results did 
not discriminate between the two disease groups. They also found 
much lower scores in treated than in untreated patients with acute 
pyogenic infection, a point which will be dealt with in depth in the 
next chapter ( 3. 3.) • Feigin et al ( 1971) r e corded false negative 
results in 23% of their patients with pyogenic infection and although the 
false positive tests are not individually detailed there is an obvious 
overlap between the groups of patients with and without pyogenic 
infection. Despite a considerable proportion of incorrect test re suits, 
the authors of these major studies still supported the value of the 
NBT test in the diagnosis of infection. Gordon et al s tate that 
"the NBT test is shown to possess a useful capacity to distingui s h 
patients with active bacterial infection from those with non-bacte ri a l 
inflammatory disease in both adults and childhood popula tionsll, despite 
the facts that viral infection was the only non- bacteria l inflamm atory 
disease studied, and that no note was made of the ages of the subjects 
studied. Sobel et al concluded that "while the NBT dye te st may be 
of value to the clinician, results r e quire c autious interpretation with 
attention being given to the the r apy r e ceived as w e ll u.S to .the 
haematological and immune statu s of the p atient", b road cloaks for 
non conformist. results, a nd adde d th at n a decreasing NBT v alue 
even in the absence of clinic a l c hange m ay reassure the physici a n 
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of early clinical improvement", which is an unsubstantiated, erroneous 
and very· dangerous assumption. Feigin et al ( 1971 ) concluded that 
11the NBT dye test ts a useful aid in differentiating patients with 
febrile disorders. It is apparent, however, that classification of 
every patient on the basis of the NBT dye test without regard to the 
patients I history, physical findings, or ancillary laboratory data 
cannot be accomplished with perfect reliability. 11 Humbert et al 0971 ) 
felt that the test shou!d be further evaluated because of its potential 
importance in the di agnosis of acute bacterial infections but that 11because 
of the number of 'fa lse-positive I and 'false-negative' results, it 
should not replace standard microbiological techniques in such clinical 
situations. u 
The bulk of the blame for the widespread interest in, 
a n d acceptance of, the NBT test as a diagnostic test for pyogenic 
infe ction in a broad clinical context rests with editorials in maJor 
medical jou r n als ( Feigin, 1971, Park, 1971, Lancet, 1971). These 
communic ations are compiled by authorities who as such have a 
r esponsibility to r eport clearly and accurately to the body of the 
medical p rofe ssion, w ho rely upon such reports for guidance. All 
these articles note the conditions in which false negative and false 
positive test r esults occur but it is the emphasis given and the general 
concept transm itted whic h has g iven such strong support to the 
NBT te s t . Fe igin desc ribed hi s earlier study and states that 
"di scrim in an t a n a lysis w as u se d to prepare a normogram permitting 
e2sy rep lacement of patie nts into one or another group". The 
replacement may have been easy, but it certainly was not accurate 
(Table 2 • IS) • 
TABLE 2,15, 1 Results of retrospective classification of 197 
individuals' Feigin et al, 1971 ( Retrospective classification according 













Viral infection, partially treated bacterial infection 
and non-infectious febrile illnesses. 
Untreated bacterial infections. 
Ineffectively treated bacterial infections. 
NUMBER OF A B C D 
SUBJECTS 
Cla ssification of nomoc ,ram 
20 14 6 0 0 
130 29 70 28 3 
36 I 9 19 7 
II 0 I 4 6 
He states that "it is imperative to realise that the NBT dye test 1s 
not infallible. Correctly used it is a valuable adjunct to history, 
physical examination and other laboratory data to support the clinical 
diagnosis of bacter•ial or systemic fungal infection; as an aid to 
differentiating patients with bacterial infection receiving ineffective 
antibiotic therapy and as a prospective aid in monitoring patients at 
high risk of infection. 11 The test is of use when clinical and other 
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evidence is equivocal. If reliance wa·s placed on a combination of 
the NBT test ·results obtained by Feigin , classified in a retrospective 
manner usmg his normograms, 28% of the patients with acute bacterial 
infection would have been denied antibiotic therapy and in 5 of the 11 
patients receiving ineffective antibiotic therapy, this fact would not have 
been appreciated. As an aid in the monitoring of patients at risk 
of infection the NBT test may have a role and this will be discussed 
later. Park · quotes the work of Feigin et al (197I) as evidence to 
support his original study and then lists a large number of subject 
groups on whom further studies have been performed. He states 
that "the results disclosed that the original hypothesis is correct with 
a few exceptions", the few is not quantitated nor are the exceptions 
detailed. He also listed a large number of conditions in which 11normal 
or nearly normal" results were obtained. No further reference is 
made to what is meant by nearly normal. His conclusions w e re 
similar to those of Feigin (197I). The leading article in 'the L ancet' 
was a broad, uncritical literature survey which conclude d that the. 
introduction of the NBT test "into the repertoire of the routine 
hospital laboratory seems justified." 
The present study and a critic a l reappraisal of the 
literature in no way supports the concept th at the N BT te st is of 
practical use in the specific diagnosis of pyoge nic infection in a broad 
clinical context. The next question to be answered is to w hethe r o r 
not it has any part to pl a y in s pecifi c clinical .s ituation s e r in m onitor ing 
patients at serious risk of infection, 
.. 
Wollman et al, (1972) found the test was useful in 
distinguishing between infection and rejection in patients after renal 
transplantation. The number ot patients in each group are very 
small and the criteria for the diagnosis of rejection are not detailed. 
The creatinine clearance, a reduction of . which is an early sign of 
rejection ( C alne, 1967), is equal in the infected group and the group 
m which rejection was said to be present. It is of interest that two 
of the eight patients had very high NBT scores preoperatively at a 
time when they were presumably uninfected and one of the six 
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infected uraemic patients also st..idied had a normal NBT score despite 
a pneumococcal septicaemia, which further emphasises the unreliability 
of the test in the diagnosis of infection per se. This study is of 
interest and the NBT test could be a valuable tool in transplantation 
where the problem of distinguishing infection from rejection is a 
difficult one ( Cullum et al, 1972) and in which the successful therapy 
depends upon prompt action. Before any such action is taken, a much 
larger, carefully controlled trial is essential to delineate the usefulness 
of the test in distinguishing rejection from infection. 
Fikrig et al, ( 197 3) studied the descriminatory v a lue of the 
NBT test in children with meningitis. They foun d that 34 of 36 patie nts 
with bacterial meningitis only 3 of 67 with viral m e ningitis and no 
patients of 5 with tuberculous meningitis had positive NBT tesl;s. 
The test may be of value as an addition a l diagnostic p a ramete r 
7 
but it 
is of inte rest that in two of the patients with pyog e n ic men ing itis the 
test was initially negative, only reverting to a pos itive r esult at a later 
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stage m the disease. 
Positive NBT tests were observed in patients with 
myocardial infarction by Lauter et al ( 197 3) • On serial testing the 
NBT score fell to normal after the first 7 days except in the two 
patients with a complicated clinical course. This emphasises the fact 
that positive test results can occur in non-infective conditions. The 
test may be of use in the diagnosis of complications after infarction, 
but some advantage over present day methods would have to be 
shown to warrant further involvement in what has been shown to be 
a rather non-specific inaccuratE:; test. 
Patients with cystic fibrosis of the pancreas are liable to 
recurrent bacterial pulmonary infections (Addington et al 1971). 
' 
Sullivan et al (1973) correlated NBT test results with the clinical and 
radiological assessment of the severity of illness of the patients and 
found that they were relatively closely related. They also compared 
the effect of treatment of infected patients on the clinical response to 
the treatment and on serial measurement of the NBT score and showed 
that in those patients who responded clinically there was a fall in the 
NBT score and that this did not occur in patients remaining clinical!y 
unwell. It was concluded that 11 the NB T test is a valu able paramete r, 
along with a histor•y, physical examination and the chest roentgenog r am 
in the surveillance and management of patients with cystic fibrosis,,. 
This is not so. The NBT test wa-s not shown to have a ny advant2,.ge 
over a clinical assessment of the patient I s condition eithe r in the 
diagnosis of infection or its : ... esponse to therapy; in fact II% of the 
NBT scores correlated poorly with the clinical assessment assumed 
as the standard. No evidence of the NBT test being 11 a valuable 
adjund in the surveillance of patients with cystic fibrosis 11 is given. 
It may be argued that the clinical assessment of a patient is subjective 
whereas the NB T test is objective, but the present study has shown 
that there is also a strong subjective component in the interpretation 
of the NBT test preparations. 
Freeman and King (1972a,b,c and d, Freeman, et al, 
1973a, Freeman et al, 1973b) are strong proponents of the test 
and have staunchly defended its reputation against reports of false 
negative results ( Freeman and King, 1972a) and methodological 
difficulties in the presence of neutropenia ( Freeman and King, 1972b). 
They found the test useful as an indication of infective complications 
in patients with intravenous catheters ( Freeman and King, 1972d) 
and after open heart surgery ( Freeman et al, 197 3b) and in the 
management of patients with infections ( Freeman et al, 197 3a) • 
Studies on patients with intravenous catheters revealed 
that all 9 patients with a positive NB T test had positive cultures 
from the catheter tip, in some of whom the test result reverted to 
normal after catheter removal, whereas the 6 patients with sterile 
catheter tips all had negative NBT tests. It is very surprising that 
none of the patients with infecte d catheter tips gave positive blood 
cultures. In a large. study pos itive blood cultures were obtained on 
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all patients in whom thrombophlebitis oi::curred m association with 
intravenous cannulas (Altemeier ct al, 1971). These results suggested 
to Mogensen (1972) that the catheters were probaLly contaminated 
during removal through the skin. In reply Freeman and King ( 1972e) 
denied this and stated that patients I pyrexia and NBT score fell to 
normal upon removal of the 11 infected 11 catheter. It was implied that 
this improvement occurred in all patients in whom the infected 
catheter was removed, which is in conflict with previous statements. 
It is possible that both the fever and high NBT scores resulted from 
phlebitis, a common complication ?f prolonged vascular c a nnulation 
(Medical Research Council Subcommittee Report, 1957), and that 
this resolved, with a concommitant fall in the fever and NBT score, 
upon removal of the catheter. 
As a means of monitoring patients after open heart surgery . 
for infection, the NBT test gave 25% false-positive results but no 
false-negative results. The occurrence of a positive test after 
myocardial infarction and its complications suggest that the test is 
unlikely to distinguish infective and non-infective complications of open 
heart surgery, which would be its . most valuable role. 
Freeman et al (1973a) described the use of serial NBT 
tests as a guide to the clinical mana gement of two infecte d patients . 
Unsubstantiated assumptions were made linki ng false-ne g a tive 
re s ults to steroid therapy, and clinic a l, and b a cteriological 
evidence clearly indicate d infection w hen a positive N B T re s u lt was 
obta ined. No conclusions as to the diagnostic v a lue of the test can 
be drawn from this study. 
2. 6. Summary 
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The role of the NBT test as a specific diagnostic marker 
of pyogemc infection was re-evaluated. The test was performed 
simul~aneously by two methods on blood from the same subjects which 
included normal controls and patients with infective and non-infective 
diseases. 
Poor correlation was obtained when the results obtained 
from the two methods were compared. Although higher NBT scores 
and total numbers of NBT positive neutrophils were found in the 
subjects with pyogenic infection than in normal subjects, similar high 
results were obtained in subjects with a wide variety of diseases. 
The overlap of results between subject groups and the previously 
unrecognised error in interpretation of the test samples suggest that 
the test has no useful discriminatory value in the specific diagnosis of 
pyogemc infective disease. 
A careful survey of the literature on the NBT test has 
shown the prime factors responsible for its acceptance as a specific 
diagnostic index of pyogenic infection to be misinterpretation of the 
results of poorly designed and documented studies and the amplification 
of such misconceptions by the editorial columns of leading medical 
journals. 
The NBT test does not appear to have any role as a non-
s pecific index of pyogenic infection. The available evidence of its 
value in specific clinical situations, including the surveillance of 
patients particularly at risk of infection . is scanty and inconclusive. 
The NBT test has not lived up to its promise as a 
specific index of pyogemc infection. 
clinical value merit close scrutiny. 
Further claims as to its 
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CHAPTER 3 · 
The mechanisms iiwolved m the reduction of NBT by neutrophils 
Although a considerable literature has accumulated about 
the spontaneous NBT test in bacterial infection and conditioris 
resulting in false negative and false positive results ( Chapter 2) , 
little attention has been paid to the basic mechanisms involved. 
In the first se.ction of this chapter an attempt will be made to 
explain how the NBT enters neutrophils. The following two 
sections will examine the conditions governing its entry. In the 
final section an investigation will be made of the effect of NBT on 
the cells themselves and the possible metabolic pathways involved 
in dye reduction. 
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3. I. l. SECTION l: The entry of NBT into neutrophils in the NBT test 
The hypothesis that the NBT test would be a useful 
test for infectiofl was based upon the assumption that in vivo 
phagocytosis of bacteria would induce metabolic changes in a 
neutrophil, sufficient to cause increased spontaneous in vitro reduction 
of NBT as is observed in the quantitative NBT test after the 
phagocytosis of latex ( Park et al, 1968) . Both the mechanism of this 
reduction a nd the site at which it occurs, whether extracellularly 
followed by phagocytosis of the formazan, or intracellularly, were 
unknown. Baehner ( 197 2) was of the opinion that the dye does not 
penetrate intact cell membranes because of its negative 
charge ( it is in fact cationic) , but that an alteration or disruption 
of the outer membrane of the leukocyte · would allow access of 
reducing substances to the NBT. Similar views were expressed 
by Park ( 1971) . Neither of these theories satisfactorily explained 
the observed morphological chatacteristics of the formazan deposits 
(Fig. I. 4) which vary greatly in size and shape, differing tc:ally 
from that of any intracellular organelle. If NBT reduction was 
resultant upon an increase in cellular metabolism and membrane 
permeability it would be expected to be a more diffuse process than 
that giving rise to the focal density staining deposits that are observed. 
In this section, it will be shown . that for microscopic 
visualisation in the NBT test, the dye must enter the cell by phage-
cytosis. For this to occur two processes are obligatory; the cell 
must be stimulated to phagocytic activity and the NBT must be 
presented to the cell in a form suitable for phagocytosis. Cells 
suspended in serum and exposed to endotoxin are unable to reduce 
significant quantities of the dye, whereas cells in plasma do. The 
addition of fibrinogen or heparin to serum corrects this deficiency. 
NBT precipitates and complexes with fibrinogen and heparin and is 
phagocytosed by neutrophils as part of this complex. 
3.1.2. METHODS 
3. I. 2. a Preparation of cells 
Blood samples were collected from healthy v olunteer s 
between the ages of 18 and 30 years. Blood samples from different 
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individuals were used for each experiment. 
A portion { 25 ml) of heparinised blood { 50 i. u. /ml) 
0 
was centrifuged at 450 G for IO min at IS C. The buffy coat 
{ approximately 5 ml) was aspirated with a Pasteur pipette and 
washed three times in 50 ml of Hanks balanced salt solution at 
4°C. After each wash, the suspension was centrifuged at 200 G 
for IO min at 1S°C. After the final wash, most of the supernatant 
was discarded and the washed cells were mixed by gentle shaking. 
A portion .{0.4 ml) of the washed cell preparation was mixed with 
0. 6 ml of the suspending media. 
3. L 2bSuspending media 
The washed cells from four individuals were suspended 
m each of the following solutions: { i) autologous serum; {ii) · autolo-
gous serum containing disodium EDTA {4.0 mg/ml); {iii) autologous 
serum containing heparin { 70 i .u. /ml) ; {iv) Hanks solution; 
{ v) Hanks solution containing heparin { IO i. u. /ml) ; (vi) Hanks 
solution containing di sodium EDT A ( 4. 0 mg/ml). Fibrinogen in 
sodium chloride solution ( 0. IS M) was added to aliquots of e ach 
of suspensions (ii)-(vi) to give a fin a l concent r atio:i of 5 mg /ml. 
Additional studies were done with solutions ( i) and (ii). 
3. I. 2. c Neutroohil stimulation 
To cause stimulation, 10 µg of Esche richia co li endotoxi n 
{type 0127 : B8) in 0.05 ml of phos p hate (0.0 90 M) saline (0.15 M) 
mixture, (pH 7.2) was added to a 1.0 ml s a m p le of each o-f the 
above suspensions in a di sposable p l astic test tube and the tubes 
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were incubated for 10 mm 
0 
at 37 C. This amount of endotoxin was 
used because m a dose:--response study it was the smallest concentration 
necessary to give a maximal response ( 3. 2). Similar amounts of 
suspenst0n were incubated without endotoxin. 
3. t. 2 .d Incubation with NBT 
To O. 5 ml of the stimulated and unstimulated cell suspensions 
was added O. 5 ml of a O .1% solution of NBT in phosphate buffered 
saline. The mixture was gently shaken and incubated at 37°C for 
30 min. 
Staining and counting of neutrophils 
Staining and counting was performed as in 2. 2. 
Twenty slides were re-examined and the standard deviation of . a 
single count (percentage of positive cells) was estimated to be 2.2. 
3. I. 2 .e Precipitation of fibrinogen by NB T 
To O. 6 ml samples of fibrinogen ( 5 mg/ml) in Hanks 
solution with and without EDT A ( 4. 0 mg/ml} and to plasma from 
blood anticoagulated with EDT A ( 2. 4 mg/ml) was added I. 0 ml of 
0 .1% solution of NBT in phosp h ate-buffe red saline. These mixtures 
were gently shaken a nd incub a te d m a w ater bath at 37°C for 30 min. 
A fter centrifugation at 500 G for IO mm, the deposit was washe d three 
times with distilled water. The washed de posit w as dissolved in Hanks 
solution by incubation in a w a te r bath a t 37°C for 30 min. The 
solution w as then c entrifuge d at 1000 G for IO min. Thrombin was 
added to the supernatant ( SO i. J. /ml) and the mixture observed 
for the presence of a clot. Precipitates produc,:,;d by the addition 
of NBT to plasma anticoagulated with EDTA were redissolved in a 
similar manner. Electrophoresis of these redissolved precipitates 
and a standard solution of fibrinogen m saline ( S. 0 mg/ml) against 
whole human antiserum was performed by a modified LaureII 
technique ( Minchin Clarke and Freeman, 1968}. 
3. I .. 2f Precipitation of heparin by NBT 
To· 0. 6 ml of a solution of heparin ( 70 i. u. /ml) in Hanks 
solution and O. 6 ml of plasma from blood anticoagulated with heparin 
( SO i. u. /ml) was added to I. 0 ml of a O. I% solution of NBT in 
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phosphate-buffered saline. The solutions were examined microscopic-
ally, using ordinary and polarized light, for precipitated particles, as 
were control solutions of heparin in Hanks solution and plasma, and 
the O. 1% solution of NBT. Reduction of the solutions was performed 
by the addition of phenazine methosulphate ( 300 µM) and NADH 
(IO mM). To investigate whether or not the precipitates obtained 
above contained NBT, they were dialysed against water for 72 hours 
using a ceilulose membrane and then :reduced by the addition of 
phenazine methosulphate ( 300 µM) and NADH ( 10 mM) and examined 
for blue coloration. 
3 .1.. 2 fl• Measurement of the r e lationship be tween the concentration of 
NBT, the pre cipitation of fib:rinogen and heparin, and the 
percentage of positive neutrophil s 
A portion (I.O ml) of solutions of NBT in phosphate-buffered 
saline tn concentrations o-f 0 . 1- 0.0032% wepe added to J.O ml nf 
whole blood anticoagulated with EDTA { 2 .4 mg/ml) or heparin 
{ SO i. u. /ml). Endotoxin stimulation, incubation, staining and 
counting were carried out as de scribed above. Por'tions (I. 0 ml) 
of solutions of NBT in phosphate-buffered saline in concentrations 
of O. 2-0. 0032% were added to O. 6 ml of plasma from blood anti-
coagulated with EDTA (2.4 mg/ml), to which was added 0.03 µCi 
of 
125
1-labell~d fibrinogen and to O. 6 ml of plasma from heparinised 
blood ( 50 i. u. /ml) containing O. 03 µCi of 
125
1-Iabelled fibrinogen 
plus O. 28 µCi of heparin ( 
35
s) sulphate ( corresponding to 60 µg). 
After incubation for 30 min at 37°C the mixtures were centrifuged 
at 4000 G for 30 min. The gamma activity in the supernatant was 
counted using a well-type sodium iodide detector. The samples 
containing no NBT gave about 14,000 c .p. m. and those with the 
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highest concentration of NBT gave about 1200 c. p. m., the background 
b . 20 Th 
35s . . d . 1· "d emg c.p.m. e activ1ty was counte m a 1qu1 -
scintillation sy,stem, the corresponding count rates being about 
25,000 c. p. m. to about 1000 c. p. m. with a backgro~nd count of 
25 c. p. m. Each sample was counted for 100 seconds with a cut;;; 
off at 10,000 counts. The observe d beta counts were corrected for 
the contribution due to 
125
1 which amounted to 13. 6% of the observed 
gamma counts. 
The concentration of fibrinogen was measured in the 
supernates of plasma containing E OT A, after incub ation with NB T, 
by a . tanned red cell hac magglutina ti on inh ibition immunoassay 
( Merskey et a l, 1969) • 
3. I. 2. h Effect of centrifugat;on of the NBT solution on the 
reduction of NBT by neutrophils 
A solution of O. 1% NBT in phosphate-buffered saline 
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was centrifuged at 30,000 G for 16 hours. A portion ( I. 0ml) of the 
suspension solution was added to I. 0ml of blood anticoagulated with 
either EDTA (2.4 mg/ml) or heparin (SO i.u./ml) with and without 
prior stimulation with endotoxin as described above. Incubation, 
staining and counting were performed as above. After centrifugation 
the solution of NBT was examined microscopically, using ordinary 
and polarized· light, for the presence of particles. 
3. I. 2, i Substitution of NBT precipitates of heparin and plasma 
proteins for NBT in solution 
To 1.0 ml of a solution of heparin (1000 i.u./ml) and 
to O. 6 ml of plasma anti coagulated with EDT A ( 2. 4 mg/ml) was 
added I. 0 ml of a O. 2% solution of NBT in saline. The mixtures were 
gently shaken and incubated in a waterbath at 37°C for 60 minutes. 
After centrifugation at IOOOG for IO minutes, the supernates were 
discarded and the pellets ( approximately O. I ml) resuspended m 
I. 0 ml of phosphate-buffered saline by vigorous shaking on a 
mechanical mixer. The suspension of precipitated heparin was added 
to I. 0 ml of heparin ised blood ( SO i. u. /ml) , and the plasma 
precipitate to I. 0 ml of blood anticoagulated with EDT A ( 2. 4 mg/ml) , 
To each was added 100 µl of endotoxin ( 200 µg/ml) in phosphate-
buffered saline to give a final concentration of IO µg/ml. The 
0 
mixtures were gently shaken, incubated for 20 minutes at 37 C, 
smeared and stained. 
3 .l. 2 .j .The effect of ficoll on the ohagocytosis of latex particles and on 
the reduction of NBT by neutrophils 
Blood from 2 normal adult maJes ( ages 28 and 29) was 
anticoagulated with EDTA (2.4 mg/ml). To 2. 7 ml of blood was 
added O. 3 ml of undiluted, dialysed latex particles. The r.1ixture was 
gently shaken and to l. 0 ml of this mixture was added l. 0 ml of 
O. 09% NBT m phosphate-buffered saline to which there had been no 
additions or to which had been added either endotoxin or ficoll m 
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final concentration of 20 J1 g and 200 mg/ml respectively. The mixtures 
I 
were gently shaken, incubated at 37°C for 30 min, specimens were 
smeared on slides and stained. 100 neutrophils were counted and the 
percentage of cells with and without associated latex particles, 
formazan reduction in association with these latex particles or as 
large clumped deposits, and the relationship between these deposits 
and the presez:ice of latex particles . in cells was observed. 
3 .I_. 2 .k.Electron microscopic studies of leucoc ytes after exposure to 
NBT 
A portion (I. 0 ml) of O. 1% NB T was added to I. 0 ml of 
whole blood, using EDTA (2.4 mg/ml) and heparin (SO i.u./ml) as 
anticoagulant after prior incubation of the blood with endotoxin ( 10 µ,g/ 
ml) at 37°C for 10 min. The mixture was incubated in a wate r b ath 
0 
at 37 C for IS min, c e ntrifuged at 400 G for 60 min a nd the huffy 
coat aspirate d with a Pasteur pipe tte, fix ed by the m ethod of Hirs ch 
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and Fedorko ( 1968) and embedded in Epon. Thin sections were 
cut and examined unstained and after staining with uranyl acetate and 
lead citrate (Renolds, 1963) in an A. E. I. EM6B electron microscope. 
Control samples were prepared by excluding the NBT or endotoxin 
from the above mixtures. 
3.l.3. RES UL TS 
3. I. 3. a Reduction of NBT by stimulated neutrophils suspended m 
various media 
A small percentage of neutrophils were found to 
reduce NBT when suspended in serum or Hanks solution with or 
without the addition of di sodium EDTA ( Table 3. l). Prior stimulation 
with endotoxin did not affect these results. The addition of fibrinogen 
resulted m a small increase in the percentage of positive cells in the 
absence of stimulation but in a marked increase with stimulated cells. 
In the presence of heparin, a large percentage of the neutrophils 
suspended in serum or Hanks solution became positive regardless of 
whether or not fibrinogen was added. The discrepancy between the 
percentage of positive cells found wheh stimulated cells were suspended 
in serum plus hep~rin ( 70 i. u. /ml) or Hanks solution plus heparin 
( IO i. u. /ml) can be attributed to the different concentrations of heparin 
added to the two solutions, a lower concentration being added to 
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FIGURE 3 . 1. 
lmrnunoelectrophoresis of proteins precipitated from plasma by NBT 
and redissolved in Hank! s solution (below), and pure fibrinogen (above) , 
showing that fibrinogen constitutes the major component of these 
precipitates. 
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TABLE 3. L Effects of the addition of endotoxin and/or fibrinogen 
to cells suspended in autologous sera and various media. Results are 
expressed as the percentage (mean and range) of NBT-positivive cells 
ADDITIONS SUSPENDING MEDIUM 
Serum Serum Serum Hanks Hanks Hanks 
Endo- Fibri- + + Soln. Soln. + Soln. + 
toxin nogen EDTA heparin EDTA heparin 
- - 0(0-3) 0 ( 0-1) IO ( 0-3 7) 0(0) 1(0-1) I( 0-4) 
+ - I ( 0-3) 0(0-2) 38(9-73) I ( 0,...2) 0(0-l} 12(0-32) 
- + - 2(0-2) 8(2-12) 3(0-7) 5 ( 0-10) 7 ( 0-10 
+ + - 14(7-36) 30 {18-39) 16 {I0-25) 28 ( 18-45) 50(39-58) 
No. of 
experiments IO 6 4 4 4 4 
3. 1.3b Precipitation of fibrinogen by NBT 
Solutions of fibrinogen in Hanks solution with or without 
added EDTA, or plasma anticoagulated with EDT A all yielded a pre-
cipitate after incubation with NBT. The precipitates were dissolved and 
subsequently formed clots upon the addition of thrombin, indicating the 
presence of fibrinoge n. lmmunoelectrophoresis of the redissolved 
precipitate from plasma s howe d that fib r inogen, identified by its electro-
phoretic mobility, fo rme d the m ajor prote in component (Fig. 3 .1). A 
number of minor p rotein peaks were a ls o seen. 
3 .13c Pre cip itation of heparin by N B T 
Numerous sm a ll precip itate d particle s could be 
seen on micros cop y with both o r dinary a nd polarized light after the 
addition of N B T to the s o luti on of hepu_rin . These particles developed 
a dark blue c o lour upon r ed1 ct ion suggesting th at N B T w a s incorporate d 
in the se p a rtic le s. 
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Relationship between the percentage of NBT-positive neutr ophi ls in 
blood anti coagulated with t:.DT A and stimulated with endotoxin ( , mean 
of five studie s :!:" I SE M) and the perc~ntage of I25I-labelled fibrinogen 
pre cipitated from EDT A-treated pla sma upon the addition of v arying 
concentrations of dye ( ... , mean of duplicate values shown) . 
FIGURE 3.3. 
Rel ationship between the percentage of NBT -positive neutr ophils fr~m 
heparinised blood after endotoxin stimulation ( , m ean of five studies 
:!:'1 S EM ) and the precipitation of 1251-!abelled fibrinogen ( ... ) and 353_ 
labe lled heparin ( ) from heparinised plasma ( individual exper iments) 
upon the add ition of varying c oncentrations of N BT . 
3 .I. 3 .d Demonstration of NBT m the precipitates of fibrinogen and 
heparin 
Unreduced NBT was found to be freely dialys3.ble across 
a cellulose membrane. After dialysis against water for 72 hours the 
precipitates of fibrinogen and heparin were incubated with a reducing 
solution and the development of a deep-blue coloration due to the 
presence of formazan indicated that NBT was not dialysed off the 
the precipitates. 
3 .l. 3 .e Effect of decreasing the concentration of NBT on the 
precipitation of fibrinogen and heparin and on the reduction of 
NBT by stimul ated neutrophils ( Appendix M ) • 
In EDT A anticoagulated blood and plasma, concentrations 
of NBT greater than O. 05% caused almost total precipitation of 
fibrinogen and resulted in a significant percentage of stimulated 
neutr ophils b e coming NBT-positive. Concentrations of NBT of 
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0. 025% or less resulted in little fibrinogen precipitation or NBT 
r e duction by neutroph ils. The critical concentration of NBT necessary 
for r eduction by a s ignifi c a nt percentage of neutrophils and for marked 
fibr inogen p recip ita tion was simila r (Fig. 3. 2). , In heparinised 
p lnsma, N BT caused the precipitation of both fibrinogen and heparin. 
The precipitation of fibr inogen and heparin and the percentage of 
positive c e lls were de cre a sed m p aralle l by dilution of the dye (Fig. 3. 3) 
3 .I. 3 J J:: ffect:s of c entri·~ug_ation of the NBT s9Iution 
No particul a te matte r c o uld be dete cted on microscopic 
examination of the solution of NBT after centrifugation at 30,000 G 
for 16 hours. Use of this NBT solution did not decrease the 
percentage of NB T -positive neutrophils in stimulated blood when 
compared with solutions of NB T prepared in the standard manner. 
3 J. 3 .g Substitution of NBT precipitates of heparin and plasma proteins 
for NB T in solution 
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Approximately half the neutrophils from heparinised blood 
and 5% ( absolute values 48% and 5%) of those in EDT A anticoagulated 
blood contained formazan deposits. These deposits were morpholog-
ically identical to those . obtained when NBT in solution is mixed with 
blood. 
3 .L. 3 .h The effect of ficoll on the phagocytosis of latex particles and 
the reduction of NBT by neutrophils 
In comparison with the blood to which only latex was 
added, endotoxin and ficoll caused a marked, roughly parallel, 
mcrease in the percentage of neutrophils associated with latex 
particles and those in which formazan deposits were observed 
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Stained electron micrograph of a neutrophil after exposure to NBT 
and endotoxin, showing membrane-lined vacuoles containing amnrphous 
material ( V), amorphous material outside the cell (A) and undergoing 
phagocytosis ( P ) , nucleus ( N) and outer membrane ( M) . 
Uranyl acetnte and lead citrate xlS,000. 
IOI 
TABLE 3. 2. The effect of endotoxin and ficoll on the reduction of 
NBT by, and association of latex particles with neutrophils, in 
blood exposed to a mixture of latex and NBT. Results of the two 
studies are expressed as percentages. 
Addition Morphological characteristics of neutrophils . 
No Latex Latex Latex Formazan 
to Latex + + No formazan No latex 
formazan large 
Blood around formazan 
latex clump 
particles 
NBT 72,72 9, 4 12, 4 5,22 2, 0 
NBT 
+ 17, 41 6, 8 72,44 4, 6 o, 1 
Endotoxin 
NBT 
+ 20,39 18, 6 51,45 11, IO o, 0 
ficoll 
3. l.3i Electron-microscopic studies of leucocytes after exposure to NBT 
Membrane-bound vacuoles, containing densely staining 
amorphous material, were found in the cytoplasm of a large proportion 
of the monocytes and neutrophils from blood exposed to both NBT 
and endotoxin. Similar amorphous less densely staining material 
was also seen both extracellularly and undergoing phagocytosis (Fig.3.4) 
The neutrophils appeared swollen and their outer membranes were 
' 
partially ruptured. The amorphous material was seen purely 
e x tr a cellularly in blood exposed to NBT alone but was not seen 
afte r exposure to endotox in in the absence of NBT. Neither c e !Iular 
FIGURE 3.5. 
Unstaim:;d electron micrograph of a neutrophil after exposure to NBT 
and endotoxin showing amorphous material outside the cell (A), 
amophous material containing electron-dense particles within the cell 
( P), nucleus ( N} and outer membrane ( M). xISPOO. 
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swelling nor abnormalities in the outer membrane of neutrophils 
were found in cells that were not exposed to a combination of both 
endotoxin and NBT. Unstained sections showed the amorphous 
material to contain electron-dense, elongated, somewhat needle-
shaped P,articles approximately 150-500 nm in length. These particles 
were most numerous when the amorphous material was within 
phagocytic vesicles and could represent formazan deposits (Fig. 3. 5). 
3.1;4 DISCUSSION 
The studies m this section were consequent upon a 
small pilot study in which an attempt was made to increase NBT 
reduction by normal neutrophils suspended in the serum of patients 
with pyogenic infection. Very little reduction was observed. 
Endotoxin, which had at that time been shown to result in a fairly 
standard increase m the reduction of NBT by neutrophils in whole 
blood ( 3. 2) failed to enhance NBT reduction by cells suspended in 
autologous serµm. It thus became .obvious that a factor, present in 
plasma but absent from serum, was having a permissive effect on 
the stimulation of NBT reduction by endotoxin. The most apparent 
difference between plasma a nd serum is the presence of fibrinogen, 
clotting factors and anticoagulant in the former and thus the experiments 
on cells s .uspended m serum were r e pe ated in the presence and absence 
of fibrinogen and EDTA (the addition of fibrinogen alone c auses serum 
to clot).. 
It w a s found th a t the addition of fibrinogen re-established 
p s 
F IGURE 3. 6. 
A flocculant precipitate 1s produced by the addition of NBT to 
plasma ( P ) but not to serum ( S ) . 
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the ability of endotox in to increase NBT reduction by neutrophils 
and that fibrinogen added to cells suspended in a balanceJ salt 
solution retained this property in the absence of other serum factors. 
Interest was then aroused as to the mechani s m of 
augmentation of NBT reduction by fibrinogen. It was noticed m 
other experiments that if NBT and blood were mixed in the standard 
concentration and the cellular components rapidly separated from the 
liquid phase by centrifugation, the clear supernate beca me opalescent 
and developed a flocculant precipitate within a short time. A mixture 
of EDT A plasma and NBT in the same concentrations and under the 
same conditions as are employed in the NBT test form e d an 
ide ntical pre cipitate (Fig. 3. 6) • The precipitates were redissolved 
and subs eque ntly form e d a firm clot upon the addition of thrombin, 
indicating the presence of functional fibrinoge n. Immunoe lectrophoresis 
of the redis s olved precipitates showed that fibrinogen, identified by 
its im munoe lectrophoretic mobility, formed the major protein 
component. ( F ig. 3 • I) 
Signifi c a nt N B T reduction occur s in cell s uspe nsions 
cont a inin g endotoxin and hepa rin tn the a bsence of fibrinogen. 
H e par in is a ls o pre c ipit ated by solutions of NBT in the s ame concen-
trations as employe d in the in v itro N B T test. The c ationic 
precip itation or h e p arin ( S cott, 1968), and of fibrinogen (Surge nor, 
1952 ) have been described , and a lthough the p r ecipitation of these 
s ubstance s by NB T was not fur the r inve s tigated, th is would s eem a 
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likely mechanism. 
The light microscopic appearance of formaz an deposits 
ts that of irregular amorphous craggy lumps, of varymg size, which 
appear to have an intracellular location. The evidence for an 
intracellular location is strengthened by observations by Nathan et al, 
(1969) that the reduction of NBT, in this case trans ported into the 
cell on zymosan particles, occurs almost exclusively within the 
phagocytic vacuole. It had been found that there is an absolute 
requirement" for fibrinogen and/ or heparin to allow significant 
reduction of NBT in the model system and that NBT caused the 
precipitation of these substances. It therefore seemed likely that 
the entry of NBT into neutrophils m visible amounts was by pha go-
cytosis of the dye in association with precipitated fibrinogen and 
heparin. This theory was strongly supported by the finding th at the 
percentage of neutrophils reducing the dye and the precipitation of 
fibrinogen and heparin depend upon the concentration of NBT, and 
that a close, parallel r elation s hip exists between these processes upon 
exposure to the same serial dilutions of the dye (Fig. 3 . 3) • Electron 
microscopy of stimulated neutrophils in the presence of p lasma ar.d 
NBT revealed the presence of amorphous m aterial outs ide the cell, 
in the process of endocytosis and within membrane-bounded cytoplo.smic 
vacuoles. The n e edle --shaped c r y s tals s een in unstained preparations 
are almost certainly for m azan depo s its. Humbert et al ( 19 7 3} 
r e ported almost identical electron m icroscop ic fi nding s but drew 
conflicting conclusions from them. They reported that 11the 
intracellular formazan was amorphous (noncrystalline) and was 
located mainly along smooth endoplasmic membranes adjacent to 
Golgi structures, and in smooth membrane-bound cisterns. It 
was occasionally observed within vacuoles. Occasional small 
deposits of formazan were also seen scattered in the cytoplasm. 
When aggregates of neutrophils were seen, extracellular formazan 
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was often localised at the cell interfaces. 11 They deduced that 11 some 
reduced NBT was occasionally seen on the outer membrane of 
neutrophils, particularly when two cells were in intimate contact. 
This finding raises the possibility that part of the formazan observed 
within the cells could have been formed outside and then carried 
into the cell by way of pinocytosis or phagocytosis. However, if 
such was the case, one would expect most of the reduced NBT to 
be found within vacuoles. Our observations revealed that most 
vacuoles were · devoid of formazan; · furthermore, formazan was mostly 
seen within a membranous system, analogous to smooth endoplasmic 
reticulum ( SER) which had no connections with vacuoles. 11 
It would seem that they equated a morphous material with 
formazan when in fact it was more likely to have been a macro-
molecular complex of NBT and precipitated fibrinogen a nd heparin, 
in which case their assumption th at the mate rial outside the cell was 
formazan rathe r than NBT is unfounded. L a rge mem b r a nous 
ciste rns asso.ci a ted with the SER w e re absent from the ir electron 
micrograph of a neutrop hil from a control s u bje ct. P hagocytic 
vacuole formation is related to phagocytosis and the finding of empty 
vacuoles suggests that they initially contained material lost during 
tissue processing. The analogy between the membranous systems 
and smooth endoplasmic reticulum was probably drawn because of 
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the irregular contour of both membranous systems; most electron 
microscopfo data on phagocytic vacuoles records them as having a 
regular contour because of the regular structures of ingested materials 
studied. The phagocytic vacuole would be expected to conform m 
shape to accommodate its contents, which if irregular in outline 
would result in an irregular vacuole (Simson and Spicer, 1973). 
These authors have attempted to link NBT reduction by the hexose 
monophosphate shunt ( HMPS) - linked oxidative pathway and the 
location of these enzymes on the SER in · neutrophils by their 
interpretation of electron microscopic findings. They fail to explain 
why formazan deposition is localised to "SER cisterns" rather than 
the smooth end.oplasmic reticulum as a whole. They conclude that 
"further ultrastructure and ultracentrifugal studies will be neesied to 
infirm or confirm that speculation. 11 The study described above . 
would see_m to 'infirm' the conclusions they have drawn from their 
observations, the hypothesis as to the location of the HMPS - linked 
oxidative pathway in neutrophils on' the SER membranes remains still 
very much an hypothesis. 
So far it has been demonstrated that NBT is phagocytosed 
by neutrophils in association with particulate matter. Prolonged 
dialysis of NBT precipitated heparin and plasma proteins led to 
partial redissolution of the plasma proteins but not of heparin. 
Exposure to a reducing solution caused blue colouration of the 
residual precipitates indicating that NBT was not dialysed off the 
precipitate and that phagocytosis of these precipitates leads to 
'?oncommitant phagocytosis of the associated dye. 
As a prelude to engulfment, particles must attach to the 
outer membrane of the neutrophil, and this attachment may result 
from electrophilic bridging ( Penny et al, 1966) by divalent cations 
between terminal carboxyl groups on the neutrophil membrane 
( Bangham, 1964) and negatively charged groups on the object of 
phagocytosis. 
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When the NBT test is performed on the blood of patients 
with bacterial infection, a smaller percentage of the neutrophils 
become NBT-positive if EDTA is used as anticoagulant, this has · 
been interpreted as resulting from the inactivation of complement by 
EDTA (Park and Good, 1970), a point which will be further 
discussed, ( 3. 3) • EDT A in concentrations less than half those used 
in the present study ( 10 mM) causes a marked reduction of phagocy-
tosis of bacteria (Allison and Lancaster, 1965) and latex particles 
( K var stein, 1969) by human neutrophils. Although the mechanism of 
this effect is unknown, it is likely to be due to the chelation of 
divalent cations ( K varstein, 1969). For phagocytosis of macro-
molecular complexes, as demonstr ated above, to occur in the 
presence of EDT A some binding mechanism must be e nvisaged. 
NBT may displace calcium ions from chelation by EDT A, in which 
event the blood would be expected to clot, a process which occurs 
++ in the presence of NBT after the addition of Ca to bloo-i anti-
coagulated with EDTA. It is more probable that NBT, itself a 
divalent cation, can replace calcium as a linking ion in the binding 
of the fibrinogen complexes to the cell surface. Stossel has shown 
097 3) that the phagocytosis of aggregated albumin by human neutro-
phils does not occur in the absence of divalent cations and that 
++ phagocytosis is restored by the replacement not only of Ca or 
++ ++ ++ 
Mg , but of Mn or Co as well. The permissive effect of 
divalent cations on phagocytosis seems to be related to the non-
specific divalent character of the ion rather than its specific atomic 
structure. The absence of free divalent cations could account for the 
110 
relatively low NBT score obtained when preformed NBT -fibrinogen 
complexes instead of NBT in solution were added to blood anticoagulated 
with EDTA (3.L.3.g). 
Gordon et al (197 3) found that the addition of the s u crose 
polymer, ficol l, to the incubation mixture restot·ed the level of the 
NBT scores obtained from the blood of patie nts with pyogenic infection 
from the low levels obtained by testing blood a nticoagulated w ith E DT A 
in the absence of ficoll (Park and Good, 1970, Fre e m an a nd King , 
1972b) to those obtained on blood anticoagu lated with he parin . The 
experiment described above revealed that both e ndotox in a nd fi coll 
s timulated the association (the term assoc iated r ather than phagocytosi s 
has been used becaus e of the diffi culty m d is tinguishing be tw e e n 
lI1 
adherent and phagocytosed particles) of latex particles with, and 
the reduction of NBT by, neutrophils. The bulk of formazan 
deposits are not around phagocytosed latex particles, but .as 
discrete irregular lumps as seen with NBT reduction in the absence 
of latex. Only a small percentage of neutrophils from normal subjects 
reduce NBT when exposed to ficoll in the absence of endotoxin or 
latex ( 2 • 3. ) It would thus appear that both endotoxin and 
ficoll enhance latex association with and NBT reduction by neutro-
phils, the latter largely as a result of increased phagocytosis of 
macromolecular complexes of NBT with fibrinogen. The mechanism 
by which ficoll enhances phagocytosis is unknown, and has not been 
further investigated in this study. Evidence to support the finding 
that ficoll enhances phagocytosis comes from a report by Cohn and 
Parks ( 1968) in which similar concentrations of ficoll were found to 
induce pinocytosis by macrophages. 
NBT tends to crystallise out of solution in the concentrations 
m which it is used in the test of Park et al ( 1968) • Phagocytosis 
of isolated NBT crystals is not a significant mode of entry of . the dye 
into neutrophils because significant dye reduction does not occur in 
the control tests in the absence of haparin or fibrinogen and removal 
of these residual crystals by high-speed centrifugation does not 
decrease the number of neutrophils becoming NBT positive. 
, Th e phag~cytosis of NBT as a ccmponent of a macro-
molecular complex with heparin and/or fibrinogen explains how NBT 
enters neutrophils in quantities visible as form azan by light microscopy, 
and ,,vhy the forrnazan depos its from such bi zarre form a tions 
within the cytoplasm . It also explains the conformation attained 
by clumps of neutrophils around previously unnoted amorphous 
m aterial (Fig . 3 . 7) which is aln:.ost certain ly the same 
rn acPomolecldar complex surrounde d by neutrophiis in attempted 
pb ago::::ytosis . 
FIGU RE 3. 7. 
Light micrograph of N BT te st preparation (heparin as anticoagulant ) 
showing neutrophi ls clumped around an amorphous precipitate , and 
form azan deposits at s ites of mutual contact. 
Leishman I s x2 , 000 
Il 2 
' 
3.1.5.SUMMARY OF SECTION I 
In this section a model system was constructed to 
investigate the mechanism of entry of NBT into neutrophils m the 
NBT test. The model system is basically similar to the standard 
NBT test, but differs in that endotoxin was used as an artificial 
stimulus of neutrophil activity. 
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It was found that NBT enters neutrophils in quantities 
visible as formazan by light microscopy as a result of phagocytosis. 
The dye is not phagocytosed when presented to the cell in solution 
but must be transported into the cell as a component of a macro-
molecular complex. The nature of this complex is dependent upon 
the anticoagulant used; in the presence of EDT A, fibrinogen, and 
with heparin, both fibrinogen and the heparin itself are preci :pitated 
from solution by, and complex with, NBT. These complexes are then 
phagocytosed in significant quantities only by neutrophils stimulated to 
phagocytic act~vity by endotoxin. 
The synthetic sucrose polymer, ficoll, enhances NB T 
reduction by promoting phagocytosis. 
3. 2. Studies on some of the factors which may enhance NBT 
reduction by neutrophils in the NBT test 
3 .2 .I. INTRODUCTION 
In the last section it was shown that in the NB T test, 
the dye enters neutrophils by the phagocytosis of the NBT complexed 
to precipitates of heparin and/or fibrinogen and that the NBT itself 
ts responsible for the formation of the complexes. These macro-
molecular complexes are present in all blood specimens to which 
NBT is added, but are phagocytosed to a varying degree, governed 
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to some extent by the clinical condition of the blood doaor and the 
conditions under which the test is performed ( Chapter 2) • There ts 
thus a variable phagocytic response by neutrophils exposed to a fairly 
uniform suspension of particles. In this section a study will be made of 
some of the factors which may be responsible for enhanced phago-
cytosis. 
A model system was constructed in order to test the 
m vitro effects of various substances on NBT reduction. Substances 
tested included endotoxin, heparin and a variety of other organic and 
inorganic chemical compounds and mixtures. 
It will be shown that endotoxin and heparin result m a 
fairly standard enhancement of NBT reduction, and that this increase 
in NBT reduction is dependent upon the concentration of these agents. 
The effect of endotoxin on NBT reduction by the neutrophils of patients 
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-..vith Crohn' s disease, diabetes mellitus, immune deficiency states, 
geriatric patients and patients receiving therapy with sodium ::1.uro-
thiomalate and prednisone is examined and compared to the dose 
response pattern in normal subjects. 
3.2.2. METHODS 
The model was designed to result in the same final 
concentrations of component mixtures as those used in the standard 
NBT test (Fig. 3.8). 
One volume ( usually O. 25 ml) of the additive, or dilutions 
thereof, in phosphate buffered saline was mixed with two volumes 
( usually O. 5 ml) of blood anticoagulated with EDT A or hepr:1rin. 
ll6 
After incubation at 37 ° C for IO minutes, one volume ( usually O. 25 ml) 
of O. 2% NBT in saline was added to this mixture which was gently 
shaken, incubated at 37 °C for a further 20 minutes, and slide 
preparations made and counted in the usual way. Control experiments 
usmg phosphate buffered saline with or without endotoxin ( 30 µg/ml) 
were also performed. 
3. 2. 2. a The effect of endotoxin on NBT reduction by the neutrophils 
of normal subjects and patients with a varity of conditions 
Subjects. Details of the normal subjects ( 38) and patients with 
Crohn I s disease ( 6) , diabetes ( 5) , immune deficiency ( 26) , geriatric 
FIGURE 3.8. (Opposite) 
Outline of the model system used to study the effect of the addition of 
various substances to blood on the reduction of NBT by neutrophils. 
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patients ( 6) , patients recetvmg therapy with sodium aurothiomalate 
( 8) and prednisone ( 6), the single patients with the Chediak-Higashi 
syndrome and another with C GDC are shown in Appendices I, J and K. 
Method. In this study blood was anticoagulated with EDT A ( 2. 4 mg/ml) 
and one or more dilutions of endotoxin added to give final concentrations 
of from IOO µg to l pg/ml. Blood with heparin as anticoagulant 
(50 i.u./ml) from the patient with the Chediak-Higashi syndrome was 
treated by identical methods. 
lmmunoglobu lin concentrations m the serum of patients 
with immune deficiency were measured by the_ Mancini radial 
immunodiffusion technique ( Mancini et al, 1965) at the Immune 
Deficiency Referal Laboratory for South East England. 
3. 2. 2. b The effect of varying concentrations of heparin on NBT 
reduction by neutrophils 
Blood was taken from 5 normal healthy adults and 
0. 5 ml immediately added to each of 7 plastic test tubes containing a 
mixture of O. 25 ml of phosphate buffered saline and sodium heparin 
(preservative fre'e, 162 i.u./mg, Evans Medical) to give final 
concentrations of O. 75, 6.6, 33, 66, 120, 175 and 330 i.u./ml. 
The standard procedure was then followed. 
3 . 2. 2. c The effect of various compounds on NBT reduction by 
neutrophils 
Screening tests were done with a large number of 
compounds, in varying concentrations, on the blood of normal adults 
anticoagulated with either EDT A ( 2. 4 mg/ml) , or heparin ( 2-50 
i.u./ml.) (Appendix L. Table 3.8 ) • Those experiments in which 
obvious changes in the amount of NBT reduction were ob~erved 
ll8 
were generally repeated a number of times together with controls 
(Appendix L, Tables 3.9, 3.10 ) • The effects of extracts of pus 
and thrombus were also tested in the model system. The preparation 
of these extracts and modifications of the model system now follow. 
Exposure of blood to pus 
1. 0 ml of sterile pus from an abdominal wound abscess 
was thoroughly mixed with 9. 0 ml of phosphate buffered sa!ine. 5. 0 ml 
of this mixture was homogenised in a Potter I s homogeniser. The 
homogenate and residual cell suspension were then centrifuged at 
2000 G at 20°C for IO minutes. The supernates, and dilutions there-
of, in phosphate buffered saline were substituted for phosphate buffered 
saline in the model system. 
Exposure of blood to thrombus supernate and lvsate 
IO. 0 ml of blood from a normal subject was defibrinated 
by continuous stirring with a wooden orange stick. The adherent 
clot was divided in two, one half was incubated in O. 5 ml phosphate 
buffered saline at 37°C for 30 minutes. The other half was homogenis-
ed in O. 5 ml phosphate buffered saline in a Potter's homogeniser. 
Both preparations were centrifuged at 2000 G at 20°C for IO minutes. 
The supe rnates were subs titute d for phos phate buffe red saline in the 
model syste m. 
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Modifications of the model system 
1, Exposure of blood to neuraminidase prior to incubation with NBt 
0.2 ml of blood ariticoagulated with heparin (20 i.u./ml) 
was mixed with 50 µI of neuraminidase (Vibrio cholerae, 500 i.u./ml) 
or 50 µI of heat inactivated neuraminidase ( I00°C for I hour} and 
incubated at 37°C for I hour. 0.25 ml of 0.1% NBT in phosphate 
buffered saline was added to and mixed with the blood and the standard 
procedure was then followed. 
11. Exposure of blood to abnormally high and low oxygen concentrations 
0. 5 ml blood samples m plastic test tubes were gassed 




• _ The blood was gently shaken, 
gaseous equilibration allowed for 5 minutes, the tubes were regassed 
for a minute and incubated at 37°C for 30 minutes. The standard 
procedure was then followed. 
m. Freezing and thawing and sonication of blood samples 
Heparinised blood samples were frozen and thawed once 
or sonicated for 15 seconds at an interpeak amplitude of 10 microns on 
a 150 watt MSE ultrasonic disintegrator with a 3. 0 mm titanium . probe 
emersed in the blood. The standard procedure was then followed. 
iv. Exoosure of blood to phosphate buffers of varying pH 
Aqueous solutions of O. ISM NaH
2
, P04 and O .15 M 
Na2 H P04 were mixed to give solutions with a pH range of 5. 5 to 
7. 5. These solutions were then substituted for phosphate buffered 
saline (pH 7.2) and the stcmdard procedure wns followed. The pH 
of the blood phosphate mixtures was not measured. 
v. The addition of Cytochalasin B to blood 
Cytochalasin B v.ras dissolved m dimethylsulphoxide 
(DMSO, I. 0 mg/ml) which was diluted to a final concentration of 
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33 µg/ml in phosphate buffered saline immediately before use, and the 
standard procedure was then followed. Control studies were performed 
with D MS O alone . 
v1. Exposure of blood to retinol 
Retinol was dissolved m ethanol ( 25 mg/ml and I. 0 
mg/ml) immediately before use. Volumes of 1-10 pJ were dispensed 
into plastic test tubes with a Hamilton syringe. I. 0 ml of blood was 
added to the test tubes during the course of continuous m1xmg on a 
mechanical mixer. The mixtures of blood and retinol were incubated 
at 37°C for IO mins, 1.0 ml of 0.1% NBT was added and the standard 
procedure was then followed. Control experiments were perfof"med 
using ethanol alone. All procedures involving retinol were performed 
in a darkened room. 
3.2.3. RESULTS 
With EDT A as anticoagulant in the model system ncrmal 
blood gave very low ievels of NBT reduction. Higher levels produced 
by the addition of compounds to the test system were therefore readily 
detected. The observation that the use of EDT A as anticoagulant 
reduced the sensitivity of the NBT test ( Park and Good, 1970) and the 
-t+ -t+ possibility that che lation of divalent cations such as Ca and Mg , 
might modify the effects of add itives led to the use of heparin as anti-
coagulant in some experiments. Before the re a lisation that heparin 
e nhance d NBT r eduction, varying concentrations were used, resulting 
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FIGURE 3.9. 
Effect of varying concentrations of endotoxin on NBT reduction by 
neutrophils of normal subjects ( EDT A as anticoagulant). 
( • Me an + l S . E . ) . 
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m different amounts of basal NBT reduction by neutroph_ils m the 
absence of any additives. Even when the same amount of heparin 
was used there was marked intersubject variation of NBT reduction. 
Analyses of the results that follow must therefore be made with 
knowledge of the anticoagulant used. The effect of an additive on 
NB T reduction by neutrophils m blood anticoagulated with heparin 
ts best interpreted by comparmg the effects of different concentrations 
of the same compound, or the effects of different compounds, 
processed simultaneously on the same blood sample. These results 
can be compared with baseline levels of reduction in the absence of 
any additives, and with levels of reduction obtained after stimulation 
with supramaximal -concentrations of endotoxin. 
3. 2. 3. a The effects of endotoxin on NBT reduction by neutrophils 
of normal subjects and patients with various diseases 
The results of exposing blood of normal subjects, 
anticoagulated with EDT A, to varying concentrations of endotoxin are 
shown in Table 3. 3 and Fig. 3. 9. There was a linear 
relationship between the NBT score and endotoxin concentration at 
concentrations of between lOO pg/ml and IOO ng/ml. At concentrations 
below 100 pg/ml there was no significant increase of NBT reduction 
above control levels and at concentrations above IOO ng/ml the NBT 
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FIGURE 3. IO. 
Effect of varying concentrations of endotoxin on NBT reduction by 
neutrophils from the blood of patients with diabetes mellitus 1:,. 
Crohn I s disease " , hypogammaglobulinaemia • , geriatric patients ,o 
patients receiving therapy with sodium aurothiomalate•and prednisone<? J 
and individual patients with the Chediak-Higashi syndrome l} and 
CGDC O compared to the response in normal subjects----.. 
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TABLE 3. 3, The effect of varying concentrations of endotoxin on 
NBT reduc~ion · by neutrophils from blood of normal subjects (with 
EDTA as anticoagulant). Results are expressed as the mean and S. E. 
NBT score. 
~ndotoxi~ g/ml lxl0-
4 10-5 10-6 10-7 10-8 10-9 10-10 10-ll 10-12 
No. of studies 7 8 23 31 28 29 29 20 4 
NBT score Mean 25.3 24.4 22.8 26.2 17. 5 9.2 3.0 I. I I. 0 
S.E. 4.7 2.2 2.0 2.5 2. I 1.4 I. I 0.4 0.5 
There was no significant deviation from the above 
pattern of NBT reduction in patients with Crohn I s disease, diabetes 
mellitus, geriatric patients and patients receiving therapy with 
prednisone or sodium aurothiomalate. Blood, whether anticoagulated 
with heparin or EDTA from the patient with the Chediak-Higashi 
syndrome gave a high level of NB T reduction in both the presence 
and absence of endotoxin, whereas ~o reduction occurred in the 






TABLE 3. 4. The effect of endotoxin concentration on NBT reduction 
by neutrophils from EDTA anticoagulated blood of patients with various 
conditions. Results are expressed as the mean and S. E. NBT score. 
The results of studies on individual patients with the Chediak-Higashi 
syndrome and CGDC are also shown. 
PATIENTS lENDOTOXIN] 
Age 
IxIO- 7 10-8 w-9 10-IO 
{ g/ml) 
Condition No. (years) 10-ll 0 
Diabetes 5 53.0 24.4 23.2 IO. 2 0.8 l.0 0.6 
mellitus ( 7. I) (4.8) (2.7) (4.0) ( 0. 3) ( 0. 6) (0.2) 
Crohn 's 6 48.0 26.2 25.3 IO. 2 2.3 0.6 0.3 
disease (6.2) (4.6) (2.9) (2.9) (0.6) (0.5) (0.3) 
Gold 8 56.8 26.6 17. 5 5. I 2.0 1.3 I. 6 
therapy (2.3) (4.7) (4.0) ( 2. I) ( 0. 7) (0.4) (0,5) 
Prednisone 6 44.5 33.5 25.5 7.8 7.0 3.8 0.3 
therapy ( 9. I) (IO.O) (6.5) ( 3. 0) (3.5) ( I. 4) (0.2) 
Geriatric 6 83.3 36.3 22.7 9.5 2.0 0.8 0.3 
subjects (2.9) (4.9) ( 5. 0) (3.2) (0.5) (0.6) ( 0. 2) 
Hypogamma- 24 24.5 19. 7 12. 6 4.6 0.8 I.0 0.8 
globulinaemia (3.3) (2.7) ( 2. I) ( I. 0) (0.2) ( 0. 7) (0.5) 
Chediak- I 3 43,60 - - - - 32,36 
Higashi 
CGDC I 4 0 - - - - 0 
The majority of patients with hypogammaglobulinaemia 
showed the same pattern of response to endotoxin stimulation. One 
patient (Appei;idix K, No. 7), a young man with childhood onset 
hypogammaglobulinaemia, was initially tested when he had a septic 
arthritis of the knee, retested when convalescent and again when fully 
recovered. The NBT scores showed a progressive rise with 
improvement in his clinical condition. The neutrophils of a 12 year old 
boy with congenital sex linked hypog ammaglobulinaemia (Appendix K, 
No. 3) and a persistent viral meningoencephalitis showed an almost 
complete inability to reduce NBT after exposure to endotoxin. 
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A young man (Appendix K, No. 15) with adolescent onset hypogamma-
globulinaemia failed to show normal NBT reduction upon endotoxin 
stimulation. He was subsequently found to have a bacterial hepatitis 
caused by one of the Borrelia species of bacteria. During the course 
of, and after, intensive prolonged intravenous penicillin therapy, NBT 
reduction by his neutrophils gradually increased as his clinical 
condition improved. Low NBT scores after endotoxin stimulation 
were also found in three other clinically well patients (Appendix K, 
No. 's I, 4 and 5) , all of whom had congenital or sex linked hypo-
gammaglobulinaemia. Brothers with sex linked disease both reduced 
NBT poorly (Appendix K, No.' s 3 and 4) while an affected male 
cousm (Appendix K, No. 9) and the maternal sibs (Appendix I, No. 1 s 
33 and 35) reduced the dye normally. 
Washed cells of the three of those patients whose 
neutrophils responded poorly when suspended in normal ABO blood 
group AB, plasma showed a slightly increased, but still highly abnormal 
NB T reduction in response to endotoxin stimulation. Washed normal 
ABO blood group O cells showed normal NBT reduction after suspension, 
together with endotoxin, in the plasma of these patients. This suggests 
that the defective NBT reduction by the se patients has a cellular 








TABLE 3. 5. NBT scores of washed cells from two sibs with sex 
linked hypogammaglobulinaemia ( Appendix K, No. 's . 3 and 4) and their 
parents exposed to endotoxin after suspension in autologous or ·heterolo-
gous plasma from blcod with EDT A as anticoagulant. Duplicate 
studies on cells from the same blood samples are shown. 
Hypogamma. Sibs. Parents (Normal) 
Number 3 Number 4 Mother Father 
Autologous 
Plasma o, 0 0, 5 10, 16 28, 14 
Heterologous 
Plasma 5, 6 4, IS 15, 17 23, 18 
(ABO group AB) 
TABLE 3. 6. NBT scores of washed cells from a hypogainmaglobulin-
aemic patient ( Appendix K, No. IS) and a normal subject suspended m 
autologous plasma or heterologous, ABO blood group AB, plasma. 
The normal cells were also suspended in the hypogamma. plasma. 
NBT scores from separate studies on cells from the same blood sample 
are shown. All plasma had EDT A as anticoagulant. 
CELLS 
Patient Normal Subject 
Hypogamma. 2, 6' 5 7' 8' 14 
Patient 
Normal 17, 16, 13 
Subjec_t 
Heterologous 
Normal 6, o, 9 18, II' 22 
(ABO Group AB) 
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FIGURE 3. II. 
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Effect of varying concentrations of heparin on NBT reduction by 
neutrophils of normal subjects. { • Mean ::!:" I S. E.). 
1 
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There was no :relationship between the serum concentration 
of the va:rio_us classes of immunoglobulins and NBT :reduction after 
endotoxin stimulation, which was normal even in the absence of measurable 
immunoglobulin. The general pattern of :reduction by the group "6.-S .a 
whole was normal (Fig. 3. IO) • 
3. 2. 3. b The effect of varying concentrations of heparin on NBT 
:reduction by neutrophils 
Increasing concentrations of heparin from 6. 7 5 to 66 i. u. /ml 
:resulted in a marked increase in the NBT score (Table 3. 7, Fig. 3.11). 
With higher concentrations of heparin there was a progressive diminution 
of NBT :reduction accompanied by increasingly marked morphologi.cal 
changes in the blood smears; the neut:rophils became clumped and 
stained poorly with Leishman' s stain. The cell clumps contained only 
ve:ry small amounts of :reduced NBT. 
TABLE 3. 7. The effect of heparin concentration on NBT :reduction by 
neut:rophils in the blood of normal subjects. Results a:re expressed as 
the NBT score. The mean and S. E. NBT score are also shown. 
Subject [ Heparin] i. u. /ml 
330 17 5 120 66 33 6 0.75 
I - 4r 52 82 39 I 0 
2 13 IS so 75 64 5 0 
3 I 8 28 53 68 57 4 3 
·-4 24 57 70 81 72 7 0 
5 30 44 59 65 57 9 I 
Number of 
4 5 5 5 5 studies 5 5 
Mean 18. 8 37.0 56.8 74.2 57.8 5.2 0 . 5 
S.E. (4.4) (6.4) (3.2) { 3. 0) ( 4 . 9) ( l. 2) {0. 5 ) 
TABLE 3.8 Screening tests of the effects of various subs~ances 
on NBT reduction by neutrophils m blood containing EDTA or 
heparin as : anticoagulant. _ 
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3.2.3.c The effect of sqme other substances on NBT reduction 
by neutrophils 
Screening tests were performed with a number of 
substances on blood containing EDT A or heparin as anticoagulant 
(Table 3 . 8 opposite) . 
In more complete studies, fetuin, immunoglobulins, 
al-acid glycoprotein ( Table 3. 9) , neuraminidase, active and 
heat inactivated, Cytochalasin B and KCN (Table 3.10) enhanced 
NBT reduction. All these substances also promoted neutrophils 
clumping, which was very marked after the addition of Cytochalasin 
B and neuraminidase. Formazan deposits observed in the 
preparations containing Cytochalasin B did not appear to have the 
normal intracellular location, but seemed rather to be adherent 
to the outer neutrophil membrane. DMSO, the solvent in which 
Cytochalasin B was solubilised, did not promoted NBT reduction 
or cell clumping. 
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TABLE 3. 9. The effect of fetuin, a 1-acid glycoprotein and 
immunoglobulins compared to phosphate buffered saline ( PBSA) + 
endotoxin on NBT reduction by neutrophils in the blood from five 
normal subjects (A-E) containing heparin ( 20 i. u. /ml) as 
anticoagulant. Results are expressed as the NBT score. The 
mean and S. E. NBT scores are also shown. 
ADDITIVE I SUBJECTS MEAN NBT 
Concentration A B C D E Score (S.E.) 
Fetuin ( 3. 3mg/ml) 30 16 48 12 3 2I. 8 ( 7. 0) 
al-acid glycoprotein 11 62 27 7 I 35 13 41. 6 (9.7) 
Immunoglobulin It 2 I 30 36 2 I 8 23.2 (4.2) 
PBSA - 9 5 33 2 0 9.8 ( 5. 4) 
PBSA 




TABLE 3. IO. The effect of active and heat inactivated neuraminidase, 
Cytochalasin B, KC N, NaF, anoxia and hyperoxia, compared to 
phosphate buffered saline :!:" end0toxin I an NBT reduction by neutrophils 
in the blood from five normal subjects containing heparin ( 20 i. u. /ml) 
as anticoagulant. The results are expressed as the NBT score. 
ADDITIVE SUBJECTS 
Concentration l 2 3 4 5 
Neuraminidase 
Active IOO~u./ml 36 53 so 39 -
Inactivated n - 78 70 42 -
Cytochalasin B IO µg/ml 45 83 92 86 ..,. 
KCN IO-3M S l - - - so 
NaF I0- 2M 4 - - - -
Anoxia l l - - - -
Hyperoxia 17 - - - -
PBSA 19 56 34 20 20 
PBSA 
+ IO µg/ml 56 8 l 70 73 -Endotoxin 
FIGURE 3.12. 
Light micrograph of a slide preparation made from a blood sample 
which was sonicated before incubation with NBT. The neutrophils 
show diffuse punctate formazan deposits. 
Leishman rs x 2,000 
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Freezing and thawing, sonication, lysolecithin and 
phospholipase C, all resulted in NBT reduction by most of the 
neutrophils. This reduction did not have the usual appearance but · 
consisted of diffuse, punctate, stippled formazan deposits which 
appeared to be confined to the outer membrane of the cell (Fig. 3. 12) • 
Cortisone acetate and hydrocortisone hemisuccinate, 
hexoestrol propionate and noradrenaline all inhibted NB T reduction, 
but only at very high, totally unphysiological levels ( Table 3. 8) . At 
these levels the corticosteroids inhibited reduction not only at a 
microscopic level but also in the supernatant plasma, where the 
customary blue colour failed to developed even after 18 hours of 
incubation. Adrenaline stimulated NB T reduction, but only at 
completely unphysiological levels. Isoprenaline reduced NBT 
directly, but did not enhance NBT reduction by neutrophils. 
Prostaglandins E1 and Ai caused partial diminution and 
NaF a marked decrease of NBT reduction. NBT reduction was 
partially inhibited by the higher concentration of r e tinol, but this 
was probably as a result of the high concentration of ethanol (I. 0%) 
which had a similar effect in the absence of re.tinol. 
ADP, Cyclic AMP, Isopre naline, lactate, phos phate 
buffers, prostaglandin F 2 a, sterile pus, Triton X 100, anoxia and 
hyperoxia 1 and products of coa gulation did not effect NBT reduction 
by neutrophiJ.s, in the test c onditions e mployed. 
3.2.4. DISCUS S ION 
In the previous sec t ion it w a s s hown that N B T enters 
neutrophil s by p h agocytos is of a macrom oledul &r complex incorporating 
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the dye. In normal neutrophils, reduction of NBT appears to be 
related to the "burst of metabolic activity" that accompanies phagocytosis 
( Park et al, 1968, Klebanoff, 1971). Thus the NBT test is a measure 
of the phagocytic activity of neutrophils. In exceptional circumstances, 
such as in C GDC, phagocytosis proceeds norm a lly ( Stossel et al, 
1972) but reduction of the dye is absent or delayed ( Nathan et al, 1969 ) .. 
In this section there are three groups of studies. The 
firs't study investigated the effect of various compounds, including 
endotoxin and heparin, on NBT reduction by the neutrophils of normal 
subjects. In the second study, a standardised endotoxin stimulation 
test was used to investigate neutrophil function in patients with a 
variety of diseases. Thirdly, the model was used to investigate the 
effect of NBT reduction of factors, the serum concentratiors of which 
are elevated in disease, and which could be directly responsible for 
the enhanced reduction of the dye observed in a positive NBT test. 
3. 2. 4. a The effect of endotoxin, heparin and · other comoounds on 
NBT reduction by neutrophils 
1. The effect of endofoxin on NBT reduction 
Enhanced NBT reduction has been demonstrated after the 
addition to blood of endotoxin ( Bark and Good, 197 0) , cell free 
bacterial culture filtrates ( Matu la and Paterson, 1971a ) and bacteria 
( C occhi et al, 1971b) . The mode l system describe d here differs from 
that of Park and Good ( 1970) in that they used blood with heparin as 
anticoagulant and a single very high concentration ( 20 µg/ ml ) of 
endotoxin. EDT A was used as anticoagulant in this study a.s it gives 
more reproducible baseline results than heparin, which itself 
enhances NB T reduction. The single high concentration of 
endotoxin used by Parl< and Good provided a supramaximal 
stimulus, and they did not investigate the dose response of' NBT 
reduction by neutrophils from normal or abnormal subjects. 
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In the model system employed in this study, in normal 
subjects, an increase in the concentration of endotoxin from 100 pg/ml 
to 100 ng/ml resulted in a linear increase in the proportion of 
neutrophils that reduced NBT. Endotoxin concentrations below 
JOO pg/ml did not stimulate, and concentrations greater than 100 ng /ml 
did not further enhance NB T reduction. 
This test was also performed on patients with CGDC 
and with hypogammaglobulinaemia because of reports of false-negative 
NBT tests in these subjects { Table 2. I) , and on the patient with 
the Chediak-Higashi syndrome in which false-positive NBT tests 
have been observed { Table 2. 2). Diabetic patients were 
investigated because they are liable to infection { Seymour and Phear, 
1963), and patients with Crohn I s disease because it is a 
granulomatous disease, the aetiology of which is unknown and which 
could be related to defective neutrophil function. The effect of old 
age and ther apy with sodium aurothiomalate was also investigated. 
It was found that all the groups of patients responded with 
a similar pattern to the normal subjects (Fig. 3. IO, Table 3. 4). These 
findings indicate that the parameters of neutrophil function measured by 
a stimulated NBT test, the enhancement of phagocytosis by endotoxin: 
and reduction of the dye, are normal in the majority of individuals m 
the various groups of patients studied. 
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The finding of normal NBT reduction by patients rece1vmg 
therapy with glucocorticoid drugs is at variance with the decreased 
reduction observed in these patients by Chretien and Garagusi ( 197 3) 
which may be a reflection of the different stimuli used to enhance NBT 
reduction, or the short duration of steroid therapy in three of their 
five patients. A few patients with hypogamm aglobulinaemia showed 
diminished, and the patients with C GDC complete absence of NB T 
reduction. The patient with the Chediak-Higashi syndrome revealed 
greatly enhanced NB T reduction in both the presence and absence 
of endotoxin, which correlates well with the observation ( Stossel 
et al, 1972) that phagocytosis of relatively inert particles is increased 
m this condition. 
11. The effect of heparin on NBT redu.ction 
Heparin resulted m a concentration dependent enhancement 
of NBT reduction in initial concentrations of up to 66 i. u. /ml ( final 
concentration 50 i. u. /ml). At higher concentrations of heparin the 
neutrophils appeared damaged and NBT reduction was decreased 
( Table 3. 7, Fig. 3 .11). These r e sults indicate that heparin itself 
enhances phagocytosis of comple x e d NBT and that the u s e of high 
concentrations of this agent as a nti c oagulant wou ld result in false-
positive results in the NBT te st of P a rk et al ( 1968) ( 2. 5) . A 
discre pancy e x ists be tween the un ifor m enhance m e nt of NBT reduction 
by heparin in this s tudy, c1nd NBT reduction by neutrophils in blood 
of normal subjects in which a standard ( initial and final concentrations 
of 50 and 25 i. u. /ml respectively) concentration of heparin was used 
as anticoagulant · in the re-evaluation of the NBT test ( 2. 3) . In the 
latter, a wide range of NB T scores was obtained. Possible 
explanations of this discrepancy are that in the present study a 
diffe.rent preparation of heparin was used ( preservative free), blood 
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was added to heparin in phosphate buffered saline rather than heparin 
alone, and blood from all five subjects was studied simultaneously, under 
the same conditions on the same day. 
Further studies on the NBT test performed on blood anti-
coagulated with heparin should utilise a standard low concentration of 
heparin to prevent enhancement of NBT reduction by heparin itself. 
m. The effect of other compounds on NBT reduction 
Cytochalasin B was studied because it is known to partially 
inhibit phagocytosis (Davies et al, 1973a), and therefore might be 
expected to diminish NBT reduction. In view of this it was surprising 
to find that it enhanced NBT reduction (Table 3. IO) . The marked 
cell clumping induced by this agent, as observed in this study, and 
the inhibition of glucose transport into cells ( Zigmond and Hirsch, 1972) 
suggests an effect on the cell membrane. Increased NBT reduction 
may result from increased adhesion of complexed NBT to the cell 
surface, a situation in which it may be susceptible to NBT reduction 
by the same mechanisms as are responsible for dye reduction within 
the phagocytic vacuole. This concept will be elaborated upon in 
section 4 ( 3 . 4 . 4 . ) . 
The effect of neuraminidase was investigated as it has 
been shown to enhance phagocytosis by macrophages (Weiss et al, 
1966) . It enhanced NB T reduction by ·neutrophils (Table 3. IO) and 
also caused marked cell clumpirig. These effects are discussed in 
the next section ( 3 • 3 . 5 . ) . 
Screening tests on the effects of other compounds on 
NBT reduction were also performed. The results of these were 
not pursued further and are only included in the discussion for the 
sake of completeness. 
In accordance with the findings of Park et al ( 1969), NaF 
inhibited NBT reduction, suggesting that glycolysis is important for 
NBT reduction. KC N enhanced NBT reduction ( Table 3. IO), and 
this finding, together with the observation which was not reproduced 
in the single experiment in this study, that high concentrations of 
oxygen inhibit NB T reduction ( C occhi et al, 1971b) , suggest that 
anaerobic respiration may enhance phagocytosis. 
Increased lactate production accompanies phagocytosis 
(Klebanoff, 1971) . Neither lactate itself nor aQidic phosphate buffers 
enhanced NBT reduction. 
Surprisingly, extracts and homogenates of sterile pus did 
not enhance NBT reduction in the single e xperiment in which these 
were tested. 
Exposure of cells to phospholipa se C, lysolecithin, 
s onication and fre ezing and thawing, proce dures which result m 
damage to the cell m e mbrane, all enha nce d NBT reduction. The 
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reduced NBT did not have the characteristic appearc:.nce c,f focal, 
discrete lumps of formazan, but took the form of minute 
punctate deposits. These may result from the reduction of NBT 
at breaks in the neutrophil membrane, as will be discussed in 
section 4 (3.4.5.}. 
3. 2. 4. b In vivo factors which might be responsible for enhanced 
NBT reduction in the NBT test 
The original hypothesis as to the mechanism of induction 
of NBT reduction in neutrophils ( Park et al, 1968} was that it 
occurred as a result of a change in the neutrophil membrane 
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resultant upon the burst of metabolic activity induced by the phagocytosis 
of microorganisms. These workers found that a mean of 5825 
neutrophils/c .mm in infected pa tients contained formazan deposits, which, 
taking into a ccount the turnover rate of peripheral blood neutrophils 
( 3. 3. 6.), would suggest tha t vas t numbers of bacteria, in the order 
of magnitude of I x 109 - x 1010 were exposed to neutrophils every 
few hours for th e duration th a t the test remains positive, which may 
be a matte r of w eeks ( Ma tul a and Paterson, I97la) . Such a 
situation could be contemplate d for a limite d period cf time in a patient 
with an overwhe lming septic aem ia but is ha rdly likely to be responsible 
for the posit ive tests reported in patients wi th streptococcal pharyngitis 
( R and all et a l, 197 3 ) o ~' par asit ic diseas e ( Chretien a nd Garagusi, 1971) 
o r to be re spons ible for the diverse c o ndition s :resulting in a false 
pos itiv e te st. (Table 2. 2 ) . 
NBT reduction has been ehanced in vitro by the 
addition to blood of bacterial endotoxin · (Park and Good, · 1970). 
In this study endotoxin in concentrations of greater than Ing /ml 
enhanced NBT reduction and could be one of the factors responsible 
for a positive NBT test in infected patients m whom endotoxaemia of 
the same order of magnitude has been recorded ( Levin et a!, 197 0, 
Caridis et al, 1972, McGill et al, 1970). 
Endotoxaemia is not limited to gram negative bacterial 
infection, but also occurs m non-infective disease, possibly as a 
result of a failure of the hepatic clearance of bacteria, or products 
thereof, originating m the gut ( C arid is et al, 1972) . False positive 
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NBT tests could result from a secondary endotoxaemia, but the 
severity of the non-infective illnesses resulting in such an endotoxaemia 
( C arid is et al, 1972) would suggest such a mechanism to be a rare 
one, at least in the P3-tients included in the re-ev&luation of the test 
performed m this study ( 2. I.) • 
As a result of the observation ( Chapter 2, Table 2. IO) 
that the NB T score was related to the degree of constituticnal 
symptoms in infected patients and the fact that myocardial infarction 
results in positive NBT tests ( Lauter et al, 197 3), factors known to 
be increased in the serum of acutely ill patients were investigated for 
their ability to enhance NBT reduction by normal neutrophils. 
Serum concentrations of glucocorticoid hormones are 
increased in stressful situations ( Smith and Hoijer, 1962), and there 
has been · a divergence of opinion as to the effect of therapy with 
exogenous gluco~orticoids on results obtained from the NBT test. 
Ng et al (1972) and Miller and Kaplan (1970) felt that prednisone 
therapy decreased NBT reduction in infe cte d patients, while Matula 
and Paterson 0971b) attributed f-3.lse positive results to this drug. 
Wollman et al ( 197 3) concluded that even mass ive doses of gluco-
corticoids do not have a prolonge d effect upon NBT test results 
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but that intravenous administration of a bolus of methyl prednisone 
caused a sharp drop in the NBT score soon after injection. In 
the model system, neutrophils of patients unde rgoing treatment with 
prednisone reduced NB T norm a lly after endotoxin stim ulation. 
Cortisone acetate and hydrocortisone he misuccinate inhibited NBT 
reduction, but only at the highly unphysiologic a l levels of I x 10-3 
and I x 10- IM respectively. Conc entra tions of lmM, about SO times 
greater than that achieved in the blood of an adult after the intravenous 
administration of 500mg of hydroc ortisone ( P e terson et a l, 1955) had 
no effect. It is unlikely that endogenous glucocorticoid hormones 
promote NBT reduction in sick p atients, or that th e r e s ults of NBT 
tests are grossly modified by the r apy with these agents . 
Physiologi8al concentrations of adren aline a nd noradrenaline, 
serum levels of which are acute ly raised by s tress ( Smith and Hoijer, 
1962) did not influence NBT r e duction. S imil a r ly , isop renaline , a 
s ynthetic f3 adrenergic receptor stimulant ( H arr ison et a l , 196 7) was 
ineffective. Adrenaline a nd is oprenaline a r e thought to m ed iate the ir 
effe ct through the "se cond me ssenger", c yc lic adenosine 3 1 , 5 ' -
monophosphate ( Robin s o n e t a l, 1971). Although level s of thi s 
\ 
compound are elevated in phagocytosing neutrophils ( Park et al, 1971) 
it did not itself stimulate NBT reduction. Raised neutrophil levels of 
cyclic AMP may be a sequel to, rather than a promoter of, 
phagocytosis. 
Prostaglandin E1 increases cyclic AMP levels in various 
tissues (Horton, 1969) including leukocytes (Scott, 1970) a:rd 
stimulates leukocyte margination ( Kaley and Weiner, 1971) . The 
prostaglandins E1 and Ai have been shown to promote an e.cute 
inflammatory response ( Kaley and Weiner, 1971). These substances 
in similar concentrations partially inhibited NBT reduction in the 
model system, whereas Fza was without effect. 
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Thrombocytosis may accompany acute tissue necrosis 
following trauma or inflammation, and may also occur in tuberculosis 
and Hodgkin I s disease ( Shaw and Oliver, 1958, Ozer et al, 1960, 
Fountain and Losowsky, 1962). Positive NBT tests may occur under 
the same circumstances. Although the platelet concentration in the 
blood smears of some of these patien ts correlated poorly with the 
NBT score ( 2. 3.) , the possibility existed tl-ut some humor al factor, 
release d from platelets, might enhance NBT reduction. ADP is a 
natural platelet aggregant and is r e leased from platelets after adhesion 
( Hovig, 1963). NBT r eduction w as n ot enhanced by ADP itself or 
by the supernatant fluid in wh ich thrombus had been incub ated. 
The I acute phase reactants w constitute a poorly defined 
group of plasma proteins including fibr inogen , haptoglobins , a, 1-acid 
glycoprotein, a 1-antitrypsin , C RP, and antichymotrypsin. The 
concentration of these proteins is elevated as a non-specific sequel to 
inflammatory disease ( Boltax and Fischel, 1956) , myccardial infarction 
(Johansson· et a·I, 1972) or $urgical trauma (Aronsen et al, 1972). 
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The patients with myocardial infarction with various complications 
sustained high levels of a '-antitrypsin, a 1-acid glycoprotein, C RP and 
antichymotrypsin. NB T tests are positive after myocardial i11farction 
and remain positive in patients with complications ( Lauter et al, 197 3) • 
The function of some of the 11 classical11 acute phase 
reactants is uncertain. Fibrinogen has an important role in the 
coagulation system (Seegers, 1967) and a 1-antitrypsin and antichymo-
trypsin may function as inhibitors of the proteolytic lysosomal enzymes 
released from damaged tissues (Janoff e t al, 1962). C RP has been 
shown to enhance phagocytosis and it has been suggested that it may 
function as an opsonin ( Hokama et al, 1962) but the · role of a I-acid 
glycoprotein remains an enigma. Fetuin has a num ber of fe a tures in 
common with al-acid glycoprotein. It is also an acidic glycoprotein 
( pK 3. 5) with the ele ctrophoretic mobility of an a
1-globulin (Pe de rson, 
1945). It occurs in the serum of those foe tal and n e onatal animals m 
whom the placenta is impermeable to m ate r n al immun oglobulins 
( Jameson et al, 1942, Hansen a nd Phi lips , 194 7, Barboriak e t a l, 1958, 
Lecce et al, 1961) . The s e rum concentrations of fe tuin fall s to very 
low levels within thre e to fou r days of birt.h , when serum imrnuno-
globulins are acquir e d from mate r n a l c o los tr um ( Smith , 194 6 , H a n s en 
and · Philips , 194 7) . 
146 
Human syncitial and foetal membranes become permeable to 
lgG but not to lgM after the first trimester of pregnancy. Human foetal 
plasma comprises at least one protein species not normally demonstrable 
in the adult, which displays certa in features similar to those of fetuin 
but which disappear early in foetal life. There is also a possibility 
that human neonatal serum has an a •-globulin of a similar nature, but 
the evidence is conflicting and awaits experimental clarification ( Schultze 
and Heremans, 1966) . C RP levels are frequently elevated in the first 
weeks of life ( Hanson and Nilsson, 1962) possibly rela ted to stress 
induced by adaptation to extra uterine life (Sand or, 1966a) . 
Fetuin and a 1-acid glycoprotein both enhance NBT 
reduction (Table 3. 9) in physiological concentrations a nd serum 
concentrations of a I-acid glycoprotei~ correlate well with NBT scores 
on the same blood (Table 2. 9) . 
Myeloma ( aspecific) immunoglobulins lgG and lgM, but not 
lgA, function a s opsonins ( van Oss and Stinson, 1970, Stinson and 
van Oss, 1971) . A non- specific rise in the Y globulins occurs m a 
vast n umbe r of diseas e s of diverse aetiology (Sand or, 1966b) . Immuno-
glob ul ins e nhanced NBT reduction in the model system ( Table 3. 9). 
E levated c once ntration s of the s e pr oteins could be responsible for false 
positiv e N B T tests in a la rge proportion of the conditions in which 
these have been r e porte d (Ta ble 2. 2) . 
In this study, many factors e nha nced the phagocytosis o-f 
com p le x ed N B T by neutr ophils. Serum concentra tions of a numbe r of 
compound s are commonly e le v a te d in di sease . Of tho se teste d, on ly 
I .cl I . · a -ac t g y coprote m , 1mmu n og lobulins and e ndotox in promoted NBT 
reduction in vitro. It ,s tentatively suggested that any one .:,f these 
' 
substances, singly or m varymg combinations, or other as yet 
unidentified substances, may be responsible for the increased 
phagocytosis of NBT indicated by a positive NBT test. 
3. 2. 4. c The physiological role of heparin, a I-acid glycoprotein 
and fetuin 
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The preceding studies demonstrated that he par in, cl: 
1
-acid 
glycoprotein and fetuin promote ·the phagocytosis of complexes of 
fibrinogen and .NBT. The physiological roleof these compounds 1s 
obscure. It is suggested that they function as a non-specific opsomsmg 
system to enhance the phagocytosis of endogenous debris as well as 
exogenous particulate matter. Current knowledge of non-specific 
opsonins and the role of heparin will be briefly discussed, after 
which this hypothesis will be expanded upon. 
1. Opsonins 
When Metchnikoff defined the process of phagocytosis 
m 1884 ( Metchnikoff, 1884) , he placed little importance on the role 
of serum. Wrig.ht and Douglas ( 1903·, 1904) established that serum 
facilitated the phagocytosis of pathogenic b a cteria, that its permissive 
effect was achieved by modification of the micro-organism rather than 
the neutrophil, and that immunity to bacterial infection developed as a 
result of changes in the serum rather than in the · neutrophils 
themselves. They called this 11 an I opsonic' effect ( opsono - I cater 
for; I prepare victua ls for) 11 and suggested the term tt r ops on ins r 
to designate the elements in the blood fluids which produce this effect". 
Subsequent investigation has established that specific 
antibody in the absence and in the presence of complement 
(Winkelstein, 1973), aspecific (myeloma) lgG and lgM (van Oss and 
Stinson, 1970, Stinson and van Oss, 1971) , and a peptide product 
of the proteolysis of Y globulin, "tufsin11 (Najjar and Nishioka, 1970), 
all facilitate phagocytosis by neutrophils. 
Proteins other than immunoglobulins have also been 
implicated as opsonins. Surgenor ( 1952) and Tullis and Surgenor 
') 
( 1956) demonstrated the presence of two heat lacile fractions with 
the electrophoretic mobility of an a '-globulin and f!, globulin 
respectively,· in normal human plasma. These fractions promoted 
the phagocytosis of inert particles by leukocyte~ and were termed 
the phagocytosis-promotion factors ( PPF). The identity of these 
proteins is unknown. When the third component of complement ( C 3) , 
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a f!, globulin_, is activated by the classical pathway, or the alternate 
pathway, which requires properdin, it acts as an opsonin ( Winkel stein, 
1973). Tullis and Surgenor (1956) observed that both heat inactivation 
of complement and inhibition of the alternate pathway by adsorption of 
properdin with zymosan r educed the activity of PPF by approximately 
35%. C 3 could be a component of the f!, globulin fraction of the PPF. 
C r eactive protei n ( C RP} is a /3 globulin (McCarty, 194 7), 
It also causes pneumococcal capsular swelling and complexes with 
a number of micro-organisms in the presence of calcium ions 
( LBfstrom, 1944) . Approximately 25% of the PPF activity was 
removed by the add ition of powdered barium sulphate which adsorbs 
CRP (Ganrot and K indm ark, 1969). C RP may be another 
component of the f3 globulin fraction of the PP F ( Ganrot and 
Kindmark, 1969) although it is only present in trace amounts m 
the serum of healthy adults ( Laurell, 1972). ~ Lacid glycoprotein 
1s one of the three major CK 1-globulins ( Laurell, 1972) . Its function 
is unknown. It could be a component of the ~ I fraction of the PPF. 
The non-specific opsonising system and PPF system are 
both inactivated by heating serum to 56°C for 20 minutes (Smith and 
Wood! 1969, Tullis and Surgenor, 1956). The effect of mat on 
opsonisation by CRP a~d oc 1-acid glycoprotein has not yet been 
investigated. This procedure should help to clarify whether or not 
these proteins are constituents of the non-specific opsomsmg systems 
so far described. 
Opsonisation 1s also important for phagocytosis by the 
reticuloendothelial system (RES). RES blockade, in which an 
initial intravenous ( i. v. ) injection of particulate matter results m 
reduced clearance from the circulation of a second i. v. dose of 
the same material, was thought to result from physical saturation 
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of the system ( Biozzi et al, 1953, Benacerraf et al, 1954) . Blockade 
1s related to the surface properties of the colloid (Murray, 1963a and b) , 
preopsonisation of particles overcorres it ( Jenkings and Rowley, 1961) 
and it has been proposed that reticuloendothelial blockade might result 
from depletion of opsonm (Saha and Di Luzio, 1965) . In the 
isolated perfused liver, a heat labile, 1 exhaustible I plasrra factor, 
independent of haemolytic complement, h as been shown to opsonise 
particulate carbon ( Filkins and Smith, 1965, Filkins et al, 1965). 
The nature of these opsonms 1s unknown, although a 
barium sulphate adsorbable a 2 globulin enhances the phagocytosis 
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of colloidal particles by Kupffer cells (Saba et al, 1966) and aand 
f3 globulins have been found to bind to colloidal gold (Simon, 1954). 
The non-specific systems that enhance phagocytosis by neutrophils and 
the RES appear to have a number of features in common. 
Tests of neutrophil phagocytosis and its modification by 
various substances, have largely involved measurement of the uptake 
of microorganisms and inorganic particles. Such systems are crude 
as the particles are generally amenable to endocytosis and a gross 
phagocytic defect is required ~o incur an abnormal result. No 
quantitative studies have been performed on the phagocytosis of fibrin 
or cell debris and as a result very little is known of the circumstances 
1 
necessary for endocytosis. There are a number of disease ·states 
in which tissue specific antibodies are associated with pathology, for 
which they may be casual ( Holborow, 1968) . It is possible that the 
phagocytosis of autologous material requires opsonisation by a system 
which is both non-specific and non-cytopathic. This probably 
precludes specific immunoglobulins which although capable of opsonic 
activity are unlikely to distinguish autologous debris from normal 
constituents of the body on which they would probably exert a 
pathological effect. 
ll • Heparin 
Heparin occurs almost exclusively within the mast cell 
( Ehrlich and Stivala, 197 3) in which it is contained within granules, 
bound to hista mine and 5-hydroxy tryptamine b y a basic granule 
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protein ( Uvnas et al, 1970, Bergendorff and Uvnas, 1972). Oegranulation 
of the mast cell is readily induced by many relatively minor physical 
and chemical changes in the environment ( Selye, 1965a) and heparin ts 
released from the basic granule proteins m the presence of cations 
{Uvnas et al, 1970, Bergendorff and Uvnas, 1972) • 
• 
The number of visiHe mast cells are acutely reduced by 
trauma (Wichman, 1955) or acute inflammation (McGovern, 1957), 
suggesting release of their contents, but are increased in areas 
surrounding chronic inflammation and neoplasia ( Selye, 1965b). 
The physiological function of heparin is unknown although 
various roles· have been attributed to it. It is known to have a 
lipolytic action ( Robinson and French, 1953) and the an a tomical 
situation of mast cells predominantly around blood vessels ( Se!ye, 
1965c) has led to postulations that the focal rele ase of h e parin 
inhibits thromboembolic di s ease ( Petterson and Hje lmman, 1964) and 
atherosclerosis (Pollak, 1957, Wexler, 1964). 
In addition to its known anticoagul ant acti on ( E hrlich and 
Stivala, 197 3) , heparin has a thrombolytic e ffect ( F itzg e r a ld et al, 
I967, Fitzgerald, 1969) , the mechan is m of which is n ot unde rstood. 
Neutrophils are important in the r esolution of fibrin in inflammatory 
exudate and in intr avascul a r thromb u s (Barnhart, 1966). The 
efficacy of low dose hepar in ther a py in the prophylax is of deep vem 
thrombosis is unexp lained, as the quantitie s admini stered d o not 
reach anticoagula nt levels a lth ough conce ntrations o f c oagulation factor 10a 
are r e duced { K akk a r et al, 1971) . 
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I 
111. An hypothesis as to the role of Cl' -acid glycoprotein, fetuin, 
heparin and other compounds as promotors of phagocytosis 
It is known that ( Winkelsteil), 197 3) there are two systems 
of opsonms. The specific immunoglobulins ar_e d irected against 
micro-organisms and may be directed against autologous tissue m 
pathological situations. There is also a system of non-specific 
opsonms, including C 3 and possibly C RP, ci-acid glycoprotein, 
fetuin and heparin, produced in preparation for, or at time of, stress 
which augment phagocytosis of foreign material and possibly also of 
endogenous particulate waste. 
-Serum levels of the 11 acute phase reactants", CRP and 
t 
Cl' -acid glycoprotein are elevated by stress. Fetuin is present in 
the neonatal animal when it is first exposed to invasion by micro-
organisms and deficient in specific opsonins. Serum levels of fetuin 
decline at the same time that specific antimicrobial opsonins are 
acquired from m a ternal colostrum. Heparin is released at the site 
of inflammation where opsonisation of the . aggressive organism and 
the resolution of damaged tissues and products of inflammation are 
most needed. It is possible that the release of heparin is a focal 
phenomenon, as a result of the decreased survival value that would 
be afforded by a substance with both opsonic and anticoagulant 
properties in a s tressful situation, when haemostasis may be vital. 
These substances together with immunoglobulins and 
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FIGURE 3.13 
The effect of varying concentration of heparin on the reduction of 
NBT by neutrophils ( this study) and on pinocytosis by mouse 
macrophages in an in vitro culture system (Cohn and Parks, 1967). 
The pinocyte index, E /C, is an expression of the ratio between the 
number of pinosomes observed in cells exposed to heparin ( E) and 
in control cells ( C) . 
complexed NB T. In studies (Conn and Parks, 1967) on 
factors inducing microscopically visible pinocytosis in a mouse 
macrophage culture system, the same compounds were observed 
to promote, and heparin in high concentrations to decrease, 
endocytosis and the concentrations necessary to exert these effects 
were similar in both studies ( Table 3. II, Fig. 3 .13). 
TABLE 3.ll. The concentration (± range) of compounds shown 
~o enhance phagocytosis of complexed NBT (this study) or pinocytosis 
by mouse macrophages (Conn and Parks 1 1968). 
Additive Neutrophil Mouse Macrophage Units 
Phagocytosis Pinocytosis 
Fetuin 0.4 - IO. 0 0.5 - 20:0 mg/ml 
P globulin 3.3 2.0 - 20.0 II 
Ficoll 200.0 10.0 - 50.0 II 
Heparin 5.0 - 400.0 13.0 - 700.0 ,u g/ml 
CRP, raised serum levels of which are found after 
stress and in some neonates, enhances phagocytosis of bacteria 
and other particles by neutrophils ( Hokama et al , 1962, G anrot 
and Kindmark, 1969). In the latter study a 1-acid glycoprote in · 
was found to be without effect . Its effect may have been pre sent 
but masked by hepar in present in the test s ystem, as both compounds 
are very acidic. Heparin h as been shown to facilit a te thrornbolysis 
which may have r esu lted from phagocytosis of the thrombus 
(Fitzgerald, 1969) and its effect in the prophylaxis of venous 
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thrombosis in subanticoagulant doses may be mediated by the 
enhanced removal of microthrombi. 
The concentration of heparin necessary to enhance 
NBT reduction cannot be directly compared with the blood levels 
of heparin reached with low dose heparin therapy ( 0. 2 i. u. /ml -
Yin et al, 197 3) , because NBT precipitates heparin, and it has 
not been established whether free or complexed NBT is responsible 
( 
for opsonisation. Heparin in a concentration of I. 0 i. u. /ml 
( the lo.,vest concentration studied) markedly enhanced the phagocytosis 
of colloidal gold by Kupffer cells ( Filkins and Di Luzio, 1966), 
demonstrating opsonisation at relatively low concentrations. 
C RP, oc 1-acid glycoprotein, fetuin and heparin are all 
acidic. Cohn and Parks observed the promotion of endocytosis 
almost exclusively by acidic . compounds. Fetuin, c.<
1
-acid glyco-
protein and immunoglobulins are rich in carbohydrate, and heparin 
and ficoll are carbohydrate polymers. This may be relevant to 
the binding of these compounds to the cellular membrane as it is 
known that the carbohydrate component of immunoglobulins resides 
in the hinge section of the Fe component of the heavy chain 
(.Edelman, 1971) which is responsible for binding the molecule to 
specific receptors on the neutrophil membrane ( Messner and Jelinek, 
197 0) . 
3.2.5. SUMMARY 
Using a model system it was found that in normal 
subjects, patient with Crohn' s disease, diabete s mellitus, geriatr.,ic 
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subjects and patients receiving therapy with sodium aurothiomalate 
and prednisone, there was a standard response of NBT reduction 
to varying concentrations of endotoxin. Abnormal, results were 
obtained in some hypogammaglobulinaemic patients and in a patient 
with CGDC and another with the Chediak-Higashi syndrome. The 
model system evolved may be of value in the in vitro assessment 
of neutrophil function. 
The concentration of endofoxin necessary to induce 
NBT reduction in vitro were of the same order of magnitude as 
are found in endotoxaemia in vivo. Endotoxin may be one of the 
humeral factors responsible for a positive NBT test. 
The serum concentration of many substances 1s 
increased under stressful circumstances. Some of these were 
investigated for their ability to enhance NBT reduction in vitro. 
This was observed with the 11 acute phase reactant", a ..-acid 
glycoprotein, and with fetuin, heparin and immunoglobulins. 
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An opsonic function as part of a non-specific opsornsmg 
system was proposed for some of the "acute phase reactants" as 
well as for fetuin and heparin. 
It was proposed that a number of humeral factors 
could be responsible for the increased phagocytosis of complexed 
NBT indicated by a positive NBT test, and that they may act 
singly, or in combination, in an individual test subject. 
3.3. SECTION 3 Possible causes of false negative NBT tests 
and studies on the effect of heterologous serum on NBT 
reduction by normal neutrophils. 
3.3.l. INTRODUCTION 
A significant proportion of neutrophils fail to reduce NBT 
despite exposure to infection in vivo ( Park et al, 1968, Matula and 
Paterson, 1971a, Feigin et al, 1971, Fikrig et al, 197 3, Gordon et al, 
1973) or bacterial products (Matula and Paterson, 1971a, Koch, 1973), 
I 
bacteria ( C occhi et al, 1971a) or endotoxin and heparin ( this study) 
in vitro. 
It thus appeared that a population of neutrophils exists 
that does not respond to infection m vivo, or stimulation in vitro, by 
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the phagocytosis and reduction of NBT. For reasons that will be 
delineated later ( 3. 3. 5.) it was felt that this absence of NBT reduction 
might be a reflection of cellular immaturity. In this section the 
reduction of NBT by immature, bone marrow, neutrophils is examined 
and will be shown to be decreased in comparison with circulating 
neutrophils. It will also be shown that p--eincubation with immune 
complexes diminishes NBT reduction by neutrophils. In the light of 
these findings, the effect of sera from infected and uninfected patients 
on whom NBT tests were performed ( Chapter 2), upon NBT 
reduction by normal neutrophils will be examined. 
3.3.2. METHODS 
3. 3. 2. a Exposure of autologous blood and bone marrow to "arious 
compounds 
Sternal bone marrow and autologous peripheral blood 
samples were obtained simultaneously from subjects with a variety of 
non-malignant disease. These specimens . were exposed to various 
compounds by the methods outlined in 3. 2. 2. and to latex particles 
by the method described in 3. l. 3. l. 
1. Exposure of autologous blood and bone marrow, with heparin as 
anticoagulant, to endotoxin, Cytochalasin B, neuraminidase and 
latex particles. 
Peripheral blood and bone marrow samples ( 2. 0 ml) 
from 6 subjects, of whom 5 had macrocytosis in the absence of 
megaloblastosis and the sixth, cyclical neutropenia, were taken into 
plastic tubes containing heparin ( 50 i. u. /ml) and exposed to either 
phosphate buffered saline alone or phosphate buffered saline containing 
endotoxin ( IO µg/ml ), neuraminidase ( 100 i. u. /ml) or latex particles, 
or to Cytochalasin B ( IO µg/ml) in OMS O. 
11. Exposure of autologous blood and bone marr0w to endotoxin m 
the presence of EDTA as anticoagulant 
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Autologous blood and bone marrow specimens ( 2. 0 ml) 
with EDTA as anticoagulant ( 2. 4 mg/ml), from 5 patients were 
exposed to endotoxin ( 10 µg/ml) . 
111. Exposure of autologous blood and bone marrow to various 
concer.trations of hepar in 
Autologous blood and bone marrow samples from two 
male subjects aged 62 and 59 years with macrocytosis in the absence 
of megaloblastosis were exposed to heparin in varying concentrations. 
3.3.2.b The effect of immune complexes on NBT reduction by 
human neutrophils 
1. Manufacture of rabbit ovalbumin-antiovalbumin immune .complexes 
Serum from two rabbits (Himalayan), hyperimmunised 
against ovalbumin, was a gift from Dr. David Brown, Department 
of Immunology, The Hammersmith Hospital, London. The animals 
had been immunised by deep intramuscular injection of ovalbumin 
( 20mg) in Freund rs complete adjuvant, followed by several booster 
doses of antigen ( 20mg in Freund rs complete adjuvant) at monthy 
intervals. The antiovalbumin antibodies consisted almost entirely of 
the lgG class of immunoglobulins. 
0. 5 ml of serum was incubated in 12 plastic test tubes 
with O. 5 ml of phosphate buffered saline containing serial doubling 
. 
dilutions of ovalbumin ( 20mg-I0µg/ml) at 37°C for 30 minutes. The 
point of equivalence was found to be l. 25 mg/ml of ovalbumin as 
mea~mred by quantitative precipitation (Kabat, 1961) . Tubes 
number I and 2 ( lO and 5 mg antigen/ml respectively) had immune 
complexes m gross antigen excess, II and 12 ( 9. 8 and 4. 9 µg 
antigen/ml respectively) complexes in gross antibody excess, 
tubes number 4 and 5 ( 2. 5 and l. 25 mg antigen/ml respectively) 
as having complexes in slight antigen excess and at equivalence, and 
tubes 8 and 9 ( 78 arid 39 µg antigen/ml respectively) as having 
complexes in slight antibody excess. 
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11. The effect of antiserum containing varymg antigen concentrations 
on NBT reduction by neutrophils 
Blood from a normal subject was anticoagulated with 
heparin ( 20 i.u./ml). 2 x IOOµI samples of this blood were 
each mixed in plastic test tubes with 50 µI of serum/ antigen mixtures 
from tubes I, 2, 4, 5, 8, 9, II and 12 and incubated at 37 °C for 
IS minutes. To one series of the mixtures was added 20 µI of 
" endotoxin in phosphate buffered saline ( 300 µg/ml, final concentration 
of :: 25 µg/ml) and to the other tubes, 20 µ I of phosphate buffered 
saline. The mixture was gently shaken, then incubated at 37 °C for 
IO minutes. ·so µl of O. 2% NBT in saline was added, the mixture 
was gently shaken and the standard procedure was then followed. 
Further studies were done on blood mticoagulated with 
heparin (50 i.u./ml) using various dilutions of the serum from both 
animals, which contained complexes in antibody excess ( 39 µg/ml of 
antigen} . 
m. The effect on NBT reduction of e xposing neutrophil s in whole 
blood to complexes in antihody excess, endotoxin a nd NBT m 
varymg com binations a nd sequence 
Blood anticoagulated with heparin ( 20 i. u. / m l) was 
exposed to complexes in antibody exce ss ( 39 µg c1ntigen/ml) in the 
unc:liluted ser um · from one of the rabbits as above (ii) wi th v a riations 
in the sequence of addition of . the components of the mixtures. In 
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the mixtures from which the complexe s or the comp lexe s and e ndotoxin 
were e x cluded, the 50 µl of O. 2% N B T in saline was replaced by 
100 ,ui of O .1% NBT in phosphate buffered saline., and the 20 .ul of 
phosphate buffered saline conta ining endotoxin was replaced by 
20 µI of phosphate buffered saline without endotoxin (Table 3 .12) . 
TABLE 3 .12 Exposure of neutrophils in whole blood to immune 
complexes, endotoxin and NBT in varying comana tions and sequence. 
The fi::iures ( except for NBT scores) r e fer to the time in minutes 
after the beginning of the experiment that the component mixtures 
""' were added to heparinised blood ( single s tudy) 
-
Summary of 
Slide NBT sequence of addition 
Endotoxin 
Immune 
NBT preparation of components to complexes 
score 
made (%) reaction mixture 
Endotoxin 
then 












5 0 e ndotoxin 20 40 12 
the n NBT 
Complexes 
then 
15 0 25 45 11 e ndotoxin 
the n NBT 
E ndotox in 
0 IO 30 74 no complexes -
No e ndotoxin 
IO 26 or c omplexes - - 30 
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3. 3. 2. c Animal experiments 
I. The effect of vitamin C deficiency m NBT reduction 
Guinea pigs were reared on autoclaved proprietary rabbit 
food containing little or no ascorbic acid. Control animals received 
green vegetables in addition. After 3 weeks the guinea pigs on the 
scorbutic diet showed evidence of vitamin C deficiency as manifest by 
weight loss, loss of subcutaneous fat and diarrhoea. Blood from 2 
scorbutic and 2 control animals was exposed to endotoxin and then 
to NB T by the standard method. 
ll • The effect of congenital deficiencies of the complement system on 
NBT reduction 
Blood from 2 adult rabbits (Himalayan) with a congenital 
deficiency of the sixth component of complement ( C 6) , and 2 guinea pigs 
with a congenital deficiency of the fourth component of complement ( C 4) 
was exposed to endotoxin and then to NBT by the standard method. 
Ill • Effect of immune complexes in vivo on NBT reduction by 
neutrophils 
Ovalbumin was injected intravenously into a hyperimmunised 
rabbit (Himalayan) in a concentration calculated to result in the 
formation of immune complexes in antibody excess after in vitro titration 
of dilutions of antigen against serum ( 40 µg/Kg) . Blood was taken 
from a marginal ear vein 30 minutes after antigenic challenge and 
exposed to endotoxin and NBT by the standard method. 
Source of animals Complement deficient animals were 
hred, and the rabbit immunised, in the laboratory of Dr. Peter Lachman, 
The Hammersmith Hospital, London. 
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3. 3. 2 .d The effect of the suspension of normal neutrophils in the 
sera -of patients with a variety of disease processes on whom 
NBT tests had been performed_. 
1. Resuspended cells exposed to EDT A plasm~ 
Washed buffy coat preparations of a normal, ABO 
blood group O positive, subject were prepared as described in 3. I. 
To each of 38, 100 µI aliquots of this preparation in plastic test tubes 
r 
was added 100 µI of serum from different subjects, the mixture was 
gently shaken and incubated at 37°C for IS minutes. 100 µ I of plasma 
from the blood of the cell donor {EDTA as anticoagulant, 2.4 mg/ml) 
and 100 µl of O. 2% NBT in saline containing ficoll ( 400 mg/ml) were 
added, the tubes were capped, mixed by gentle shaking, incubated at 
37°C for 30 minutes and then at room temperature for IS minutes 
and slide preparations made and counted in the usual manner. This 
treatment of the resuspended cells is analogous to the EDT A/ficoll 
NB T test { 2. 2. 2. ) 
11. Resuspended cells exposed to a · solution of fibrinogen and heparin 
To each of 29, 100 µI aliquots of the washed cell 
preparation was added 100 µI of sera from different patients. After 
mixing and incubation at 37°C for 30 minutes, to each tube was 
added 100 µl of a solution of fibrinogen {IO mg/ ml) and heparin ( SO i. u. / 
ml) in phosphate buffered saline and IOOµI of 0.2% NBT in saline. 
The suspension was mixed by gentle shaking, incubated at 37°C for 
IS minutes, at room temperature for a further IS minutes and the 
samples smeared , stained and counted. This treatment of the re-
suspended cells is analogous to the heparin NBT test ( 2. 2. 2.) 
3.3.3. RESULTS 
3. 3. 3. a Exposure of autologous blood and bone marrow t0 various 
compounds 
1. Exposure of autologous blood and bone marrow to endotoxin, 
Cytochalasin B, neuraminidase and latex particles 
A much higher NBT score was obtained~ under all 
( 
circumstances examined, with peripheral blood neutrophils than with 
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bone marrow neutrophils (Table 3 .13 ) • NBT reduction was enhanced 
m peripheral blood by endotoxin. It was also enhanced by Cytochalasin 
B and neuraminidase, but cell clumping in the presence of these 
substances was very extensive and the clumps contained a lot of 
reduced NBT. Counting of unclumped cells containing reduced NBT 
would seem to underestimate the percentage of cells containing 
this compound. 
The reduction of NBT by bone marrow neutrophils was 
increased by endotox in, latex, neuraminidase and Cytochalasin B. 
Cell clumping was a ls o observed with Cytochaldsin B and neuraminidase, 
but it was less extensi\€ than in peripher a l blood. Examination of the 
periphera l blood neutrophils in the single patient with cyclical 
neutropenia was impossible because of the profound neutropeni a ( 200 
neutrophils/cmm}, but the mc1rrow neutrophils revealed low levels of 
NBT reduction which w as enhanced by Cytochaiasin B and latex 
particles. 
TABLE 3 .13. The NBT scores obtained upon exposure of 
autologous blood ( B) and bone marrow ( M) to NBT after 
incubation with phosphate buffered saline ( PBSA),. endotoxin~ 
(ENDO), Cytochalasin B (CB), latex particles Oatex) and 
neuraminidase ( N) • The mean and S. E. of th~ NBT scores 
are also shown 1 
SUBJECTS . NBT SCORE 
PBSA ENDO CB LATEX -Age Sex Condition B M B M B M B M 
80 M Macrocytosis 26 4 57 11 29 IS 31 4 
78 M It 43 13 so 49 69 80 39 25 
81 M II 83 0 74 I6 91 34 70 12 
62 M II 9 3 47 13 7 2 22 16 
81 M II 39 0 87 30 14 3 46 13 
68 F Neutropenia - 0 - 0 - 8 - 28 
Mean 40.0 4.0 63.0 23. 8· 42.0 26.8 41. 6 14. 0 
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Effect of endotoxin on NBT reduction by neutrophils from peripheral 
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FIGURE 3.15 
Effect of varying concentr a tions of hep a rin on NBT reduction by 
neutrophils from the periphe ral blood a nd bone m a rrow of two 
s ubje c ts. The effect of v a rying concentrations of heparin on NBT 
reduction by neutrophils of n o r m a l subje cts is a ls o shown • 
167 
11. NBT reduction by autologous peripheral blood and bone marrow 
neutrophils exposed to endotoxin m the presence · of E OT A as 
anticoagulant 
NBT reduction by peripheral blood neutrophils was 
normal. In comparison, dye was reduced by a much lower 
proportion of marrow neutrophils (Table 3. 14, Fig. 3 .14). 
TABLE 3 .14 NBT reduction by autologous peripheral blood and 
bone marrow neutrophils of 5 patients (EDTA as anticoagulant) 
exposed to endotoxin. Results are expressed as the NBT scores 
obtained. The individual results and the mean of three tests on a 
single blood and bone marrow sample from each subject, and the 
overall mean and standard error are shown . 
NBT SCORE 
SUBJECTS 
BLOOD BONE MARROW 
Age Sex Condition Individual Mean 
Individual 
Mean Results Results 
45 F Normal 12, 8, 5 8.3 3' 4, 2 3.0 
79 M Macrocytosis 48, 33, 23 34.7 28, 22, 25 25 .0 
26 F Epilepsy IO, 12, 17 13. 0 3' I ' 
3 2.3 
80 M Macrocytosis 29, 27, 19 26.0 18 , 11 
' 
17 15 . 3 
68 M Macrocytosis 27, 27, 22 25.3 3' 3, 13 9 .7 
MEAN 21. 3 11. 0 
(S.E.) (2.8) ( 2 . 3) 
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m. The reduction o-f NBT by autologous peripheral blood and bone, 
marrow neutrophils exposed to varymg concentrations of heparin 
TABLE 3 .15. The effect of various concentrations of heparin ( i. u. /ml) 
on NBT reduction by autologous peripheral blood ( B) and bon~rn.arrow ( M) 





(HEPARIN) i.u./ml I 2 
B M B M 
2 0 3 - · · 0 
33 16 0 - 20 
66 IS 3 29 8 
120 25 3 48 14 
175 35 I 30 12 
Increasing concentrations of heparin resulted in increased 
NBT reduction by peripheral blood neutrophils. This was lower than 
that observed in normal neutrophils (3 · 2 · 3. I:) • This di s crepancy may 
result from some abnormality of the neutrophils of the s e subjects or from 
experimental variation. 
A much lower proportion of bone marrow neutrophils 
reduced the dye under similar circumstances (Table 3 .15, Fig. 3 . JS ) • 
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3.3.3.b The effect of rabbit ovalbumin-antiovalbumin immune complexes 
on NBT reduction by human neutrophils 
1. The effect of varying antigen concentration 
Immune complexes at equivalence, and in slight antibody 
excess from both rabbits, caused markedly diminished NBT reduction 
by neutrophils in comparison with NBT reduction by neutrophils of 
animals exposed to complexes m gross antigen or antibody excess 
and neutrophils of control animals (Table 3 .16} . 
TABLE 3 .16 · The effect of immune complexes formed by different 
antigen/antibody combinations on NBT reduction by neutrophils m 
blood anticoagulated with heparin ( 20 i. u. /ml) m the presence and 
absence of endotoxin. Results are expressed as the NBT score. 
NBT SCORE (%) 
COMPLEXES ANTIGEN 








Gross antigen 1.0 X 104 20 19 
excess 5.0 X 103 IO 15 21 20 
At equivalence J.25 X 103 8. 2 
Slight antibody 6.3 X 
102 3 15 I I 6 
7.8 X 10! 0 2 4 4 excess 
3.9 10! ·7 4 X 
G ross antibody 9.8 30 2 
excess 4.9 29 l 4 20 3 
No antigen Control I 29 I 7 (serum + - -
PBSA 
No antigen Control 2 
23 2 I or antibody (PBSA ) - -
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11. The effect of varying concentrations of immune complexes on the 
reduction of NBT by neutrophils 
Complexes in antibody excess were most inhibitory when 
undiluted but significant inhibition was still apparent when diluted I in 
25 in phosphate buffered saline ( final antigen concentration of I. 5 µ g/ml, 
Table 3 . 17) . 
TABLE 3 .17 The effect of dilutions of immune complexes on the 
inhibition of NB T reduction by neutrophils in blood anticoagulated with 
heparin ( 50 i. u. /ml). Results are expressed as the NBT score. 
DILUTIONS OF 
ANTIGEN 
NBT SCORE (%) 
COMPLEXES 
SERUM DONOR SERUM DONOR 
Dilution µg/ml I 2 
0 3.9 X 101 2 8 
I m 5 7.5 IS 24 
I m 25 I . 5 41 33 
I 1n 125 3.0 X 10-l 70 68 
I 1n 625 6.0 X 10-2 57 42 
No complexes 




55 serum or endotoxin 
The enhanced reduction of NBT when compared with the 
previous experiment can be related to the higher heparin concentrations 
used in this experiment. 
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m. The effect of the sequence of addition of the component mixtures on 
NBT reduction by neutrophils. 
The addition of endotox in to the test system before, after, 
or simultaneously with the complexes did not grossly alter the inhibitory 
effect of the complexes on NBT reduction. However, if the complexes 
and NBT were added simultaneously, reduction was not diminished 
(Table 3 . 12 ) • 
3. 3. 3. c Animal experiments 
In limited studies complement defic ient animals appeared 
to reduce NBT normally (Table 3.18 ) • 
TABLE 3 .18. NBT reduction by neutrophils of normal animals 1 
rabbits deficient in the sixth component of complement ( C 6) , gume~ 
pigs deficient in the fourth component of complement ( C4), a hyperim~·une 
rabbit after the intravenous injection of antigen and scorbutic guinea pigs, 
in the presence and absence of endotoxin. Quantified results are 
expressed as the NBT score. 
Test 
Animal 
Normal rabbit l 
C6 deficient rabbit 2 
Normal rabbit l 
Normal rabbit 2 
C6 deficient rabbit 1 
C 6 deficie nt rabbit 2 
Anticoagulant 
EDTA 
Heparin ( 20i. u. /ml) 
NBT SCORE 
Endotoxin PBSA 
(IO µg/ml) Control 
33 2 
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In comparison with normal rabbits, there was 
diminished reduction of NBT by the neutrophils of a hyperimmune 
rabbit after antigenic challenge (Table 3 .18) . Lack of knowledge of 
the ability of neutrophils from this rabbit to reduce NBT before 
antigenic challenge detracts from the value attributable to these results. 
3. 3. 4. d The effect of heterologous sera on NBT r eduction by 
normal neutrophils 
TABLE 3.19 Comparison between the NBT scores of normal 
neutrophils exposed to NBT, by the methods analogous to the EDTA/ 
ficoll or heparin NBT test, after resuspension in heterologous sera, 
and the NBT scores on blood of the serum donors, serum 
concentration of CRP and serum concentration of a l-acid glycoprotein . 
Results are expressed as the cor r e lation coefficients obtained. The 




CRP I .d l . NBT score 
a -ac1 g ycoprotem 
Resuspended 
NBT score EDTA/ 0.43 (38) 0. 01 (12) 0. 01 (33) 
of normal c e lls ficoll p <. 01 
in heterologous · 
sera Hep a rin 0 .18 (29) 0. 09 ( 9) 0.27 (24) 
The same norm a l neutrophils, s uspended in different 
hete rologous sera, r educed NBT in var-ymg proportions (Fig s . 3 . 16 
and 3. 17). The NBT scores of the resuspended cell s compared best 
with the origina l NBT te s t results of patients with acute di s ease . A 
large propor tion of pati e nts with chron ic di sE.:RS8 h ad ,, l ow NBT test 
result, while a higher NBT score was obtai e d fro m n o rmal ce lls 
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suspended m serum from these p a tients. 
There was a significant correlation {p< 0. 01) between 
the NBT scores of norm a l cells suspended in he terolog·ous sera, and 
exposed to NBT by a method ana logous to the EDT A/ficoll NBT 
test, and the NBT scores obtained on the blood of the serum donors 
(Table 3 .19) . 
There was poor correlation between the NBT scores 
obtained on blood when the NBT test was performed by the heparin 
method and the NBT scores of normal neutrophils suspende d in serum 
from the same subjects and expos ed to NBT by an analogous method. 
There was poor corre lation betwe en the NBT scores 
of normal neutrophils resuspe nded in heterologous s e ra a nd the serum 
I concentrations of C RP and a -acid glycoprotein. 
3.3.5. DISCUSSION 
Circulating cells comprise but a sm a ll fraction of the 
body I s total complement of neutrophils. The_ bone marrow contains 
approximately l. 8 x 10
10 
ne utrophils and neutrophil precursors per kg 
of body weight in normal hum ans. Approximate ly h a lf of these cells 
constitute a marrow storage pool of b a nd and segmented neutrophils 
totalling a minimum thirteen ti mes the number in blood ( 7 x 108 cells / 
kg) (B oggs, 1967 ) . Blood ne utrophils a re distr ibuted in approximate ly 
equal number betwe en a circu lating pool a nd a marginal blood pool 
( Athe ns et a l, 1961) . The latte r comprises a pool of neutrophils 
mar ginated along ve nule and capill a ry w a lls, fro m w h ich the y can be 
induced to re-enter the circulating pool by exercise or the 
administration of adrenaline, 
Segmented neutrophils develop from last dividing 
myelocytes in approximately 2-3 days and subsequently e:--:it from 
17 5 
the marrow after a further 4-6 days, totalling a transit time through 
the non-dividing neutrophil compartment of 6-9 days, Infection 
apparently shortens neutrophil marrow residence time by about 
2 days. The appearance of band neutrophils in the circulation 
preceeds seg.mented forms by I day, but no sequential relationship 
has been found to exist between the time of appearance of ne utrophils 
and the number of nuclear lobes, suggesting the degree of 
segmentation should not be used as a measure of neutrophil age 
( Fliedner et al, 1964, Athen et al, 1965, Galbraith et al, 1965) . 
The neutrophils have a half life in the circ ula ting pool 
of about 6. 6 hours and egress occurs in a random fashion, 
irrespective of age (Cartwright et al, 1964)'. The fate of the 
neutrophil after it leaves the circulation and marginates is unknown. 
There is some evidence that they can survive in the circula tion for 
at least 50 hours ( Rosse and Gurney, 1959), . Entry into the 
tissue s is random and is unrelated to the time after r e lease from 
the bone marrow ( Fliedner e t al, 1964). 
The relationship between neutrophil age and fun ctional 
capacity is unknown. Thi s probably r e fle cts the g re at diffi c u lty in 
establi s hing the r el ative age of s e gmented n e u'trophil s and of separating 
neutrophils into g roups of different chronologica l age for study 
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purposes. The surface properties of granulocytes vary with cellular 
development. As cells mature the negative surface change density is 
reduced, they become more deformable, adhere more readily to glass 
or plastic on which they spread more prominently, migrate more 
rapidly, become more actively phagocytic and form pseudopodia more 
actively ( Lichtman and Weed, 1972) • 
Neutrophil bactericidal activity is diminished m infected 
subjects ( Alexander and Meakins, 1972) , an effect which is most 
marked in the presence of a shift to the left of the myeloid series of 
leukocytes ( Solberg and Helium, 1972). This bactericidal defect may 
be related to the premature release of neutrophils from the marrow pool 
and a younger circulating neutrophil population as a result of increased 
neutrophil turnover observed in infected subjects ( Fleidner et al, 1964, 
Athens et al, 1965, Galbraith et al, 1965) • 
Bone marrow samples obtained by aspiration must be 
contaminated to a variable degree by peripheral blood. Despite this 
limitation, it is a simple method of obtaining immature neutrophils. In 
this study NBT reduction was obs8rved in a much smaller proportion 
of m s.rrow neuL...ophils than in autologous circulati ng neutrophils in the 
presence of endotoxin, heparin and various other compounds, and in the 
single patient with severe neutropeniu it was almost completely absent. 
Marrow neutrophils have a normal capacity to reduce NBT m a 
quantitative NBT tes t ( 3 . 4 ) and thus d imini shed reduction by these ce lls 
probably reflects the ir in abi lity to ph a gocytose c omplexed NBT. 
It is postulated that the finding of negative NBT tests 
m patients m whom the result should otherwise be positive usually 
indicates replacement of the normal blood neutrophil pool by a 
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population of less mature neutrophils. There is no method of accurately 
measuring the age of circulating neutrophils and thus there is no 
means of comparing cellular maturity with spontaneous or stimulated 
NBT reduction by neutrophils. Reliance must be placed on circumstan-
tial evidence linking the occurrence of a high proportion of young 
neutrophils in the circulation with false positive NBT test results. 
An abnormally high proportion of neutrophils reduce 
NBT in uninfected neonates ( Park et al, 1969). Neutrophil 
precursors and immature neutrophils comprise a significant per<?entage 
of the total circulating neutrophil pool in neonates with maJor infections 
( Xanthou, 1972) . In such patients the NB T test result is greatly 
diminished in the absence (Cocchi et al, 1969) and presence (Cecchi 
et al, 197~ of an in vitro phagocytic stimulus. 
'The conversion of p~sitive to negative results in infected 
patients after treatment with antibiotics and lower initial results in 
treated than untreated patients has been attributed to the antibiotics 
themselves ( Matula and Paterson, 1971a , Sobel et al, 197 3, Feigin et 
al, 1971). The decrease in NBT reduction may be purely a function 
of time. Present day antibiotic therapy is commenced very soon after 
the diagnosis of pyogenic infection. Thus studies on infected subjects 
in which comparisons are drawn between a group of untreated patients 
and a ·group of patients after the initiation of chemotherapy are unlikely 
to be comparing groups of subjects at the same temp0ral stage of the 
disease. Observations that reductions in the NBT score of patients 
receiving antibiotic therapy may occur before clinical improvement 
(Matula and Paterson, 1971a, Hawkins, 1973, Ridgway and Johnson, 
1973) suggest that the inhibitory effect is probably unrelated to 
eradication of the disease. In addition, Rubenstein et al. (197 3) have 
shown that a numbe~ of commonly used antibiotics, m therapeutic 
concentrations, have no effect on the reduction of NBT by neutrophils 
in vitro. 
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The likelihood exists that in the face of systemic infection, 
demargination of neutrophils moves large numbers of mature neutrophils 
into the circulating neutrophil pool, and that these cells may be provoked 
to phagocytose complexed NBT leading to a positive NBT test result. 
As the disease process continu8s, the more mature neutrophils . migrate 
to the site of pathology and are replaced by prematurely released 
neutrophils from the marrow pool. Because egress from the 
circulating pool 1s random, considerable time may elapse before the 
newly released neutrophils, themselves ageing, but possibly not yet 
mature enough to reduce NBT, constitute the majority of circula ting 
neutrophils which may be reflected by a false negative NBT test. In 
support of this Esposito and De Lal.la 0972) studied 12 patients with 
advanced untreated bacterial meningitis; NBT tests performed on 
peripheral blood samples were universally negative, whereas in all 7 
cases in which tests were performed on the cerebros pinal fluid from 
the same patients, a very high percentage of the neutrophils reduced 
the dye. 
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Failure of e nhance d NBT r e duction in infected s ubjects 
ts not an optimal indica tor of the ina bility of neutrophils to reduce NBT 
because of the variability of disease processes. The exposure of 
blood to endotoxin in vitro produces a mor e uniform stimulus to the 
cells. Under these circumstances failure of NBT reduction was 
found in a p atient following a 25 pint blood transfusion, when most of 
the patient's blood and circulating leukocytes would have been replaced 
by transfused blood, and in the same patient after a major episode of 
infection ( Freeman et al, 197 3a) . Suppressed NBT reduction was 
found in those patients with burns whose lesions bec a me infecte d 
( Curruri et al~ 197 3) , a complication which has been shown to reduce the 
bactericidal capacity of neutrophils ( Alexa nder and Meakins, 197 2) , 
and in infe cte d diabetic patients ( P ujol-Moix, 197 3) . The development 
of the I NBT test stimulated' w hich reveals the inability of neutrophils 
to reduce N B T afte r a n endotoxin challe nge ( P a rk and Good, 1970) ts 
m itself an indication that infection can pre dispose to a diminution of 
NBT reduction, as no such d e pression h a s been found in normal 
subjects ( 3 . 2 . 3 . a) . 
Suppre s sed NBT reduction afte r · endotoxin s timulation was 
found in 9 of 93 subje cts studie d (3.2.3.a). Six of these p a tie nts had 
h ypogammaglobulinae mi a , of whom 2 h a d major chronic infection , a 
third had a cute pyoge n ic a r thr it is and the other three had childhood 
onset hypogammaglobul inae mi a in the absence of serious infection . 
In the two patie nts w ith m a jor infection th a t responded 
to a n tibiotic the rapy, there was an incre a s e d ab ility of their n eutrophils 
to reduc e NB T after endotoxin s timu lation , while the th ird , a b oy with 
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viral meningoencephalitis, did not respond to therapy and there was 
no change in the amount of NBT reduction by his neutrophils. These 
findings are consistent with the hypothesis that NBT reduction 1s 
diminished by prolonged infection. The reason for poor reduction by 
the neutrophils of the 3 patients with hypogammaglobulinaemia in the 
absence of obvious infection is unknown. One possible explanation 
is that a rapid turnover of both the myeloid and lymphocytic cell 
series is responsible for immaturity of both neutrophils and lymphocytes 
resulting m a diminished a.bility to reduce NBT and deficient 
immunoglobulin synthesis respectively. 
A final indication that neutrophils from the marrow pool 
are unable to reduce NBT comes from the study of Wollman et al 
(1972). Massive systemic glucocorticoid therapy did not reduce the 
NBT score in infected subjects unless the test was performed soon 
after the intravenous administration of the drug as a bolus. Gluco-
corticoids promote rapid release of neutrophils from the marrow into 
the blood pool ( Bishop et al, 1968) so a reduction in the NBT score 
after such therapy may reflect a sudden release of marrow neutrophils 
into the blood. 
Seg mented marrow neutrophils have a higher negat ive 
surface charge density than circulating neutrophils. This is due 
primarily to negatively charged carboxyl groups of N-acetylneuraminic 
acid (Lichtman and Weed, 1972). Reduction of the s urface 
charge density of monocytes by the action of neuramin idase increased 
cellular deformability and phagocytosis (We is s et a l, 1966). The 
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enhancement of NBT reduction in peripheral blood ( 3. 2. 3. d) and bone 
marrow neutrophils ( 3. 3. 4. a) in this study by treatme~t of the cells 
with neuramini·dase, suggests that a smaller proportion of immature 
neutrophils reduce the dye as a result of the greater surface charge 
density on these cells. This negative surface charge may prevent 
NBT reduction by repulsion of the complexed NBT (attem;>ts to 
measure the nett charge of these complexes failed) or because of a 
general reduction of the phagocytic process. The decreased surface 
charge density after treatment of the cells with neuraminidase is also 
probably responsible for the marked cell clumping, as such charges 
are important for repulsion between cell membranes ( Pethica, 1961 ). 
It is difficult to control experiments in which neuraminidasl3 is used, 
because heat inactivation caused precipitation of the enzyme. The 
enhanced neduction of NBT observed in the presence of heat inactivated 
neuraminidase ( 3. 2. 3. d) probably results from enhancement of 
phagocytosis by this precipitate. 
The evidence presented 1s strongly suggestive that 
relatively immature neutrophils have · a diminished capacity to reduce 
NBT. In order to prove this a number of experiments have been 
devised, but not as yet implemented. Neutropenia could be induced m 
animals by the administration of antineutrophilic serum (Lawrence, et al, 
1967) or antimetabolic drugs ( Shadd~ck and Nagabhushanam, 1971) and 
the NBT score after endotoxin stimulation related to the age of the 
emerging neutrophils. This system would have two major drawbacks; 
any remnants of the agent employed to induce neutropenia m a y effect 
the emerging cells, and implementation of a stimulated NBT test is 
very difficult in the presence of neutropenia bee.a use of the scarcity 
of visible cells. Another method would be to deplete the subject 
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of neutrophils by leukopheresis ( Craddock et al, 1955), and measure 
NBT reduction, after endotoxin stimulation, before and after the 
procedure. One such experiment has been performed and the 
rem0val of 4 x 10
10 
neutrophils from ·a normal subject resulted in a 
50% reduction of the stimulated NBT score after the procedure, 
This would have to be repeated numerous times under carefully 
controlled conditions before the results could be regarded as 
significant. 
The correlations between the NBT scores and 
neutrophil count, total white blood count ( T able 2. 7) and the presence 
of a shift to the left of the myeloid series (Table 2. 12) probably 
reflect the relationship between the NBT scores and the severity of 
the disease process (Table 2. IO) . E xtrapolation cannot be made from 
these indices as to the relative proportions of cells of differing maturity·. 
Another possible cause of fals e negative test results 
1s immune complex disease. Nyde gger et a l (1 973 ) demonstrated 
that immune complexes enhance d NBT reduction by neutroph ils. In 
their test system, cells were suspended in serum and simu ltaneously 
exposed to NBT and immune complexes. The suspension of ce lls in 
serum alone would accou;:it for the !ow le vel of NBT reduction in the 
absence of complexes, a p a.rticulate phagccytosable substance being 
obligatory for significant visible NB T rc ·:luction ( 31. ! ) . Im mune 
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complexes are voraciously engulfed by neutrophils ( Hawkins and 
Peeters, 1971) and probably constituted the particulate object of 
phagocytosis alongside which NBT passed into the cell. In the 
present study it was demonstrated ( 3. 3. 3. b) that NBT reduction 1s 
greatly diminished by prior incubation of blood with immune complexes 
at eq-.1ivalence or in slight antibody excess, or by antigenic cha llenge 
of a previously immunised animal ( 3. 2. 3. c) . These conditions 
closedy mimic in vivo immune complex disease, where cells would 
have prolonged exposure to the complexes before encountering NBT 
in vitro. Simultaneous exposure of neutrophils to NBT and complexes 
was also shown to enhance NBT reduction in this study. The 
mechanism of inhibition of NBT reduction by immune complexes 1s 
unknown, but as the neutrophils did not appear morphologically changed, 
and as there was no evidence of cellular swelling and engorgement, 
they may have coated the neutrophil membrane,, so preventing adherence 
of complexed NBT to the neutrophil, or may have inhibited phago-
cytosis as a result of 11 Kamikaze 11 cell damage, a process which 
receives its name as a result of the lack of regranulaticn and 
eventual death of neutrophils after phagocytosis ( Spicer and H a rdin, 
1969) . 
Immune complexes occur in s ystemic lupus erythematosu s 
( Koffler et al, 1971) and meningococcae mi a ( Greenwood e t a l, 197 3) 
a nd could account for fa lse negative NBT tests in these subjects 
(T a ble 2.1). Wollm a n et al (1972) found the NBT tes t to b e u sefu l 
in p a tie nts afte r r e n a l transpla ntation, 1.,in iform ly low r e sults be ing fo und 
m pn.tients with rejection, whereas infected patients gave high results. 
It is possible that the low results obtained in the patients with the 
rejection phenomena were the more abnormal, resulting from a 
secondary abnormality of neutrophil function, induced by immune 
complexes ( Milgrom et al, I971), which inhibited the high NBT test 
result usually found in acutely ill patients. 
If the hypothesis that diminished NBT reduction after 
endotoxin stimulation reflects a decreased phagocytic capacity of the 
neutrophils, either as a result of relative cellular immaturity or the 
11 Kamikaze" effect of autodestruction after phagocytosis, is correct, 
184 
it would have important clinical application. The circulating concentration 
of 'functional I neutrophils, which may be a more relevant index of host 
defence than the current measurement of the total neutrophil concentration, 
could be assessed and might indicate the necessity for "normal 
g ranulocyte transfusion therapy" ( Graw et al, 1972) . A screening 
test could be devised to detect and monitor the response to therapy 
of p atients with immune complex disease. 
Complement inactivation was postulated as the reason for 
the lower amplitude of NBT reduction when EDT A rather than heparin 
is used as anticoagu lant ( Park and Good, 1970). EDTA has ·not been 
s hown to be anticomplementary in the presence of excessive divalent 
NBT cations which may repla ce the essential role of calcium m 
c omplement activation. Heparin is anticornplementary (Walton et al, 1957), 
NBT is reduced by cells suspended in balanced s a lt solution in the 
absence of complement ( 3. I.) and NB'"f reduction is the same in normal 
and comple ment deficient animals ( 3. 3. 3. c. ) . In the light of these 
facts it seems very unlikely that complement ts important for NBT 
reduction by neutrophils. 
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The assumption that immunoglobulins are necessary for 
NBT reduction ( Freeman and King, 1972b) was based solely on the 
report of Park and Good ( 1970) that false negative tests had been 
obtained in hypogammaglobulinaemic patients. The present study 
(3.2.3.a) indicates that '" negative stimulation tests are exceptional m 
these patients and are unrelated to the pattern of immunoglobulin 
deficiency. 
Having investigated possible causes of false negative 
NBT tests, the effect of humoral factors in serum upon NBT reduction 
by normal cells can be investigated with the knowledge that factors 
which may enhance NBT reduction by normal cells may have been 
unable to exert their effect on autologous cells because of an inate or 
induced inability of these cells to reduce NBT. 
Varying degrees of NBT reduction was obtained by 
the same cells suspended in different sera. There was good correlation 
between the initial and resuspended NBT scores when the cells were 
exposed to N B T in the presence of ficoll and EDT A ( Table 3 .19 
Fig. 3 .17 ) but not in the presence of heparin (Table 3 .16, Fig. 3 .16 ) • 
In the majority of cases where high NBT scores were obtained in 
both the initial test and resuspended cells the patients had acute disease. 
The majority of patie nts with chronic disease had low initial NBT scores 
and high resuspended scores , perhaps· indicative of an inability of their• 
cells to reduce N BT . Unfortunately this cannot be established as N BT 
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stimula te d tests we re not p e rforme d on the se patients. The re was 
poor corre lation b e tween the re s u s pende d NBT scores and the serum 
concentrations of C RP and ex 
1
- acid glycoprotein a lthough the number 
of studies was too small to allow defin ite conclusions to be drawn 
(Table 3.19 ) • 
The clos e corre la tion b e tween the initial a nd resuspended 
NBT score s of cells exposed to ficoll and EDT A sugge sts that there 
is a humeral factor r esponsible for promoting the phagocytosis of the 
complexed NBT. The initial close corre la tion betw een the EDT A/ficoll 
(p <o.OOI) and heparin (p<OoOS) N B T test scores and the serum 
concentration of ~ 1- a cid g lycoprote in (T a ble 2. 9 ) indicates that 
this substance may be one of these h umeral factors. 
Howeve r, the N B T score s are increased with increasing 
severity of disease (T able 2. IO) and the a cute phase protein levels 
and NBT scores m a y both be inde pend ently re s ultant upon disease 
severity, r ather than c a u sally re lated. 
The p oor c or r ela tion . betwe e n the N B T score of resus-
pe nded cells a nd the hepar in N B T test re sults , and be tween cells 
r e suspe nde d by both methods and se rum c oncentratio ns of oc 1-acid 
glycoprote in a nd C RP pos sibly reflect the low number of studie s 
performed, which m agnify the errors of the methods a nd counting 
te c hniques emplo yed. It is possib le th at hep a rin, which is very a cidic, 
k th · · · f I .d l . d h h" m as s e opsomsmg ,3ct1o n o Cf.'. - ac1 g y c oprotem , a n t a t t 1s, 
together with fa ls e p o sitive tests ind uc ed by heparin, a cco unts fo r the 
di screpancy be tween r esults of N B T tests pe rformed on the same blood 
sample by the E OT A/ficoll and heparin methods ( 2. 3. I.) 
It is difficult to establish that an increase in the NBT 
test result reflects opsonisation of complexed NBT by some or all of 
the acute phase proteins. Enhanced NBT reduction on the addition 
of purified proteins to blood in vitro may result from modification of 
the protein by the purification procedures;whereas manouvres 
designed to increase serum levels of these proteins in laboratory 
animals will have a concomitant effect on the neutrophil population. 
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A possible method of demonstrating binding of complexed NB T or other 
particles to the cell surface would be to inhibit phagocytosis, an energy 
dependent process (Rabinovich, 1967, Sbarra arid Karnovsky, 1959) 
with metabolic inhibitors, or with Cytochalasin B, and to demonstrate 
the association of the cell and particle in the presence of, but not in 
the absence of, the opsonin. Such binding could be established by 
microscopy or by the association of radiolabelled cells, opsonin and. 
particles after separation of unbound particles from cells by manouvres 
such as cell washing and density centrifugation. Such a system would 
separate opsonisation per se from increased phagocytosis as a result 
of enhanced cellular phagocytic activity. 
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3. 3. 6. SUMMARY 
The relationship between neutrophil maturity and NBT 
reduction was investigated by comparing NBT reduction by autologous 
bone marrow and peripheral Slood neutrophils. Spontaneous NBT 
reduction by bone marrow neutrophils was minimal, significantly 
different from that of circula ting neutrophils, but was enhanced by 
exposure to latex and neuraminidase. This suggests that immature 
neutrophils are less capable than m ature neutrophils of reducing NBT 
and that false-neg a tive NBT tests might result in conditions in which 
there is an incre a sed turnover rate of neutrophils leading to a 
predominance of younger cells in the circulation. The bactericidal 
capacity of neutrophils may be diminished in younger cells. If the 
relationship between cellular immaturity and de fici e nt NBT redudjon 
is subs tantiated, a s timulate d NBT te st may be a simple method of 
measuring the proportion of circulating neutrophils comprise d by 
mature cells capa bie of effective b a cte ricidal activity. Immune 
complexes inhibit NBT r e d u ction by neutrophils, a stimulated NBT 
test m a y also be u seful a s a n indic ator of circula ting immune comple xes. 
Nor mal ce ll s suspended in he terologous sera from normal 
and di seas e d subjects in the p r esen ce of fib r inogen reduced NBT to a 
variable e xtent. T he re was a close correlation be tween the NBT 
scores obtained in the b lood of the serum donor s , and the NBT scores 
of n o rmal ce ll s resuspended m serum and exposed to NB T by a 
m e thod analogous to the EDTA /fi coll NBT test - s uggesting a h u meral 
promotor of NBT reduction . There was poor c0rrelation between 
the initial and resuspended NBT scores m the presence of heparin. 
Chronic disease resulted in a low initial but higher resuspended 
NBT score suggesting the p-- esence of a humor al promoter of NBT 
reduction, the effect of which was masked in the initial NET test by 
an incapacity of the cells to reduce NBT. 
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3.4. SECTION 4. Mechanisms involved m the reduction of NBT 
by neutrophils 
3.4.1. INTRODUCTION 
In the past three sections an examination has been made of 
the method of entry of NBT into neutrophils in the NBT test, and of 
factors influencing this entry. This section will be devoted to an 
investigation of the mechanisms involved in the reduction of the dye by 
~ 
isolated neutrophils; in suspension, in the quantitative NB T test, and 
adherent to glass slides in the test of Gifford and Malawista (1970). 
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It will be shown that NBT is toxic to neutrophils and that it is probably 
reduced as a . consequence of damage to the outer membrane of the cell 
allowing free contact between the dye and intracellular reducing 
substances. 
Damage to the neutrophil membrane was assessed by the 
release of the cytoplasmic enzyme lactate dehydrogenase (LOH} . Dye 
reduction was quantitated spectrophotometrically after extraction from 
the cells with . pyridine. 
3.4.2. METHODS 
3. 4. 2. a The effect of saline I endotoxin I latex and heparin on lactate 
dehydroge nase release in ·the presence and absence of NBT, 
and on the quantita tive reduction of NBT by neutrophils. 
l. S e paration of le ukocytes 
Venous blood ( 15-- lOOml) from 8 normal subjects, taken into 
heparin ( 4 i. u. /ml) was imme diately mixed with an equal volume of 
cold ( 4 ° C) separ ating solution, containing dextran in a balanced salt 
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After sedimentation at 4 °C for I hour the erythrocyte poor supernate 
was aspirated and centrifuged at 400 G at 4°C for IO minutes in a 
Sorval centrifuge. The supernate was discarded and erythrocytes 
destroyed with a haemolytic shock by the addition of 7. 5 ml of cold 
(4°C) sterile water to the cell pellet, which was resuspended by 
gentle pipetting up and down approximately IO times. After 60 seconds 
2.5 ml of cold (4°C) saline (0.54M) was added to and mixed with the 
cell suspension to restore isotonicity. 20 ml of cold ( 4 °C) balanced 
salt solution ( BSS) was added to and gently mixed with the cell 
suspension which was then centrifuged as above. 
11. Incubation of cells with NBT and other materials 
The supernate was discarded and the cell pellet resuspended 
m BS S ( 2-10 ml depending upon the final volume required) by gentle 
pipetting up and down. A small sample of the cell suspension was 
removed to determine the neutrophil concentration ( whi::::h range::I from 
2-16 x 106 / cmm) • To each of 2, l. 0 ml samples of the cell suspension 
in disposable plastic test tubes was added 50 µI of either saline, endotcxin 
( 30(µ.J/ml) in saline, dialysed latex particles or heparin ( 2000 and 200 
i.u./ml, final concentration of 100 and IO i.u./ml). The tubes were 
capped, mixed by inversion and incubated at 37 ° C for IO minutes. A 
further 50 µI of the same additive was added to each tube. To one 
series of tubes was added O. 9 ml of phosphate buffered saline and to 
FIGURE 3 .18 
Diqgrammatic representation of the methods used for cell separation, 
incubation of leukocytes with various additives in the presence and 
absence of NBT and the measurement of LOH release from and NBT 
reduction by these cells. 
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the other O. 9 ml of O .1% NBT in phosphate buffered saline. The 
suspensions were mixed by gentle shaking and after incubation at 37 °C 
for 30 minutes they were centrifuged at !000 G at 4 ° C for 20 minutes. 
I. 0 ml of the supernate from each tube was added to I. 0 ml of an 
aqueous solution containing Triton X IOO ( 0 .1%, a detergent) · and bovine 
albumin ( 0 .1%, to stabilise the LOH). This solution is henceforth 
referred to as the supernate fraction. 
m. Cell lysis 
I. 0 ml of the aqueous solution of Triton X IOO and albumin 
was added to the remaining supernate and cell pellet, mixed by 
vigorous manual shaking and centrifuged at 2000 G at 4 °C for 20 
minutes. 0. 2 ml of the supernate, henceforth referred to as the 
subnate lysate was transferred to fresh plastic tubes and s tored at 4°C. 
1v. Extraction of form azan 
The tubes to which NBT had been added, containing the 
remainder of the subnate lysate and cell debris or cell debris and 
formazan, were washed 3 times with 2. 0 ml of IN HCI, the washings 
from each tube were pooled in 15 ml glass centrifuge tubes and 
centrifuged at 2000 G at room temperature for 20 minutes. The 
supernate was discarded, 9. 0 ml of pyridine was added to each tube 
which was then; sonicated in a MS E 150 Watt ultrasonic disintegrator 
at an inter peak amplitude of IO microns for 15 seconds, with the 3. 0 mm 
titanium probe tip posi tioned immediately above the cell button; incub ated 
at 37 °C for 1 hour and then centrifuged at 2000 G at room temperature 
for IO minutes. Residual forrnazan was extr acted from the plastic tubes 
with l. 0 ml of dimethyl sulphoxide ( DMSO ) which was incu bated in the 
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tube at 37 °C for I hour> and then added to and mixed with the 
corresponding extract of formazan in pyridine. The optical density was 
read at SIS nm <;m a Gifford spectrophotometer against a blank containing 
a mixture of 9. 0 ml of pyridine and I. 0 ml of DMSO. 
v. Measurement of LOH 
Lactate dehydrogenase (LOH) was assayed in the supernate 
fraction and subnate lysate by determining the rate of oxidation of NADH 
at 340 nm following exactly the instructions issued with Biochemica Test 
Combination LOH UV-test No. 15948 TLAC. Assays were always 
completed within a few hours of obtaining the samples. The release 
of LOH into the supernate fraction was expressed as a percentage of 
the total L DH concentration assayed in the subnate lysate. 
3. 4. 2. b The effect of NBT, in the presence and absence of latex, on 
LOH release and NBT r eduction by peripheral blood neutrophils 
of two patients with CGDC and a patient with hY.2_qg_ammaglobulin-
aem1a, and by bone marrow neutrophils from two normal subjects 
Duplicate studies were performed by the same methods on 
neutrophils from two patients with CG.DC and a patient with hypogamma-
globulinaemia who reduced NBT poor ly after endotoxin stimulation in the 
stimulated NBT test (Appendix K No. IS) . The patients with CGDC 
were both patients under the care of Professor J. F. Soothill ( patients 
number 3 and 9 in the study of Thompson and Soothi ll, 1970 ). 
Studies were also performed on neutrophils from the 
bone marrow of two normal subjects. 2. 0 ml of sternal marrow 
aspirate was mixed with IO. 0 ml of autologous plasma anticoagu lated 
with heparin ( 4 i. u. / ml) and processed as in 3. 4 • 2. a. · Differential 
cell counts were performed on the isolated marrow cells. 
3. 4. 2. c·. The effect of endotoxin and of polyvinyl pyrrolidone ( PVP l 
on NBT reduction by cells m the slide test of Gifford and 
Malawista ( 1970) 
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I. 0 ml of venous blood was added to O. I ml of O. ISM ·saline 
or saline containing endotoxin (100 µg/ml) in a plastic test tube, 
rapidly mixed by shaking, and I drop of the mixture was placed on a clean 
glass slide and incubated at 37°C in a moist chamber. 'The superficial 
blood clot was washed off with O. IS M saline, the excess fluid drained 
off by tilting the slide, and the adherent leukocytes covered with a 
mixture containing pooled human serum and 0.2% NBT in 0.15 M s a line 
in the ratios of 5: 9 by volume, with and without PVP ( 2. 0 mM), and 
incubated in a moist chamber at 37°C for 20 minutes. The serum NBT 
mixture was washed off with O o 15 M saline, rapidly ai r dried, fixed by 
immersion in methanol for I minute, washed with w ate r, dried and 
counter-stained with O o 7%- aqueous safronin for 5 minute s. 100 cells 
were counted in 4 different areas on the slide a nd the mean pe r ce ntage 
of swollen, blue 11formaza.n cells" r ecorded. Studies were pe rformed 
on the neutrophils from 25 norm a l subje cts m the p resence and a b sence 
of endotoxin, on a furthe r 16 subjects in the absence of endotox in and on 
2 s ubjects in the pre sence a nd absenc e of PVP . 
3.4.3. RES UL TS 
3. 4. 3. a The effect of endotoxin, latex and heparin on the release o~ 
~ 0 H by cell? in the presence and absence of NB T and on 
the quantitative reduction of NBT by neutroRhils. 
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LOH release from cells was increased when NBT was 
present in the incubation mixture. Latex and endotoxin markedly 
enhanced LOH release in the presence but not in the absence of NBT 
(Tables 3. 20and 3. 21 ) • 
TABLE 3.20. The effect of endotoxin and latex,in the presence end 
?-bsence of NBT, on the release of LOH from cells. LOH release 
( as a percentage of the total LOH released after cell lysis) ts 
expressed as a percentage of LOH release from control cells 
{exposed to saline only). The mean, S. E. and number of studies 
are shown. 
Additive to LOH activity Number of studies 
cell in supernate 
suspension compared with 
control 
( saline onlv) 
Saline 100% 8 
Endotoxin 103. 2 (8.2) 3 
Latex 86.3 (5.7) 3 
' 
NBT 132. 2 (IL2) 8 
NBT 
+ 222.8 (25.7) 8 
Endotoxin 
NBT 
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FIGURES 3 .19 and 3. 20. 
15 
The relationship between the release of LOH from, and NBT reduction 
by; neutrophils of 6 normal subjects axposed to saline • , endotoxin l!I 
or latex p a rticles ® in a modified Quantitative NBT test (Fig. 3 .19); 
neutrophils of 6 normal subjects and two patients with CGDC, before 
o , o, and after l!I , 0 ,the addition of latex particles to the same test 
system {Fig. 3. 20). 
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Heparin promoted the rekiase of LOH m the presence and absence 
of NBT (Table 3. 22) and in a concentration of 100 i. u. /ml the 
cell suspension became very viscid, suggesting the release of nuclei 
acids as a result of cell rupture. 
TABLE 3. 22. The effect of hepflrin m concentrations of IO and 100 
i. u. /ml on LOH release from neutrophils of 4 normal subjects. Th,.e 




suspension I 2 3 4 
Saline 2.4 2.2 3. I I. 9 
Saline 12. 5 21. 7 3.9 3.0 
and 
Heparin 
NBT 3. I 2o9 4.9 6.8 
NBT 41. 9 I2o 5 8.4 8.3 + 
Heparin 
Heparin ]00 100 IO IO 
concentration 
(i.u./ml) 
There was a close correlation between N B T reduct;on 
and LOH release by cells expo sed to NBT alone or in the presence of 
endotoxin or latex particles (Fig. 3. 19). Three such c omparisons 
between LOH release and NBT reduction in six normal subjects resulte d 
in a correlation coefficient of O. 89 which is highly significant ( p <O. 001). 
This relationship can be expressed as the increase in optical density 
( in OD units x 10- 6 ) at 515 nm per additional unit of LO H released 
Fig. 3. 21. 
Fig. 3. 22. 
FIGURES 3. 21 and 3. 22 
Photomicrographs of neutrophils exposed to NBT m a modified 
Ouantitative NB T test in the absence (Fig. 3. 21) and presence 
(Fig. 3. 22) of latex particles. Only some of the neutrophils 
(arrows} demonstrate NBT reduction. 
Saf-ronin x2,000. 
induced by the presence of latex particles in the cell suspension. 
In stx normal subjects these units, termed 11formaz an/LOH units" 
had a mean value of 6. 97 with a standard error of 2. 71. 
Only some of the cells exposed to NBT, or to NBT 
and latex particles, reduced the dye (Figs. 3. 2 l and 3. 22 ) • 
Those cells that did reduce the dye closely resembled the formazan 
cells of Gifford and Malawista ( 1970) • They were swollen and 
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amorphous and exhibited dye reduction both as faint blue cytoplasmic 
staining and as denser deposits which appeared to be associated with 
the outer membrane of the neutrophil. 
3.4.3.b NBT reduction and LOH release by peripheral blood -
neutrophils of two patients with CGOC and a patient with_ 
hypogammaglobulinaemia, and by bone marrow neutrophils 
of two normal subjects. --------~---..::__ __ 
A greater than normal percentage of LOH was 
released by neutrophils of the patients with CGOC upon the addition 
of saline alone. NBT reduction by unstimulated cells was normal, 
however, the characteristic increase of NBT reduction after the 
addition of latex particles to the cell suspension was greatly diminished 
( Table 3. 23 Fig. 3. 20 ). Expressed in absolute figures, the 
enhanced NBT reduction amounted to O. 062 and O. 434 formazan/LDH 
units, which is significantly different from NBT reduction (expressed m 
the same units) by neut:rophils of norm a l subjects (p<O. Ol. The 
absolute values were transformed to logarithms and compared by 


























































































































































































































































































































































































































































































































































































































































































































































































Normal results were obtained from a hypogammaglob-
ulinaemic patient ( Appendix K, No .15) whose neutrophils reduced 
NBT poorly when whole blood was incubated with NBT in the 
presence of endotoxin ( Table 3. 23 ) o 
The differential counts m the marrow samples are 
shown in Table 3 . 24. 
TABLE 3.24. The differential cell count on marrow cell 
suspensions. Results are expressed as a percentage. 
203 
CELL TYPE MARROW SAMPLES 
I 2 
Segmented neutrophils 10 II 
Stab cells 26 38 







Lymphocytes 3 3 
Erythrocytes 0 
Other cells 19 26 
LOH release by bone marrow neutrophils w as slightly 
greater than normal as was NBT reduction. When expressed m 
formazan/LOH units, values of 3 . 13 and 1.21 indicate that the 
relationship between LOH release and NBT reduction is s inii la r to 
that found with circulating neutPophils. 
3.4.3.c The effect of endotoxin and PVP on NBT reduction m the 
slide test of Gifford and Malawista 
TABLE 3.25. The effect of endotoxin (lO_µg/ml} and PVP 
( 2.0 mM } on NBT reduction by neutrophils adherent to glass slides. 
Results are expressed as the mean and stand a rd error of the 
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percentage of neutrophils in which dye reduction was observed. The 
number of studies is shown. The absolute figures of the two studies 
performed in the presence ar.d absence of PVP are also shown . 
Additive Formazan Cells Number of Studies 
Nil + 42.6 - 3.0 41 
+ Endotoxin 900.S - 1. 6 25 
PVP 0 0 2 
No PVP 60 28 2 
In the absence of endotoxin approximately half the 
neutrophils were converted to formazan cells whereas endotoxin 
stimulation resulted in NBT reduction by almost all the c e lls. In the 
two studies performed, PVP completely inhibite d NBT reduction by , 
and structural disorganisation of, the cells (Table 3. 25. ) • 
Attempts to damage the cells by the a ction of p hospho--
lipase C, lysolecithin and sonication failed because e xposur e to these 
agents resulted in almost complete cell loss from the s lide after w a.sh i, g . 
3 .4.4. DISCUSSION 
NBT is toxic to ne utr ophils. Lactate dehyd.rogenc1sc 
( LOH) is a cytopl a smic e n z yme and i~s r e lec1se from cells is a rrD ci~,ll<'8 
of the integrity of the outer me mbrane of the cell ( Davies e t al, 19 '1 3.,). 
The addition of NBT to neutrophil suspensions increased LOH 
released from the cells, and this was further increased m the 
presence of endotoxin or latex particles. The increase m cell 
damage is not due to the endotoxin or latex per se, as they do not 
promote LOH release in the absence of NBT (Tables 3.20 and 
3. 2 I ) • The mechanism of this· toxic effect is unknown, but it is 
unlikely to be due to processes involved in the transfer of electrons 
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to the tetrazolium salt, as in the two patients with CGOC, latex 
particles markedly increased LOH releas e from cells in the absence 
of significant formazan production. 
There was a very close correlation ( p < 0. 001) between 
NBT reduction and LOH release from neutrophils of norm a l subjects 
(Fig. 3. 19 ) • Damage to the neutrophil membr a ne sufficient to 
allow the efflux of LOH, · the molecular weight of which is approximat.-: 
ely 150,000 (Boyer et al, 1963) would allow the efflux of other cyto-
plasmic constituents, including dehydrogenase enzyme systems , their 
+ substrates and cofactors, and the influx of NBT ( molecular we ight -
7 SO (Altman, 1972)) • This contact would a llow the r eduction of NBT . 
The enhancement of N B T reduction in the presence of 
latex p articles may re sult from either increased mcrnb!' ane damage, 
allowing greater c0ntact between the NBT and reducing substances, 
or beca use of the increased generation of reducing equivalents in the 
extramitochondrial cytoplasm induc ed by enclotoxin or latex . Patients 
with C GDC exhibit norm a l glycolysis but an ausence of the norm a l 
burst of HMP shunt a ctivity afte r the phagocytos is of latex. !n two 
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such patients NBT reduction was minim -:i. lly inc r eased, despite a 
marked increase of LOH release m the presence of latex (Fig. 3. 22) 
suggesting that in normal neutrophils the enhanceme nt of NBT 
reduction by latex phagocytosis results from a concomitant 
stimulation of NADPH production by the HMP rather than through 
further damage to the cell membrane. 
These results indicate that for the accur a te assessment 
of NBT reduction by ne utrophils in the quantitative NBT test of 
Baehner and Nathan (1968) it 1s essential not only to quantitate NBT 
reduction but also to cpmpare this with the a mount of LOH r e lease, 
thereby deriving a sta ndardised value for N B T reduction. 
In these studies cyanide was excluded from the cell 
suspension so as to avoid tox ic effects of cya nide on the s tudi es of 
LOH release by cells exposed to NBT. The classical obser vation 
in CGOC is a deficiency of cya nide insens it ive NBT reduc tion. T he 
absence of cyanide from the test system did not h amper the 
distinction between normal subjects a nd the p atients with CGDC but 
may have be en respons ible for higher than normal leve ls of NBT 
reduction by unstimulate d cells. 
In the stimulate d NBT test , in which N BT was added 
to blood or bone m a rrow in the presence of endotoxin, dye~ ·reduction 
occurred in an abnorm a lly low proportion of bone m arrow neub·oµhi ls, 
a nd the neutrophils of some patients with hypogamm agk.bu linaemia 
(3.3.4. a ) (3.2.3. a ). Quant itative NBT r eduction by bone mo.r>row 
neutrophils and the neutrophils of one of the hypogarnn1,~sdobulin,_;,·n,ic 
patients w as normal. This indicate s that the defect in t.hcse c c,:b 
m the stimulated NBT test is one of inefficient phagocytosis of the 
NBT complexes rather than an iriability of the cells to reduce the 
dye. The theory of C occhi et al (1969) that the failure of NBT 
reduction by neutrophils of infec:ed premature infants and p a tients 
with CGDC shares a common pathogenesis seems unlikely. 
In the NBT test, the dye enter neutrophils complexed to 
heparin or he parin and fibrinogen ( 3. 1) • NBT and heparin in 
. 
solution (Tables 3. 21 and 3. 22) d a mage the neutrophil membrane 
resulting in the extracellula r release of cytopla smic constituents. 
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Cell damage was also observed by electron microscopy in a model 
system simulating the NBT tes t ( 3. I. 3. i) . Although not quantitated, 
NBT appears to be concentrated on the precipitates of heparin and/or 
fibrinogen. It 1s suggested that whe n these complexes are engulfed 
by c e lls, close contact with the complex is tox ic to the membrane of 
the phagocytic v a cuole a llowing c ytopla smic d e hydrogena se syste ms to 
pour over and r e duce the NBT. Although the influx of hydrogen ions 
from incre ased HMP s hunt activity ( to be discuss e d be low) is 
proba bly the major s ourc e of r e duc ing equiva lents in norma l ne utrophils 
the r e duction of NBT by cytoplasmic dehydroge n ase systems m ay be 
re spon s ible for the s low reduction obser ved in the phagocytic v acuole s 
of p atie nts w ith C GDC ( Nath a n e t a l , 1969) • 
C ytochalasin B parti ally inhibits pha.gocytosis , y e t it 
e nhanced N BT red uction by neutrophils in whole b lood. These effects 
appear incompatible as NBT reduction under these circumstances is 
depe nde nt upon the phagocytos is of complexed NBT . However, C yto-
chalasin B does not reduce the adhesion of mic o-organisms to neutro-
phil s ( Davies et · I, 197 3.:d, and the gr ss c ell c lumping observed in the 
presence of this agent suggests that it may increase membrane 
stickiness • The mechanism of NBT reduction in the presence 
of Cytochalasin B may be envisaged as the adhesion of complexed 
NBT to the neutrophil membrane, followed by reduction as a 
result of the release of reducing compounds from the damaged 
membrane. Reduction is unlikely to be entirely dependent upon 
/ 
the selective exocytosis of lysosomal enzymes induced by this 
compound ( Davies et al, 197 3a), as retinol which has a similar 
effect (Davies et al,l973b) did not enhance NBT reductiono 
The meche.nisms underlying the NBT test and the 
quantitative NBT test are basically different. The former is a 
measure of phagocytosis of NBT complexes whereas the latter 
1s a measure of the toxicity of NBT and the metabolic activity 
of the cell. This explains the observation of Ashburn et a l ( 197 3) 
that despite widely vary;ng results of the NBT test in normal 
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subjects and patients with infection, chronic granulocytic le ukaemia, 
neoplasia and polycythaemia vera, the results of quantitative NB T 
tests did not differ signific a ntly between the groups. Indicating that 
although the phagocytic activity of neutrophils diffe r e d in these 
conditions, the toxic effects of NBT and the burst of metabolic activity 
a ssociated with phagocytos1·s d1'd not. A ..,epo"'t (De L Vee P. t I , , a ga - a , 
197 3) of negative NBT tests in an infected diabetic patient
1 
and 
decreased NBT reduction in the quantit a.tive NBT test whe n lasma 
' from this patient was added to the incubation mixture }was i.ri~crp r et.cd 
as indic ating the presence of a plasma fnctor th a t i11hibit0d NBT 
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reduction. The negative NBT tests in this patient probably resulte d 
from a relatively immature neutrophil population ( a shift to the left 
of the myeloid series of leucocytes was evident) and the addition of 
plasma to the incubation mixture in the quantitative NBT test would 
cau.3e binding of NBT to f ibrinogen, thus reducing the concentration 
of free NBT and possibly its toxic effects on the neutrophil membrane. 
Control experiments examining the effect of the addition of normal 
plasma to the test system were not performed. 
Exposure of the neutrophil suspension to NBT under 
similar conditions to the quantitative NBT test, both in the presence 
and absence of latex particles, led to reduction by some but not all 
of the cells (Figs. 3. 2 1 and 3. 22 ) • The reasons for the 
selectivity of this reduction have not been examined. The cells that 
reduced the dye were swollen and amorphous and dye reduction was 
predominantly in a granular pattern which appeare d to be mainly 
on the outer membrane of the cell. There was also a light blue 
diffuse staining which probably represents cytoplasmic stain ing. T hese 
cells closely resemble the 11form azan" cells describe d by Gifford and 
Malawista ( 1970) after• exposure of neutroph ils adherent to glass 
slides to a solution conta in ing NBT. In this test approximate ly h alf 
the neutrophils reduce the dye in the absence of endotoxin .::md almost 
all the neutrophils in th e presence of endotoxin ( 3.4.3.c). These 
cells look dam aged.They a re swollen, amo rphous and their nuclei 
are disintegrating. The cytoplasm is · diffusely blue and dc11so gr,_.r-1uLw 
formaz an de po siLs appear localised to the outer rnernbrane of the cc: iI 
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( Fig. I. 3) . Polyvinyl pyrrolidone ( PVP) protects 
cells from freezing injury ( Leibo et al , 1970). It is suggested that 
NBT alone is toxic to an undefined population of the neutrophils 
which are adherent to glass, that this toxicity 1s enhanced by 
endotoxin, as was shown witli. cells in suspension, and it is possible 
that PVP prevents this toxicity• NBT reduction probably occurs 
predominantly at the site of membrane rupture, but also to a lesser 
extent within the cytoplasm. The reasons for the variability of 
NBT reduction by cells, all of which are adherent to glass, 1s 
unknown. · It may- be a · function of age, but is difficult to investigate 
because of the unequal adhesive properties of neutrophils of different 
age ( Lightman and Weed, 1972) which would· result in selective 
detachment of younger cells when the adherent cells are washed m 
the experimental procedure. 
In the NBT test the vast majority of cells which reduce 
NBT contain deposits of form azan, Occasional cells have a different 
appearance in which the reduced NBT takes the form of multiple · 
minute dots which appear to b e in the outer membrane of the cell 
(Matula and Paterson.t 1971a) (Fig. 3.12 ) • Exposure of 
neutrophils to lysolecithin, phospholipase C, free z ing and thawing and 
sonication, procedures which result in focal perforation of membranes 
( Bang ham and Horne, 1964, Benedetti and Emme lot, 1966, Leibo et 
ai, 1970, H ughes and Nyborg, 1962) also result in this stippled 
appearance ( 3. 2. 3. d). It is probable that any procedure which 
cause s fo cal d isruption of the outer neutrophil membrane will allow 
focal contact between NBT and reducing substances at the aperture, 
resulting m focal formazan deposition~ 
The extensive interest in the extremely rare condition 
of CGDC results from the fact that neutr•ophils from these patients 
are unable to kill certain bacteria normally and that specific 
biochemical abnormalities which could account for this defect have 
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been demonstrated m the cells of these patients. The characterisation 
of the mechanism underlying these defects may allow specific 
treatment of these patients, but of more general importance in view 
of the extreme rarity of this condition, it may help to promote an 
understanding of the mechanisms underlying the bacteriocidal activity 
of normal neutrophils. 
One of the prime bacteriocidal mechanisms seems to be 





oxidising agent (Klebanoff, 1971) . The production of peroxide requires 
hydrogen ions, the initial source of which is thought to be NADPH 
produced by the HMP shunt, and a means of combining these with 




. The production of reducing equivalents can be 
measured by the activity of the HMP shunt, and their consumption can 
be measured by cyanide insensitive, therefore non-mitochondrial, oxygen 
utilisation, or by the reduction of some other hydrogen receptor such as 
NBT. Neutrophils of patients with CGDC do not exhibit the increased 





bacterial iodination or N BT reduction normally promoted by phagocytosis. 
The normal increase in t~1e turnover of reducing equivalents is 
therP-fore absent. This may result from an inability of the cell to 
produce the reducing equivalents, or because of their defective 
transfer from NADPH to oxygen. Although inadequate production 
has been reported in a single family with chronic granulomatous 
disease, haemolytic anaemia and complete a bsence of glucose-6-
phosphate dehydrogenase ( Gray et al, 197 3) the usual finding that 
methylene blue stimulates HMP shunt activity and NBT reduction 
( Baehner and Nathan, 1967, Humbert et al, 197 3) indicates that the 
defect in these patients lies in the transport of the reducing 
equivalents in the face of a normal ability to enhance their production. 
The kinetics of NBT reduction by neutrophils conform to those of 
an enzyme mediated reaction with regard to pH and temperature 
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( Baehner and Nathan, 1968). A search was then made for cyanide 
insensitive enzyme systems capable of oxidising NADPH and/or NADH. 
These investigations ignored a vital concept, that of 
the localisation of the H 2o 2 production. HzOz is toxic to cells 
( Massie et al, 197 2) and must therefore be produced within the 
phagocytic vacuole itself. Biologica l membranes are relatively 
impermeable to the pyridine nucleotides and s ome shuttle system, 
as occurs across the mitochondrial membrane (Chappe ll, 1968) 
must be envisaged to transport reducing equivalents into the 
phagocytic vacuole. 
The following hypothesis as to the mechanisms of 
H20,, production and stimulation of the HMP shunt in neutrophils as a result 
"" 
of phagocytosis is proposed, Ascorbic acid enters the phagocytic 
vacuole. Initial degranulation of the specific granules which contain 
lactoferrin and basic protein cause an abruot increase of the intra-
vac.uolar pH ( Bainton, 197 3) . As a result of this pH change, or 
through catalysis by lactoferrin bound iron, ascorbic acid undergoes 
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non-enzym1c convertion to dehyctroascorbate with the release of 
reducing equivalents which in the presence of molecular oxygen form 
super oxides, or free hydroxyl radicals and subsequently hydrogen 
peroxide (Slater, 1972a). 
The dehydroascorbate enters the cytoplasm where non-
enzym1c reduction by reduced glutathione ( GS H) reforms ascorbate. 
Reduced glutathione and ascorbate also protect the cells by acting as 
free-radical scavengers (Slater, I972b) through enzymic ( Bracci et al, 




diffusing into the cell from the phagocytic vacuole. Glutathione (GSSG) 
is reduced by NADPH-dependent GSSG reductase and the resultant 
decrease in the NADPH/NADP ratio stimulates the HMP shunt. 
Superoxides and other free radicals produced from ascorbate are 
primarily responsible for damage to the bacteri a l cell w a ll. When 
degranulation of the specific granules 1s followed by degranulation of the 
azurophilic granules ( Bainton, 197 3) , the intravacuolar pH drops to the 
optimal pH for myeloperoxidase which then induce s halogen a tion with 
any residual peroxide. Such a system would be cyanide insensi tive 
and a lthough the final p athways m a y be non-enzymic, the kinetics of 
the overall system would conform to those of an e n zyme system, 
because of dependence upon the enzyme controlled HMP shunt for 
the supply of reducing equivalents. 
The participation of ascorbic acid and glutathione as 
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hydrogen carriers m a mammalian electron transport system involving 
substrates oxidasable by NADP has been a recurring speculation 
(Borsook et al, 1936, Kinoshita, 1964, Pirie, 1965) and has been 
demonstrated m corneal epithelium (Anderson and Spector, 1971). 
Ascorbate is concentrated m neutrophils ( Loh and Wilson, 1970) 
but its concentration m phagocytic vacuoles is unknown. Although 









has much greater bactericidal activity in the presence of ascorbate 
(Miller, 1969) • Ascorbate produces free radicals in the presence of 
oxygen and a metal complex (Slater, 1972a), which damage biological 
membranes (Slater, 1972c). Ascorbate reduces NBT under alkaline 
conditions ( Nathan et al, 1969), a process which is largely mediated 
through superoxides when phenazine methosulphate transports reducing 
equivalents to NB T under aerobic conditions ( Nishikimi et al, 19 72) • 
Superoxides are produced by ne.utrophils, a process which is enhanced 
by phagocytosis ( Babior et al, 197 3) . Superoxides are oxygen 
molecules containing an additional electron which can be donated to 
other molecules with resultant ionisation and increased reactivity. It 
is possible that ascorbate produces superoxides directly, or indirectly 
after catalysis of Hz02 by mye loperoxidase and that these superoxides 
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are responsible for damage to bacterial cell walls. 
Dehydroascorbate crosses plasma membrane by active 
transport ( Loh and Wilson, 1970) and may be reduced by GS H 
spontaneously (Anderson and Spector, 1971) or enzymatically by 
dehydroascorbic acid reductase which has been demonstrated m 
erythrocytes ( Christine et al, 1956) and guinea pig tissues ( Grimble 
and Hughes, 1967) . The glutathione could be reduced by the 
glutathione reductase present in human leukocytes ( Baehner et al, 
1970b) . Ascorbic acid has a redox potential very close to that of 
methylene blue ( Burns and Ashwell, 1960) which stimulates HMP 
shunt activity in patients vyith CGDC. Dehydroascorbic acid reduces 
bacterial killing when added to a neutrophil suspension (McCall et al, 
1971) an effect which may be explained by competition with oxygen for 
reducing equivalents, resulting in decreased H 2o 2 production. 
It thus seems that ascorbic acid has the potential to 
transport reducing equivalents from reduced glutathione to oxygen, 
and to damage bacterial cell walls. Whether its ionic nature ( pKa 4 .17, 
Burns and Ashwell, 1960) will allow rapid enough movement of the 
molecule across plasma membrane. has yet to be investigated. 
Two experimental systems have been designed to 
investigate the importance of ascorbate in bacter ial killing . Neutrophils 
form scorbutic and normal guinea pigs will be compared wtth regard to 
bacterial killing and the effect of phagocytosis on HMP shunt acttvity, 
oxygen consumption, iodination and H 2o 2 production. It is of interest 
that NBT reduction by neutr'ophils of scorbutic guinea pigs is defective . 
( 3. 2.) Specific granules will be isolated from normal human 




production by intact 
and disrupted granules measured in the presence and absence of 
ascorbate. 
Ascorbic acid may play an important role in the 
bacteri cidal function of neutrophils. Damage to bacterial cell walls 
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in the absence of myeloperoxidase, could explain why myel~peroxidase 
deficiency is not alwc.ys accompanied by liability to bacterial 
infection (Klebanoff, 1971) • 
The underlying defect in CGDC may be in the transport 
of reducing equivalents into the phagocytic vacuole ori if the hypothesis 
/ 
as to the release of reducing equivalents from ascorbate by a sudden 
rise in the intra vacuolar pH or the presence of iron bound to Iacto-
ferrin is correct, in the sequence of degr anulation, or the absence of 
Iactoforrin, as other aspects of degranulation appear normal ( Stosse l 
197 3) • It would seem appropriate to measure· the ascorbic acid 
concentration in neutropl1ils of patients with CGDC and to treat these 
patients with ascorbic acid if a deficiency is observed. Another 
approach to the treatment of these patients would be to direct an 
artificially constructed bacteriocidal system into their cells. Liposomes 
could function as a vehicle for the transport of antibiotics or other 
bacteriocidal mechanisms ( Gregoriadis and Ryman, 1972). Hydrogen 
peroxide and a halogen could be coentrapped in liposomes and 
administered to these p alicnts. In patients lacking myeloperoxidase, a 
separa.te lipo s om · 1 prep or at.ion cont a ining thi s enzyme or some other 
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catalytic system could be administered simultaneously m the hope of 
umon within a phagocytic vacuol0 harbouring infecting microorganisms . 
Before contemplating such therapeutic manoeuvres an exact knowledge 
of the fate of intravenously administered liposomes ts essential. 
An attempt has been made to gam this knowledge as will be fully 
discussed m Chapter 5. 
3.4. 5. SUMMARY 
NBT is toxic to cells and this toxicity is enhanced m 
the presence of endotoxin or latex particles. There is a close 
relationship between LOH release, a marker of cellular integrity, 
and NBT reduction by cells. This relationship is absent in the 
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cells from patients with CGOC which indicates that the toxicity of 
NBT is unlikely to be related to the removal of reducing equivalents 
from the cell, and that the degree of membrane damage alone does 
not govern NBT redudion. Measurement of LOH release should be 
made in parallel with NBT reduction in the quantitative NBT test 
to more accurately predict the amount of NBT reduction that should 
be expected by correcting for the variation of NBT toxicity on 
different cell preparations. 
It was postulated that ascorbic acid may link the 
production of reducing equivalents by the HMP shunt to intravacuolar 
oxygen and that glutathione might act both as a step in this pathway 




on extravacublar cellular components . 
The use of liposome entr a pped therapeutic agents was 
proposed as a possible new npproach to the treatme:it of CGOC. 
3.5. SUMMARY 
There are basically two different NBT tests. They 
have different mechanisms of dye reduction and different clinical 
applir.ation. 
The first type of test, developed by Park et al ( 1968) 
was modified by Gordon et al 0973) by substituting EDTA for 
heparin as anticoagulant. These have been used as a non-specific 
. diagnostic test of bacterial infection. In this test, the dye enters 
neutrophils by phagocytosis after which it may be seen by light 
microscopy as discrete, dense blue black deposits. Before the 
dye can be phagocytosed it must assume a particulate conformation, 
which it does by precipitating and complexing with heparin and/ or 
fibrinogen. These precipitated complexes are present in all blood 
samples after the addition of NBT, but only a very small proportion 
of the neutrophils from the blood of normal subjects phagocytose the 
complexes and reduce the dye, whereas a variable proportion of 
neutrophils from the blood of patients with diverse diseases do so. 
Serum from patie!1ts with various diseases enhanced 
phagocytosis and reduction of NBT by neutrophils from normal . 
subjects. There was a close correlation (p <O.Ol) between the 
proportion of the patient I s neutrophils that r e duced the dye in the 
initial NBT test and the proportion of normal neutrophils that reduced 
the dye after being suspended in serum from these patients, when 
both tests were performed in the prese~ce of EDTA as anticoagulant. 
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This suggests that the cells of both the patient and the normal 
subject were exposed to similar modific a tion, and as the serum 
was the only link between the two cell suspensions, that this 
modification was mediated by humoral factors. 
Normal cells suspended in heterologous serum and 
exposed to NB T in the presence of heparin also showed varying 
degrees of enhanced phagocytosis but NBT reduction correlated 
. poorly with the initial NBT test result. Possible explanations are 
that heparin itself may stimulate phagocytosis and produce a false 
positive test, that heparin may inhibit the action of some of the 
humoral factors, or it may reflect the small number of studies 
performed. The effe cts of heparin may explain the different results 
of NBT tests performed by the two diffe rent methods on the same 
blood sample. 
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A number of factors were tested in an in vitro model 
syste m for the ir effect on the phagocytosis of complexed NBT. 
H e p a rin, d:1- acid glycop rotein, immunoglobulins, fetuin and endotoxin 
all e nhance d pha gocytosis, whereas a number of other factors were 
wi thout e ffe ct. The phys io logic a l roles of heparin, fe tuin and c:£.. I-acid 
glycop rote in a r e . u n clear - the y ar e all acidic and contain high 
concentrations of carbo hyd r a te . It was s ug g e ste d tha t the y may form, 
together w ith othe r acute p h ase p rote ins s uch as C RP, part of a 
non-spec ific opsonising syste m for the r esolution of autologous 
debris or exogenous mater ia l , eithe r locally in the c ase of he parin, 
or within the circulation. Low dose heparin therapy may have a 
prophylactic effect in the prevention of deep venous thrombosis 
by enhancing the phagocytosis of microthrombi. In a large group 
of studies the close correlation between the serum concentration of 
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cc. Lacid glycoprotein and the results of NBT tests performed by 
the E OT A/ficoll and heparin methods ( p < 0. 001 and < 0. OS 
respectively) suggests that this protein may be one of the factors 
responsible for positive NBT tests, though both may be independently 
related to disease severity. Complement and immunoglobulins 
are not obligatory for the phagocytosis and reduction of complexed 
NBT. 
Complexed NBT 1s not readily phagocytosed by normal 
neutrophils in the absence of enhancing factors. The fact that NBT 
is responsible for the formation of these complexes together with the 
fact that the precipitates contain a I built in' indicator of phagocytosis, 
readily identifiable by light and electron microscopy, make this agent 
a valuable tool in the study of phagocytosis and factors effecting it. 
Endotoxin enhanced NET reduction by neutrophils and 
resulted in a fairly reproducible dose response in normal subjects. 
This does response was assumed as a standard for comparison 
with various groups of patients in whom neutrophil function could 
have been abnormal. Most patients with hypogammaglobulinaemia, 
Crohn I s disease , diabetes mellitus, geriatric patients and patients 
receiving therapy with prednisone and sodium autothiomalate showed 
a similar dose response to normal. This suggests that the 
parameters of neutrophil function measured by this test, the ability 
of neutrophils to be stimulated by endotoxin, to phagocytose complexed 
NBT and to reduce the dye, are normal in the majority of these 
patients. 
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Immature bone marrow neutrophils are unable to 
phagocytose complexed NBT as well as mature circulating neutrophils. 
The replacement of the mature circulating pool of neutrophils by a 
less rrnture population in infected subjects could account for both the 
bacteriocidal defects and diminished NBT reduction observed in 
these patients. If the maturity of circulating neutrophils is indeed 
shown to be related to NBT reduction, this might be a very simple 
test system for the rreasurement of the proportion of immature 
circulating neutrophils, with a decreased bacteriocidal capacity, and 
may indicate the necessity for transfusion with norm~! granulocytes. 
Immune complexes also diminish NBT reduction, an 
effect which could be used to test for circulating immune complexes 
and the response of the causal disease process to therapy. 
The second type of NBT test is the quantitative NBT 
test whi c h is of value m the diagnosis of CGDC. This test 
differs from the NBT test used for the diagnosis of bacterial 
infection because the cells in this test are suspended in a protein 
free balanced salt solution. The mechanism of dye reduction in 
this test is also different -from that of the test performed on whole 
blood. In the quantitative NBT test, NBT reduction is related to 
toxicity of the dye on the ce ll membrane and the production of 
reducin g equivalents by the cell. 
Cell damage, assessed by LOH release, correlates 
closely with NBT reduction in normal subjects (p<0.001). The 
measurement of LOH release, and its use as a standard against 
which the observed NBT reduction can be compared, should 
enhance the accuracy of the quantitative NBT test. 
The mechanisms involved in the transfer of reducing 
equivalents from the HMP shunt to oxygen m the phagocytic 
vacuole are unknown. It was postulated that ascorbate may be 
involved in this pathway and that the production of superoxides, 
other free radicals or HzOz within the phagocytic vacuole by 
this compound may be an important component of the bactericidal 
armamentarium of the cell. 
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CHAPTER 4 
The as s oci a tion of r e duce d N B T with · se rum lipopr oteins a nd the 
use of NBT as · a lipoprotein s tain. 
4. I. INTRODUCTION 
Incubation of NBT with whole blood results in reduction 
of the dye by a variable proportion of leukocytes ( Chapter 3). If 
the mixture is left for some hours a blue discolouration of the super-
natant pl a sma develops, indicating th at reduced NBT is not confined 
to the cellular -components of blood. This reduce d dye appeared to 
be in solution in the plasma, as it p assed through a Millipore filter 
224 
with a pore size of O. 22 microns and r e maine d m the supernata nt plasma 
after centrifugation a t 10,000 G for 30 m inutes. As formazan is 
insoluble in water ( N a chlas et al, 1957) , some plasma constituent 
must be responsible for m a in ta ining it in s olution. 
In this chapter it w ill be s how n that fo rmazan s e le ctively 
binds to s e rum lipoproteins. This property toge the r with its vivid 
blue colour make it a u s eful pre stain fo r the identifi c ation of lipo-
proteins afte r separation by e lectrophores is. 
Its u s e as a p re s ta in in the separation of s erum lipo-
proteins by acrylam ide disc e lectr ophores is r esu lts in the appear a nce 
of s e veral bands n ot normally identified by th is s e paratiort tec hn ique. 
The ide ntity .of these bands a n d the ir prese nce in the seru m of 
norm a l and hyperlip id a emic su bje cts is investiga te d and d iscusse d. 
4.2. METHODS 
4. 2. I. The demonstration of the binding of formazan to ser!tm 
lipoproteins 
Blood samples were allowed to clot at room te:nperature 
and electrophoresis of the separated serum was performed within 6 
hours. To I. 0 ml of each serum was added 0. 5 ml of an aqueous 
solution of NBT m concentrations from O. 05% - 0. 80% and O. 5 ml of an 
aqueous solution of NADH (IO mM). After gentle m1xmg, the addition 
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of approximately IOOµg of solid phenazine methosulphate resulted m very 
rapid reduction of the dye and the mixture developed a deep blue colour. 
This will be referred to as a I pre stained I sample. Unadulterated sera 
were used as control samples except in immunoelectrophoretic - systems 
where the serum was diluted with an equal volume of O .15 M saline. 
4. 2. I. a. Immunoelectrophoresis of NB T pre stained and unstained serum 
Samples consisted of 5 prestained and control sera and 5 
prea-ained and control sera to which had been added an equivalent 
volume of both anti-al and anti-/!> lipoprotein serum. Laurell immuno-
electrophoresis of the samples against anti-whole human serum in an 
agarose/barbitone mixture was performed by the method of Minchin 
Clarke and Freeman ( 1968) • u Mono rocket I immunoelectr ophores is w as 
performed on 5 prestained and control samples by the method of Laurel ! 
(1966) using O. 2 ml of anti-whole human serum in 18. 0 ml of agaro s e. 
After completion of the procedures, the lipoproteins in the control s amples 
were stained with Sudan black ( satur ated solution in 60% ethanol), Oil 
Red O dye ( 0. 4 g/J in a mixture of equal volume s of ucetone and w a ter) 
or Amido black ( 2. 2. 4.). 
Antigen-antibody crossed electrophoresis was also 
performed on prestained plasma from the supernate of a mixture of 
blood and an equal volume of O .1% NBT which had been incubated 
at 37 °C for 12 hours. 
4. 2. I. b Polyacrylamide disc electrophoresis 
Samples consisted of sera from 3 normal subjeds 
prestained with either NBT ( 0. 3%.) or Sudan black, and serum 
from l subject which was depleted of lipoproteins by repeated 
ultracentrifugation at a background density of I. 21, retaining the 
bottom fraction ( Hatch and Lees, 1968 · .- This serum was a gift 
from Dr. B. Lewis, The Hammersmith Hospital, London) and 
then prestained with NBT (0.3%). 
Electrophoresis was performed by the m e thod of Fring Us 
et al 0971), which is a method of discontinuous acrylamide electro-
phoresis with concentrating and separating gels containing acrylamide 
and bisacrylamide in concentrations of 2.50 and 0.63%, and 3. 75 .and 
0.10% in TRIS/HCI buffers of pH 6.7 and 8.6 respectively. 
This method was followed exactly for the sera prestained 
with Sudan black. The sample gel was not used for NBT pre stained 
serum and delipidated serum , which was mixed with a half volume of 
a saturated solution of sucrose in the TRIS/ glycine r eservoir buffer 
(pH 8.3} diluted to 20% of the initi a l concentration with buffer . 75 p l 
(equivalent to 25 /11 of serum) of this mixture was gently layered on 
the s urface of the concentrat ing gel immediately before electrophore s is. 
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4. 2. I. c Cellulose acetate and agarose electrophoresi2,. 
Ten NBT prestained and control sera were electro-
phoresed on agarose by the Millipore Agaroslide system following 
exactly the methods described in the Millipore Application Manual 
AM 305, and on cellulose acetate following exactly the rrethods 
described by De Baets and Lezy ( 1971) . 
4. 2. 2. Further studies with polyacrylamide disc electrophoresis 
4. 2. 2. a Methods of pre staining and sample application 
1. The optimal concentration of NBT as a prestain 
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Normal serum was prestained as described above with 
aqueous NBT m concentrations of 1.0, 0.8, 0.6, 0.3, 0.2, 0.1 and 
0.05%. Electrophoresis was performed as described above (4.2.I.b). 
11. The optimal concentration of sucrose 
Serum prestained with NBT (0.3%) was layered on 
the surface of the concentrating gel after mixing with solid sucrose 
or with a half volume of a saturated solution of sucrose in 
TRIS/glycine reservoir buffer, undiluted, or diluted to 80, 60, 40 
and 20% of the initial concentration with buffer. The standard 
procedure was then followed. 
4. 2. 2. b. The lipoprotein pattern obtained m the serum of normal 
and hvperlipidaemic patients after prestaining with NBT 
Serum samples from 50 normal, non-fasting hospital 
staff ( 25 males, mean age 33. 0, S. D. 12. I years and 25 females, 
mean age 32. 3, S. D. II. 7 years) and from 9 hyperlipoproteinaemic 
patients ( 2 females) were pre stained with NBT ( 0. 3%), mixed 
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with a half volume of a 20% saturated solution of sucrose and 
electrophoresed by the standard method. ( Sera of patients with 
hyperlipoproteinaemia were characterised by preparative ultra-
centrifugation and were a gift from Dr. B. Lewis, The Hammersmith 
Hospital, London) . 
All serum samples were tested on the day of collection. 
Samples from 2 normal subjects were stored at 4°C and re-
investigated after 2, 7 and 28 days. 
4. 2. 2. c Characterisation of the lipoprotein bands obtained after 
separation by acrylamide disc electrophoresis 
1. Immunoelectrophoresis 
Two dimentional crossed immunoelectrophoresis was 
performed on samples of NBT pre stained serum, and control serum, 
from a normal subject. A simultaneous primary separation by 
electrophoresis on polyacrylamide was followed by electrophoresis 
into agarose containing antiserum . The duration of the polyacrylamide 
electrophoresis depended upon the lipoprotein under investigation in 
this part of the study; for the a lipoproteins it was 35 minutes, but 
l-2 hours was necessary for adequate separation of the /3 lipoproteins. 
The gels were bisected longitudinally and laid cut surface down on a 
5 cm x 5 cm glass cover slide ( Kodak), parallel to and I cm from 







Laure11 electrophoresis of serum prestained with reduced NBT showing 
the localisation of stain in the positions normally occupied by the a and 
{!, lipoproteins. 
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of a solution containing I. 0% agarose and O. I ml of anti-/J lipoprotein 
serum, or 0. 4 ml of anti-a -lipoprotein serum in O .·03M barbitone 
i 
0 
buffer, pH 8. 6, preheated to 48 C. After solidification of the gel 
the plate was positioned so that the bisected acrylamide strip lay 
transversely across its cathodal end. Electrophoresis was 
performed in barbitone buffer for 18 hours at a voltage of 2 volts/cm 
between wicks. 
u. Electrophoresis of fractionated lipoproteins 
Serum fractions from 2 normal subjects were separated 
into very low density ( VLDL, d < I. 006 g/ml), low density ( LDL, 
d I. 006-1. 063 g/ml) and high density ( HDL, d I. 063-1. 21 g/ml) 
lipoprotein fractions by preparative ultracentrifugation. ( Hatch and 
Lees, 1968) ( The fractions were a gift from Dr. B. Lewis, 
The Hammersmith Hoppital, London. ) The lipoprotein fractions 
were prestained with NBT and electrophoresed by the standard 
procedure. The VLDL fraction was precipitated by NBT and to 
prevent this it was mixe d with de - lipoproteinised serum ( 4. 2. I. b) 
before the addition of NBT. 
4.3. RESULTS 
4. 3. I. Identification of the serum orote ins that bind formazan 
4. 3. I. aJmmunoelectrophoresis 
1. Antigen-antibody crossed electrophoresis 
Blue colouration was found only in the precipitates 
previous ly identified as a and /J lipop roteins ( Minchin Clarke and 
Freeman, 1968 ) (Fig. 4. I) . T he size , shape and posit ion of the 
lipoprotein arcs did not differ appreciably from those produced when 
+ 
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FIGURE 4.2. 
I Mono rocket' electr ophoresis of serum. Rockets of similar height 
resulted from the precipitation of the /J lipoproteins after electrophoresis 
of the same serum sample, prestained with NBT (numbe rs 1-4), oi::-
unstaine d, and then pos t s tained with Sudan black ( numbers 5-8). 
a b a b 
+ 
FIGURE 4.3 
Polyacrylamide disc electrophore sis of sera, from three normal 
subjects, prestaine d with ( a) Sudan black and ( b) nitroblue 
tetrazolium. 
the control serum was run simultaneously and stained afterwards 
with Ami do black ( a protein stain) , Sudan black or Oil Red 0 
( lipid stains) . · Mixing with specific antilipoprotein sera resulted m 
disappearance of the lipoprotein precipitates from both the NBT 
pre stained and the control sera. 
t1. r Mono rocket' electrophoresis 
Repeated single volume samples, prestained with NBT 
m initial concentrations of less than O .15% resulted in rockets of 
fairly constant· height which matched the rockets obtained from equal 
volumes of the control serum and post stained with Sudan black 
(Fig. 4. 2). Increasing concentrations of NBT greater than O .15% 
resulted m a progressive reduction in the height of the rockets. 
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4. 3. I. b. Acrylamide disc electrophoresis 
Compared with Sudan black as a pre stain, NBT gave 
a greater intensity of colour. The lipoprotein bands were comparable 
in electrophoretic mobility, but additional bands were demonstrated in 
the a region (Fig. 4. 3. ) 
' When the procedure was performed on the serum 
fraction of density ) I. 21, no staining was seen in the separating gel; 
all the stain was found as a precipitate on the surface of the condensing 
gel, suggesting that proteins other than the lipoproteins, which were 
removed by density centrifugation, do not bind formazan. 
4. 3 .1. c Cellulose acetate and agRrose gel electrophoresis 
The pattern of lipoprotein separation was similar whether 





Electrophoresis of sera from three normal subjects , prestained with 
NBT (a) or stained after electrophoresis with Sudan black (b), on 
agarose by the I Agaroslide I method. 
less, or post stained with Sudan black (Fig. 4. 4). Higher 
concentrations of NBT were only tested on agarose, and resulted 
in progressively decreased mobility of the pre-/3 lipoprotein band 
which fused with the /3 band when NBT was used in initial 
concentrations greater than O. 4%. 
4. 3. 2. Polyacrylamide disc electrophoresis 
4. 3. 2. a Identification of the optimal pre staining conditions 
1. The optimal concentration of NBT 
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The use of NBT in initial concentrations of l. 0 and O. 8% 
caused over staining and collapse of the concentrating gel layer. 
Concentrations of less than O. 3% resulted in inadequate staining of 
the a lipoproteins. Clear delineation of the /3 lipoproteins together 
with adequate staining of the a lipoproteins was obtained with initial 
concentrations of O. 6, 0. 4 and O. 3%. 
NBT in an initial concentration of O. 3% was used in 
further studies. Changes in the concentration of NBT resulted in 
changes in the intensity of staining of the a bands, but not in their 
electrophoretic mobility. 
11. The optimal concentration of sucrose 
The addition of l volume of a concentrated sucrose 
solution diluted in l in 5 in buffer, to 2 volumes of prestained serum 
was found to be optimal ·. More c,oncentrated solutions, and solid 
sucrose, caused the cor.centrating gel to collapse, while the absence 
of sucrose resulted in inefficient appliC?ation of the sample, which 





























































































































































































































































FIG URE 4.6 . 
Pre-{3 
f3 
NBT prestained sera from 6 normal subjects, after separation by 
polyacrylamide disc electrophoresis, demonstrating multiple a 
lipoprotein bands . 
s L H V s L H V 
+ 
FIGURE 4. 7. 
Polyacrylamide disc electrophoresis of NBT prestained samples 
from two normal subjects of serum ( S) , and serum separated 
by preparative ultracentrifugation into fractions containing predominantly 




4. 3. 2. b The lipoprotein patte rn of normal and hyperlipidaemic sera 
after separation by po!yacrylamide disc electrophoresis 
A very reproducible picture was obtained on normal 
sera (Fig. 4. 5. ) . Chylomicra remained localised to the su':"face of 
the concentrating gel. The /3 and pre- f3 bands occupied the position 
described by Frings et al ( 1971) . An additional band, referred to 
as the I inter /3 1 band m this study, was present between the /3 and 
pre- /3 bands in the serum of 14 males and 6 females. This band 
remained constant in the sera of 5 individuals restudied over a period 
of 6 months. Two of the men, both with densely staining f3 bands, 
had another faintly staining band anodal to the /3 band. 
The a lipoproteins showed a discrete densely staining 
band in the position described by Frings et al ( 1971) • An additional 
4-5 broad ill-defined I slow a I bands, present in all normal sera , 
were found cathoda l to the conventional a band (Fig. 4. 6). These 
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bands were most clearly defined early in the electrophoretic procedure, 
before ciear separ ation of the a bands occurred. Prolonged electro-
phoresis caused the a bands to become broader and less well defined. 
The characte1"isation of those b ands was confirmed using 
ultracentrifugally- isolated V L DL, LDL and HDL serum fractions 
which migrated to the regions occupied by the pre-·/3 , /3 and a 
lipoproteins respecti vc ly ( F ig. 4 . 7) . 
Laurell crossed irnm unoeiectrophores is w as used to 
further identify the b .. rnds. The. pos'tion of the lipoprctcin bands of 
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1 n er- /3 
t pre-13 
lmmunoe1ectrophoresis of normal, unstained serum into agarose 
containing anti- /3 lipoprotein serum after preliminary separation on 
polyacrylamide. The positrons occupied by the pre- /3 , inter- f3 
and (3 lipoprotein bands of serum, pPestained with NBT and 
electrophoresed simultaneously, are indicated. The position of the 
inter-/3 band corresponds with a shoulder on the cathodal margin 
of the /3 arc . · 
Amido black. 
UNSTAINED SERLM 
N. B.T. PRESTAINED 
SERLM 
POLYACRYLAM I DE DI SC I 
ELECTROPHORETIC PATTERN 
FIGURE 4.9 . 
' 
+ 
lmmunoelectrophoresis of unstained ( stained after electrophoresis with 
Ami do black) and NBT pre stained serum, from a normal subject, 
into agarose :::!Ontaining anti- 0 1, lipoprotein serum, after preliminary 
separation on polyacrylamide . The immunoprecipitation arcs are shown, 
as is the lipoproteiri pattern after separation of the same serum, 
















































































































































































































































































































































































































































with the position of the same band after simultaneously electrophoresis 
of NBT prestained serum. All the bands except the pre-/3 band 
moved freely from the acrylamide disc into the surrounding agarose 
gel. In samples of both pre stained and control serum, the f3 bands 
gave a distinct line of precipitation with anti- /3 but not with anti- ll'J , 
lipoprotein serum while the I inter /3 ' band gave a shoulder on the 
cathodal side of the /3 arc. (Fig. 4. 8) . The a lipoproteins gave 
lines of precipitation with anti-a1 , but not with anti-j) lipoprotein 
serum. Unstained serum reveale d a fairly narrow precipitation arc 
with a distinct shoulder on the cathodal margin. The same serum, 
prestained with NBT, and electrophoresed simultaneously under the 
same conditions gave a precipitation line with anti- a 1 , lipoprotein 
serum coinciding with the major band and with a contour skewed 
towards the c athodal side, showing at least I shoulder correspondng 
to the slow- migrating a lipoprotein components (Fig. 4. 9.) . 
Poor · staining of the a bands was observed in all the 
hype rlipoprotein a emic patie nts. A ge neral inc r e ase in the intensity 
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of sta ining of the f3 lipopr ote in b and s was also obse rve d in these 
patie nts. Thi s w as p r edominantly . in the pre- /3 and /3 r e gions in 
patients with pre-/3 and /3 hyper lipoprote inaem ia res pective ly. A de nse 
inter - /3 b a nd w a s prese n t m ser a of pat ient with hyper/3 li poprote inaemia. 
An intensely staining inte r /3 b and was prese nt in a serum sample 
containing the Ybroad f3 ' lipoprote in in wh ich there w ,qs v irtually n o 
p r e- {3 band and only a small /3 band ( F igs. 4. IO and 4 . ll). 
Storage of serum s ample s for up to one month a t 4 °C 
did not result in gross changes in the lipoprotein pattern described 
above. However, after storage for a few days there was non-
specific staining in the /3 region of the gel between the lipoprotein 
bands. 
Ouantitation of the intensity of stai ning of the individual 
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ban0s was attempted using a densitometer (Joyce Loebel, Chromoscan); 
prolonged electrophoresis was necessary before the /3 bands could 
be adequately separated for scanning. 
4.4. DISCUSSION 
Reduced NBT is insoluble in aqueous and lipid media 
and binds to cellular protein ( N :1chlas et a l, 1957) . When reduced 
in plasma, either spontaneously or with artificial reducing 9-gents, 
NBT remains in solution. In this study the binding of this compound 
to serum proteins was investigated. 
Reduced NBT was found to bind exc lusive ly to lipoproteins. 
This was demonstrated by:-
1. . The conformity between the localisation of reduced 
NBT and the localisation of serum lipoproteins , identified by 
classical lipid stains, after separ at ion by electrophoresis on cellulose 
acetate, agarose and polyacrylarnide or by imrnunoelectrophores is on 
agarose; 
11. The absence of the se sta ined bunds from serum 
depleted of lipoprote in s by density centrifug ation , and their presence in 
serum preparations containing the var1_ous lipoprote in fractions; 
111. The absence of the se bands afte r the additi on to 
prestained serum of specifi c antisera ; 
1v. Precipitation of prestained bands with specific 
antisera after separation on polyacryl-amide. 
The · mechanism of the binding of reduced NBT to 
lipoproteins is unknown and has not been investigated in detail •. 
An aqueous solution of NBT was reduced in the presence of solid 
cholesterol and phosphatidic acid and liquid triolein. It did not 
colour these substances, but precipitated in the aqueous phase 
except in the case of triolein, where a very fine non-particulate 
layer developed at the interface between lipid and water. Binding 
studies with delipidated apoproteins were not performed, though 
this would indicate whethe r reduced NBT binds to these proteins 
in the absence of lipid. Formazan might form a monolayer between 
triglyceride, bound to the lipoproteins, and water as it consists of 
both hydrophilic and hydrophobic components. 
Hyperlipidaemia is as s oci a ted with a number of 
pathological conditions, foremost of which is v ascular disease 
( Fredrickson et al, 1967). The di sease processes and their 
treatment ( Levy et al, 197 2) is dependent to some extent upon the 
type of hyperlipidaemia. The accepted classification of the hyper-
lipid aemias has been base d upon lipoprotein analyses by electro-
phoresis and ultracentrifugation ( Beaumont et a l, 1970). 
Ana lytical centrifugation is the most accurate method of 
lipoprotein analysis ( Hatch and Lees, 1968) • However , it is 
expensive, intricate and time consuming, factor s which limit its 
general application. 
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The commonly used methods for the investigation of 
hyperlipidaemia emi:?loy inspection of plasma from fasting patients 
for opalescence, and chemical quantitation of the serum cholesterol 
and triglyceride concentrations, to indicate the presence or absence 
of hyperlipidaemia. If present, the pattern of hyperlipidaemia is 
further investigated. Plasma frc.ctions containing the various classes 
of lipoproteins are separated by preparative ultracentrifugation and 
the lipid concentrations in these fractions measured. Electrophoresis 
of these fractions should also be performed to identify lipoproteins 
with anomalous centrifugal and electrophoretic characteristics such 
as the 11 sinki"ng pre-[!> " or 11 floating{!> 11 lipopf'oteins. Preparative 
ultracentrifugation is expensive and time consuming and is usually 
reserved for patients on whom the simple r techniques of 
quantitative measurement of cholesterol and triglyceride and 
qualitative assessment of the serum lipoprotein pattern by electro-
phoresis are insufficient for clear classification of the hyperlipidaemia 
( Beaumont et al, 1970) • 
Electrophoresis ts clearly an important technique in 
the investigation of abnormalities of the serum lipoproteins. Paper 
electrophoresis has been extensively used ( Lees and Hatch, 1963) 
but this is a slow process a nd has been largely superceded by the 
use of ceilulose acetate (Kohn, 1957), agarose ( Ressler et a l, 1961), 
starch gel (Lewis, 1961) and finally polyacrylamide (Narayan, 1965). 
Electrophoresis involves two · processes , separ at ion and 
identific ation . The standard e lectrophoretic methods separ.:1te the 
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lipoproteins into three clasf'ical groups, the pre- /3 lipoproteins, 
equivalent to the VLDL ultracentrifug at ion fraction with a d e nsity 
of < I. 006 g/ml, the {3 lipoproceins , equivalent to the LDL fraction 
with a density of I. 006 - I. 063 g/ml and a lipoproteins, which are 
equivalent to the HDL with a density of I. 063- 1. 121 g/ml. Identi-
fication of the separated lipoproteins involves staining with standard 
lipid stains such as Sudan black and Oil Red 0. Staining can be 
performed before or after electrophoresis. Staining after electro-
proresis has several disadvantages, it prolongs the duration of 
the procedure as time must be allowed for both stain ing of the lipo-
-protein bands and destaining of the surrounding medium to highlight 
the regions with specific affinity for the stain. D e staining is often 
incomplete, or excessive, resulting in destaining of the lipoprotein 
bands. Prestaining of samples before electrophoresis is the ideal 
method as it allows observation of the progress of the electrophoretic 
migration, immediate interpretation of the separation, and eliminates 
background staining. 
The comenti onal lipid stains h ave one maJor dis a dvantage, 
they are solubilised in organic solvents. When used as prestains 
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they alter the electrophoretic mobility of the lipoproteins ( Hatch and Lees, 
1968) and post staining tends to e lute the lipoproteins and lipids 
( Naito and Lewis, 197 3) . The observation that reduced NBT 1s 
an intense lipoprotein s ta in which results m staining of lipoprote ins in 
the absence of an organic solve nt suggested that it niight serve as an 
efficient prestain for identification of lipoproteins sepa rated by electro-
phoresis. 
Reduced NBT was found to be an efficie nt prestain for 
lipoprotein separation by Laurell 'mono rocket' and two dimensional 
crossed immunoelectrophoresis, and cellulose acetate, agarose and 
polyacrylamide electrophoresis. In initial concentrations of less than 
0. IS% it did :10t appear to alter the elac trophoretic sepa ration ( ex cept 
on polyacrylamide) , or the immune reactivity of the lipoproteins. The 
advantages of using N B T as a prestain are clearly s hown in the 
Millipore t Agaroslide ' system. The electrophoresis time can be 
varied by direct obse rvation of the migration of the lipoproteins and 
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the lipoprote in pattern c a n be dire ctly recorded by obta ining an immediate 
tracing from a dens itometer. The entire process takes 30 minutes 
compared with 150 minutes necessary to obtain a r esult by the 
prescribed .method. 
Discontinuous polyacrylamide disc electr ophoresis is a 
rapid proce ss resulting in high r e solution of the separ a ted lipopr otein 
bands. Prestaining is ess e ntia l, a s de staining of acryla mide d is c s 1s 
inefficient, b ut S udan b la ck results in re lativ e ly poor stain ing of the 
lipopr otein b a nds (Fig . 4. 3) . The c o mbination of an e ffici ent 
s y s tem for the separation of lipoprote ins and a .clear indic ator of the 
sep a rate d band s should provide the optimal system for the e lectr o -
phoretic separation of lipoprote ins. Further studies were therefor e 
performed w ith th is s ystem to established the normal lipoprotein 
pattern. 
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Prestaining of serum with NBT followed by polyacrylamide 
disc electrophoresis is an efficient method for the separation and 
identification of serum lipoproteins. The method described has the 
advantages of being able to dispense with a sample gel, so reducing 
operating time, while at the same time maintaining reproducibility 
(Fig. 4. 5) . 
The positions occupied by the f3 , pre-/3 and a lipo-
proteins in the acrylamide discs were established using specific 
lipoprotein fractions and crossed immunoelectrophoresis. They 
conformed, in the main, to those described by Frings et al ( 1971) . 
Additional bands between the f3 and pre-/3 bands have 
been previously reported (Frings et al, 1971; Grajnert et al, 1972) 
in the serum from hyperlipidaemic patients. In this study a similar 
band, here referred to as the I inter f3 ' band, has been demonstrated 
in 56% and 24% of normal male and female subjects respectively. The 
presence or absence of this band m any one individual was constant 
over a period of 6 months. The finding of similar bands when Sudan 
black was used as prestain, and the presence of a shoulder on the 
immunoprecipitation arc of normal _serum corresponding with the 
inter {3 band of pre stained serum, suggest that its identification in 
such a large proportion of norm.:11 subjects is probably a reflection 
of the intensity of staining of the lipoproteins by NBT rather than 
the formation of an artefactual band by the methods used. 
Separation by acrylamide electrophoresis is dependent 
upon both electrical charge and molecular size ( Frings et a l, 1971) . 
Electrophoretic mobility is inversely related to molecu!ar size, 
the large chylomicra remaining on the surface of the concentrating 
gel and the small a lipoproteins migrating furthest. This accounts 
for the difference between the migration of the /3 and pre-/3 
lipoproteins on acrylamide and paper electrophoresis. In the latter, 
electrophoretic mobility is related almost entirely to charge and the 
pre- /J band migrates more rapidly than the /3 band, which accounts 
for its name . 
It 1s though· that the large ( Sf 20-400) VLD L molecule 
1s catabolised to the smaller ( Sf 0-20) LDL molecule, a process 
accompanied by loss of the VLDL and HDL apoproteins ( Levy 
et al, 1971). The LDL are heterogenous having two maJor 
components in the analytical centrifuge (Lewis, 1971) • The minor 
of these two components ( Sf 12-20) is possibly an intermediate in 
the catabolism of VLDL to the smaller LDL molecule (Sf 0-12). 
This intermediate lipoprotein ( Sf 12-20) may be identical to the 
'broad /3 ' lipoprotein which might accumulate as a result of 
delayed catabolism to the Sf 0-12 fraction ( Levy et al, 1971) . 
The size of the lipoprotein components of the inter 
band is likely to be intermediate between that of the pre-/3 and/3 
lipoproteins. It is possible that this band consi sts of the LDL 
component with a Sf value of 12-20. This would be compatible 
with its precipitation by anti- fJ lipoprotein but n0t anti- a lipoprotein 
serum and the presence of a very dense band in this region in 
serum containing the 1broad /J' lipoprotein m which a disproportionate 
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increase of this subclass of the LDL is characteristic ( Beaumont 
et al, 1970) . 
If the diagnosis of I broad {3 ' hyperlipidaemia by the 
described method of electrophoresis is sufficiently reliable it 
could have important clinical application as "there is urgent need 
for a simple diagnostic method" of this condition ( Rifkind, 1971) . 
The HDL are known to be heterogenous. Petek et 
a·I (1972) described 2 a lipoprotein bands on agarose gel electro-
phoresis and Scanu ( 1965) has shown three bands by immuno-
precipitation, only one of which was detected by a lipid stain. The 
HDL may be composed of a number of subunits, each with its own 
complement of phospholipid, neutral lipid and the major constituent 
proteins (Gotto, 1969) . It is therefore of interest that a number 
of a lipoprotein bands have been detected with the above methods. 
Prestaining with NBT reduces the electrophoretic mobility of some 
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of the a lipoproteins, as shown by a broadening of the immuno-
precipitation arc with anti- a: 1 lipoprotein serum (Fig. 4. 9) . However, 
the identical pattern of banding present in almost all normal sera 
(Fig. 4. 6) suggest that this reduction is related to specific subgroups 
of the a lipoproteins which are heterogenous on the basis of 
composition or subgroup configuration. The asymmetry of the 
precipitation arc between unstained serum and anti- a1 lipoprotein 
serum is confirmatory of the he terogenous nature of the a lipoproteins. 
It is therefore suggested that the a lipoproteins are composed of a 
number of fractions of like electrophoretic mobility which arz 
modified in a non-uniform manner by the use of NBT as a 
prestain, resulting in the observation of discrete bands. 
Densitometric scanning of the discs was attempted 
and found to be feasible, but was not further pursued. Because of 
the variable uptake of standard lipid stains by different lipids 
( Hatch and Lees, 1%8), densitometry gives results which are 
related to the concentration of the various bound lipids, rather 
than the concentrations of the lipoproteins themselves. NBT 
would be of greatest value as a lipoprotein stain if it were shown 
that the intensity of staining of the various lipoproteins was 
directly related to the protein, rather than the lipid, concentration. 
Experiments are at present being performed to compare lipoprotein 
analyses by analytical ultracentrifugation of unstained sera with 
densitometer scans on the same sera, pre sta ined with NBT. If 
the lipoprotein profiles determined by these two methods were 
found to correspond, the quantitation of serum lipoproteins might 
be greatly simplified by the combination of electrophoresis and 
densitometry of NBT prestained serum samples. 
Labelling of lipoproteins with r e duced NBT may be 
a useful adjunct to te chniques of lipoprotein separation other than 
ele ctrophoresis, as the lipoprote ins are vi s ible and could be 
qu a ntitate d s pectrophoto metric a lly. 
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4.5 .. SUMMARY 
Reduction of NBT is the presence of serum resulted 
m binding of the dye specifically to lipoproteins. This property 
together with the intense blue colouration of reduced NBT allow its 
use as a prestain for the demonstration of lipoproteins separated 
by electrophoresis. In the correct concentrations, reduced NBT 
does not alter the electrophoretic mobility of lipoproteins in agarose 
or cellulose acetate, and does not alter its immune reactivity. Its 
use as a prestain in polyacrylamide results in the appearance of 
several new bands. A band, commonly present between the /a and 
pre- J3 lipoprotein bands, may r3present a minor fraction of the 
LDL. The clear demonstration of this band in the single patient 
with a 'broad /3 1 lipoprotein, suggests that NBT might be useful 
m the diagnosis of this condition by electrophoretsis. A number 





The localisation of intravenously administered liposomes 
5. I. INTRODUCTION 
In conventional parenteral drug therapy the therapeutic 
agent is not specific a lly directed to any particular target or cell. Most 
cells in the body are exposed to the drug, the therapeutic action of 
which is dependent upon a qualitative or quantitative metabolic 
peculiarity of the target cell or organism. Disadvantages of this form 
of therapy are that normal cells, as well as the target cell or 
organism, are exposed to the possible deleterious effects of the 
therapeutic agent, and that this agent ts itself vulnerable to metabolic 
and immunological modification before reaching its target. 
Structural and metabolic peculiarities of micro organisms 
usually allow efficient antimicrobial therapy with drug concentrations well 
below those toxic to the host. However, when the target is an autono-
mous quasi-normal cell as in a neoplasia, or when infecting agents are 
sequestered within cells, normal cells are susceptible to the toxic effects 
of therapeutically effe ctive concentrations of the drug, the beneficial 
effects of which must be weighed against its toxic effects on normal tissues. 
Inher ite d enzyme deficiencies in man could pos s ibly be 
corrected by gene r eplacement or treate d by enzyme replacement 
(Strauss, 1971), p a.re ntal admin istration of e nzymes or nuclei c ac ids 
e xposes these substance s to immunological or c hernical m odifica.tion 
within the c irculation, without in any way r egulating the site of action 
or eventual destination of such ·19ents. 
FIGURE 5.1. 
Electron micrograph of a liposome, showing it to. consist of alternating 
concentric lamellae of lipid separated by aqueous compadments. 
Sodium silico tungstate x360,000. 
A system capable of directing therapeutic agents to 
specific target cells or tissues should be a major therapeut.ic 
advance. 
Trouet et al ( 1972) attempted to localise the site of 
action of a drug to neoplastic tissue by complexing daunorubicin, 
which inhibits DNA replication, to heat denatured DNA, a carrier 
designed to direct the drug to cells capable of pinocytic activity. 
In animal experiments, the toxicity of the drug was reduced, and 
its therapeutic effect enhanced, and encouraging results were 
obtained in the treatment of neoplasms in humans. However, 
they felt that DNA might prove undesirable as a carrier, owing 
to its informational content, antigenicity, ability to induce plasma 
DNJ\:u:e and the fact that its use is limited to drugs capable of 
combining with it, and suggested that a search should be made for 
other carriers. 
Liposomes ( Bangham et al, 1965) are lipid 
spherules of val"'ying shapes and sizes ( approximate diameter: 
1 x 102 - 104 A O , Bang ham, 1968) , composed of a closed system 
of concentric lipid bilayers approximately 40A O wide in the dried 
state, separated by aqueous compartments {Fig. 5 .1) approximately 
SSA O wide ( Sessa and Weissmann, 1968) . Sessa and Weissmann 
0970) entrapped lysozyme in the aqueous compartment of liposomes 
in an attempt to construct an experimental model of lysosomes. 
Gt:-egoriadi s et al ( 1971) proposed the use of liposome-entrapped 
256 
enzymes m the treatment of enzyme deficiency diseases, a 
procedure which was later shown to be effective m an in ·vitro 
model system ( Gregoriadis and Buckland, 197 3) . 
The use of liposomes as a carrier systerr. would 
allow the transport of substances specially tailored to the therapeutic 
requirements at the target site while at the same time both 
protecting them from modification within the circulation and 
preventing non~specific action on normal cells. 
It was proposed in Chapter 3 that liposome-
entrapped enzymes or the rapeutic agents might be useful in the 
treatment of CGDC, a condition in which the neutrophils are unable 
to kill certain b acteria, which remain within the cell, protected 
from the letha l effects of serum and drugs. 
The use of so highly selective a form of treatment 
must hinge upon the exact cellular and subcellular localisation of 
the transported m aterial after intravenous administration as a 
lipos ome- entrapped molecule. Although there 1s evidence that 
Iipos ome -entr apped s u bstances loc a li s e mainly m the lysosomes of 
the live r and sp leen of anim als ( G regori ad is and Ryman, i972), 
the ir p rec ise cellular. destination w ith in these organs a nd the fate 
of the carrier liposome s w ithin these cells is unknown. 
Jn an attempt to answer these questions, the fate 
of intraven ously adm ini stered liposomes was m onitored by light 
and electron microscopy. NB T was c hosen a s the liposomal 
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marker because; reduction, either spontaneously with:n cells 
or artificially in vitro, converts it from a pale yellow water-
soluble compound to a dark blue water-insoluble formazan, 
visible by light microscopy, and under certain circumstances 
by electron microscopy, which does not diffuse from the site of 
reduction ( Nachlas et al, 1957); when entrapped within liposomes 
and then reduced, the dye should remain localised to the liposome 
0 
because of its insolubility in both water and lipid. 
5.2. METHODS 
5. 2. I. Preparation of liposomes 
Liposomes were prepared by the method of 
Gregoriadis et al (1971). Lecithin (40.0µM), cholesterol 
(II. 4 µM) and phosphatidic acid ( 5. 7 µM) , giving a molar ratio 
of 7. 2: 1, were dissolved m chloroform ( 5 ml) m a 100 ml round 
bottomed flask (Quickfit). Rotary evaporation at 37°C (Blichi 
rotavapor-R, speed 7) for approxim ately 2 minutes resulted m 
the formation of a thin film of lipid on the walls of the flask. The 
flask was gasse d with Oz free N 2 , 2. 0 ml of the aqueous solution 
to be entrapped was added, the flask regassed with N 2 a nd shaken 
vigor6usly until the lipid film was dispersed in the aqueous phase . 
The milky suspension was ke pt at room temper ature for 2 hours 
and then sonicated 4 times, each time for a duration of 15 second s 
( ISO Watt MSE ultrasonic disintegrator ) at an interpe a k ampli tude 
of 8 microns, with the 2. 0 cm titanium probe placed just be low 
the surface of the liquid and the bottom of the fl ask r esting on ice. 
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The flask was regasse d with N2 and kept at room t~mperature 
for 3 hours. Liposomes were s e parated from non-entrapped material 
by centrifugation at 100,000 G for 30 minutes or by molecular sieve 
chromatography on a Sepharof-e 68 column ( I x 25 cm) equilibrated 
with 6. 6 mM phosphate buffer, pH 7. 2, containing O .15 M NaCl. 
5. 2. 2. Entrapment of the dye within lipos omes 
NBT was entrapped in liposomes m two ways. 
Free NBT ( 2 and IO mg/ml in aqueous solution) was entrapped 
m the liposomes which were then sonicated and allowed to stand 
at room temperature for 3 hours. Afte r centrifugation, the pellet 
was washed with and resuspende d in O. ISM saline. 
Liposomes containing reduced NBT were obtained 
by first entrapping an aqueous mixture of NBT ( 2 mg/ml) and NADH 
( IO mM} as described above, and then promoting intraliposomal 
reduction of the dye by the addition, 3 hours after sonication, of 
a portion ( 5% of final volume) of an aqueous solution of phenazine 
methosulphate (IO mM). The dark blue s uspension was allowed 
to stand at room temperature for 16 hours, after which the 
liposomes w e re sep e rated from the unentrapped for m a zan by 
molecular s ie ve chromatography, cmtrifiuge d at 100,000 G for 
30 minute s , and r esuspe nde d in l. 0 ml of O .15 M N a Cl. 
To ensure that the for mazan was e n trapped within 
liposomes a nd not attache d to non-lipos oma l lipids, 0. l ml of a n 
aqu e ous solution of 
131
1 ( Y a ctivity: 6 x 105 cpm) w as a dde d to 
the mix tu r e of N B T and NADH befor e e ntrapment. A compari s on 
was made between the radioactivity, counted using a well-type 
sodium iodide detector, and formazan concentration, measured 
as absorbance at 515 nm after extraction with pyridine, on 
fradions eluted from the column. 
The amount of NBT entrapped within liposomes 
was measured by reduction of the NBT to formazan by the 
addition of NADH (5 mM) and phenazine methosulphate ( 5 mM) 
followed by sonication. The formazan was then extracted into 
pyridine, the absorbance measured at 515 nM against a blank 
containing a mixture of water and pyridine, and the concentration 
extrapolated from a standard curve for NBT reduced and 
extracted in the same way. 
Liposomes conta ining NBT and formazan were 
examined by electron microscopy. 
5. 2. 3. A n imal expe riments 
Male albino rats ( Wistar) weighing 100-120 G were 
injected intravenously with: 
( i} I. 0 ml of a sus pe n s ion of lipos omes 
containing 4 0. 0 mg of lipids and; 5. 0 mg ( 3 anim a ls ) or l. 0 . mg 
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of unreduce d NB T ( 6 animals ) ; or 1. 0 mg of formazan ( 2 a n ima ls) ; 
(ii) 1.0 m l of s oluti on containing 1.0 mg (4 animals); 
or 5. 0 m g ( 5 ani rnals ) of N BT in O. 3 6 M dextrose ; 
(iii) I. 0 ml of a mixture of e q ua l volu mes of a 
s aspe n s ion of li posome s ( 80. CJ mg of lip id/ m l) and n on- e n trapped 
aqueous NBT (10.0mg/ml) in 0.36 M dextrose (I animal). 
(iv) I. 0 ml of a mixture of rat serum and I. 25 mg 
of formazan. This was made by mixing an aqueous solution of 
NBT (2.5 mg/ml) and NADH (10 mM) with 0.9 ml of he~erologous 
rat serum (to prevent precipitation of the formazan) after which 
0 .1 ml of phenazine methosulphate ( 10 mM) was added to promote 
reduction of the NBT. The mixture was then dialysed against 
2 litres of O .15 M saline for 16 hours at 4 °C across a cellulose 
membrane. 
5. 2. 3. a Light microscopy 
The animals that survived the injection were 
decapitated from IS minute s to 20 hours after injection and specimens 
of brain, myocardium, lung, liver, kidney, pancreas, inguinal lymph 
node, small and large gut and spleen were immediately fixed in 10% 
formaldehyde for 24 hours, embedded in wax, sectioned and examined 
unstained and after staining with a saturated solution of tar trazine m 
2-ethoxyethanol. Smears of blood and bone marrow were also 
examined unstained and after staining with Leishman I s stain. 
5. 2. 3. b Electron microsco2.Y_ 
Specimens of liver and spleen from animals 
injected with l. 0 mg of NBT in solution ( 2 animals ) , or entrapped 
within liposomes ( 2 animals ) and decapitated at 2 hours, and from 
control animals, were immediately fixed in a mixture of glutaraldehyde 
(2.5%) and sodium cacodylate (0.l M ) at pH 7.4 followed by 1.0% 
osmium tetraox ide in phos phate buffe r ( pH 7. 4 ) , dehydrated 





Light micrograph of kidney IS minutes after the injection of free NBT 
showing the dye (arrows) localised to the basal layers of the distal 
convoluted tubules. A glomeruh ... s ( G) can be seen in Fig. A. 
(A) Unstained x 300 




Light micrograph of liver 20 hours after the injection of free NBT, 
an intravacuolar needle-shaped formazan crystal is visible within an 
hepatocyte (arrow} . 
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The association between the entrapment of formazan, measured as 
absorbance at 515 nM, and the gammc' activity of entrapped 131 I, 
indic a ting co-entrapment of these substances within the liposome s. 
Thin sections were exarrined unstained or after staining with 
lead citrate (Reynolds, 1963) and uranyl acetate. 
Control liposomes and liposomes containing 
entrapped formazan were examined unstained and after n~gative 
staining with 2. 0% sodium silico tungstate. 
5. 3. RES UL TS (Table 5.1) 
1. Unreduced NBT unentrapped m liposomes 
All 5 rats injected with 5. 0 mg of NBT in 
aqueous solution and the single animal injected with 5. 0 mg of 
NB T together with but unentrapped in liposomes, convulsed 
and died almost immediately. Rats injected with I. 0 ml of NBT 
did not show side effects of injection. 
Light micros copy 
Punctate form a zan de pos its w e re observed sub-
endothclially in the distal convoluted tubules of the kidney ( ide ntified 
by staining with Periodic Acid Schiff ) in the rat kille d IS minutes 
after injection (Fig. 5. 2) . In the rat k ille d 20 h ours after 
inje ction the formaz a n was s c att e red throughout the cytoplasm of 
these c e lls and very occasiona l ne edle-shap e d crysta ls w e re 
found in hepatocyte s (Fig. 5. 3) a nd splenic m acr oph a ge s. 
11 • F ormaz a n entr app e d in _JjQosoflles 
The close assoc iation between the r adioactivity a nd 
the absorbance a t SJ S nM after column chromatography of the 
liposome a nd fo rmazu.n m ixture (Fig. 5 . 4 ) indi cated co-entrapm ent 
of 1311 and for maz a n w ithin li po s omes. 
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Light micrograph of spleen 1 hour after the injection of liposomes with 
entrapped formazan . Abundant deposits of formazan are present within 
macrophages and neutrophils, m the red pulp (RP, but not in the white 
pulp (WP). 
T artrazine x 400 
FIGURE 5.6. 
Light micrograph of liver 1 hour after the injection of liposomes 
containing entrapped formazan. 
and localised to, l<upffer cells. 
Tartrazine xl, OOu 
Formazan deposits are present m 
None of the rats injected with liposome-entrapped 
I 
formazan showed any side effects of the injection. 
Light mtCroscopy 
Abundant deposits of formazan were presert in 
splenic macrophages and neutrophils (Fig. 5. 5) and Kupffer cells 
and neutrophils in the liver (Fig. 5. 6) , and in smaller quantities 
in bone marrow macrophages and neutrophils, of animals that 
received liposome-entrapped formazan and were sacrificed l hour 
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after injection. Formazan deposits were observed in very occasional 
peripheral blood neutrophils and macrophages - the extreme rarity 
of such cells did not allow accurate quantitation. 
m. Unreduced NBT entrapped in liposome s 
All animals that received 5. 0 or 1. 0 mg of NBT 
were free of side effects after injection. 
Light microscopy 
Liposome-entrapped NBT gave rise to a picture 
which was a hybrid of that obtained with free NBT and liposome-
entrappe d formazan. Punctate deposits were p--esent in the distal 
convoluted tubules of the kidney after 30 minutes. Formazan deposits 
were also found in the spleen, and to a lesser extent in the bone 
marrow, in macrophages and neutrophils after 3 hours, and in 
Kupffer cells and neutrophils of the liver after 20 hours . The 
concentration of the visible formazan deposits was unrelated to the 
concentration of entrapped NBT and is probably a reflection of the 
number of particles rather than the tota l quantity of dye. 
FIGURE 5.7. 
Electron micrograph of splenic macrophage 2 hours after the iajection 
of liposome entrapped NBT. Lysosomes can be seen in close 
proximity to and actually fusing with (arrows) phagocytic vacuoles 
containing liposorr:al remnants. 
Uranyl acetate and lead citrate xl5, 000 
F IGURE 5.8 . 
Splenic macrophage 2 hours after the injection of liposome-entrapped 
NBT, showiry a phagocytic vacuole containing multilamellate d liposomes 
(arrows) . 
Uranyl acetate and lead citrate x200, 000. 
.< 
FIGURE 5.9. 
Unstained electron micrograph of splenic macrophage 2 hours after 
the injection of liposome-entrapped NBT, showing electron dense 
formazan crystals within phagocytic vacuoles. xlS, 000. 
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1v. Forma z a n une ntrappe c in lipos omes 
I 
The animal injected with formazan in the absence of 
liposomes did not show side effects of the injection. 
Li0ht microscopy 
No deposits of formazan were observed. 
S. 3 .1. Electron microscopy 
5.3.1.a Spleen 
Numerous la mellated myelin figures were observed within 
membrane bounded vacuoles in macrophages and neutrophils of 
animals inj e cte d with liposome-entrapped NBT (Fig. 5. 7) • 
Fusion of lysosomes wi th . the ph agocytic vacuoles was 
clearly visible and the lamellae of the myelin figures h ad roughly 
the same pe niodicity as those of the intact liposome (Figs. 5 .1 and S. 8) . 
In unstained sections formazan crystals were clearly 
visible within the phagocytic vacuoles (Fig. 5. 9). 
In comparison with liposomes the myelin figures appeared 
distorted and irregular. 
No such changes were observed m control m imals or 
anima ls injected with NB T alone. 
5.3.1.b Liver 
Identical mye lin figures w e re abundant m Kupffe r cells 
and in occasional neutrophi!s a nd porta l tract m a crophages of 
a n imals inje c ted with liposome-entrapped N BT. No s uc h changes 
were observed in the live r s of control anim als a nd an imals inje cte d 
w ith NB T a lone . 
5.3.l.c Liposomes 
I' 
Liposomes containing formazan (Fig. 5. I) were 
identical in size and conformation to control liposomes. The 
form=i.zan produced by intraliposomal reduction of NBT was 
electron translucent. 
5.4. DISCUSSION 
Liposomes are phagocytosed by cells of the reticulo-
endothelial system and by neutrophils after intravenous administration. 
When pre stained with formazan, deposits of this material were 
observed by light microscopy almost exclusively in Kupffer cells and 
neutrophils of the liver (Fig. 5. 6) and macrophages and neutrophils 
in the spleen ( Fig. 5. 5) and, to a lesser extent, the bone marrow 
and blood. Electron microscopy showed large concentrations of 
liposomes in the same cells in the liver and spleen (Fig, 5. 7) . 
After the administration of free NBT, formazan 
deposits were found predominantly in the distal convoluted tubules 
of the kidney (Fig. 5. 2) . Accumulation at this site occurs ·very 
rapidly and could result from pinocytosis by these cells. Trace 
amounts of formaz an also occurred as needle-shaped crystals within 
vacuoles in hepatocyte s (Fig. 5, 4) and splenic macrophages. 
A hybrid picture was obtained with liposomes 
a ssociated with unreduced N BT, which probably resulted from 
the injecti on of a mixture of liposome-entrapped NBT, and free 
NBT, sequestered be tween the liposomes during centrifugation 
o.nd r e leas e d by r esu s pension a nd intr avenous injection. Of 
inte r est is the d e lay before r e duction of th is NBT. Macrophages 
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and neutrophils reduced dye very rapidly after endocytosis 
( Nathan et al, 1969) , which suggests that the lag period is 
a measure of the rate of liposomal degradation within the cell. 
Structural disorganisation of ingested liposomes is apparent 
on electron · microscopy and is suggested by the observation of 
formazan crystals within phagocytic vacuoles; when reduced 
within liposomes the dye is electron translucent and thus must 
be released from the liposome in the oxidised form to allow 
crystal formation. Degradation of liposomes probably results 
from the action of lipases released from lysosomes, which were 
seen to fuse with and discharge their contents into phagocytic 
vacuoles containing liposomes (Fig. 5. 8). 
The protective action of liposomes was demonstrated 
by the immediate death of all the animals to whom a large dose 
( 5 mg) of unreduced NBT was administered alone or in the 
presence of, but unentrapped in, liposomes, whereas the animals 
which were given the same amount of NBT entrapped within 
liposomes were unaffected. 
Formazan is insoluble m water, but it remains m 
solution in serum m which it 1s bound to lipoproteins ( 4. 3). Its 
circulation in this form when administered without liposomes , could 
account for the absence of focal tissue deposition . 
C GDC was initially thought to represent 11 a 
generali sed d is ease of the reticuloendothelial s yste m 11 ( Bridges 
et n l, 1959) be cause of the wide s pread di s trib u,;ion of granu lomata: 
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consisting predominantly of macrophages and epitheloid cells, 
and abscesses containing neutrophils and macrophages, throughout 
the reticuloendothelial system. It is now known that the primary 
defect in this disease results in a decreased capacity of peutrophils 
from these patients to kill certain micro-organisms ( Guie et al, 
1967) after phagocytosis. 
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Bacteria are removed from the circulation by 
phagocytosis, and the patients do not develop overwhelming 
septicaemia (Bridges et al, 1969, Thompson and Soothill, 1970), 
however, the b acteria remain viable, sequested from the lethal effects 
of antibody and most antibiotics , and capable of prolonging the 
infection upon release from the cells. 
There are three possible methods of eradicating 
the infecting organism . A neutropenia can be induced to prevent 
neutrophils from harbouring the infecting agent, thereby allowing 
antibiotics to gain access to them. This form of therapy has been 
used in two patients by Thompson and Soothill 0970), who 
employed busulphan to promote neutropenia, with limited success. 
Although a theoretical possibility, this approach to therapy appears 
dangerous because of the risk of s uper infect ion by organisms 
resi stc1nt to the antibiotic therapy, and because of the non- infective 
complications of cytotoxic therapy ( C alabresi and Welch, 1962). 
Another approach to ther.apy in th8se patients 1s 
the use of antibiotics capable of ga1nmg access to and killing 
organisms within neutrophils . Rifarnp in 1s concentrated in 
neutrophi ls, unlike penicillin v,1hich does not ga111 access to 
intracellular sites, and is the only one of a large number of 
commonly used antil:::iotic s to kill intracellular bacteria (Mandell, 
197 3). The use of this drug would appear to be the most 
logical treatment of patients with C GDC and its use is at present 
being evaluated by Professor J. F. Sooth ill ( Department of 
Immunology, Institute of Child Health, London; personal 
communication) . 
The third approach to the treatment of these 
patients is the· introduction of bactericidal agents or sys terns 
directly into the leukocyte. The defect in leukocytes of patients 
' with CGDC has been partially corrected in vitro with HzOz 
producing drugs such as phenazine or methylene blue (Lehrer , 
I \ 
1969) or H202 generating systems such as latex particles coated 
with glucose oxidase (Johnston and Baehner, 1970), but although 
these techniques are helpful in establishing the bactericidal action 
of H202, they appear impractical for therapeutic use. 
In this study, liposomes were shown to localise 
predominantly in the reticuloendotheli·al system, in Kupffer cells 
and occasional neutrophils in the liver, and macrophages and 
neutrophils in the spleen and, to a lesser extent , the bone marrow. 
The reason for the scarcity of liposomes in circulating leukocytes 
is unknown. It is possible that the injection of liposomes as a 
bolus resulted in mixing of the liposomes with only a small 
proportion of the circulating leukocytes and th at most of the 
liposomes were removed by a single passage of the b lood through 
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the organs m which they were later located. It is also possible 
that having phagocytosed particulate matter, leukocytes rapidly 
leave the circulation and enter the tissues. 
Liposomes localise in the anatomical areas and 
cells in which pathological lesions are observed in C GDC. It 
has been shown that macrophages migrate to areas of inflammation 
after the phagocytosis of particulate matter ( Ginsberg et al 1 1969) , 
a process which might result in the accumulation of liposome 
containing cells in inflammatory tissue. These vehicles may 
therefore be of use in the transport of bactericidal agents or 
systems into neutrophils and macrophages. 
It is unlikely that liposomes would be toxic to cells 
as they are composed of naturally occurring lipids and there 1s 
evidence in this and other ( Gregoriadis and Buckland, 197 3) stud ies 
that they are degraded within the phagocytic vacuole. Neverthe less, 
toxicity studies on liposomes and any entrapped therapeutic agents 
should be performed in animals before use in humans, unless 
treatment employing these agents could possibly cure an other w ise 
rapidly fatal disease. 
In vitro e xperimentation on the b actericidal and 
toxic effects of liposome-entrapped compounds after uptake by· 
phagocytic cells of CGDC patie nts or in the model syste m of 
CGDC (Mandell et al, 1970) should be informative and simple 
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to perform. Agents that shoul<l be tried include: penicillin and 
other antibiotics in case the rifamycins are ineffective in vivo, or 
for the treatment of in~ections by organisms resistant to therapy 
with these agents; various enzymes implicated m the pathogenesis 
of CGDC; ascorbic acid and other systems capable of the 
formation of HzOz or super oxides. The generation of HzOz or 
other oxidising compounds within the phagocytic vacuoles of 
phagocytes may be toxic to cells with a poor. capacity for 
producing reducing equivalents, as cytoplasmic free radical 
scavengers (Slater, 1972b) may be incapable of detoxifying these 
com!=)ounds. This possible toxic effect should be carefully 
investigated. 
Even if liposomes or other bactericidal mechanisms 
were to prove effective in killing bacteria, this does not mean that 
the granulomata would regress. It is possible that granulomata 
occur as a result of ineffective digestion of antigenic bacterial 
material, which may be a completely separate process from that 
of bacterial killing (Ginsberg, 1972). Little is known of the 
digestive processes and as a result, no dignostic tests or clinical 
abnormalities of this system have been described. 
Liposomes may be useful in the study and possibly 
in the treatment of other disorders of neutrophil function, such 
as the Chediak-Higashi syndrome and myeloperoxidase deficiency. 
They may also be useful for the investigation and selective treatment 
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of disorders of the reticuloendothe lial system. Disec.ses such 
as Gaucher' s disease, in which there is a disorder of the 
metabolism of glucosyl ceramides ( Fredrickson and Sloan, 1972) 
might eventually be amenable to therapy with liposome-entrapped 
enzymes. Histeocytosis X, a granulomatous lesion, composed 
predominantly of histiocytic cells (Wintrobe and Boggs, 1970) and 
histiocytic medullary reticulosis, a neoplasm of erythrophagocytic 
histocytes ( Scott and Robb- Smith, 1939), would seem to be ideal 
conditions for therapy with liposome-e ntrapped cytotoxic agents. 
S.S. SUMMARY 
The cellular destination of liposomes has not been 
previously demonstrated, and their proposed in vivo therapeutic use 
was thus highly theoretical despite successful implementation in a 
mode l s ystem. 
In this study, intrave nously inje cted liposomes were 
observe d to localise predominantly in splenic macrophages and 
neutrophils, and in Kupffer cells of the liver and, to a lesser extent, 
in bone marrow macrophages and ncutrophils. This suggests 
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that liposorne - entrapped agents w ·ould be suitable for experimentation· 
upon, or as therapy for, inherited enzyme deficiencies and infective 
disease, as in C GDC, or neoplastic disease, of phagocytic cells. 
The scope and advantages of so highly selective an approach to 
ther apy are great. 
CHAPTER 6. Conclusions 
6.1. The N B T test 
t. The NBT test, whether performed by the method of Park 
et al ( 1968) or Gordon et al ( 197 3), was found to be unreliable 
m distinguishing between pyogenic infection and other diseases. 
11. There was no relationship between the result of tests 
performed by the two different methods. 
Ill. There ts an appreciable observer error m the interpretation 
of the slide preparations. This error seemed to be reduced by 
expe rience in the interpretation of these spectmens. 
tv. NB T precipitates and complexes with heparin and/ or 
fibrinogen and acts as a histochemical marker of the phagocytosis 
of these complexes by neutrophils. The NBT te s t is therefore a 
measure of the phagocytic activity of neutrophils. 
v. Ne utrophil uniformly exposed to the comple xed NB T e xhibit 
a variable phagocytic response. In patients with pyogenic infection, 
the exte nt of this phagocytic response appeared to be related to 
the severity of the illness. 
Vt. E xperiments conducte d with an in vitro mode l syste m, 
simula tin g the NBT test, indicated that a humor a l factor might be 
r e spons ib le for the enha nce d NBT r e duction observ e d in s ick 
p atients . 
v11. Serum concentrations of a numbe r of compounds a r e kn own 
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to be e levated in acute ly ill patients . Of tho s e tested, on ly a Lacid 
g lycoprote in , endotoxin ar!d im munog lobu lin s enhanced N B T red uction, 
any of which, singly or in combination, could be responsible for 
positive NBT tests in ill patients. 
v111. Evidence for the enhancement of NBT reduction by a humeral 
factor and by a I-acid glycoprotein was strongest in tests 
performed on blood anticoagulated with EDT A. Heparin itself 
could be responsible for the poor correlation between these 
factors and the NBT score of tests performed on blood in which 
it was used as anticoagulant. 
1x. The physiological roles of heparin, a '-acid glycoprotein and 
fetuin, a closely related acid glycoprotein present in the foetal 
serum of certain animals, are unknown. They all promo~e the 
phagocytosis of precipitates of fibrinogen and heparin, and might 
function as a non-specific opsonising system to enhance the 
phagocytosis of exogenous material and autologous debris, both 
locally and within the circulation. 
x. False-negative test results occur m patients with diseases 
such as CGDC, m which the neutrophils have a diminished 
ability to reduce the dye. These conditions are extremely rare 
and false-negative results would appear to be most commonly 
relate d to the replacement of mature circulating neutrophils by 
immature cells, which have a normal capacity to reduce the 
dye, but in which phagocytosis of complexed NBT is diminished. 
Under unusua l circumstances, immune complexe s could als o 
resu It m false-negative tests. 
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x1. An in vitro model system, in which endotoxin is used as 
an artificial stimulus of phagocytosis, can be used to measure 
the capacity of neutrophils to phagocytose and to reduce the dye. 
In this system it was shown that there was no difference i'n the 
dose response to endotoxin of neutrophils from normal subjects 
and patients with C rohn I s disease, diabetes mellitus and hypo-
gammaglobulinaemia, geriatric patients and patients receiving 
therapy with predniso~ and sodium aurothiomalate. 
xii. Complement and immunoglobulins are not obligatory for 
dye reduction. 
x111. The NBT test does not seem to have wide application as 
a diagnostic test for bacter ial infection, however, an tn vitro 
stimulation test appears to be of potential value in the assessment 
· of phagocytosis and dye reduction, which seems close ly related 
to microbicidal mechanisms, by neutrophils, and as an indicator 
of the maturity of circulating neutrophils and of circulating immune 
complexes. 
6. 2. The quantitative NB T test 
1. The qu a ntitative NBT test h a s a different underlying 
mechanism and differ e nt applic ation . 
11. NBT is toxic to neutrophi ls, and dye r eduction by these 
cells 1s closely related to the r e lease of cytoplasm ic constituents 
from the c e ll, probably as a result of enhanced c ontact between 
intracellular reducing compounds and NBT at the dam aged outer 
membrane of the c e ll. 
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111. In neutrophils from patients with CGDC, the amount of 
dye reduction is abnormally low when compared with the release 
of cytoplasmic constituents. This suggests that NBT does not 
exert its toxic effect purely by the consumption of reducing 
equivalents, and that the factor, or factors, responsibb for 
the reduction of NB T is absent from the cytoplasm of these 
cells. 
1v. The expression of NBT reduction by cells as a factor of 
LOH release, should allow more accurate standardisation of 
the quantitative NBT test. 
v. The main application of the quantitative NB T test is in the 
diagnosis of C GDC. It is also of use in distinguishing between 
inefficient phagocytosis and defective dye reduction by cells which 
exhibit diminished dye reduction in a stimulated NBT test. 
6. 3. Lipoproteins 
, . Reduced NBT binds specifically to and is solubilised by 
serum lipoproteins. The mechanism of this binding is unknown. 
11. This property allows the use of reduced NBT as a specific 
prestain for the identification of lipoproteins after separation by 
electrophoresis . 
111. The separation of NBT prestained serum lipoproteins by 
polyacrylamide gel electrophoresis was found to b e simple and 
reproducible, and of value m the qu a litative ide ntification of the 
various hyperlipidaemias. A number of minor slow a. lipoprotein 
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bands were present in all normal sera. A band with electro-
phoretic mobility intermediate between that of the /3 and pre-/3 
bands was present in a significant proportion of normal subjects, 
This band, referred to as the I inter- /3 1 band, could represent 
a minor ( Sf 12-20) component of LDL. It might also represent 
the 1broad /3 1 lipoprotein. If broad /J hyperlipoproteinaemia is 
shown to be clearly distinguishable by this technique, it would 
greatly simplify the diagnosis of this condition. 
1v. There is urgent need of a simple method for the quantitation 
of Iipoproteins that measures protein concentration rather than the 
concentrations of protein-bound lipids. If the binding of reduced 
NBT is found to be related to the concentration of proteins, rather 
than to that of any particular lipid, it should allow the quantitation 
of these proteins by densitometry, 
v. Reduced NBT could be a useful marker for lipoproteins m 
other separation techniques. 
6. 4. Liposomes 
1. Liposomes are potentially useful vehicles for the selective 
transport of therapeutic agents to particular intracellular targets. 
11. The whole principle of the use of these microbodies as 
a therapeutic tool hinges upon their exact cellular and subcellular 
localisation after intravenous administration. These facts were 
unknown. 
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111. Liposome-entrapped NBT and formazan were traced by 
light and electron microscopy to determine the fate of liposomes 
after intravenous administration. They were found to localise 
predominantly in Kupffer cells in the liver and splenic ma~rophages 
and to a lesser extent in neutrophils in these organs, and m 
macrophages and neutrophils in the bone marrow. 
1v. These findings suggest that liposome-entrapped agents 
should be useful for experimentation upon, and therapy for, 
diseases involving phagocytic cells. 
NBT has been a use ful tool in the studies 
described in this thesis. In view of its unique properties 
it should be of value, and should find wide application, 
in many other fields of experimental biology and clinical 
medicine. 
SOURCE OF MATERIALS 
Analar grade materials were used throughout 
this study. Special materials, materials which are not freely 
available from the major pharmace utical suppliers, or materials, 
the source of which is of speci~ic importance, are described 
below. 
Source or 
Com pound _§_pecification 
al-Acid glycoprotein Human 
Supplier 
Kindly donated by 
Dr .A. Tavill 
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North wick Park Hospital 
This protein was isolated from human serum by ion 
exchange chromatography on diethylaminoethyl cellulose 
( DEAE, DE 52, Whatm an ) , followed by separation by 
polyacrylamide ( 8%) electrophoresis and elution from 
the gel. Its purity was confirmed by Laurell electrophoresis. 
Adenosine diphosphate Equine muscle 
(ADP) 
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r I I 1 E-~ ~ ' ~ "' fj co E-i 8 
GUOUP I STlIDY s ~ rn z .... x,"> U) 0 z H AGE SEX Pi-~ ....:1 C,) E-i 0 '<: ~ NO. NO. ~~ H co E-i E-i 0 E-i 8 'C 0 E-i P-i ~ E-t ~i "8 ~ . . zo . ~ C,) ~~ ~ E-t P-4 (1!0 . . ~; 8 ~ . u U2 P'.l j . tii >< <1 ~ I :>-I . . 0~ . - ....:1 ~ ~ P-4 rn E-i 0 u -il0 
I 43 2L! F - 6.7 64 - 0 0 -· -
2 62 29 M - 6.7 66 - 0 0 - -
. 3 64 I6 F I - 5.7 52 - 0 0 - -
4 65 21 F - 7.0 78 - 0 0 - -
5 66 2I F - 6.8 60 - 0 0 - -
6 82 31 M - 5.9 70 - 0 0 - -
7 95 25 M 3 6.3 68 - 0 0 - 37 
8 96 28 F 9 5.2 66 - 0 0 - 90 
9 97 22 M 2 5.3 80 - 0 0 - 75 
IO 98 2I F I 17 5.9 74 - 0 0 - 90 
II II5 45 F I 4 5.3 70 2 0 0 - -
12 II6 50 F IO I8.8 85 I 0 0 - 85 
13 126 29 M I 4.4 53 I 0 0 - -
14 128 37 F 23 8.~ 63 2 0 0 - -
15 139 16 F 7 5.0 60 2 0 0 - -
16 140 IO }, 6 4.3 35 2 1 0 0 - -
17 166 l16 F 12 6.4 411 - 0 0 - l10 
18 173 23 M 2 7.4 42 - 0 0 - -
19 196 53 M 9 6.5 59 I 0 0 - -
20 I97 46 F 17 6.I 62 2 0 0 - -
21 210 70 F II 4.9 51 I 0 0 - e~ 
22 250 36 F 13 9.6 G2 - 0 0 - 55 
23 251 46 F 13 6.3 54 - 0 0 - II2 
211 252 63 M 12 5.3 67 - 0 0 - 85 
25 257 29 M 2 7 .11 65 I 0 0 - 145 
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Detail s of patients with untreated py...9genic infections (g!:.Qllp_g) 
~. 
' 
GROUP STUDY AGE 
·NO. NO. 
. 
I 263 34 
Ii 
2 253 2I 
3 2':1:5 7I 
q 2ql1: q9 
5 236 57 
I: 6 23q 25 
' :., 7 23I 5 
i• 8 227 7 .. . . 
9 2I7 80 
IO 216 2 
II 2I3 2 
I2 20I 70 
,; 
1 
13 I99 7I 
I4 193 67 
15 I92 66 . 
I6 I87 Il1: 
I7 I78 6q 
r 
' ,. I8 I59 50 
( I9 158 5 ., 
20 Jqq ql 
., ..._ .... 
SEX DIAGNOSIS 
M Liver abscess 
F Pharyngitis 
M Multiple abdominal absces ses 
F Fungal endocarditis 
M Appendix abscess 
M Abdeminal wound abscess 
M Lung abscess 
M Otitis media 
F Pneumonia 
M Otitis media, pneumonia 
M Pneumonia 
F Wound abscess 
M Wound abscess 
F Wound abscess 
M Liver abscess 
M Appendicitis 
F Infected burn of scalp 
F Pneumonia 
M Erysipelas 
F Wound abscess 
I Bac~ero idcs spec ies 
2 Escherichia coli 
3 Haemophi lus influenza 
4 Proteus vulgaris 
5 Pseudornonas aerugino sa 
6 Staphylococcus albus 
7 Staphy l ococcus aureus 
8 Streptococcus faecali s 
9 Streptococcus non-haemolytic 
IO Salmonel l a species 
II Streptococcus p haemo l ytic 



























~ :NBT Score 
" ~ cD 
8 ~ s EDTA/FlCOLL HEPARIN -Ul $ >• ~ Ul z ~~ Ul 0 z ~ H ~ oA ~..:l u 8 0 " ~ 0 OBSERVER OBSERVER ___,. ~~ H !:::D s Ul 8 0 ~1 I 
s "O 0 ~ Ul 8~ ~ 8 -~ ~ H Ul . . zo . H Ul 
;~ ~ . u ~~ ~ 8 ~ ~o I~ . . ~s j ~ . u Ul i:i=l H ~ I >,i l 2 . 3 I 2 3 • . ~~ ~ . - ..:l AH ~ ~ ~ Ul E-4 c.!:) I u -t c.!:) Ul H 
I 
3 II8 7.2 90 - 2 2 - 625 3 60 65 - 33 29 -
4. 4. 6.8 74 - 0 0 - 95 l 8 23 - 20 28 -
5 25 17.5 95 2 2 0 - 360 2 I2 l.1 - 28 22 -·' 
>30 72 6.o 4.0 2 0 0 - 60 I 2 2 - 3 3 -
2 64 I0.5 89 2 0 0 II4 350 2 22 9 - 57 17 -
3 30 6.9 60 2 0 0 60 I55 I Il.1 IO - 4 3 -
I4 68 9.5 85 2 2 2 - 355 2 6 IO 5 44 II IO 
2 20 3.1 42 I 0 0 - - 3 ,1;2 12 8 12 I8 I5 
2 27 I6.6 69 - 0 0 I -
315 l 2 I 2 - - -
3 27 7.9 70 0 0 l 8I 64 85 63 71 81 - - -
3 67 28.2 96 2 I I - - I l 68 50 48 67 83 85 
2 57 16.5 69 2 0 0 75 250 I II 6 8 5 0 3 
l.1 83 II.O 78 2 0 0 - - l 5 9 0 19 II 13 
3 58 6.9 71 2 0 0 - 235 l 6 2 2 I2 5 l.1 
I 80 12.0 86 2 0 I - 290 3 46 35 12 86 39 I3 
I I5 13.7 - I 0 0 - - 2 I 7 13 6 I2 I6 I2 
4 2I 7.9 77 - 0 0 - 225 I 0 3 I 5 II 3 
2 60 6.2 70 - 0 0 - - 2 I 73 54 27 
0 s 5 
2 30 I5.0 90 - 0 0 - - 2 40 65 52 33 40 l10 
3 88 13.2 82 - I I - - I 0 5 I3 114 25 I9 
AS 
GROUP STUDY AGE · NO. NO. 
21 Il.1:2 20 
22 Il.J:I l.1:6 
23 123 62 
2l.1: II7 6 
25 II3 7l.1: 
26 III l.1A .,. 
27 IIO 5lJ: 
28 IOI 30 
29 IOO 83 
30 91 25 
31 86 2 
32 78 27 
33 77 22 
34 75 9 
35 59 89 
36 57 65 
37 53 18 
38 l.1-8 5/12 
39 38 61 
40 29 79 
SEX DIAGNOSIS 
F Wound abscess 
F Pyeloncphritis 
F Wound abscess 
M Appendicitis 
F Wound abscess 
M Perianal abscess 
F Urinary tract infection 
F Infected uterus 
F Wound abscess 
M Urinary tract infection 
M Pneumonia 
M Perianal abscess 
M Perianal abscess 
M Pyonephrosis 
F Urinary tract infection 
F Wound ab scess 
M Portal pyaemia 
F Gastroenteritis 
M Wound abscess 
F Subphrenic abscess 
I Bacteroides species 
2 Esc her i chia coli 
3 Haemophi l us influenza 
4 Pro i~cus v111gari s 
5 Pscudomonas aeruginosa 
6 Staphylococcus albus 
7 Staphylococcus aureus 
8 Streptococcus faec al i s 
9 Streptococcus non-haemo l ytic 
I O Salmonella spec i es 
II SLrcptococcus ft haemo l ytic 

























E-t ~ NBT Score 
"' ~ :I) -- § t3 s EDTA/FICOLL HEPARIN U) 
~~ ~ 
U) 
~ z U) 0 z 
"' 
H ~ oA ~~ u E-t 0 ell ~ 0 ....._, 
~~ H s E-t s U) E-t 0 ~, "O 0 ~ U) OBSERVER OBSERVER E-t P-t ~ E-t ·M ~ H U) . . ~~ . 0 P-t H U) ~~ P:: u ~ t P-t r.'50 I~ . . ~; ~ . u U) i:q ~ P:: _I~ I 2 7 I 2 3 . . . .) AH ~ :== P-t U) E-t c.., u d c.., U) H 
7.6 
I 
3 II 58 - 0 0 - - I IO 5 4 43 39 36 
3 113 7.1 66 - 0 0 - - 2 3 5 4 5 7 6' 
4 77 9.8 58 2 0 0 - - I 9 8 8 13 13 17 
I l.1:2 4.7 39 2 0 0 - 190 2 5 4 II 27 15 7 
3 35 13.0 83 2 0 0 - - I 0 3 6 21.1: 26 19 
3 32 9.4 68 2 0 0 - 155 I 9 20 14 2 I 3 
7 17 9.3 88 I 3 I - 135 I l.1:I 40 12 17 17 9 
4. 20 13.5 1 84. 2 0 0 - - I I 7 5 2 25 8 14. =I 3~5 6 4. 91 12.I 86 2 0 0 I I 5 0 6 3 9 
2 15 13.0 86 - 0 0 I 52 IO 7 19 28 17 
4. - II. 6 4.8 0 0 I 2 II 6 I - - - - - -
~ 
• "l 
4. - IO.I 80 - I 0 - 150 2 7 I I 36 4.0 4. 
4. - I0.8 70 - 0 0 - - 2 20 6 3 31 5 I 
IO - 7.1 54. - 0 0 - - I 49 29 4. 8 3 4 
5 - 5.9 58 - 0 0 - - I :, I 5 17 9 7 4. - 6.o 4.8 - 0 0 - - I 0 3 I 3 I 
3 - 15.3 I 90 - 0 0 - - 2 8 - 7 21:1: 14. 7 
3 - 9.3 78 - 0 0 - - 2 - - - 26 II 7 
4. - 32 .9 86 - 2 0 - - 2 30 12 12 27 5 9 
5 - II.O 72 - I 2 - - I 6 3 2 24. 7 l.1: 
A7 
APPENDIX C 


































STUDY AGE SEX 
NO . 
32 2 M 
35 52 F 
39 50 F 
40 30 F 
52 60 F 
67 25 M 
124 35 M 
I33 38 F 
143 27 M 
174 50 F 
I85 50 F 
200 35 M 
202 74 M 
205 45 M 
206 15 F 
214 2 F 
219 53 M 
222 21 M 
224 23 F 
226 8 M 
238 65 F 
241 21 M 
243 71 F 
2116 54 M 
249 39 M 








Acute osteitis femur 
Abdominal wotmd abscess 
Abdominal wound abscess 
Abdominal wotmd abscess 
Oesophag i tis 
Infective arthritis knee 




Abdominal wound abscess 
Generalised peritonitis 
Cholecystitis 




Subphrenic abscess , lymphoma 
Appendix abscess 
Tubo ovarian abscess 
Bronchopnetunonia 
Celluli tis of leg, S.L.E. 
Re s olving liver abscess 
Cellulitis of leg 
Abdom:i_nal wound abscess 
Generalised peritonitis 
Pharyngeal abscess 





























o.f i solation: 
G Genta.micin -i<- :::., li ] ood. cul-Lure -
II Prmicillin all other s i so J a Led 
I Sul plw.dimi dine f rom the site oJ 
J 'l'etracyt:-l i ne iU.8en.::;e. 
--U). 
~ J::ci ..._,, U). 
0 ~...:l ~, ~~ i~ . . ~i ~ Q . . ffi ~ U). ~ . . ~~ A E-i i:,:i :::: 
7 - IO.O 62 
3 - 6.2 79 
4 - 8.7 74 
4 - 9.r 80 
3 - 8.3 62 
Il1: - II.2 79 
4 III I2.2 78 
) 30 95 5.4 52 
4 37 4.I 72 
I 2 6.o 86 
2 II2 II.3 6l1: 
2 60 7.5 82 
4 l.1: 21.1: .. 7 9I 
)30 IOI II.9 79 
I 56 13.8 85 
2 - I0.5 75 
2 I2 8.8 5I 
9 106 I 6. 2 . 79 
l.1: I08 I4.3 -
0.5 7 ,±. 2 38 
I 0 • .5. 93 12.3 96 
IO 75 7 .11: 83 
l.1: I35 II.O 89 
2 311: 5.5 64 
0.5 50 16. 7 68 
I 55 15.3 82 
Key to organisms : 
I Bacteroides species 



































3 Jfo.emuphiJ.us i11:flnen:,r,a 
'1 Proteus vulgaris 
5 Pseudomonc1.s aerugj_Hosu 









s§ E-1 E-i J::ci 






























"' ::I) s EDTA/FICOLL HEPARIN 
z 
~ H J::ci 
"' 
i:,:i 0 
::I) E-i "d 0 s ~ U). 'j ~ OBSERVER OBSERVER . H U). 
~ ro o I~ . Q ~ -' ~ I 2 3 . Q -t i:.:, U). H 
- - I 59 44 I6 
- 230 I 5 0 8 
I 6 3 ' - - ~l 
- - I I6 2 5 
- - 2 - IO -
- - 2 3 5 8 
- - 2 0 "" 9 ./ 
- - I II 9 I3 
- 2I5 3 39 23 15 
- - 3 I6 9 4 
- - I 26 20 2I 
I6I I80 3 l.1:6 35 I4 
- - 2 0 I I 
- - 2 3 I I 
7I I65 3 12 I2 3 
- - I 48 48 36 
- I70 2 I2 Il.1: 6 
I70 290 2 54 49 66 
25 300 2 57 59 82 
- - I 25 28 26 
- - 2 35 II -
- 270 l 3 I -
- 225 I 5 6 -
- I57 I 39 30 -
- 211:5 3 26 2I -
: 
- 120 2 36 22 -
7 Staphyl ococcus aureus 




























9 Streptococcus non-haemolytic 
IO Salmonella species 
II Streptococcus p haemolytic 

































Details of patients with tuberculosis (group_!! ) 
GROUP STUDY AGE SEX SITE OF LESION TREATMENT NO. NO. 
-----· 
I 30 I6 F Cervical adenitis Nil 
2 105 34 M Miliary Nil 
3 136 50 M Pulmonary Nil 
4 137 33 M Distal ileum Nil 
5 151.1: 33 F Distal i l eum Nil 
6 221 l.1:0 F Cervical adenitis Nil 




8 ~ NBT Score ".... ~ co 
E-4 ~ s EDTA/FICOLL HEPARIN s ~ en z en 0 z ~ H 




s 'O 0 OBSERVER OBSERVER 8~ ~ 8 -~ ~ . . zo . 
~ Q J;q ~ J;q 8 ~ ti!O . . ~, j ~ . .~ Ui il'.l H ~ I 2 3 I 2 3 . . ~ . - ~ J;q ~ ~ 8 c.., Q ~c.., 
- 4.I 78 - 0 0 - - II 4 0 8 6 6 
50 8. l.1 78 2 I I - - 3 I 3 40 9 II 
27 8.0 5I 2 0 0 - - I6 9 5 IO 7 9 
37 6.3 68 I I 0 - - 8 I3 8 0 IO 5 
66 9.7 82 - 0 0 - 295 48 60 36 46 21.1 26 
I7 6.3 63 2 0 0 - - 48 42 4I II 27 I3 
31.1 6.o 62 - 0 0 - I05 52 37 - 0 3 -
All 
.. 
~ .. , 
APPENDIX E 
., Details 0f patients ,vith non-bacterial infection or infestation (g!:QYp-2) 
--
1 GROUP STUDY AGE SEX DIAGNOSIS DIAGNOSTIC 
I NO. NO . CRITERIA 
r 
I I 76 7 F Mumps . Polyarthritis Serology .• ., 
~ . 2 79 32 F Infectious mononucleosis Serology . , . 
3 II2 30 F Rubella Clinical 
' l1 I20 5I F Erythema nodosum after Clinical ,; 
I 
I smallpox vaccination I 
I 5 I55 I8 M Massive ascaris lumbricoides Barium meal 
i infestation Microscopy of stool . 
,. 6 I6I 27 F Mild enterovirus 
I 
Serology 
7 I62 42 F Strong enterovirus Serology I ,,. 
8 163 I 37 F ECHO I and rhinovirus Serology I' 
' 9 I I6l1 23 F Strong enterovirus and Serology I 
I 
I rhinovirus 




II I I67 20 F' Rh.inovirus Serology 
I2 I68 23 F Strong enterovirus and Serology 
rhinovirus 
I3 I69 27 F Strong enterovirus and Serology 
I 
I rhi:qovir.us 
:, I4 i I70 5I M Influenza virus Serology 
I 
J 
I5 I7I 50 F Rhinovirus Serology 
I6 I72 l15 F Ilhinovirus Ser ology 
'~ I7 80 29 M Hepatic schi s tosomiasi s Liver biopsy 
I8 225 IO F Rubella Cl i nical 
., I9 240 I8 F Viral meningitis Sero logy 
~ (L.C.M. vir us ) 
' 
·-'" 20 2l.t:8 67 F Herpes zoster Cl inical 
\. 






3 -1 8.9 
14 i - 8.5 
3 ! nl n.2 
: 2 i 19 I 7. 6 
JO I ~ 1 5,3 
5 I IO I 7.1 
5 j IO I 7.0 
5 I 6 
1 
9. 3 
5 I IO 7.8 
5 '1 2 6. 6 
5 6 7.1 
5 5 9.0 
5 8 6.8 
5 2 9.4 
5 17 7.6 






























































I 2 5 







68 - o o i - 85 I o 









o - - l O 
30 I - I0.4 62 - , - 0 I 2 
2 I! 26 5. l 52 O 2 0 - ! - 1 l.1:l I 30 
NBT Score 
OilSERVER 
l 2 3 
0 2 l 7 
9 50 48 19 
9 IO 7 l 
6 Il.i: 20 13 
4 13 20 4 
6 17 l.1: 7 
6 IO 2 3 
5 14 12 8 
3 l.1: 8 l 
l I 2 






61 o I 2 
31 IO I 5 







I ! 19 7 I 5 
I 
l II I 7 5 
29 15 . 26 12 
1 
- 3 l -l , 29 6. 9 5z~ -· I O O 1 - I lIO I 12 jl II 
I I I ' I 
--~- '_2_:_1_~_: ~-----~_:__.._=_~I _· _: ...... l_~ ____ .... _tl_l.._3_~-l--=_..___: ___ J _ .___=_ 
AI2 
Al3 
APPEJ.1HX . F 
Deta:i.ls of patients with non infective conditions (group 6) 
·GROUP STUDY 





























































































I' ;; · I ~~: 
L· L 
F Fibroadenosis of the hreas t 
11 Broncho spasm (acute ) 




M Haemorr hoids Nil 
M Rhemnatoid arthritis 
F Multiple myeloma 
Steroids , salicylates 
Nil 
M Duodena l ulc er with dyspe_psia 
F Pregnant 
F Diabetes 
F Temporal artcritis 
F Jam1dice 
F Crohn 1 s disease 
F Carcinoma of the colon 
F Crohn 1 s disease 
M Cirrho s is of the liver 
I 
with asci tes 
F Cer vical spon.dy losis 
M Chronic lymphatic l eulcaemia 
F Cervical spondyl os is 














F Sys t emi c lupus e:r:ythemato sus Predni sonc I O mg/day 
F Mul tiple mye loma Me lphe l an 
F Multipl e mye loma Me l phe l an 
F Ha sh imoto 1 s t hyroiclitis Nil 
F Diabetes Insulin 
F Diabetes I nsulin 
F Post chol ecystectomy . No complications . 
F Pos t chol e cys t ec tomy. No complicat ions . 
F Myocardial infar ct Nil 











F Carcinoma of t he c olon j N:i. 1 
.. --------- - .i-- - --- - - - --....... 
Al4 
t ~ NBT Score ~ 
;j t:D tEDTA/FIC OLL ~ 
s HEPARIN 
f@ en ~ z en 0 s H ~H C,.) 8 ~ ~ 
~~ H r ·8 z 8 0 ~, 'O 0 OBSERVER OBSERVER 0 8 P--t ; 8 ·j~ H..-.., . • ~~ . ~~ i:i:l C,.) 8 P--t (!$ 0 . . ~, ~ ~ . I f;::l en P=l ~ i:i:l I 2 3 l 2 3 . . . - H A~ ~ ~ P--t en 8 c.!:) C,.) -6 c.!:) 
) 30 - 5.9 6l.1: - l I - - 0 0 l.1:li: 33 I5 5 
0.5 - I2.7 82 - 2 l - - 50 28 II 58 I5 I6 
l - 12.6 62 - 0 0 - - 26 I2 3 29 IO I 
> 30 - 8.5 57 - 0 0 - - 50 35 I3 li:O 17 2 
> 30 - 7.5 86 - 0 0 - - 5 2 6 I5 I2 7 
) 30 - Ii:. l.1: l.1:0 - 0 0 - - 30 IO IO I7 IO II 
2 - 8.3 76 - 0 0 - - l - IO 2 IS 2 
84: - 6.1 59 - l , 0 - - 2 0 5 5 Ii: 5 
) 30 - 3.8 62 2 0 0 - - - - 3 IO 9 9 
) 30 - 9.8 66 - 0 0 - - - - 7 I9 9 7 
7 - 12.5 35 - 0 0 - - - - - 39 22 23 
)30 - 9.3 82 - 2 2 91 - 2 2 6 li:li: I3 35 
I 
) 30 - 8.2 82 - I 0 - - 3 2 3 - - -
) 30 - I0.3 92 - l l 83 300 19 3 3 66 I5 5 
) 30 - 8.2 86 - I 0 - - l.1: 5 5 50 5 7 
) 30 - 5.7 76 - 0 0 - - 18 II 6 0 0 0 
) 30 - I6.6 IO - 0 0 - - I l 3 l 5 2 
) 30 - 5.9 li:I - 0 0 - - 6 5 5 28 3 9 
)30 - 6.I 56 - 0 0 - - 30 Il.1: 2 50 I8 I3 
)30 - 7.9 · 74: - 0 0 - - 2 2 I 0 0 0 
) 30 - 2.7 74: - 0 0 - - 67 33 5 I3 I2 7 
) 30 - 6.9 52 - 0 0 - - Ii: l.1: 3 II 7 I 
7 - 8.I 60 - 0 0 - - 3I i I9 6 I7 3 8 
) 30 - 6. 8' 38 - 0 0 - - - 2 2 I5 9 8 I ) 30 - Ii:. 7 68 - 0 0 - - o I o 3 8 8 2 
3 7I 5.0 63 - 0 0 - - 2I Il.1 5 55 27 IO 
3 li:3 9.0 70 0 0 ' 4 I 6 2 0 I - - I -0.5 I8 6 . 2 79 - 0 0 - - 0 I 0 3 3 2 
I Ili: lI . 8 70 - 0 0 - - I I I I 0 Ii: 
) 30 l.1: 8.8 66 - 0 0 -
l 
70 3 () 0 l-:1:8 I9 8 "-
) 30 17 5.3 68 - 0 0 - - I 0 5 30 20 Il1 
l 2 7 I5 .4 82 2 0 0 - I -· 2 6 9 '1 It 6 
) 30 26 8 . l.1: 73 2 0 0 - I - 3 /1 I 7 2 3 
' 
AIS 
Details of patients wi t h non infective conditions (group_fi ) 






























































F Post laparotomy . No complications 
F I Abdominal pain, constipation 
M Disseminated abdominal 
adenocarcinoma 




F Ulcerative colitis 
F Myelofibrosis 
F Erythema nodcsum, 
hilar l ymphadenopathy 
F Myxoedema, pernicious anaemia 















F Rheumatoicl arthritis I Penicillamine 
M Histiocytic medullary reticulosis* Nil 
F Adenocarcinoma colon Nil 
M Carcinoma bronchus Nil 
M Ulcerative colitis Sal azopyrin 
M Crolm I s disease Prednisone 
F Ulcerative colitis Codeine pho sphate 
F Chronic lymphatic l eukaemia 
M Crohn' s disease 
M Rheumatoid arthrit i s 
M Mye lo f ibro sis 
F Mye lof iLr osis 
F Erythcma nodo stun 
M Cr ohn ' s diseas e 
F Di sseminated abdomi.nul 
adcnocar.cinoma 
Nil 
, SaJ. az opyrin 
I Preduisone 






60 I60 13 M Abdominal pai n , co;1stipatj on Ni ] 
61 I 75 I 12 M Post ]Mnic olcctoruy. No 





~ "' ~ bj) EDT A/FI COLL I s HEPARIN ~ U) z U) z ~ H ~H u 0 "' ~ ~~ H bD E-t z 8 0 s "O 0 OBSERVER OBSERVER 0 E-t ~ ~ E-t -~ 8:: H,....._ . • ~~ . 
~~ 
~ u ~ E-t ~, ~ ro o . . ~, ~ ~ . I~ U) ~ H ~ ~ I 2 3 I 2 3 . . ::r:: . - H A.._,,. ~ :::: P-4 U) E-t 0 u --{o -
3 20 8.I 62 2 0 0 - - IO 6 6 33 I5 8 
3 18 5.7 55 2 0 0 - - 2 9 I2 2 I 3 
)30 95 2I.5 78 2 I 0 - - 26 I9 2 IO 8 IO 
l.i 50 11. 3 117 0 0 0 - 180 I3 I5 l1 38 2I I7 
+I96 3l.i 7.5 70 
I 
0 0 I - - 3 3 8 l1 IO 2 .... 
') 30 I3 8 .11 82 - 0 0 - I80 2 0 l1 25 23 Il.i 
) 30 5 7.7 69 2 0 0 5l.i - 31 
0 l.i l.10 l.10 50 
7.6 6 7 37 25 25 )30 88 58 I I 0 - -
l.i: I Il.i 75 9.7 72 2 0 0 I87 260 l1l.i 25 58 Lil 2I 
) 30 30 6. l.i 6l.i 2 0 0 - - 3 I 5 3 6 8 
)30 73 7.8 73 2 0 0 - - 9 6 8137 12 23 
)30 63 6.l.i 68 2 0 0 - - 2 ~, 3 IO II 5 )30 75 2.2 5l.i I 0 0 50 - l1 6 6 7 IO 
I 
)30 58 7 .11 69 2 0 0 - - 12 13 I 6 26 I7 II 
'> 30 8 17.5 76 I l 0 - - 17 25 IO I8 I7 8 ' 
) 30 3 8.2 l.10 - 0 0 - - 50 311 22 IO 9 8 
)30 8 6.l.i 72 - 0 0 IOI - I5 II 8 2I 25 33 
)30 20 8. l.i 80 - 0 0 l.12 - I 3 l1 I 7 I 
>30 I4 30.0 II -· 0 0 - - 0 I 2 0 0 5 
I 
>30 62 2I. 2 911 - 2 0 - - '1 12 2 17 I3 I5 
)30 89 s.2 90 l 0 0 421 220 l10 l.14 26 l10 I5 15 
>30 I8 3.9 72 - o I 0 45 - 2 3 4 II ')~' 7 -) 
)30 33 7.0 82 - 0 0 50 - I 6 9 7 65 ,,2153 
>30 57 6.3 56 - 0 0 - - 9 I2 9 G ! o z1 
'. I )30 48 16.2 71 - 2 3 46 -
I 
6 9 4 6 I 8 I 3 
)30 81 15.2 85 - I I - - 9 6 I3 I5 I 9 IO 
I 
l 5 5. 5 - l i - - - - 60(
1
29 o! J. I 
21 5 21 9 .6 7!1 0 0 - - ! 0 1_lJ_I i r, I - j - I l.--1 I 
A17 
Details of patients with non infective conditions (group_§) 
[ OU~ STUDY AGE SEX DIAGNOSIS DRUG NO. NO . THERAPY 
, . 
62 176 52 M Lymphoma* , post splenectomy Nil 
63 177 -61.,; M Abdominal wound haematoma Nil 
I 
· 64 ISI 53 M Chronic lymphatic leukaemia Nil 
65 I82 39 M Crohn 1 s disease Salazopyrin 
I 66 183 35 M Chronic lymphatic leukaemia Chlorambuci l 
I . 67 184 25 F Acute myeloid leulrnemia Busulphan i 
I 
68 I86 72 M j Multi~le myeloma Hydrocortisone 
Calcitonin 
69 I89 27 M I Backache (non specific ) Nil I 
I 
70 I 191 I 18 M Crohn 1s disease Nil I 
71 I 194 22 F Pregnant Nil I 




73 I98 39 Pregnant Nil i I F 1 · 
I 
74 I 203 31 F Cyclical fever Nil 75 204 ~.1:9 H , Carcinoma bronchus Nil I 
I 
I Benign gastric ulcer I 76 I 207 85 M Alkalis I i 
I 77 I 208 15 F Acute myeloid leukaemia Busulphan I 78 209 73 F Chronic lymphatic leukaemia Nil I I I 79 2II 82 F ' Multiple myeloma Nil 
I 80 212 
170 
F Chronic lymphatic l eukaemia Nil 
l 
' 
81 I 215 76 M Polyart e:ritis noJ.osum Preclni s one I 
82 I 220 70 F Ulc er ative colitis Ferrous sulphate 
I 
83 I 229 59 F Scler oderma Predni sone 
8Zt I 230 69 M Ulc er ative colitis Nil 
I 
85 I 232 49 F Crohn 1 s disease Nil 
86 235 66 F Oe s ophageal s tr i ctur e , dehy<lrn:ti on Nil 
S7 237 30 I M I Non specif ic abdominal pain Nil 
88 239 65 F Glioma I Nil 
89 247 7 F Diabe tic I I · 1 · prec oma j .nsu 1.n 
90 255 6 M Diabetic precoma I nsu lin 
. ,9I 256 6 F Diabetic precoma In su .l in 
92 262 IS J.il Systemic lupus e:i:yl.l1cmato sus Ni l 
-. ---
. ·X· Sam~ pa. t i en L 
' I • I ,....-. ~ . 
·:.it~ . . 
. . 
1Z c.;) . . 
en ~ . . 
~ :;;i; 
5 I 8.5 
3 49 II.8 
)30 2 7. 6 
) 30 6l.1: IO. 3 
)30 18 9. 0 
) 30 l.1:0 35. 7 

















') 30 64 7. 6 
)30 18 6. 6 
)30 5 3.5 
)30 I3 I6.2 
~30 32 3.4 
)30 30 8.4 
>30 58 13.5, 
)30 I6 5.0 
)30 83 12.5 
)30 I06 I9.4 
)30 61.1: 9.0 
;1 
) 30 I 
2 
5 IO. 7 
13 6. l.1: 
I6 6.8 
30 I 9. o 
2 26 6.o 
.2 


























































































NBT Score ~ 
"' L--------------1 
~ ED'r.A/FICOLL I-IEPARilI 
~ ~~----1-------~ 
) ~ 
~ ~ OBSERVER OBSERVER 
• Q /:'...j 
~ al 0 
i:J 1 ~ I 2 3 • ..., ...:i I 2 3 



























5 12 9 
6 14 6 
2 15 Il! 
- 3 -







3 5 2 23 9 5 
81 5 
3 · 3 
31 I 
5 31 15 




II I 8 5 









6 6 5 2 0 2 
3 1 6 1~ I1J: 
I 












I I I I 
























IO i IO 3 9 
26 i 23 ; 20 12 
41 I 66 ! 50 51 43 qq 
I I 
30 I I7 I 19 0 0 I 
82 l 72 I 71 36 25 26 
,s I qi; 134 IO 
14 4 I - 9 
32 3I - 8 
6 
6 
38 23 - 5 9 
33 20 - 34 36 
69 74 - 28 32 
24 I2 - 2I 32 





Details of patie~ts with undiagnosed disease (group_l ) 
GROUP STUDY AGE SEX UNCONFIRMED DIAGNOSIS 
NO . NO . 
I 1*6 I5 F Infectious mononucleosis 
2 · 50 62 F Pyrexia of unknown origin 
3 51* Details lost 
1* 55 Details lost 
5 SI 1*3 M Cholecystitis 
6 85 3I F Abdominal pain - urinary tract 
infection 
7 I09 59 M Pyrexia of unknown origin 
8 I32 72 
I 
M Subacute bacterial endocarditis 
9 I38 36 F Details lost 
IO I79 Details lost 
I II ISO 9 M Infectious mononucleosis 
I2 I88 I6 F Infectious mononucleosis 
I3 I90 711: H I Pyrexia and abdominal pain -
? cholecystitis 
11* 2I8 83 M Pneumonia 
I5 223 83 M Pulmonary consolidation -
? pneumonia ? infarction 
I6 228 53 M Pyrexia of unknown origin 
I7 233 25 F Pyrex:i.a of unknown origin 
A20 
8 ~ IBT Score 





(/} 0 s H ~H Q "' ~ ~~ H ::J) "C 8 8 0 8 8 ·r-l 0 OBSERVER OBSERVEll 8S::: ~ 8 
gi 
g re . . zo . 
1Z Q ~ 1Z ~ 8 P--4 0 . . ~; j ~ . ·~ U) P:'.:l ~ 1Z I 2 3 I 2 3 . . . ~G ~ ~ P--4 U) 8 C!) Q 
- I0.5 48 - 0 0 - - 14 I6 I6 3z1 I5 IO 
- IO. I 72 - 0 0 - - 2 0 3 0 I 3 
- I5.6 90 - 2 0 - - I 2 I 14 14 9 
- 9.6 50 - 0 0 
I 
- - 2 3 3 14 I2 6 
- 5.2 20 - 0 0 - - 4 6 0 8 0 9 
- 5.I 66 - 0 0 - - 0 4 8 24 3 2 
90 11*.7 72 I 0 0 - - 25 22 IO II I2 8 
2I I4.9 - 77 
I 
I 0 0 - - 6 IO 8 4 0 2 I 
7 4.2 64 2 0 0 - - l.1; 5 I 4 7 3 
7 7.5 - I - - - - 37 22 II 28 24 23 
II 8.6 59 2 O · 0 - - I6 14 I6 I 4 I •"' 
IO 5.I 52 ' I 0 0 - IO 9 IO 23 22 8 _, 
80 9.8 87 2 0 0 - 23 4 5 I7 5 9 
I 
I 
56 9.0 66 - 0 0 _ I 1100 36 26 36 8 IO 9 I I 
591 
8 .0 76 I 3 0 0 ·- I - 35 41 51 39 2I l.1: 0 I 
' i 
s 2 JI I06 I0.5 82 3 0 0 - - n 71 7 7dJ l1 5.6 50 I 0 0 - 30 IS 15 6 
A2l 
API'ENDIX H 
Details of patients with non-infective disease (g!:.Q.:Q.p-2 ) 
'Auto-immune' disease 
R11eumatoid arthritis 
Systemic lupus erythematosus 
Hashimoto 1 s thyroiditis 












Chronic l ymphatic leukaemia 
Hyeloma 
Myelofibrosis 
Acute myeloid leukaemia 
Inflammatory bowel disease 















Erythema nodoswn with hilar lymphadenopathy 
Fibroadenosis of the breast 
Gastric ulcer (benign) 
Haemorrhoids 
Hypertension 
J aundice (phys iological) 
Myocardial infarct 
Oesophageal stricture and dehydration 
Oral contraceptive pill recipient 
Pancreatiti s (acute) 






















































. ·• . 
+ Itesults are expressed as the mean - S.E. NBT Score 
EDTA-FICOLL SCORE 
SUBGROUP 
GROUP HEP ARIN SC ORE 
SUBGROUP 
••• s. s (:!:3.9 ) •• 19 .4(:!:6 . 2) 
••• 6.0 (±2.4) 
• • • 4 . 0 !:!:r. 5) 
•• 16.0 :!:rr.1.1: ) 
••• 3.3 ±r.r) 
•• 12.s(:':4.5) 
•• 35.4 (:!:13.6) 
•• • 9. 6(:':3.3) 
•• • 11.s(:':r.s) 
20.9 (:':6.4 ) 
' 
23 .7(:':6.4) 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































, -J- - : 
! GROUP PA'J'Ji•:N'I' AGE SEX HYI'OG ANMAGLOBULINAEMIA CLINICAL ASSOCIATED 
NUMUEll I CONDITION DISEASES 
J f 
' . . 
I D. C. 4 M Sex linked Well -
-· ·-
2 J" .F. Iii F Childhood onse t I 
Sl ightly Bronchiectasis unwell -










4 S.G. 9 M Sex lj nlced Well Bronchitis 
5 M.G. I5 M s~x linked Well Recurrent bronchitis - ·· 6 A.G. I3 M Sex linked Well -




- Well Cured 
8 D.W. 2 M Congenital Well 
Previous septic 
arthritis 
9 C.L. I2 M Sex linked Well -
IO B.H. 25 M Childhood onse t Well -
II H.J. I5 M Childhood onset Well -
12 B.S. 26 M Sex linked Well -
13 A.H. 8 M Childhood onset Unwell 
Hepatitis ? 
cause 
14 D.G. 19 M Sex linked Well -
; 
--
. NBT Score 
' . 
~NDOTOXI~7 g/ml 






I gM IgG I gA IxI0-
6 IxI0-7 IxI0-8 IxI0-9 IxIO-IO rxro-·II o ! . I 
' mg}fo I 
i 
(2 120 0 0 0 - - - - - 29. I. 73 ! ·-
8 180 0 28 I'.1: 5 4 0 0 Ih.8.72 
i:, -
4 210 9 - 0 0 0 2 I 0 5.11.72 . 
I I I I 0 23.6.72 
·, 
- - - - - · ,, 
I 27.6.72 ' - - - - - - - I - - ,,..· 
4 360 9 I - - - - - - 2.8.72 • :·,· 
- - - 0 0 2 0 0 - 0 2. II. 72 l . 
(2 190 0 7 4 3 0 0 - 0 H. B. 72 r. 
7 360 0 35 39 8 2 0 - 0 21. 8. 72 · 
7 385 102 - 27 31 IO I 0 0 21. 8. 72 
--
0 385 0 - 6 8 I 0 0 0 29.12.71 l · 
(2 250 0 - 12 9 0 0 0 0 13.3.72 
16 
,,-'; 
5 2'/0 0 15 9 5 0 - 0 30.10.72 , 
0 515 0 - 5 4 5 0 0 0 5.4.72 
(2 230 0 35 19 '* 0 r 0 
I - 20.2.73 I -
15 0 0 18 31 16 3 2 0 0 31. 7. 72 
4 270 0 27 31 IO I 0 - 0 31.7.72 
0 440 0 25 I5 5 9 
I 
2 - 12 5.9.7q 
200 145 0 46 39 28 II 0 - 0 18. I. 73 
33 900 0 - 20 5 ,· 11 0 0 0 18.I. 73 l 
;: I I I 
GROl:TP PATIENT AGF. ~EX HYPOG.A.MMAGLOBULIN.AEMIA CLINICAL ASSOCIATED I 
N(J1'ID1'..'R CONDI'l'ION DISEASES I 
'"""-- ·--r- -
I5 C • I-I. 25 M +--/~ie:cent onset. Unwell B::irrelia ·, -
II Hepatitis ,. 
Penicillin II 
therapy II 
-----· --- I 
Well Ni l 
f.-----"l I 
16 I C.B . 62 M Adult onse t Well Bronchiectasis . ,... _____ -
)~~ 17 M.H. 112 4,Adult onset Well -
' "· 
.......... , ... ____ i-------- --·· ,:-1,; 
60 I8 M. ,J. F Adu.1 t onset Well -..._ ___ -
I9 J.W. lJ:3 F Adult onset Unwell Bronchiectasis 
20 M.T. 35 I F Adult onset We ll -
I . 
21 B.L. 30 F Adult onse t Unwell 
Recurrent 
bronchi t is -·-
22 R.F. 29 M Adult onset Well -
-
23 c.c. 40 M Adult onset Unwell Chronic sinusitis 





25 C.E. 3 M 
Chediak- Well Nil Higashi Syndrome 
' 
• . 
• . 26 K.L • 4 M C. G.D.C. Unwell Ni l 
NilT Score -;-i frMHUNOGLOBULI~7 i'ENDOTOXI~7 g/ml 
' 
'rEST I I~ 
IgM IgG I gA -6 - 7 rxro·-8 L-x:rn-9 IxIO-IO IxIO-II 0 IxIO IxIO 
mrr 7% 
<2 (2 (2 - I 3 I I 2 2 8.3.72 
8.5 280 0 - 2 6 2 0 0 2 13.3.72 
3 8 2 I 2 - O j 13. 6. 72 
3 8 2 I 2 I 17.7.72 - 0 1 
8 8 11 0 0 - 0 16.9.73 
n.5 3h5 0 - 17 32 8 2 2 3 8. 3.'i'2 
25 400 0 34 110 14 7 / 0 - 0 I4.8.?2 
5 130 0 - 22 211 3 I 0 0 2.5.72 
4 350 0 - 32 19 9 I 0 0 8.3.72 
0 0 0 35 35 29 24 - - 0 13.6.72 
(2 I80 0 - 37 I9 0 0 0 2 5.4. 721 
(2 60 0 34 II I2 2 2 0 0 I8. I. 73 
12 4=115 0 50 46 4.0 4 0 - 0 17.7.72 
5 360 (2 I6 23 I I 0 - 0 2I. 8. 72 
\ 
ANTICOAGULANT 
60 lJ:20 148 43 EDTA ( 2. 4mg/ml ) 32 IO. 8. 73 





- - - 0 EDTA (2.4mg/ml ) 0 ro.8.73 
J :w c J fpct of_ hormone:~_ c,n NBT Fu.\.1ct i on ~T 11 1; -.i Lr ophi l s . __ H.c:ml ts are 
P-:p1·es'>c<1_ ,·s_·GlJ e_ NJl'I' S<'o1·c J fc,J. ___ 'J' l,c· conc en t?·aL:i. un of h q>ttr:~n _is s h own 
,_.ml Uie cr,.:c,·ntr ;:ti., :i.cn o r _ _Lllc add.it.i:vc is_s h own in b.ra clre ts . Duplic a te 
values ,n·c ·i u di. c ai., ivc o.C two stttdies . 
,-----
ADD I'I' J. VE I AD~ ALINE con.TISO.NE HYDROCOR'l'I SONE 
ACE'I'ATE 1:IBMI SUCC I NA'l'E 
L -------- I -I I I .1TIBPAR1N7 units/ml I2 I2 50 , - -
- -- ~ ·
-
ADD IT W E Ii8 (IO-~) - (IO-I) o,o 
(CONCB;NTRATJ.ON) _ 
M 
I (10- t) (10-?t) I IO 0 119,IJ.7 
·-
5 (IO-it) 68 (IO-~) 11-.6, l1-.8 
----- ----




(IO-~) ( - ·9y (.) 5 59 44,48 lfJ IO M 
H - -C'.'.:l z 
(ro-~) (IO-I!) 4 - 57,52 
4 (IO-~) - -
PBSA 4 (o) 57,56 -coi-..TTROL 
+ ENDOTOXIN 
74 (o) 7 '± ,86 
I0J1g/ml -
P.t\R'J'ICUL.ATE 
No reduction No reduction 
COMHEl\TTS 
in supernate in supernate 
after I8 hours after I8 hours 
at con5entration at co!:1entration of 10-M . of IO M 
- --
HEXOES'1'IWL NORADRENALINE ISOPBENALINE PRO STAG l.i1UID IN -PROPI01 lA.'fE EI I F2oL 
I 
A 
50 50 12 12 I2 12 12 
l (rn-t) 30 3 (IO-~) 29 21 IO 30 (lJ1G/ml ) , _ 
1*4 (IO-~) 35 22 (IO-~) l.1: 23 2I 36 ( IOONG/ml) 
29 (IO-~) 1*1 30 ( IO-~) 11* 
41 ·(10·-I~) 55 54 ( -·9) IO H 5 
-
3/i (IO-I2 ) 40 - -M 
·-- -
l.1:3 (10-1;~) 37 - -
-
- - - -
53 43 ~ - 37 . 
• - - - - 1*5 
Decreased reduct i on Direct 
in supernate at reduction 
co:!!5entration of of NBT in 
IO M supernate 
A 33 
.: . ·, 
1J_l_Q_Pf f ccL ot l yso l Pe.i.L dn,_ pho_spho lipas c· C, re i., jn1,l, n--1- ac i d_glJ.e opr ot ~ir1 
:rnd. fc i,uin on NB'I' rcunc ti on _hf nentr opln 1 :-;. RcsnJ.-1.,;-;_c::sc~prcssecLu.Lllk 
Nlb~J}~Q_re.. @ °bi.QJi,,gnl-:mt c'_ ·,nd Lcp, •r i11 _c_oneen tratj 0 1, 11r.c _ _.1:;i hown .0~e 
c oncentration of l,h1~ .,1drl:i t ive is shom1 in brw; l,et:--:._ _Mul tipl e r e s ults irnlicak 
Q.!...'{c.rc n L s tudie.§ , 
G ,----1-·, PHOSPHOLIPASE C RGTINOL ADDI'I'IVE LYSOLECITHIN ( O' ~Jig/ml causing Jysis of 50% . I ll . B.C. s rnpH 7 ,1!.. ) 25mg/ml in Ethanol 
-- -· - 1 .. 
' ADDITIVE 
(II=llEPARIN i.u./mg ) 
H 50 H 2 35 






' 0 25 ' 
36 (IOpg/ml) 57 -
I 23 --· ... ---~-
.· 0 5 30 72 
i 
43 ( Iµ.g/ml ) 37 ·:~ - 0 - 65 :-
';\. 
-'~ t 
2 - 33 -
35 (IOONg/ml ) 33 
·. ~ ! ~ - 0 - 48 H 
0 
'· <) 
0) 0 2 23 70 
H 119 ( I0Ng/ml ) 26 ... , ~ - -... 
: 1 
.. ·" 0 63 . - -'· 
I 
~ .!,. 
- .? ... 
..!i 
·J ~ . . - -
t~~ /. 
' J \' PBSA 40 8 O,I I 60,63 . :,. CONTROL 
!><1' 
+ ENDOTOXIN 
(IOurr /ml) 9I - - - ---
. Lysolecithin I-IOO)lg/ml I 15 32 .... 
Pho sphol:i.pase C IOONg-IOug/ml 
resulted in punctate fo rmazan Inhibition at higher 
COMMENTS deposits which appeared to be concentration due to 





RETINOL I a - ac i d 
GLYCOPROTEIN FE'.i'UIN 
I.Omg/ml in Ethanol ' 
I i ' - ·-
50 EDTA H 50 
I 
ED'l'A H 50 EDTA I 
- (250ug/ml) I 
(200ug/m1) 




- ( I50ug/ml ) 
( IOOug/ ml) 
1±2 43 (I . 7mg/ ml ) 38 (2mg/ml ) 
-
3I 
- (50ug/ ml ) 
- (30ug/ ml ) 
30 ( 400ug/ml) 37 
- (25ug/ m~ 
! 
- (IOug/ml ) 
2I (80ug/ml ) IO 
' 
- (5ug/ml ) 
0 0 (2. 5ug/ml ) 
43 (I6ug/ml ) 2 
- - (I . Oug/ml ) 
I2 - (o. 5ug/ml) 
----
40 - 23 0 23 4 
87 - - - - -
I% Et hano l 
• 
;\ 35 
The_ effect of pla-Lelet_clot, l ac t a t e an:l pH variations , sterile pus 
a nd 'fr iton X IOO on the reduction of NllI by: neutrophi l s . Re sults 
ary~;{J_.)~~ as _t.l~~ NJ3'11 Scor.Q.., (%). Anti_!;.Q_agu l an ts and He parin 
concentration are _shown arid the concentrati on of p1:lof the ~g.di tive 





S~ATE I HO~!OGENA'.l'E i LACTATE SUPERNA'rE HOHOGEN.ATE 
----
AN'I'ICOJ\G. 
I H 50 I . ( H·,.,J~CP ARIN H 50 EDTA 2 EDTA 
i . u~/1lll} J. 
~ 
- -
32 I 11 -t 3 I9 
0 o(ro!) 
II 0 O (I52) I 
M 
-- I I9 0,2 0(103) z ,-~ M 0 I 0(10! ) §j 19 I,O Q) 1--l 
I 0(10~) .o II 0 · 1 J;; A ;z; ~ fj -1 ~ 
. bs l z 
i'.Q • 0 
:z. I u 
I '-' 
PBSA 44 44 5 I 5 18 l, ~ 0 [ CEiTROL _ 
+ El\'DO . 
· ~ 
r 
t-.KIOno- ml - lil 23 
Reac t ion 
mixture 
COMMENTS clotted. No clottin g , 
NBT reduc tion 
seen i n c l ot 
• 
A 36 
PHOSPHA'l'E STERILE PUS TRITO:J 
BUFFER SUPERNATE HOMOGE.NATE X IOO 
.. 
I 
I-I 2 EDTA EDTA I F,DTA H 2 , 
I -
(5.f.H) ( -I% ' I 
j 
0 0 0 3. }xIO o by volume) 0 0 o. 05% 0 . 
0 (6.o) 0 0 (3.}xI52 % by volume) 0 I 2 0.01% ;-1 ! 
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THE MECHANISM OF THE ENTRY OF DYE INTO 
NEUTROPHILS IN THE NITROBLUE TETRAZOLIUM 
(NBT) TEST 
A. W. SEGAL AND A. J. LEVI 
Department of Gastroenterology, Northwick Park Hospital and Clinical Research Centre, 
Harrow, Middx. 
(Received 24 July 1973) 
SUMMARY 
1. Washed huffy-coat preparations of human blood suspended in different media 
were exposed to the Nitro blue Tetrazolium (NBT) and the mechanism of entry of the 
dye into neutrophil polymorphonuclear leucocytes was investigated. 
2. Stimulation of neutrophils with endotoxin and the presence of heparin and/or 
fibrinogen in the suspending medium were necessary for dye reduction. 
3. NBT complexed with and precipitated heparin and/or fibrinogen from solution. 
The percentage of cells reducing the dye and the degree of precipitation of fibrinogen 
and heparin depended on the concentration of dye; the critical concentration of 
NBT necessary for each effect was the same. 
4. Electron microscopy of stimulated neutrophils revealed the presence of amorphous 
material, which was probably complexed NBT, outside the cell, in the process of 
endocytosis and within membrane-bound vacuoles within the cytoplasm. 
5. Neither complement nor immunoglobulins were obligatory for dye reduction in 
this system. 
6. It is suggested that NBT only enters neutrophils in quantities visible by light 
microscopy, after stimulation which produces phagocytosis of a macromolecular 
complex of the dye and heparin and/or fibrinogen. 
Key words: infection, granulocytes, phagocytosis, fibrinogen, tetrazolium salts. 
The Nitroblue Tetrazolium (NBT) test is a rapid, simple non-specific method of distinguishing 
bacterial, fungal and protozoa! infections from other disease processes such as viral infections, 
autoimmune diseases, neoplasms and rejection of allografts (Park, Fikrig & Smithwick, 1968; 
Matula & Paterson, 1971; Anderson, 1971; Wollman, David, Brennan, Lewy, Stenzel, Rubin 
& Miller, 1972). The test is performed by incubating a small volume ofheparinized blood with 
a dilute solution of Nitroblue Tetrazolium. This dye is water-soluble and light yellow in colour 
G 
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but forms a dark-blue water-insoluble formazan compound on reduction. When the test is 
performed on the blood from a normal person, a small proportion of the neutrophil polymorpho-
nuclear leucocytes contain formazan deposits in their cytoplasm. When more than 10% 
of neutrophils are found to contain formazan deposits, the test is classified as positive and this 
strongly suggests the presence of a bacterial or other treatable infection. 
The mechanisms of the entry of the NBT into the cell and of its provocation by infection are 
unknown. It has been postulated that the finding of formazan deposits in neutrophils is related 
to their phagocytic activity and that the increased metabolic activity associated with phago-
cytosis is responsible for the reduction of NBT to formazan (Park et al., 1968). Park (1971) 
holds the view that a change of membrane permeability is necessary to allow the entry of NBT 
into the cytoplasm. The activation of complement has been implicated as a result of the 
decrease of sensitivity of the test when ethylenediaminetetra-acetate (EDTA) is used as anti-
coagulant instead of heparin (Park & Good, 1970). It has been suggested further, that immuno-
globulins have a functional role because of the finding of false negative results in infected 
hypogammaglobulinaemic patients (Freeman & King, 1972). 
METHODS 
Preparation of cells 
Blood samples were collected from healthy volunteers between the ages of 18 and 30 years. 
Blood samples from different individuals were used for each experiment. 
A portion (25 ml) of heparinized blood (50 units/ml) was centrifuged at 450 g for 10 min at 
15°C. The huffy coat (approximately 5 ml) was aspirated with a Pasteur pipette and washed 
three times in 50 ml of Hanks balanced salt solution at 4°C. After each wash, the suspension 
was centrifuged at 200 g for 10 min at 15°C. After the final wash, most of the supernatant was 
discarded and the washed cells were mixed by gentle shaking. A portion (0·4 ml) of the washed 
cell preparation was mixed with 0·6 ml of the suspending media. 
Suspending media 
The washed cells from four individuals were suspended in each of the following solutions: 
(i) autologous serum; (ii) autologous serum containing disodium EDTA (4·0 mg/ml); (iii) 
autologous serum containing mucous heparin (Weddel Pharmaceuticals) (70 units/ml); (iv) 
Hanks solution (Oxoid); (v) Hanks solution containing mucous heparin (10 units/ml); (vi) 
Hanks solution containing disodium EDTA (4·0 mg/ml). Fibrinogen (Kabi) in sodium chloride 
solution (0· 15 mol/1) was added to aliquots of each of suspensions (ii)- (vi) to give a final 
concentration of 5 mg/ml. Additional studies were done with solutions (i) and (ii). 
Neutrophil stimulation 
To cause stimulation, 10 µg of Escherichia coli endotoxin (type 0127 : B8, Difeo) in 0·05 ml of 
phosphate (0·075 mol/1)-saline (0· 15 mol/1) mixture (pH 7·2) was added to a l ·O ml sample of 
each of the above suspensions in a disposable plastic test tube (Luckham L/P 3S) and the tubes 
were incubated for 10 min at 37°C. This amount of endotoxin was used because in a dose-
response study it was the minimum necessary to give a maximal response. Similar amounts of 
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Incubation with N BT 
To 0·5 ml of the stimulated and unstimulated cell suspensions was added 0·5 ml of a O· l % 
solution of NBT (Sigma) in phosphate (0·075 mol/1)- saline (0·15 mol/1) mixture (pH 7·2), 
which was centrifuged at 1000 g for 10 min immediately prior to use. The mixture was gently 
shaken and incubated at 37°C for 30 min. 
Staining and counting of neutrophils 
Thin smears were made on glass slides, air-dried and stained with Leishman's stain. Then 
100 neutrophils were counted on each slide and those containing a densely staining formazan 
deposit at least the size of one lobe of the nucleus of the cell were classified as positive. All 
counts were performed by the same person (A.W.S.). Twenty slides were re-examined and the 
standard deviation of a single count (percentage of positive cells) was estimated to be 2·2. 
Precipitation of fibrinogen by NBT 
~ To 0·6 ml samples of fibrinogen (5 mg/ml) in Hanks solution with and without EDTA 
'r (4·0 mg/ml) and to plasma from blood anticoagulated with EDTA (2·4 mg/ml) was added 1 ·0 
ml of 0· 1 % solution of NBT in phosphate-buffered saline. These mixtures were gently shaken 
and incubated in a water bath at 37°C for 30 min. After centrifugation at 500 g for 10 min, the 
deposit was washed three times with distilled water. The washed deposit was dissolved in 
Hanks solution by incubation in a water bath at 37°C for 30 min. The solution was then 
centrifuged at 1000 g for 10 min. Thrombin (bovine, Parke- Davis, 50 units/ml) was added to 
the supernatant and the mixture observed for the presence of a clot. Precipitates produced by 
the addition of NBT to plasma anticoagulated with EDTA were redissolved in a similar man-
ner. Electrophoresis of these redissolved precipitates and a standard solution of fibrinogen 
(Kabi) in saline (5·0 mg/ml), against whole human antiserum (Burroughs Wellcome) was 
performed by a modified Laurell technique (Minchin Clarke & Freeman, 1968). 
Precipitation of heparin by NBT 
To 0·6 ml of a solution of heparin (70 units/ml) in Hanks solution and 0·6 ml of plasma from 
blood anticoagulated with heparin (50 units/ml) was added 1 ·0 ml of a 0· 1 % solution of NBT 
in phosphate-buffered saline. The solutions were examined microscopically, using ordinary and 
polarized light, for precipitated particles, as were control solutions of heparin in Hanks 
solution and plasma, and the 0· 1 % solution ofNBT. Reduction of the solutions was performed 
by the addition of phenazine methosulphate (BDH) and NADH (Boehringer). To investigate 
whether or not the precipitates obtained above contained NBT, they were dialysed against 
water for 72 h using a cellulose membrane and then reduced by the addition of phenazine 
methosulphate and NADH and examined for blue coloration. 
Measurement of the relationship between the concentration of NBT, the precipitation offibrinogen 
and heparin, and the percentage of positive neutrophils 
A portion (l ·O ml) of solutions of NBT in phosphate-buffered saline in concentrations of 
0·1-0·0032 g/100 ml was added to 1·0 ml of whole blood anticoagulated with EDTA (2·4 mg/ 
ml) or heparin (50 units/ml). Endotoxin stimulation, incubation, staining and counting were 
carried out as described above. Portions (1 ·0 ml) of solutions of NBT in phosphate-buffered 
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saline in concentrations of 0·2-0·0032 g/100 ml were added to 0·6 ml of plasma to which was 
added 0·03 pCi of 1251-labelled :fibrinogen (The Radiochemical Centre, Amersham) and to 
0·6 ml of plasma from heparinized blood (50 u/ml) containing 0·03 pCi of 
1251-labelled 
:fibrinogen plus 0·28 µCi of heparin [35S] sulphate (corresponding to 60 µg, The Radiochemical 
Centre, Amersham). After incubation for 30 min at 37°C the mixtures were centrifuged at 
4000 g for 30 min. The gamma activity in the supernatant was counted using a well-type sodium 
iodide detector. The samples containing no NBT gave about 14 000 c.p.m. and those with the 
highest concentration of NBT gave about 1200 c.p.m., the background being 20 c.p.m. The 
35S 
activity was counted in a liquid-scintillation system, the corresponding count rates being about 
25 000 c.p.m. to about 1000 c.p.m. with a background count of 25 c.p.m. Each sample was 
counted for 100 s with a cut-off at 10 000 counts. The observed beta counts were corrected for 
the contribution due to 1251, which amounted to 13·6% of the observed gamma counts. 
Effect of centrifugation of the NBT solution on the reduction of NBT by neutrophils 
A solution of 0· 1 % NBT in phosphate-buffered saline was centrifuged at 30 000 g for 16 h. 
A portion (1 ·0 ml) of this solution was added to 1 ·0 ml of blood anticoagulated with either 
EDTA (2·4 mg/ml) or heparin (50 u/ml) with and without prior stimulation with endotoxin 
as described above. Incubation, staining and counting were performed as above. After centri-
fugation the solution of NBT was examined microscopically, using ordinary and polarized 
light, for the presence of particles. 
Electron-microscopic studies of leucocytes after exposure to NBT 
A portion (1·0 ml) of 0·1% NBT was added to 1·0 ml of whole blood, using EDTA (2·4 
mg/ml) and heparin (50 u/ml) as anticoagulant after prior incubation of the blood with endo-
toxin (10 µg/ml) at 37°C for 10 min. The mixture was incubated in a water bath at 37°C for 
15 min, centrifuged at 400 g for 60 min and the huffy coat aspirated with a Pasteur pipette, fixed 
by the method of Hirsch & Fedorko (1968), embedded in Epon (G. T. Gurr and Searle Scien-
tific Supplies, Bucks.). Thin sections were cut and examined unstained and after staining with 
uranyl acetate and lead citrate (Renolds, 1963) in an A.E.I. EM6B electron microscope. 
Control samples were prepared by excluding the NBT or endotoxin from the above mixtures. 
RESULTS 
Reduction of NBT by stimulated neutrophils suspended in various media 
A small percentage ofneutrophils were found to be NBT-positive when suspended in serum 
or Hanks solution with or without the addition of disodium EDTA (Table 1). Prior stimulation 
with endotoxin did not affect these results. The addition of:fibrinogenresulted in a small increase 
in the percentage of positive cells in the absence of stimulation but in a marked increase with 
stimulated cells. In the presence of heparin, a large percentage of the neutrophils suspended in 
serum or Hanks solution became positive regardless of whether or not :fibrinogen was added. 
The discrepancy between the percentage of positive cells found when stimulated cells were 
suspended in serum plus heparin (70 units/ml) or Hanks solution plus heparin (10 units/ml) 
can be attributed to the different concentrations of heparin added to the two solutions, a lower 




Entry of dye into neutrophils in NBT test 821 
Precipitation of fibrinogen by NBT 
Solutions of fibrinogen in Hanks solution with or without added EDTA, or plasma anti-
coagulated with EDT A, all yielded a precipitate after incubation with NBT. The precipitates 
were dissolved and subsequently formed clots upon the addition of thrombin, indicating the 
presence of fibrinogen. Immunoelectrophoresis of the redissolved precipitate from plasma 
showed that fibrinogen, identified by its electrophoretic mobility, formed the major protein 
component. A number of minor protein peaks were also seen. These probably result from 
entrapment of protein within the fibrinogen precipitate but could be due to precipitation of 
other proteins by NBT on a smaller scale than in the case of fibrinogen. 
TABLE 1. Effects of the addition of endotoxin and/or fibrinogen to cells suspended in autologous sera and 
various media. Results are expressed as the percentage (mean and range) of NBT-positive cells 
Suspending medium 
Additions Serum Serum Serum Hanics Hanics Hanks 
+EDTA +heparin solution solution+ solution+ 
Endotoxin Fibrinogen EDTA heparin 
0 (0-3) 0 (0-1) 10 (0-37) 0 (0) 1 (0-1) 1 (0-4) 
+ 1 (0-3) 0 (0-2) 38 (9-73) 1 (0-2) 0 (0-1) 12 (0-32) 
+ 2 (0-2) 8 (2- 121) 3 (0-7) 5 (0-10) 7 (0-11) 
+ + 14 (7-36) 30 (18-39) 16 (10-25) 28 (18-45) 50 (39- 58) 
No. of experiments 10 6 4 4 4 4 
Precipitation of heparin by NBT 
Numerous small precipitated particles could be seen on microscopy with both ordinary and 
polarized light after the addition of NBT to the solution of heparin. These particles developed 
a dark-blue colour upon reduction. 
Demonstration of N BT in the precipitates of fibrinogen and heparin 
Unreduced NBT was found to be freely dialysable across a cellulose membrane. After 
dialysis against water for 72 h the precipitates offibrinogen and heparin were incubated with a 
reducing solution. The development of a deep-blue coloration of these precipitates indicated 
the presence offormazan. Thus NBT was not dialysed off the precipitates. 
Effect of decreasing the concentration of NBT on the precipitation of fibrinogen and heparin and on 
the reduction of NBT by stimulated neutrophils 
In EDTA anticoagulated blood and plasma, concentrations of NBT greater than 0·05% 
caused almost total precipitation of fibrinogen and resulted in a significant percentage of 
stimulated neutrophils becoming NBT-positive. Concentrations of NBT of 0·025% or less 
resulted in little fibrinogen precipitation or NBT reduction by neutrophils. The critical con-
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centration of NBT necessary for reduction by a significant percentage of neutropruls and for 
marked fibrinogen precipitation was similar (Fig. 1). In heparinized plasma, NBT caused the 
precipitation of both fibrinogen and heparin. The precipitation of fibrinogen and heparin and 
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Flo. 1. Relationship between the percentage of NBT-positive neutrophils in blood anticoagulated 
with EDTA and stimulated with endotoxin (• , mean of five studies ± 1 SEM) and the percentage 
of 1 251-labelled fibrinogen precipitated from EDTA-treated plasma upon the addition of varying 
concentrations of dye (.i. , mean of duplicate values shown). 












No particulate matter could be detected on microscopic examination of the solution ofNBT 
after centrifugation at 30 000 gfor 16h. Use of this NBT solution did not decrease the percent-
age of NBT-positive neutrophils in stimulated blood when compared with solutions of NBT 
prepared in the standard manner. 
Electron-microscopic studies of leucocytes after exposure to N BT 
Membrane-bounded vacuoles, containing densely staining amorphous material, were found 
in the cytoplasm of a large proportion of the monocytes and neutropruls from blood exposed to 
both NBT and endotoxin. Similar amorphous less densely staining material was also seen both 
extracellularly and undergoing phagocytosis (Fig. 3). 
The neutrophils appeared swollen and their outer membranes were partially ruptured. The 
"' 
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FIG. 3. Stained electron micrograph of a neutrophil after exposure to NBT and endotoxin, showing 
membrane-lined vacuoles containing amorphous material (V), amorphous material outside the 
cell (A) and undergoing phagocytosis (P), nucleus (N) and outer membrane (M). Magnification 
X ]2 000. 
FIG. 4. Unstained electron micrograph of a neutrophil after exposure to NBT and endotoxin 
showing amorphous material outside the cell (A), amorphous material containing electron-dense 
particles within the cell (P), nucleus (N) and outer membrane (M). Magnification x J 2 000. 
(Facing p. 822) 
" 
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amorphous material was seen purely extracellularly in blood exposed to NBT alone but was not 
seen after exposure to endotoxin in the absence of NBT. Neither cellular swelling nor abnor-
malities in the outer membrane of neutrophils were found in cells that were not exposed to a 
combination of both endotoxin and NBT. Unstained sections showed the amorphous material 
to contain electron-dense, elongated, somewhat needle-shaped particles approximately 150- 500 
nm in length. These particles were most numerous when the amorphous material was within 
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Fm. 2. Relationship between the percentage of NBT-positive neutrophils from heparinized blood 
after endotoxin stimulation ( e , mean of five studies ± 1 SEM) and the precipitation of 125!-
labelJed fibrinogen (• ) and 35S-labelled heparin (• ) from heparinized plasma (individual 
experiments) upon the addition of varying concentrations of NBT. 
DISCUSSION 
The availability of a rapid indicator of bacterial infection has important clinical application. It 
gives direction to further lines of investigation and helps safeguard against indiscriminate 
therapeutic manoeuvres. An understanding of the mechanism of such a test delineates exactly 
what it is that is being measured and makes the interpretation of the results obtained more 
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logical. In order to investigate this a model system was used. This system is basically similar to 
the standard NBT test, but differs in that endotoxin was used as an artificial stimulus of neutro-
phil activity. 
The present study shows that NBT has a dual action. It causes the precipitation of a macro-
molecular complex, the nature of which depends upon the anticoagulant used. In the case of 
heparin, both heparin and fibrinogen are precipitated, whereas in the presence of EDTA, 
fibrinogen alone is precipitated. The cationic precipitation of heparin (Scott, 1968) and fibrino-
gen (Surgenor, 1952) have been described and although precipitation of these substances by 
NBT has not been investigated, this would seem a likely mechanism. The NBT could not 
be dialysed from the macromolecular precipitate and it is therefore either bound to or enmeshed 
within this precipitate. Phagocytosis of the precipitated material results in concomitant 
phagocytosis of dye which turns dark blue after intracellular reduction. The blue colour is 
easily seen under the light microscope and the cell containing it is labelled NBT-positive. 
The failure of NBT uptake and reduction by stimulated cells when the dye is presented to 
them in solution emphasizes the necessity for the phagocytosis of NBT in association with 
particulate matter. The phagocytosis of these complexes with their associated dye explains 
how the NBT enters the cell, and why the formazan 'granules' assume such bizarre formations 
within the cytoplasm. The neutrophils cluster around particulate matter, probably in attempted 
phagocytosis, and this clumping leads to difficulty in making accurate counts of positive cells 
in a blood smear. This is the main technical problem in the test of Park et al. (1968). NBT tends 
to crystallize out of solution in the concentrations in which it is used in the Park et al. (1968) test. 
Phagocytosis of NBT crystals is not a significant mode of entry of dye into neutrophils because 
significant NBT reduction does not occur in the control tests in the absence of heparin or 
fibrinogen and removal of these residual crystals by high-speed centrifugation does not 
decrease the number of neutrophils becoming NBT-positive. 
When the NBT test is performed on the blood of patients with bacterial infection a smaller 
percentage of the neutrophils become NBT-positive if EDTA is used as anticoagulant instead 
of heparin. This has been interpreted as resulting from complement inactivation by EDT A 
(Park & Good, 1970). The demonstration that the addition of ficoll to the NBT solution can 
reverse this effect (Gordon, Rowan, Brown & Carson, 1973), that a normal NBT response can 
be obtained in the blood of C6 (complement fraction)-deficient rabbits and C4-deficient 
guinea-pigs (A.W. Segal, unpublished work), and in cells suspended in a balanced salt solution, 
suggests that EDT A does not mediate its effect through complement inactivation. It is more 
likely that the nature of the precipitates presented to the neutrophils for phagocytosis deter-
mines the degree of dye reduction. 
Similarly, as washed cells can reduce NBT when suspended in Hanks solution in the presence 
of heparin, it is unlikely that soluble immunoglobulins are essential for NBT reduction. 
Although these experiments do not completely exclude the possibility that adsorbed immuno-
globulins play a role, in another study, using similar methods, it was found that in only four 
of twenty hypogammaglobulinaemic patients was a negative NBT test obtained after endotoxin 
stimulation in vitro. The reduction of NBT was unrelated to the pattern of immunoglobulin 
deficiency and occurred despite immeasurably low (less than 2 mg/100 ml) serum levels of 
lgG, lgA or lgM (immunoglobulins G, A and M respectively). When neutrophils from those 
patients in whom impaired NBT reduction was observed were suspended in normal plasma 
the deficient reduction was not corrected. Nor was NBT reduction decreased in normal cells 
•' 
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: 
suspended in their hypogammaglobulinaemic plasma (Segal & Webster, unpublished work). ;, 
These facts imply that the primary defect of NBT reduction by the neutrophils of hypo gamma- : 
globulinaemic patients is cellular rather than humeral. 
A positive NBT test depends upon enhanced phagocytic activity of neutrophils. This may : I• 
result from the presence of bacteria, or products thereof, in the peripheral circulation (Cohn & . Morse, 1960). The minimum concentration of E.coli endotoxin necessary to produce a positive ' . test in vitro in this model system is 1 ng/ml (Segal, unpublished work), which is in the con-
' centration range found in endotoxaemia in vivo (Levin, Poore, Zauber & Oser, 1970; McGill, 
• Porter & Kass, 1970). Circulating bacterial products could be the natural stimulus of phago-. cytosis that is demonstrated by a positive NBT test in patients with bacterial infection. The 
' percentage of positive cells never reaches 100% under any of the experimental circumstances f' .. 
investigated even when a large excess of endotoxin was used in vitro. This raises the possibility .. 
that there may be more than one functional population of neutrophils. 
~ 
The conversation of a neutrophil into an NBT-positive cell encompasses a wide spectrum 
of neutrophil function, from the ability to be stimulated to phagocytic activity, through 
phagocytosis, to reduction of the dye by functional intracellular reductase enzyme systems. 
Thus an in vitro stimulation test is a good screening test of normal neutrophil function, and 
quantitation of such a test has enabled the demonstration of partial defects of neutrophil 
function in a series of patients (Segal, unpublished work). 
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RE-EVALUATION OF NITROBLUE-
TETRAZOLIUM TEST 
A. W. SEGAL SHEILA F . TRUSTEY 
A. J. LEVI 
Divisions of Clinical Investigation and Hospital Infection, 
Northwick Park Hospital and Clinical Research 
Centre, Harrow HAI JUJ, Middlesex 
The nitroblue tetrazolium (N.B.T.) test Summary has been widely recognised as a useful 
method of distinguishing between pyogenic bacterial 
infection and other disease processes. This test, done 
by two different methods, has been re-evaluated on 
223 individuals including healthy controls and patients 
with a wide spectrum of disease. There was a wide 
overlap in the results obtained from controls, patients 
with pyogenic infection, and patients with other dis-
eases; and the test had no diagnostic relevance. The 
N.B.T. result in patients with pyogenic infection was 
found to correlate with the severity of the illness. 
There was poor agreement between the results 
obtained from the two methods used for the test. 
Significant observer error was found in interpretation 
of the results and this was related to observer experi-
ence. The test has not upheld its early promise as 
a simple accurate method of distinguishing bacterial 
infection from other disease processes. 
Introduction 
THE nitroblue tetrazolium (N.B.T.) test was devel-
oped in 1968 by Park et al.1 as a non-specific in-vitro 
diagnostic test for bacterial infection. Heparinised 
blood is incubated with a dilute solution of N.B.T., 
and the percentage of neutrophils containing deposits 
of dark-blue formazan, the reduced product of N.B.T., 
within their cytoplasm is counted. In patients with 
bacterial or fungal infections the percentage of neutro-
phils containing formazan, called N.B.T.-positive cells, 
was greater than 10 % ; in healthy controls and patients 
with non-pyogenic diseases the percentage of N.B.T.-
positive cells was less than 10 % . These findings have 
been confirmed in children 2•3 and adults,'- 5 and the 
list of diseases resulting in a positive test has been 
2 
expanded to include malaria 6 and helminthic 7 and 
Mycoplasma infections.8 Occasional false-negative 
results have been recorded, and these have been 
attributed to an inability of the neutrophils to respond 
to the stimulus of infection. To distinguish true and 
false-negative results an in-vitro stimulation test, 
using Escherichia coli endotoxin, was developed 9 to 
indicate the ability of neutrophils to respond to 
stimulation. 
One of the technical difficulties of the test, as 
described by Park, is the tendency of neutrophils to 
clump around particles, since shown to be precipi-
tated fibrinogen and heparin.10 This makes identifica-
tion and counting difficult. Clumping can be reduced 
by the use of ethylenediamine tetra-acetic acid 
(E.D.T.A.) instead of heparin as anticoagulant, but this 
reduces the sensitivity of the test; Gordon et al.11 
showed that the addition of the sucrose polymer 
' Ficoll ' to the incubation mixture prevented this 
loss of sensitivity and clumping of the cells. 
It thus appeared that a very powerful tool for the 
specific diagnosis of pyogenic infection had been 
developed and that a major technical difficulty in its 
application had been circumvented. 
False-negative tests on patients with major i,-u and 
with minor bacterial infections 15 and false-positives on 
patients with viral meningitis,18 neonates,17 recipients 
of oral contraceptives,18 and various disease pro-
cesses 3•13 have been recorded. 
We have attempted to clarify the value of the N.B.T. 
test as a diagnostic test of pyogenic infections, by doing 
it in two ways using modifications of the methods of 
Park et al. and of Gordon et al. on blood from 197 
patients with a wide spectrum of disease, and on 26 
healthy controls. The findings were correlated with 
the total white-blood-cell-count, neutrophil-count, 
erythrocyte-sedimentation rate (E.S.R.), and the serum 
concentration of C-reactive protein (C.R.P.). 
Patients, Controls, and Methods 
Patients and Controls 
The numbers, ages, sex, and classification of the 
patients and controls are shown in table 1. 
Group / .-Healthy hospital staff. 
Groups 2 and 3 .-Patients with pyogcnic infection. 
Those in group 3 had received antimicrobial chemo-
therapy at the time of the test; 4 patients had received 
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treatment for the remainder was 2·2 days. The criteria 
for inclusion of patients in these groups was the clinical 
diagnosis supported by either bacteriological identification 
of the organism, in 38 of the patients, the detection of 
significant quantities of pus in patients with abscesses, or 
the histological picture of acute suppuration in appendi-
citis. These patients were clinically subdivided into three 
grades of severity according to the systemic manifesta-
tions of the disease process. These were absent or mini-
mal in patients classified as grade 1, which included 
patients with small localised abscesses of postoperative 
wound sepsis. Grade-III patients were severely ill with 
infections of the order of severity of septicremia or liver 
abscess. Grade-II patients had illnesses of intermediate 
severity. 
Group 4.-Patients with bacteriologically proven active 
tuberculosis. 
Group 5.-Patients with non-bacterial infections: 1 
with hepatic schistosomiasis, 1 with massive ascaris 
infestation, and 19 with viral disease of whicb 16 were 
confirmed serologically; a clinical diagnosis was made in 
2 cases of rubella and in 1 of herpes zoster. 
Group 6.-Hospital patients with a diverse ran&e of 
non-infective diseases. 
Group 7 .-14 patients in whom bacterial infectiop. 
was suspected but not proven. 
2 patients were included in group 2 and in group 6. 
N.B.T. Tests 
Blood was taken by venepuncture into a disposable 
plastic syringe and 1 ·0 ml. was transferred to plastic 
test-tubes containing 0·05 ml. of a heparin solution con-
taining 1000 1.u. per ml. (50 1.u. per ml.) and 5·0 ml. to 
glass bottles containing 12 mg. of disodium E.D.T .A. solu-
tion (2·4 mg. per ml.). All tests were done immediately 
or within 1 hour of venepuncture after storage of blood 
samples at 4°C. 
For the test with heparinised blood, 0·2 ml. was incu-
bated at 37 °C for 10 minutes in a disposable plastic test-
tube (Luckham LP/ 3S). 0·2 ml. of a O· l % solution of 
N.B.T. (Sigma) in phosphate-buffered saline, pH 7·2, was 
then added. The mixture was gently shaken, then incuba-
ted at 37 °C for 15 minutes, then at room temperature 
( ± 25 ° C) for another 15 minutes. The sample was 
applied to glass slides by running a drop of the test mix-
ture down the slide as described by Wollman et al.19 
This method is here referred to as the heparin method. 
The E.D.T .A. blood was tested as above, except that the 
N.B.T. solution contained ficoll (Pharmacia, 200 mg. per 
ml.); the mixture was incubated at 37°C for 30 minutes 
and then at room temperature for 15 minutes; and the 











method is referred to as the E.D.T.A./ficoll method. 
Smears were air-dried and stained with Leishman's 
stain (British Drug Houses). 
Counting 
The smears were counted independently by three 
observers who did not know the patient details; one 
(observer 1) was very experienced (having previously 
counted 3000 such preparations), one was relatively 
experienced (observer 2), and the third had no previous 
experience with this test (observer 3). One hundred 
neutrophils were counted on each slide; cells containing 
formazan deposits at least the size of one lobe of the 
nucleus were recorded as N.B.T. positive and the percentage 
of N.B.T.-positive cells was designated as the "N.B.T. 
score". The 45 slides in which the greatest counting 
difference between the two more experienced observers was 
obtained were recounted by both observers to obtain an 
artificially correct result for comparison with other data. 
20 slides prepared by the heparin method and 20 
prepared by the E.D.T.A./ficoll method were randomly 
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7 
selected and recounted to assess the observer error. 
The scores obtained by observer 1, modified in the light 
of observer 2's results, were regarded as the test result for 
intergroup comparison and for relating to the other 
measurements. 
Other Investigations 
The cell-counts were performed on a Coulter counter 
model S. Blood-smears were examined by an experienced 
technician. The E.S.R.s were determined by the Wester-
gren method in disposable plastic tubes (' Dispette '). 
Serum-C.R.P. was measured by the radial immunodiffusion 
technique on ' Partagen' plates (Boehringer) on 18 
patients from groups 2 and 3 and 18 patients from 
group 6. 
Results 
The controls gave consistently low N.B.T. scores by 
the E.o.T.A./ficoll method. In all other groups there 
was considerable overlap of the N.B.T. scores (fig. 1). 
Consistently high scores were obtained in patients from 
group 6 with inflammatory bowel disease, erythema 
nodosum, myelofibrosis, and diabetic precoma. 
A comparison of the clinical assessment of severity 
of illness of patients in groups 2 and 3 with the N.B.T. 
scores showed an increased N.B.T. score with increas-
ing severity. This was more striking for the heparin 
than the E.D.T.A. / ficoll method (table II) . 
The total number of N.B.T.-positive neutrophils per 
c.mm. (i.e., N.B.T. score X neutrophil-count) showed 
even less group specificity than the N.B.T. score. 
Attempts at the separation of patients with bacterial 
infection from other groups by the use of nomograms 
constructed by Feigin et al.2 did not result in greater 
accuracy in the interpretation of the results of the 
N.B.T. tests. 
The discrepancies between duplicate counts tended 
to be smaller when the counts were themselves small, 
and to counteratt this the counts were transformed to 
angles before (Fisher and Yates, table X 20) analysis. 
In these units the error variances were 20·5 and 15·1, 
and 17-6 and 20·3 for counts performed by observers 
1 and 2 on slides prepared by the E.D.T.A./ficoll and 
heparin methods, respectively. The average variance 
is 18·4, corresponding in the original units to a stan-
dard deviation oi ±7·5% at a count of 50%. After 
allowing for coun~ing errors the correlation between 
observers 1 and 2 was very high (figs. 2 and 3), esti-
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Fl11, 2-E,D,T,A, lftcoll method: relation between duplicate 
count• obtained by two experienced obaervera, 
E,D.T,A./ficoll and heparin methods, respectively. 
Despite these close correlations there was an inter-
observer difference in the absolute results obtained, 
observer 1 consistently counting higher than observer 
2 on the preparations from the heparin tests. There 
was closer agreement of the counts performed on 
slides made by the E,D.T.A./ficoll method (figs. 2 and 
3). There was only a low correlation between the 
scores obtained from the two methods performed on 
the same individual (fig. 4). Using angular trans-
formations we made comparisons between the scores 
obtained by observer 1 and observer 3. The corre-
lation coefficients were 0·32 and 0·57, and 0·58, and 
0·53 for the first 100 and last 100 scores by the 
E.D.T.A, / ficoll and heparin methods, respectively. 
Thus the counting error of observer 3 is reduced 
with experience with regard to the E.D.T.A./ ficoll but 
not the heparin preparations. 
Comparisons were made between the N.B.T. score 
obtained by both methods of performing the test and 
the E.S.R., and white-blood-cell and neutrophil counts 
in the various groups. Group 4 was excluded because 
of small numbers. Apart from the correlation co-
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Fis, 4--Relation between the N.B.T. ,coreo obtained when the 
teot w .. done slmultaneou,ly on the oame individuals by the 
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2 between the heparin scores and the w.B.c. and 
neutrophil counts, respectively, there was no corre-
lation between the N.B.T. score and other variables. 
No correlation was obtained between the N.B.T. scores 
and the serum-c.R.P. concentration. 
Discussion 
To have broad clinical application a diagnostic test 
should give few false-negative or false-positive results. 
This is not our finding with the N.B.T. test. There 
was a wide overlap in the results from patients with 
pyogenic infection-whether or not antimicrobial 
treatment had commenced-in non-pyogenic infec-
tion, and in non-infective disease. In addition, a 
wide range of values was obtained in healthy controls 
when the test was done with heparinised blood. False-
positive tests were seen with inflammatory bowel dis-
ease, non-pulmonary tuberculosis, and, as previously 
described,13 in myelofibrosis. High results were also 
found in children with acute non-inflammatory dis-
eases such as acute bronchospasm, diabetic precoma, 
and paraffin inhalation. This finding, the false-
negative results in patients with localised sepsis, and 
the positive correlation between the N.B.T. score and 
the white-blood-cell and neutrophil counts in patients 
with untreated pyogenic infection suggests that the 
test may reflect an acutely stressful situation rather 
than its underlying cause. If so, false-negative results 
might be expected in critically ill patients with 
pyogenic infection, as has been recorded in fatal 
meningitis.13 Abnormalities of neutrophil function 
are known to occur in overwhelming infection,21 and 
the possibility that neutrophils become refractory to 
similar repetitive stimuli is being investigated. The 
presence of defective neutrophil function secondary 
to infection would account for the false-negative 
results recorded. by Park and Good, in which the 
"N.B.T. test stimulated" was found to be negative.9 
No such failure of stimulation was found by us when 
the test was done on the blood from SO healthy 
individuals. 
Immune complexes decrease N.B.T. reduction by 
neutrophils 22 and could cause the false-negative results 
obtained in systemic lupus erythematosus and 
meningococcal meningitis, both diseases in which 
circulating immune complexes are known to occur. 23 
Wollman et al.19 found the N.B.T. test to be useful in 





results being found in patients with rejection, whereas 
infected patients gave high results. It is possible 
that the low results obtained in the patients with 
the rejection phenomena were the more abnormal, 
resulting from a secondary abnormality of neutrophil 
function, induced by immune complexes, which 
inhibited the high N.B.T. result we have found in 
acutely ill patients. 
The difference between our results and those of 
other studies is difficult to explain. It may be partly 
due to different methods of patient selection, but the 
wide range of results found in healthy controls when 
the test is done on heparinised blood indicates that 
some other factor is involved. 
In many cases the two tests gave different results. 
This suggests a basic difference in the mechanism 
underlying the two tests. The dye enters stimulated 
neutrophils complexed with precipitated heparin and/ 
or fibrinogen,10 so the difference in the mechanism 
of the two tests is likely to lie in the interaction of 
neutrophils with these complexes. 
The counting error has not been previously com-
mented upon. The result recorded by any one 
observer is subjective and depends on the interpreta-
tion not only of the amount of formazan within a 
cell necessary to qualify the cell as N.B.T. positive, but 
also the interpretation of whether or not a cell is in 
fact a neutrophil; large deposits of formazan within 
a cell may make identification difficult. Taking into 
account the individual counting error and the sub-
jective nature of counting, observations that N.B.T. 
counts above 10 % are universally positive 5 seem 
unfounded. Our results also indicate that experience 
is important for an accurate assessment of the result 
and that the test is not suitable for irregular perform-
ance by untrained staff. 
The N.B.T. test is valuable in the investigation of 
neutrophil physiology and function and may be of 
value in specific clinical situations 19•2' and in monitor-
ing the clinical course of patients in whom the pre-
treatment status of the test is known.15•141 However, 
as a simple specific test for pyogenic infection in adults 
it docs not seem to have fulfilled its early promise 
because of the large overlap of results with those 
obtained in healthy people and in patients with dis-
eases other than pyogenic infection, both microbial 
and non-microbial, and because of the variation 
between the results of different observers. 
12 
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Short Communication 
• , NITROBLUE TETRAZOLIUM - A NEW LIPOPROTEIN STAIN 
A. W. SEGAL, D . PUTMAN AND H . G . MlNCHlN CLARKE 
Clinical Research Centre, Watford Road, Harrow, Middlesex, HAJ JUJ ( Great Britain) 
(Received June 4th, 1973) 
SUMMARY 
The di-formazan of nitroblue tetrazolium (NBT) is presented as a new, specific 
pre-stain for lipoproteins. NBT requires no organic solvent and is shown to be 
effective in agarose, cellulose acetate and polyacrylamide gel. When added in the 
correct concentrations, NBT does not appear to alter the electrophoretic migration 
or antigen antibody reaction of the lipoproteins. 
Key words: Disc electrophoresis - Laure/I electrophoresis - Lipoprotein pre-stain -
Monorocket immunoelectrophoresis - Nitroblue tetrazolium 
The lipoproteins, concerned with transport of fats and fat-soluble substances, 
may be separated and quantitated by ultracentrifugation but for clinical investigation 
the simpler, less expensive, electrophoretic separation techniques have been exploited. 
Accurate characterisation depends upon combining a separation technique 
giving good resolution with a sensitive indication of the various components. In this 
study it will be shown that the di-formazan of nitroblue tetrazolium (NBT), which 
needs no organic solvent, stains the lipoproteins a dark blue-purple colour. NBT, 
when added to serum samples prior to electrophoresis, gives satisfactorily stained 
lipoprotein bands or precipitates in each of the media tested and does not appear 
to alter the electrophoretic properties of the lipoproteins when added in the correct 
concentrations. 
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MATERIALS AND METHODS 
Blood samples from normal subjects were allowed to coagulate at room temper-
ature and electrophoresis of the separated serum was performed as soon as possible. 
To l ml of each serum was added 0.5 ml of a solution of NBT (Sigma) in water, in 
concentrations from 0.05 % to 0.80 % and 0.5 ml of an aqueous solution (10 mg/ml) 
of the reduced form of nicotinamide adenine dinucleotide (NADH (Boehringer). 
Unless otherwise described, a concentration of 0.15 % NBT was used. After gentle 
mixing, reduction of the NBT was brought about by the addition of approximately 
100 µg of solid phenazine methosulphate (B.D.H.). This will be referred to as a 
"pre-stained" sample. Unadulterated sera were used as control samples except in 
immunoelectrophoretic systems where the serum was diluted with an equal volume 
of physiological saline. 
The efficiency of reduced NBT as a pre-stain for Ii po proteins was tested onf our 
electrophoretic systems. In three, the pre-stained sample was run together with the 
control sample, the lipoproteins in the latter being stained with Sudan black (saturated 
solution in 60 % ethanol) after electrophoresis; in the case of the fourth, using poly-
acrylamide gel, the control sample was pre-stained with Sudan black. 
Conventional electrophoresis 
(a) on cellulose acetate (Millipore), 
(b) on agarose, using the "Agarosl ide system" (Millipore). 
In both these systems sera were pre-stained with concentrations of NBT from 
0.05 %-0.8 %. 
Antigen-antibody crossed electrophoresis (Laurell electrophoresis) 
Was performed according to Clarke and Freeman1 using anti-whole human 
serum (Burroughs Wellcome) . 
.. M onorocket" immunoelectrophoresis 
Was performed by the method of Laurell2 using anti-whole human serum 
(Burroughs Wellcome). 
Polyacrylamide disc electrophoresis 
The method used was reported by Frings et af.3. Twenty-five µI serum pre-
stained with Sudan black and 50 µl serum pre-stained with Sudan black and 50 µl 
se rum pre-stained with concentrations of NBT from 0.05 %-0.8 % were run simul-
taneously. The use of NBT as a pre-stain allowed the sample gel to be dispensed with 
and after the addition of a small amount of solid sucrose to the sample it was layered 
on the polymerised concentrating gel layer. 
RESULTS 
The addition of phenazine methosulphate to the serum sample containing NBT 
' ; 
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and NADH resulted in blue colouration of the mixture. The colouration developed 
within a few seconds and reached maximum intensity within 5 minutes. 
Conventional electrophoresis 
The pattern oflipoprotein separation was similar whether pre-stained with NBT 
or post-stained with Sudan black provided that the concentration of NBT did not 
exceed 0.15 %. The experimental time using NBT was reduced by the time necessary 
for staining the sample after electrophoresis; this time was approximately 120 minutes 
for both cellulose acetate and the Agaroslides. 
Antigen-antibody crossed electrophoresis 
Blue colouration was found in the precipitates previously identified as alpha-
and beta-lipoproteins (Fig. 1). The size, shape and position of the lipoprotein arcs 
did not differ appreciably from those produced when the control serum was run 





Fig. I. Laurell electrophoresis of serum pre-stained with nitroblue tetrazolium. 
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2 3 4 5 6 7 8 
Fig. 2. "Monorocket" electrophoresis of serum : samples 1-4 pre-stained with nitroblue tetrazolium; 
samples 5- 8 post-stained with Sudan black. 
"M onorocket" immunoelectrophoresis 
Repeated single volume samples, pre-stained with NBT in concentrations less 
than 0.15 %, resulted in rockets of constant height (standard error 0.16) which 
matched the rockets obtained from equal volumes of serum post-stained with Sudan 
black (Fig. 2). Increasing concentrations of NBT greater than 0. I 5 % resulted 111 a 
progressive reduction in the height of the rockets. 
Aery/amide disc electrophoresis 
Compared to Sudan black as a pre-stain, NBT gave a greater intensity of colour. 
The pre-beta and beta-lipoprotein bands were comparable in appearance but additio-
nal bands were demonstrated in the alpha region (Fig. 3). The absence of a sample 
gel layer did not affect reproduceability. 
DISCUSSION 
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(a) (b) (a) (b) (a) (b) 
·, - - ... 
Fig. 3. Disc electrophoresis of three normal sera pre-stained with (a) Sudan black and (b) nitroblue 
tetrazolium. 
substances with a specific affinity for the indicator. It allows observation of the pro-
gress of the electrophoretic migration, immediate interpretation of the separation 
and eliminates background staining. 
Although the mechanism is still uncertain, NBT has been shown by means of 
antigen-antibody crossed electrophoresis to be a specific pre-stain for lipoproteins. 
The pattern of staining in all but polyacrylamide gel is the same as that found after 
staining with conventional lipid stains and , in suitable concentrations, there is no 
evidence of interference with electrophoretic responses or antigen- antibody reactions . 
The additional alpha-bands on polyacrylamide may have become visible due to the 
intensity of the stain . 
The advantages of using NBT are clearly shown in the Millipore Agaroslide 
system. The electrophoresis time can be varied by direct observation of the migration 
of the lipoproteins and the lipoprotein pattern can be directly recorded by obtaining 
an immediate tracing from a densitometer. The entire process takes 30 minutes com-
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pared to 150 minutes necessary to obtain a result by the prescribed method. 
Pre-staining of serum with NBT should also simplify lipoprotein separation 
by column chromatography and high speed centrifugation as the lipid-rich fractions 
appear blue and could be localised spectrophotometrically utilising the absorbance of 
light by formazan at a wavelength of 580 nm. 
In the correct concentrations NBT causes intense pre-staining of lipoproteins 
without changing their electrophoretic or immunoelectrophoretic characterisation 
in the systems tested. It has the advantages of being inexpensive, rapid, simple to 
apply and active in the absence of organic solvents. In the rapidly expanding field 
of lipid research, with all its clinical applications, it is hoped that the introduction 
of NBT as a pre-stain will resolve some of the difficulties of lipoprotein characterisa-
tion. 
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